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ABSTRACT 
Background 
Internet interventions have the potential to provide self-management support to patients with 
type 2 diabetes. However, little is known about the adoption and use of internet interventions 
within routine healthcare by services and patients. Available data on the reach and use of such 
interventions has been collected in the context of research which may not generalise to routine 
practice. Implementation of e-health into healthcare settings is frequently described as 
challenging, and concerns about a digital divide are reported. 
 
Aim 
To employ implementation science methods to investigate the implementation of HeLP-
Diabetes, an internet based self-management intervention for people with type 2 diabetes into 
routine healthcare.  
 
Methods 
A theoretically informed implementation plan was developed and applied to the implementation 
of HeLP-Diabetes within routine healthcare. A mixed methods case study in one National Health 
Service (NHS) Clinical Commissioning Group evaluated the implementation. Data were 
collected to describe: the adoption and implementation by NHS services, uptake and use by 
patients, and barriers and facilitators to implementation and use.  
 
Results 
Adoption was high but relatively few NHS services actually implemented HeLP-Diabetes. 
Barriers included the current NHS context with limited time and resources to undertake the work 
of implementation and the prioritisation of incentivised tasks over HeLP-Diabetes. A wide range 
of patients registered to use HeLP-Diabetes including those with basic computer skills and no 
education. Over half of registered patients made some use of HeLP-Diabetes. Staff facilitation 
of access and the accessibility of HeLP-Diabetes promoted uptake and use.  
 
Conclusion 
In the context of diabetes self-management there seems to be good potential for internet based 
interventions. Staff facilitation of access has the potential to provide access to patients with 
lower education and basic computer skills. However, to become part of routine practice 
resources need to be allocated and the work has to be prioritised by staff.  
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GLOSSARY 
 
Adoption A decision to make full use of an innovation as the best course 
of action available. 
 
Assimilation 
 
In the organisational context adoption may also be referred to as 
assimilation. 
 
Complex intervention 
(intervention) 
 
Interventions with several interacting components 
Diffusion The process by which an innovation is communicated through 
certain channels over time among the members of a social 
system. 
 
Dissemination 
 
An active approach of spreading evidence-based interventions 
to the target audience via determined channels using planned 
strategies. 
 
Embedding 
 
The innovation becoming routinely incorporated in everyday 
work of individuals and groups. 
 
Implementation  
 
The active process of putting to use or integrating evidence-
based interventions within a setting. 
 
Innovation 
 
An idea, practice or object that is perceived as new by an 
individual or other unit of adoption. 
 
Normalization  
 
The point at which the innovation becomes so embedded into 
routine practice that it disappears from view. 
 
Routinized  
 
The innovation becoming an ongoing element in the 
organisations activities. 
 
Uptake  The action of taking up something that is available. 
 
Use The action of or making use of something that is available. 
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THESIS AIMS AND OBJECTIVES 
 
The aim of the research presented in this thesis was to employ implementation science 
methods to explore the implementation of HeLP-Diabetes, an internet based self-management 
intervention for people with type 2 diabetes into routine NHS care.  
 
Specific objectives were to: 
 Design a theoretically informed implementation plan that reflected best practice 
according to the available literature 
 Evaluate the effectiveness of the implementation plan, including identifying and 
describing barriers and facilitators to implementation 
 Identify modifications and improvements to the implementation plan in light of the 
barriers and facilitators identified 
 Draw generalizable inferences to inform future implementations of similar interventions 
in similar contexts.  
 
This PhD thesis explored the implementation of HeLP-Diabetes within the National Health 
Service (NHS). It provides data on what happens in practice, and what actions and resources 
are needed to successfully implement and realise the potential benefits of HeLP-Diabetes. To 
the best of my knowledge, no other research has addressed the implementation of an e-health 
initiative within routine care in as much detail or with as much intellectual rigour. As a result of 
the work in this thesis, HeLP-Diabetes is now the only International example (again, to the best 
of my knowledge) of an internet based self-management service for people with type 2 diabetes 
in use in routine healthcare. Five inter-related pieces of intellectual property contribute to this 
thesis. These are: 
 
 An update of a systematic review of reviews, with a new approach to data extraction, 
coding, analysis and synthesis;  
 The design of an implementation plan, based on my understanding of the theoretical 
and empirical literature; 
 A quantitative study, looking at adoption, uptake and use of HeLP-Diabetes by NHS 
services and patients;  
 A qualitative study, determining staff perspectives on the implementation of HeLP-
Diabetes; 
 A qualitative study, determining patient perspectives on reasons for observed use of 
HeLP-Diabetes.  
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THESIS STRUCTURE 
 
Chapter 1 presents background information on key areas pertinent to this thesis including, 
diabetes, self-management, e-health and implementation.  
 
Chapter 2 provides a description of the HeLP-Diabetes intervention including a description of its 
development and content. 
 
Chapter 3 presents a systematic review of the literature exploring factors that are important for 
the implementation of e-heath within health services.  
 
Chapter 4 discusses and describes implementation theories, frameworks and models. It 
provides a rationale for the selection of the framework and model selected to inform the 
development of a theoretically informed implementation plan to implement the HeLP-Diabetes 
intervention into routine practice. 
 
Chapter 5 describes the original, theoretically informed implementation plan, including details of 
how the selected theory and model where operationalised.  
 
Chapter 6 presents the mixed methods selected to evaluate the implementation plan. The 
specific research questions addressed with these methods were: 
 
 To what extent was HeLP-Diabetes adopted by NHS services? 
 To what extent was HeLP-Diabetes implemented within NHS services? 
 What was the uptake of HeLP-Diabetes by patients? 
 How was HeLP-Diabetes used by patients? 
 Were there any factors that predicted patient use of HeLP-Diabetes? 
 Were there any factors that predicted HeLP-Diabetes registration method?  
 What barriers and facilitators did staff identify to the adoption and implementation of 
HeLP-Diabetes by NHS services? 
 What barriers and facilitators did patients identify to the uptake and use of HeLP-
Diabetes? 
Chapter 7 describes the implementation plan that was actually implemented in the case study 
Clinical Commissioning Group (CCG). A description of the case study CCG (Islington), the 
changes that occurred to the original implementation plan and the final plan to implement HeLP-
Diabetes are described.  
 
Chapter 8 is the first of three results chapters. This chapter describes the adoption and 
implementation of HeLP-Diabetes by NHS services and the uptake and use of HeLP-Diabetes 
by patients.  
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Chapter 9 is the second of the three results chapters. It presents the results from interviews with 
staff, which explored the implementation of HeLP-Diabetes within practice and the barriers and 
facilitators to adoption and use.  
 
Chapter 10 is the third of three results chapters. It presents the results from interviews with 
patients, which explored the uptake and use of the HeLP-Diabetes intervention and barriers and 
facilitators to use.  
 
Chapter 11 brings together the findings of the results chapters (chapters 7, 8 and 9) and 
discusses them in relation to the literature. Overall methodological strengths and weaknesses 
are considered, together with implications for policy, research and future practice. 
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1 CHAPTER 1: BACKGROUND 
 
1.1 Chapter summary 
 
In this chapter key background information to the thesis is presented. Diabetes is a long term 
condition which, if poorly managed, can lead to a range of health complications which in turn 
may have a significant impact on quality and longevity of life. A description of this condition is 
presented in order to give the reader an understanding of the growing problems of diabetes 
faced by populations and health services and to set the scene for how a self-management 
intervention such as HeLP-Diabetes may support living with this condition. The concept of self-
management, the current dominant paradigm for managing long term conditions in many 
countries, is described in order to illustrate the work involved for patients in living with a long 
term condition and the potential of internet interventions to support this. The use of e-health is 
presented as a promising method for delivering and supporting healthcare. Given the focus of 
this thesis on implementation, background information on e-health, the adoption and 
assimilation of e-health interventions into healthcare and factors that have been found to 
influence individuals’ adoption and continued use of e-health are presented.  
 
1.2 Definitions 
Within this thesis many terms referring to the adoption and use of new innovations are used. 
One challenge in implementation research as a whole is the lack of standardised terminology 
which is partly explained by the numerous different fields of research that contribute to this 
research area (1), the variation in thinking in scientific circles and the range of policies that 
cover this subject (2). Rabin and colleagues attempted to clarify the most commonly used terms 
and their definitions by synthesising the most frequently cited manuscripts on dissemination and 
implementation research in health (1). These definitions along with other key definitions in the 
field are presented here to aid the reading and understanding of this thesis. A glossary of terms 
can be found on page 13 for reference.  
 
An innovation is “an idea, practice or object that is perceived as new by an individual or other 
unit of adoption” (3). Most innovations investigated in diffusion and implementation research 
have been technological innovations and the term ‘technology’ is often used in the literature as 
a synonym for innovation.  
 
Diffusion, a term coined by researcher Everett M. Rogers is described by him as: “The process 
by which an innovation is communicated through certain channels over time among the 
members of a social system” (3). In other definitions, diffusion is described as being at the 
beginning of a continuum characterised by the intensity of the approaches used to spread new 
innovations (4). The continuum ranges from ‘let it happen’ to ‘make it happen’ with diffusion 
being a process of ‘let it happen’ or a “passive, untargeted, unplanned, and uncontrolled spread 
of new interventions” (1).  
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Dissemination, “an active approach of spreading evidence-based interventions to the target 
audience via determined channels using planned strategies” (1) falls in the middle of diffusion 
and implementation on the continuum. It is a “planned and active process intended to increase 
the rate and level of adoption above which might have been achieved by diffusion alone” (4). 
 
At the other end of this continuum (‘make it happen’) is implementation which is described as 
“the process of putting to use or integrating evidence-based interventions within a setting” (1). 
Implementation encompasses all the activities that take place “between making an adoption 
commitment and the time that an innovation either becomes part of the organizational routine, 
ceases to be new, or is abandoned” (5). Implementation is a much more active process than 
diffusion and has been described as “dissemination plus action to actively encourage the 
adoption recommendations contained in a message” (6) 
 
Adoption is defined by Rogers as the “decision to make full use of the innovation as the best 
course of action available” (3). This definition applies to decisions at the individual level, 
however quite often, especially in healthcare settings, the adoption decision “to commit to and 
initiate an evidence-based intervention” (1) is a group or organisational one. In the 
organisational context adoption may also be referred to as ‘assimilation’ which highlights “the 
long and complex processes involved, with multiple decisions made by multiple agents” (4).  
 
The following terms are used to describe what may (or may not) happen to an innovation once a 
decision to adopt it has occurred. The innovation may be embedded into routine practice which 
refers to the innovation becoming “routinely incorporated in everyday work of individuals and 
groups” (7). It may become routinized which refers to the innovation becoming an “ongoing 
element in the organisations activities and [the point at which the innovation] loses its distinct 
identity” (4). Routinization is similar to the innovation becoming normalized which refers to the 
point at which the innovation “becomes so embedded into routine practice that it ‘disappears’ 
from view” (8). Innovations, once adopted, may also become rejected, denormalized or 
discontinued if they fail to bring about desired change or if they are replaced by newer, more 
advantageous innovations. 
 
1.3 Diabetes 
The focus of this thesis is on the implementation of a self-management intervention for people 
with type 2 diabetes within the NHS. Diabetes mellitus (diabetes) is one of the most prevalent 
long term conditions globally, with current estimates suggesting that 347 million people 
worldwide have diabetes (9) and the WHO predict that by 2030 diabetes will be the 7th leading 
cause of death worldwide (10). In England, approximately 4.5% of the population are affected 
by diabetes (11), however, there are also an estimated 822,000 people aged 16 and over in 
England who have diabetes but have not yet been diagnosed which increases prevalence 
estimates to 7.4% of the population (12). In real terms these statistics equate to more than 400 
adults in England being diagnosed with diabetes every day (11). Diabetes poses a tangible 
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threat to the health of the nation. In 2004, an estimated 3.4 million people globally died from 
consequences of high fasting blood sugar (13) and this figure is set to increase.  
 
Diabetes is a long term disorder of metabolism, resulting from a diminished ability to use insulin 
and / or defective insulin secretion (14). According to the International Classification of Diseases 
there are several different forms of diabetes (15). Diabetes is not a single condition; rather there 
are different types with differences in pathophysiology, presentations and treatments (16). All 
however, are characterised by a raised blood glucose level (17). The most predominant types of 
diabetes are type 1 diabetes mellitus and type 2 diabetes mellitus (16). Type 2 diabetes is the 
most common type of diabetes globally, representing 85-90% of all diabetes cases in the UK 
and its prevalence is increasing across all groups, including children and young people, and 
particularly among black and minority ethnic groups (17). It is characterized by disorders of 
insulin action and insulin secretion, either of which may be the predominant feature. The exact 
cause is not fully understood although it is believed there are probably several different 
mechanisms which result in this form of diabetes (14).  
 
Significant inequalities exist in the risk of developing type 2 diabetes. Its frequency varies in 
different racial and ethnic subgroups. In the UK it is up to six times more common in people of 
South Asian descent and three times more common in those of African and African Caribbean 
descent compared with the white population. It is also more common in people of Chinese 
descent and other non-white groups (17). It is often associated with strong familial, likely genetic 
predisposition, however, the genetics of this form of diabetes are complex and not clearly 
defined (14). There are also links between type 2 diabetes and socio-economic status with 
diabetes more prevalent among less affluent populations in the UK. Those in the most deprived 
fifth of the population are one-and-a-half times more likely than average to have diabetes at any 
given age (17). The majority of patients with type 2 diabetes are obese; those who are not 
obese by traditional weight criteria may have an increased percentage of body fat distributed 
predominantly in the abdominal region (14). The risk increases with age; type 2 diabetes is most 
commonly diagnosed in adults over the age of 40, although increasingly it is appearing in young 
people and young adults (17). 
 
The long–term effects of diabetes mellitus are generally categorised as microvascular and 
macrovascular, referring to the damage it can cause to small and large blood vessels 
respectively. Microvascular complications include; retinopathy (disease of the retina of the eye) 
with potential blindness; nephropathy (kidney damage or disease) that may lead to renal 
(kidney) failure; neuropathy (nerve damage); neuropathic arthropathy (bone and joint changes); 
and, sexual dysfunction. Macrovascular complications include; cardiovascular, peripheral 
vascular and cerebrovascular disease (14) which can lead to heart attacks, stroke and 
circulation problems. People with diabetes are also at risk of mental health problems, including 
depression and eating disorders (17). 
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In addition to the potential impact on physical and mental health, diabetes can also result in 
significant financial burden. It is estimated that people with diabetes in the UK are spending 
around £500m per year on coping with their condition due to missing work, the cost of travel for 
medical treatment, and, loss of employment or early retirement because of ill health (18). The 
presence of diabetes related complications increases personal expenditure three-fold, and 
doubles the chance of needing a carer. As well as personal cost, the financial burden of 
diabetes to health services is great. As diabetes increases globally so does the need to provide 
health services to meet the needs of people with the condition. As such, associated costs have 
risen, particularly those related to the treatment of complications (19). The Department of Health 
(20) report that diabetes related spending accounts for between 5% and 10% of the total health 
budget in England, with the total direct cost of diabetes in the UK estimated at £13.8 billion 
annually with a spend of £3,717 per person with type 2 diabetes (19). 
 
As discussed, type 2 diabetes can have a major impact on the physical, psychological and 
material well-being of individuals as well as being a serious financial burden to health services. 
Management of type 2 diabetes is complex; it requires lifelong attention to lifestyle routines, 
particularly adjustments to diet and physical activity patterns, self-monitoring of blood glucose, 
medication management, and attendance at numerous screening tests and appointments to 
monitor for complications associated with having diabetes. However, evidence shows that with 
successful management life expectancy can increase and the risk of complications can 
decrease (17). Meeting the demands of successful management requires support from a team 
of healthcare professionals, although as most management tasks occur on a daily basis and 
health services often struggle to give the recommended level of diabetes care within the 
constraints of time limited appointments (21), responsibility for management lies primarily with 
the individual with diabetes.  
 
1.4 Self-management 
Traditionally, healthcare systems dealt predominantly with acute illness and the role of the 
healthcare professional was to diagnose and treat. This traditional model of care is not well 
suited to long term conditions as the emphasis shifts from treatment to management. An ageing 
population, increased sedentary lifestyles and the successful treatment of many acute 
conditions have made long term illness the main challenge to Western 21
st
 Century healthcare 
systems (22). In managing a long term illness, the role of the healthcare provider becomes that 
of teacher and partner (23) and the responsibility is placed on the patient to care for themselves 
on a daily basis. The Chronic Care Model developed in the 1990’s and based on literature of 
strategies to manage chronic conditions (24), emphasised the role of the patient in the care of 
long term illnesses, with self-management the cornerstone of this.  
 
Self-management has been defined by Barlow and colleagues as “the individual’s ability to 
manage the symptoms, treatment, physical and psychosocial consequences and lifestyle 
changes inherent in living with a chronic condition”. Barlow further states that self-management 
also incorporates the psychological and social management of living with a chronic condition 
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and encompasses the “ability to monitor one’s condition and to effect the cognitive, behavioural 
and emotional responses necessary to maintain a satisfactory quality of life” (25). 
 
Self-management in long term illness has been conceptualised by Corbin and Strauss as the 
“work” involved in living with a long term condition (26). From qualitative work with patients with 
long term conditions they identified three major tasks that people living with a long term 
condition must undertake: medical and behavioural management; role management; and, 
emotional management. For people living with diabetes, medical management may relate to 
tasks such as; taking medications; attending appointments; and modifying behaviours around 
eating and physical activity. Role management may involve learning to adjust to the ‘patient’ 
role, managing the impact of diabetes on relationships with others, and adjusting to the 
disruption of one’s biographical narrative. Emotional management involves learning to manage 
the emotions associated with having a long term condition such as anger, fear, frustration, and 
depression.  
 
In order to achieve the tasks required for successful self-management of a long term condition, 
patients need to acquire the necessary skills. A common classification in the literature of the 
core self-management skills needed to achieve successful self-management comes from Lorig 
and Holman (23) who describe the five core self-management skills as: problem solving, 
decision making, resource utilization, forming of a patient/healthcare provider partnership, and 
taking action. These skills describe the medical, behavioural and role management aspect of 
self-management but skills to deal with the emotional burden of a long term illness are also 
needed. In the UK, current policy states that people with diabetes should be offered access to 
educational programmes which teach the skills necessary for self-management. Diabetes self-
management education (DSME) in which the knowledge and skills necessary for self-
management are taught, has been found to have beneficial effects on health and psychosocial 
outcomes (27, 28), including reducing the risk of diabetes related complications developing (29) 
and improving patient glycaemic control in the short term (30). DSME programmes are thought 
to work by changing patients’ knowledge and attitudes, and the role of self-efficacy in achieving 
desired self-care behaviours is becoming increasingly recognised (31).  
 
DSME programmes are widely used in the UK. The National Institute for Health and Care 
Excellence (NICE) recommend structured education at diagnosis with annual reinforcement for 
all people with type 2 diabetes. Current diabetes education programmes offered through the 
NHS include; the diabetes education and self-management for ongoing and newly diagnosed 
(DESMOND) programme for people with newly diagnosed type 2 diabetes (32); the 'Diabetes X-
PERT Programme' (33) for people with type 2 diabetes; and the dose adjustment for normal 
eating (DAFNE) for people with type 1 diabetes (34). Despite being recommended by NICE and 
free for patients to attend in the UK, uptake of such educational programmes is low. Only 5.3% 
of those newly diagnosed with type 2 diabetes in England were recorded as having attended 
structured education in the National Diabetes Audit published in 2016 (35). 
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Non-uptake of DSME by patients is associated with poorer health outcomes (36) and as these 
programmes are of considerable cost to the NHS (37), non-uptake by patients reduces the cost-
effectiveness for health services. The reasons for DSME non-attendance among patients with 
type 2 diabetes are not well understood and this represents an understudied research area (37). 
Depression, self-efficacy and readiness to change may influence self-management in general 
(38), however, little research has been conducted into the reasons for non-attendance at DSME 
when it is made available as part of routine diabetes care. The predominant mode of delivery of 
DSME in the UK is through group based sessions and several qualitative studies with non-
attenders at group based DSME report that barriers include: healthcare professional factors (a 
lack of information about DSME from healthcare professionals, lack of healthcare professional 
support for attendance, satisfaction with current care); cognitive factors (patients not perceiving 
the benefit of attendance, the timing of the referral with patients not feeling ready to attend, 
satisfaction with current knowledge and current diabetes management activities); emotional 
factors (shame and stigma of diabetes); health factors (absence of diabetes complications and 
comorbidity impeding attendance, feeling well or not feeling sick enough, low perceived concern 
for the disease); accessibility factors (being unable to take time off work or unable to afford time 
off work, being unable to attend because of caring responsibilities, transportation or distance 
difficulties); mode of delivery factors (a dislike of groups, a preference for alternative sources of 
help, particularly the internet) (36, 37, 39-41). Associations between female gender, non-
smoking status and better glycaemic control and attendance at structured education have been 
reported, as have associations between performance of general practices on diabetes clinical 
outcomes and attendance at education (42). Several studies of patient reported barriers to 
attendance at diabetes education also suggest that healthcare professionals may play an 
important role in patient attendance (37, 40-42).  
With NHS resources unlikely to increase for such education and the poor referral and uptake of 
existing programmes there is an urgent need for new cost effective ways of delivering self-
management education which are acceptable to patients and healthcare professionals.  
 
1.5 e-health 
e-health, defined as ‘the use of emerging information and communications technology, 
especially the Internet, to improve or enable health and healthcare’ (43), is providing new, 
promising and potentially cost effective ways for delivering healthcare to patients. 
 
This broad definition of e-health encompasses other terms often used to describe the 
application of information, computer, or communication technology to some aspect of health or 
healthcare. These other terms include; medical informatics, consumer health informatics, public 
health informatics, telemedicine, telehealth, and interactive health communication. Specific 
examples of e-health technologies becoming widely used include; management systems, such 
as the electronic health records (EHR) that allow the acquisition, transmission and storage of 
patient data; computerised decision support systems including diagnostic support, alerts and 
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reminder systems; communication systems such as telecommunication that act as an 
intermediary between users; and information resources such as the internet.  
 
In industrialised countries the use of the internet is rapidly growing. One of the most common 
reasons that people use the internet is to access information about health (44). In the first 
quarter of 2015, 86% of adults (44.7 million) in the UK had used the internet in the last three 
months and 49% reported using the internet to look for health related information, up from 18% 
in 2007 (45). An abundance of health related websites exist and entering the search terms 
‘health information’ into Google returns approximately 344,000,000 results (as of 05.05.2016). 
As spending on health continues to rise, many governments and medical health agencies, such 
as the NHS, are also using the internet as a cost effective way to distribute health information 
(46). The interactive nature of the internet, combined with the potential to store large volumes of 
information, provides a unique opportunity to offer high-quality interactive evidence-based 
information to consumers (47) . 
Health consumers are accessing internet based health information for a number of reasons 
including to: educate themselves; gather information before visiting a doctor; gain a second 
opinion; become more actively involved in decisions relating to their health; inform lifestyle 
choices and to participate in virtual healthcare activities (48). Consumers access health 
information in a number of ways including searching directly, by participating in online support 
groups and by consulting with healthcare professionals online (49). The Pew Social Life survey 
(44) reported that 27% of internet users have tracked their weight, diet, exercise routine or 
some other health indicators or symptoms online; 6% have posted comments, questions or 
information about health or medical issues online; 4% have posted a review of a doctor and 3% 
have posted a review of a hospital. 
 
From the inception of the internet healthcare has thought to be a ‘major potential beneficiary’ 
(50). Benefits of the internet in the healthcare setting may include: enabling more informed 
decision making; remote consultations; and more accessible, convenient and efficient service 
delivery. Studies have shown that accessing online health information can have significant 
effects on consumer health behaviours and interactions between patients and healthcare 
providers with internet users more likely to ask more detailed questions, make self-diagnoses, 
or ask for specific treatments (47, 51, 52). The internet has the potential to be empowering for 
health consumers and may be particularly beneficial for those with long term conditions as 
interactive components, such as self-assessment tools, permit the provision of personalized 
tailored information to users and provide decision support, peer support, and behaviour change 
support (47). One in four internet users living with high blood pressure, diabetes, heart 
conditions, lung conditions, cancer, or some other long term ailment say they have used the 
internet as a form of peer support by finding others with similar health concerns (53). 
 
The use of new information and communication technologies to improve health and healthcare 
is now a central part of NHS policy (54) and NHS Choices is already delivering a number of 
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websites to patients, although many of these have yet to be evaluated. The internet offers huge 
potential for delivering public health interventions (55) offering convenience, accessibility, and 
anonymity as well as potential cost effectiveness in delivering education to large numbers of 
people.  
 
Although the current evidence on the use of new technology in diabetes care is still evolving, 
positive effects of such interventions have been demonstrated in several studies. A Cochrane 
systematic review of interactive healthcare applications looked at 24 randomised controlled 
trials in a range of long term diseases including diabetes. It found mostly positive effects, with 
users tending to become more knowledgeable, feel better supported, with possible improved 
behavioural and clinical outcomes compared with non-users (56). Another systematic review 
produced a narrative report of interactive computer-assisted technology in diabetes care (57). It 
identiﬁed 14 studies that looked at HbA1c levels (a measure of glucose metabolism which 
reflects average blood glucose levels over six to eight weeks) and found that 6 of the 14 studies 
demonstrated signiﬁcant improvements in HbA1c. Evidence from a systematic review of 16 
randomised control trials suggests internet-based self-management programmes for people 
with type 2 diabetes can improve HbA1c (58), but that this positive effect may decrease over 
time. This is similar to the effect of more traditional group-based self-management education 
which also shows a similar decline in improved HbA1c over time (28, 59, 60). The American 
Diabetes Association’s standards for self-management education recognise the need for both 
initial training and subsequent on-going support to try and maintain the benefits of educational 
interventions (61), something the internet is suited to do. 
 
As well as improving HbA1c, internet based interventions for type 2 diabetes have been shown 
to have the potential to improve, behavioural, psychological, emotional, and psychosocial 
outcomes. Systematic reviews have reported improvements in, healthcare utilisation, physical 
activity, dietary changes, medication use, smoking, knowledge, self-efficacy, stress, diabetes 
distress, psychological well-being and communication (57, 62-65). Internet-based interventions 
are ideally suited to providing ongoing self-management support that could promote sustained 
improvements and long term improvements in outcomes.  
     
Despite the potential of the internet to deliver accessible, convenient and anonymous DSME to 
patients, and to address some of the identified barriers to group based education (38, 39), an 
area of concern for delivering DSME through the internet is the issue of the digital divide. The 
digital divide refers to the gap between those who have access to information technologies such 
as the internet and those who do not (66). For people with diabetes, it is often those who 
experience the burden of diabetes the most who are also most likely to lack access to the 
internet, as older age, lower educational status and income are negative predictors of diabetes 
outcomes and internet use (62). However, a study to explore engagement with an internet 
DSME intervention indicated that patients with a variety of education, age, income levels, ethnic 
backgrounds, socio-demographic, psychosocial, and clinical characteristics were able to use the 
intervention. Moreover, older, ethnic minority patients as well as those with a higher risk of 
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diabetes complications, lower health literacy, and little experience of computers were equally as 
engaged with the intervention (38).  
 
Although research has been conducted to establish that internet DSME interventions can be 
beneficial for people with type 2 diabetes; less is known about how they are perceived and used 
by patients. Internet interventions show promise in meeting many of the barriers that have been 
identified to patient attendance at group based DSME, and evidence demonstrates that they 
can impact positively on patient outcomes. However, the majority of research into internet 
interventions for self-management has been undertaken in controlled research with a focus on 
the efficacy outcomes of the intervention. What is lacking from the literature is an insight into 
patients’ experiences of using internet interventions that gauges whether these interventions 
meet user needs of people with type 2 diabetes. If internet interventions are to become part of 
routine care for people with type 2 diabetes, as an alternative or adjunct to group based DSME, 
it is particularly important to understand how these interventions are perceived and used by 
patients as patient uptake, use, and attrition become of central importance in order for the 
potential benefits to be realised. Low levels of engagement with and attrition (discontinued 
usage) from internet interventions in general is common (38), suggesting that users may not 
use them as intended (55, 67). This may be particularly true when interventions are 
implemented into ‘real life’ settings where there are complex, unmotivated patients; practitioners 
who have many competing demands; and systems which have few resources (68).  
 
1.6 Patient engagement with e-health  
In order to actualise the potential of e-health interventions, intended users must engage with 
them. Studies of e-health interventions often report that the frequency and intensity of 
intervention use is important in achieving desired outcomes (68, 69). Understanding factors that 
influence user engagement with e-health interventions is therefore an important consideration 
for those developing and implementing e-health. A systematic literature review of factors that 
influence public engagement with e-health, (including health information on the internet; custom 
made online information such as kiosks and CDs; online support and telehealth) (70) suggests 
that socio-demographic characteristics (including; age, ethnicity economic status, educational 
attainment and literacy levels); interest in one’s health; openness to experience and; belief in 
the efficacy and trustworthiness of information, are important factors in e-health use. 
Technological issues such as: access to computers, internet connection, support in using the 
technologies, accuracy of information, and security and privacy concerns, also proved 
important. Characteristics of the e-health services including: the content of the information, the 
way the information is delivered, anonymity and trustworthiness, influenced use as did the ease 
of use of a system, usability, and fit with everyday life (cost and time). Social aspects of e-health 
proved important for users including the ability to connect with others (peers and professionals) 
and share experiences. However, one study reported in the review found that online support 
was not always received favourably, with the sharing of experiences and receiving alternative 
points of view a barrier to on-going participation in a support group.  
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The above factors have been found to influence whether users will engage with e-health. 
Another important issue, particularly for internet interventions, concerns factors that keep users 
coming back. Many research studies of e-health interventions have reported that participants’ 
use of the interventions decrease over time (68, 71, 72). Eysenbach (67) labels this phenomena 
as the ‘law of attrition’, and states that the law of attrition is one of the “fundamental 
characteristics” of e-health applications. He describes the usage patterns of e-health in research 
studies as a curve; at the beginning participants have agreed to adopt the intervention as part of 
the study and therefore usage is high, but over time participants discontinue their use or drop 
out of the research study all together. He cites losing interest as the underlying variable to 
explain this curve. Several strategies have been proposed to protect against attrition including 
the use of push reminders; incentive programmes; self-monitoring systems; tailored messaging; 
and social networking (55). A systematic review of factors that promote engagement with 
interactive internet-based interventions for long term illness self-management (73) found that 
interventions with the lowest attrition rates (ranging from between 0% to 8%) included features 
such as tailored information, professional feedback, social networking, dynamic content (new 
content added weekly), rewards for logging in, the function to add self-monitoring data and the 
ability to make contact with a healthcare professional.  
 
Much has been written of the potential of e-health to improve medical practices. E-health may 
improve healthcare through assisting decision-making processes by facilitating access to 
guidelines; simplifying the prescription of diagnostic procedures; producing alerts and 
reminders; producing lower rates of medication errors and preventing adverse drug events; 
increasing productivity among professionals; and, lowering costs (74-81). In order to actualise 
this potential within healthcare systems, the adoption and use of e-health by healthcare 
professionals is pivotal. In particular, General Practitioners (hereafter GPs), because of their 
links to all tiers of the healthcare system, and between healthcare and social care have been 
described as being potential catalysts or bottlenecks for e-health innovation (82).  
 
A survey of over 9000 GPs was conducted in 31 countries (including 27 EU countries) to 
measure e-health availability and adoption (82). The findings suggest that the use of basic e-
health by GPs is now universal, however, there is still much more progress needed in providing 
access to, and promoting use of, more complex e-health systems. For example, internet use by 
GPs is now widespread, with 97% of all GPs surveyed reporting having access to and using the 
internet in consultations. However, figures for GPs access to advanced internet based 
technologies such as mobile devices (including smartphones, laptops and tablets), broadband, 
and high-speed internet are not as impressive: 13%, 65% and 9% respectively. This study 
suggested that in the UK there are variable rates of adoption and use of e-health by GPs. Whilst 
99% (n=482) of GPs from the UK (surveyed between November 2012 and March 2013) stated 
that they used aspects of the electronic health record (EHR), availability (43%) and use (21%) of 
telemedicine and health information exchange (HIE) technologies were much lower. In the 
qualitative data from this report, GPs highlighted the main barriers to adoption as financial, 
concerns about security, lack of regulatory frameworks and strains on the doctor-patient 
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relationship. The most important impact of e-health adoption that GPs hoped for was the 
possibility to access structured and up to date clinical data. They were more sceptical about the 
possibility of e-health increasing efficiency or enhancing doctor-patient relationships. Issues of 
barriers and facilitators to the adoption and use of e-health by health services and healthcare 
professionals are explored in depth in Chapter 3.  
 
1.7 Evaluating and implementing e-health 
 
Many e-health interventions have been studied in the context of randomized controlled trials 
(RCTs), which are designed as experiments with high internal validity - the ability to determine 
cause-effect relationships. The same characteristics that contribute to the high internal validity 
of a trial (well-defined inclusion and exclusion criteria, blinding, controlled environment) can 
potentially hamper its external validity, the ability to generalize the results in an extended 
population and clinical setting (83). As such the need for high-quality, widely applicable 
evidence is gaining momentum, especially amidst health care policy makers (84-86).  The 
increased costs of interventions and health care in a resource-limited environment have fuelled 
the demand for clinically effective and applicable evidence and over the last several years, there 
has been a substantial movement toward practical, pragmatic implementation research that will 
translate into usable health-related policies, programs and practices (87). 
 
Implementation science is a relatively new field which is concerned with “the scientific study of 
methods to promote the systematic uptake of research findings and other evidence-based 
practices into routine practice” (88). It seeks to understand the behaviour of healthcare 
professionals and other stakeholders as a key variable in the sustainable uptake, adoption, and 
implementation of evidence-based interventions. The study of implementing innovations into 
routine practice is a growing area of interest; the Medical Research Council framework (89) 
recommends that the implementation of interventions should be considered from the early 
stages of intervention development and researched alongside the efficacy of interventions. A 
continuum of implementation research in healthcare with certain research activities being 
implementation-light and others implementation heavy has been proposed (90).  
 
Pragmatic trials fall in the middle of this continuum and seek to provide proof of implementation 
and are designed to increase the generalisability of findings from trials. In contrast to 
explanatory trials which seek to address the question if and how an intervention works (and are 
situated towards the implementation light end of the continuum), pragmatic trials seek to 
address whether an intervention actually works in real life (83). Explanatory trials are 
undertaken in an idealised setting to give the innovation under evaluation the best chance of 
demonstrating beneficial effect whereas pragmatic trials are undertaken in ‘real world’ settings 
where the innovation is intended to be used and aim to maximise the applicability of the 
intervention to usual care (91). The PRECIS-2 tool (91) highlights specific domains which are 
likely to vary depending on where a trial falls on the continuum between ‘explanatory’ or 
‘pragmatic’ and include participant eligibility criteria, recruitment, setting, flexibility in delivery 
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and adherence, follow up and outcomes, with pragmatic trials reflecting a closer match between 
trial and usual care than explanatory trials. 
 
Problems with implementing evidence based interventions, even ones that have been positively 
evaluated in pragmatic trials, are reported widely in the literature (92). Many promising health 
interventions, when implemented, fail to achieve their maximum potential and/or reach those 
most in need (92). Even in the most pragmatic trials the constraints required to achieve internal 
validity may affect external validity (93).  For example, often pragmatic trials rely 
on controlling/ensuring the delivery of the clinical intervention, albeit in a less restrictive setting 
(94) and targets for recruitment must still be met in order to produce robust statistical outcomes. 
As such, other types of implementation studies at the implementation-heavy end of the 
implementation research continuum may be particularly useful to better understand 
implementation successes and failures, informing scale-up of interventions, informing how to 
integrate interventions into health systems and to make interventions sustainable (90). Study 
designs at this end of the continuum include mixed methods and quasi-experimental studies to 
determine the changes in delivery or acceptability of an intervention, cluster RCTs to evaluate 
the effects of implementation strategies and observational studies on adaptation, learning, and 
scaling-up of interventions. Studies of this type are used to explore implementation related 
barriers and facilitators to routine use and sustainability of “effective” practices, test 
implementation strategies to support uptake of interventions in routine practice and focuses on 
the adoption or uptake of clinical interventions by providers and/or systems of care (2, 95, 96).  
These studies are likely to add valuable data to that provided by pragmatic trials which will be 
necessary for commissioners of care.  By identifying the barriers and facilitators and trying to 
address them in the design of strategies, implementation research of this type increases the 
chances of producing positive outcomes and can help to; map the political and institutional 
context in which policies will be implemented, identify barriers to implementation and the 
determinants which prevent effective access to interventions, develop practical solutions and 
monitor and evaluate new implementation strategies, introduce evidence-informed 
implementation strategies in health systems and facilitate full scale implementation (92).  
1.8 Summary 
Diabetes is a long term condition which, if poorly managed, can lead to a range of health 
complications which in turn may have a significant impact on quality and longevity of life. Self-
management is the current dominant paradigm for managing type 2 diabetes in many countries 
and internet interventions have great potential to support patients in this. The research in this 
thesis will use a case study design to explore the implementation of HeLP-Diabetes, an online 
self-management programme for people with type 2 diabetes within routine NHS care. The 
focus is on evaluating the implementation, including the uptake and use by services and 
patients and will provide an assessment of barriers and facilitators to use. Research of this kind 
has the potential to characterise population based reach and adoption of internet based 
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interventions designed to be delivered through health services. The next chapter presents the 
HeLP-Diabetes intervention.  
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2 CHAPTER 2: THE HELP-DIABETES INTERVENTION 
 
2.1 Chapter summary 
Although the development of the HeLP-Diabetes intervention is not the focus of this thesis, this 
chapter briefly describes the theoretical underpinning and the development process as well as 
giving an overview of the content of the intervention in order to provide context to the thesis. 
 
2.2 Grant and team  
As part of a National Institute for Health Research (NIHR) grant (Grant Reference Number RP-
PG-0609-10135), I was part of a team of researchers and general practitioners (GPs), with 
support and input from; psychologists, dieticians, consultants, nurses and patients with type 2 
diabetes who developed an internet based self-management programme for people with type 2 
diabetes; HeLP- Diabetes (which stands for: Healthy Living for People with Diabetes). My role in 
developing HeLP-Diabetes included writing content, creating video content, assisting with the 
design, managing the Web Designer and facilitating the collaborative design with patients with 
type 2 diabetes.  
 
2.3 Theoretical underpinnings 
The Medical Research Council, in their guidance on developing complex interventions (89), 
recommends that development, evaluation and implementation of healthcare interventions 
requires a strong theoretical foundation. The HeLP-Diabetes intervention was informed by 
several theories described briefly below. 
 
Corbin and Strauss’ theory of the work involved in living with a chronic condition (26), provided a 
guide to the nature of the content of HeLP-Diabetes. As described in Chapter 1, this model 
states that patients living with long term conditions face three tasks: medical management; 
emotional management; and role management. The three tasks outlined by this theory guided 
the content of HeLP-Diabetes. 
 
Individual theories of behaviour change underpinned the behaviour change tools in HeLP-
Diabetes; and Normalisation Process Theory (NPT) (7, 97), which offers an explanatory 
framework of why interventions work in practice (or fail to) was also drawn upon. Qualitative 
development work including focus groups and interviews with staff and patients was guided by 
NPT in order to determine the needs and preferences of these key stakeholders with regard to 
an internet-based self-management programme for type two 2 diabetes, as well as to 
understand factors that might promote or inhibit implementation and use. 
 
2.4 Description of HeLP-Diabetes 
 
HeLP-Diabetes takes a holistic view of self-management and addresses a wide range of patient 
needs including; education, lifestyle changes, medicine management, emotional management, 
social and peer support and also addresses how patients interact and work with healthcare 
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professionals. A facility to interface with patients’ electronic medical records had been designed 
to provide patients access to self-management metrics recorded by GP surgeries. The 
information provided on HeLP-Diabetes is evidenced based and compliant with National 
Institute for Health and Care Excellence (NICE) guidelines.  
 
Guided by the Corbin and Strauss model, HeLP-Diabetes content was divided into eight 
sections, available from the homepage (see Figure 2-1). 
 
 Understanding diabetes (explaining what type 2 diabetes is and how it can affect 
patients) 
 Staying healthy (focusing on what patients can do to help themselves) 
 Treating diabetes (about treatments for diabetes) 
 Living and working with diabetes (food, socialising, shift work, travel, impact on 
relationships, driving, financial issues) 
 Managing my feelings (managing emotions experienced by people with diabetes) 
 My health record (personal information about medications, care plan, results of self-
monitoring and tests) 
 News and research (new research, stories behind the headlines, information for 
healthcare professionals) 
 Getting help (useful resources, online forum, ask the expert function, personal stories). 
 
Medical management tools include information, behaviour change tools, self-monitoring tools 
and care planning. Emotional management tools include information, computerised cognitive 
behavioural therapy (CBT), mindfulness, journaling, a forum, and personal stories. Role 
management tools included information, Cognitive Behavioural Theory (CBT), personal stories 
and the forum. 
 
A range of resources are available on HeLP-Diabetes including behaviour change tools, such 
as decision support to help users determine what they most want to do, goal setting, action 
planning, self-monitoring, feedback and email and text message reminders. There are also a 
large number of videos and animations on HeLP-Diabetes, presenting the core information in an 
accessible format.  
 
Behaviour change modules for individual behaviours were both developed by the HeLP-
Diabetes team and licensed from collaborators. Down Your Drink (University College London) 
(98) addresses drinking alcohol in moderation, POWeR (University of Southampton) (99) targets 
weight loss, Stop Advisor (University College London) (100) tackles smoking cessation, Living 
Life to the Full is an online CBT course (University of Glasgow) (101) that was adapted 
specifically for people with type 2 diabetes and Health Talk Online (previously DIPEx) 
(University of Oxford) (102) is a repository of personal stories of which all those related to type 2 
diabetes were imported into HeLP-Diabetes.  
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Figure 2-1 The HeLP-Diabetes homepage 
 
 
2.5 Promoting engagement with HeLP-Diabetes 
HeLP-Diabetes employed a number of strategies to promote patient use. The use of 
technology-based reminders or prompts has been found to promote engagement with digital 
interventions (69). As such patients who were registered to use HeLP-Diabetes were sent 
regular emails and newsletters from November 2013 and text message prompts were 
introduced in October 2014. The prompts were sent at a frequency of three a month and 
contained topical and seasonal information as well as links to HeLP-Diabetes content. The 
prompts were developed by a PhD student (Ghadah Alkhaldi) and were then sent to members 
of our Patient and Public Involvement in research (PPI) group for comments and feedback. 
Following this the prompts were sent to members of the research team for further comments 
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and proof reading. The effects of the prompts on patient engagement with HeLP-Diabetes are 
being evaluated as part of Ghadah Alkhaldi’s PhD.  
 
2.6 Access to HeLP-Diabetes 
HeLP-Diabetes was designed to be an online diabetes education service that could be offered 
by healthcare professionals to patients alongside existing group based structured education 
programmes. HeLP-Diabetes was not meant to replace group based education but rather 
become one of a menu of options that healthcare professionals can offer to their patients.  
 
As described in Chapter 1, healthcare professionals’ engagement with and promotion of with 
diabetes self-management education may be important in patient uptake of the education (37, 
40, 41) and the ability to make contact with a healthcare professionals may be important to 
reduce attrition to e-health interventions (73). As such, HeLP-Diabetes was designed to be 
delivered to patients through the NHS.  
 
For the duration of this implementation study (July 2013-August 2015), access to HeLP-
Diabetes was restricted to those who had access to the URL, and it was not searchable on any 
internet search engines. This was in order to protect HeLP-Diabetes access as it was also being 
evaluated in a randomised control trial. Further, in order to access the content of HeLP-
Diabetes, patients had to register to use it by completing an online registration form (described 
in Chapter 6) and creating a username and password which had to be entered on each visit to 
the site. As discussed in Chapter 5, it was planned that staff would assist patients in completing 
the online registration form. 
 
2.7 The HeLP-Diabetes Randomised Control Trial 
 
In parallel to the implementation study reported in this thesis, as part of the wider NIHR funded 
program grant, the HeLP-Diabetes intervention was evaluated in a randomised control trial 
(RCT). The RCT is described here in order to provide additional context to this study in relation 
to the overall programme grant and to highlight the additional contribution to understanding that 
undertaking an implementation study in routine practice adds to the data provided by the RCT.  
 
2.7.1 Aim 
This RCT aimed to determine: 
 
1. The effect of HeLP-Diabetes on clinical outcomes and health related quality of life in 
people with T2DM; 
2. The incremental cost-effectiveness of the intervention compared to usual care from the 
perspectives of health and personal social services and wider public sector resources. 
 
2.7.2 Design 
This was a multi-centre, two-arm individually randomised controlled trial in primary care.  
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2.7.3 Participants 
Participants were adults, aged 18 or over, with type 2 diabetes, registered with participating 
general practices.  In order to maximise the generalisability of this pragmatic trial, exclusion 
criteria were kept to a minimum. People were excluded who were: unable to provide informed 
consent, e.g. due to psychosis, dementia or severe learning difficulties; terminally ill with less 
than 12 months life expectancy; unable to use a computer due to severe mental or physical 
impairment; unable to use the intervention due to insufficient mastery of spoken or written 
English; and those who were currently participating in a trial of an alternative self-management 
programme.  Participants did not have to have home internet access or prior experience of 
using the internet to participate.  Participants with previous or current experience of self-
management education were eligible to participate.  
 
2.7.4 Setting 
The RCT was undertaken in General Practices in the UK. Practices were recruited with 
assistance from the Primary Care Research Network (PCRN). In order to maintain staff blinding 
to the intervention that each patient received, participating practices were required to have two 
nurses to participate in the RCT, one nurse to act as a practice nurse (training participants in 
use of the intervention, providing routine clinical care) and one to act as a research nurse (blind 
to allocated intervention, collecting follow-up data). In some areas the PCRN had employed and 
trained research nurses.   
 
Service support costs were provided to all practices for their participation in the RCT to 
reimburse staff time. 
 
 
2.7.5 Procedure 
Recruitment 
Recruitment took place in two stages: first practices were recruited through the research 
networks including the Primary Care Research Network (PCRN) and the North Central London 
Research Consortium (NoCLOR).  Once a practice had agreed to participate, and completed 
set up procedures, patient recruitment started. 
 
Patient recruitment followed standard opt-in procedures.  Each practice had a register of 
patients with type 2 diabetes as they needed it for the Quality and Outcomes Framework.  A 
nurse or other qualified health professional reviewed the electronic medical record of each of 
the patients on this register with a view to screening out ineligible patients.  All remaining, 
potentially eligible patients were sent a letter from their GP inviting them to participate in the 
study.  A participant information sheet, consent form, expression of interest and stamped 
addressed envelope was included.  Patients who were interested in participating were asked to 
return the expression of interest form to the trial manager.   
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On receipt of the expression of interest form, the trial manager contacted the practice research 
nurse who offered the patient an appointment at the practice.  This appointment provided 
patients with an opportunity to discuss the pros and cons of participation, and if they wished to 
proceed, sign the consent form.   
 
Baseline clinical data were obtained either at this appointment or a subsequent one.  After 
signing the consent form, patients were asked to complete the self-report baseline data, and 
only once all baseline data were complete were patients randomised.  Randomisation marked 
the point of study entry.  
 
Randomisation 
Randomisation was performed centrally using a web-based randomisation system provided by 
Sealed Envelope. Randomisaton was at the level of the individual participant, and conducted 
using random permuted blocks of sizes 2, 4 and 6, stratified by recruitment centre.  The practice 
nurse was informed which arm the participant had been randomised to, so that those in the 
intervention arm could be offered the training appointment.  
 
Intervention 
The intervention consisted of facilitated and supported access to HeLP-Diabetes.  There were 
three components to the supported access: first an introductory training session, secondly 
supportive follow-up phone calls, and thirdly, on-going discussion of patient’s self-management 
goals in routine appointments for diabetes-related matters.  
 
In the training session, practice nurses gave the patient a booklet containing the url for the 
programme, the participant’s log in details, and information about the content of the website and 
how best to use it.  Nurses showed the patient how to access the website, and introduced them 
to the main content areas.  The nurse was asked to discuss with the patient what the patient’s 
most pressing needs are and use this to guide the patient toward certain sections (for example, 
improving diet, being more physically active, or managing emotions).   
 
Follow-up phone calls were offered to support the patient in use of the programme.  Nurses and 
doctors in participating practices were asked to refer to the programme in consultations with 
participating patients and to integrate information from the programme into management plans.  
 
 
Comparator 
From an NHS perspective, the important research question was whether HeLP-Diabetes could 
improve health outcomes when compared to current practice.  However, to improve 
acceptability to participants and help maintain blinding, all participants had access to a website.  
Participants in the control arm were given access to a simple information website, based on the 
information available on the Diabetes UK and NHS choices websites.  These participants were 
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also given a booklet with the URL and user log in details, but did not have the introductory 
session with the nurses.  
 
2.7.6 Outcomes 
Primary outcomes. 
The outcomes reflected the aims of improving clinical outcomes and health related quality of 
life.  Two joint primary outcomes were selected: glycated haemoglobin (HbA1c) and health 
related quality of life, measured by the Problem Areas in Diabetes (PAID) scale (103, 104). 
PAID has 20 items focusing on areas that cause difficulty for people living with diabetes, 
including social situations, food, friends and family, diabetes treatment, relationships with health 
care professionals and social support.   
 
Secondary outcomes 
Secondary outcomes were selected to reflect the proposed pathway of action of HeLP-Diabetes 
and allow health economic analysis and can be categorised as clinical, patient-reported, or 
economic.   
 
Clinical outcomes include: 
 Systolic and diastolic blood pressure; 
 Body mass index; 
 Total cholesterol and HDL (not fasting); 
 Completion of “9 essential processes” (= weight, BP, smoking status, measurement of 
serum creatinine, cholesterol and HbA1c, urinary albumen and assessment of eyes and 
feet). Data were obtained from notes for the 12 months prior to randomisation and the 
12 months after randomisation at the 12 month follow-up point.  
 
Patient-reported outcomes: 
 Depression and anxiety, measured using the Hospital Anxiety and Depression Scale 
(HADS)  (13); 
 Diabetes-related self-efficacy measured using the Diabetes Management Self-Efficacy 
Scale (DMSES) (105); 
 Satisfaction with treatment, measures using the Diabetes Satisfaction with Treatment 
Questionnaire status and change version (DTSQs & DTSQc)  (15). 
 
Economic outcomes: 
 Cost of developing the intervention; 
 Cost of supported access; 
 Costs of training NHS staff both in using the intervention and training patients to use the 
intervention; 
 Costs of maintaining and updating the intervention; 
 Health service utilisation during the study period; 
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 EQ-5D to calculate QALYs (106); 
 Clinical parameters required for modelling long term cost-effectiveness of the 
intervention (detailed below). 
 
In addition automated software was used to automatically record each participant’s use of the 
intervention (date and time of log-ins, pages visited). 
 
2.7.7 Data collection 
Each practice provided information on the number of invitation letters sent out, and the age and 
gender of the patients invited.  
 
Data to describe participants were collected at baseline and included demographic and clinical 
data.  Demographic data collected consisted of: age, gender, highest educational attainment, 
ethnicity, current employment status, presence or absence of home internet access, level of 
expertise in computer use, current or previous participation in diabetes self-management 
education.   
 
Baseline clinical data obtained from the medical record included:  
 date of diagnosis of diabetes;  
 HbA1c, blood pressure, total cholesterol, HDL cholesterol and smoking status at 
time of diagnosis;  
 presence or absence and date of diagnosis of complications of diabetes including 
ischaemic heart disease, myocardial infarction, congestive cardiac failure, atrial 
fibrillation, peripheral vascular disease, amputation, cerebro-vascular disease, 
retinopathy, renal failure and neuropathy; 
 a list of current medications.  
 Additional clinical data on height (cm), weight (kg), systolic and diastolic blood 
pressure, current smoking status, and current levels of HbA1c, total cholesterol and 
HDL cholesterol will also be obtained during the baseline visit 
 
Baseline patient reported outcomes include: 
 PAID,  
 HADS,  
 DTSQ,  
 EQ-5D,  
 DMSES 
 
Baseline health economic data includes: 
 Clinical data as above; 
 Health service utilisation in 12 months prior to baseline visit. 
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Follow up data were collected at 3 and 12 months, with 12 months as the primary outcome 
point.  The ‘window’ for 3 month data was 60 – 120 days post randomisation (90 days +/- 30 
days), while that for the 12 month data was 305 – 425 days (365 days +/- 60 days).   
 
Data on health service utilisation were collected for the past 6 months at baseline, the past 3 
months at 3 month follow-up and the past 9 months at 12 month follow-up. Data on completion 
of the “9 essential processes” were collected from the GP record for the 12 months prior to 
randomisation and the 12 months after randomisation at the 12 month follow-up point to avoid 
triggering behaviour change amongst the study nurses. 
 
Standard operating procedures (SOPs) covered every aspect of data collection and nurses 
were trained in these procedures.  Adherence to SOP was monitored.  Participants completed 
self-reported questionnaires (demographics, PAID, HADS, DMSES, DTSQ and EQ-5D) online, 
prior to the nurse recording clinical outcomes and taking blood for HbA1c and lipids. Clinical 
data were entered directly into the online database by the nurse.  Health service utilisation data 
were extracted from the clinical record by the nurse.  
 
2.7.8 Summary of results 
Of the 374 participants randomised between September 2013 and December 2014, 185 were 
allocated to the intervention and 189 to the control.   
 
Final (12 month) follow up data for HbA1c were available for 318 (85%) and for PAID 337 (90%) 
of participants.  Of these, 291 (78%) and 321 (86%) responses were recorded within the pre-
defined “window” of 10-14 months.  
 
The mean age of participants was nearly 65 years, over two-thirds (n = 258, 69%) were male, 
and most were White British (n = 300, 80%).  Just over half (n = 210, 56%) rated themselves as 
experienced computer users.  Around one-third (n = 134; 36%) had been diagnosed for less 
than 5 years, with a further third (n = 115, 31%) having been diagnosed between 5 and 9 years 
ago.  Overall, this was a population with well-controlled diabetes at baseline: mean HbA1c was 
7.3% (56 mmol / mol), mean systolic (SBP) and diastolic (DBP) blood pressures were 135 and 
78 mm Hg respectively.  Self-reported levels of distress were low, with mean PAID score of 19 
 
Participants in the intervention group had lower HbA1c than those in the control (mean 
difference -0.24%; 95% Confidence Interval -0.44 to -0.049; p=0.014). There was no significant 
overall difference between groups in the mean PAID score (p=0.21), but pre-specified subgroup 
analysis of participants who had had diabetes for less than 7 years showed that a beneficial 
impact of the intervention in this group (p = 0.004).  There were no reported harms.  
 
Economic data were still being analyzed at the time that this thesis was submitted for 
examination.  
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2.8 Rationale for an implementation study 
 
The decision to undertake an RCT and an implementation study was made by the programme 
grant team as it was believed that even in the most pragmatic of trials, the constraints to 
achieve internal validity can affect external validity so that benefits demonstrated in trials can be 
hard to achieve in routine practice. Evidence of effectiveness derived from randomised 
controlled trials does not always transfer to “real world” use.  By their nature, trials such as the 
HeLP-Diabetes trial described above, involve selected participants, whose characteristics may 
differ substantially from non-trial participants; and tightly controlled procedures.  Trial 
methodology emphasizes the importance of fidelity of the intervention, and these types of trials 
of complex interventions may devote considerable resource to ensuring that the intervention is 
delivered as intended.  However, once the intervention becomes approved for routine use, 
these resources are often not available, and the emphasis often changes from ensuring fidelity 
to the original intervention to enabling adaptions which improve local uptake and use.  This 
combination of changes in the population using the intervention and changes to the intervention 
mean that the effects seen in trials may not be replicated in routine use. Implementation studies 
can help researchers to better understand the uptake and adherence to an intervention in more 
relevant populations.  
 
Even though the HeLP-Diabetes RCT was designed as a pragmatic trial, delivered in the 
intended setting to patients who are likely to use HeLP-Diabetes in the real world, constraints of 
the research design limited how pragmatic the trial could actually be.   
Table 2.1 presents a summary, using the PRECIS-2 framework (91) of study designs of the 
RCT and the implementation study to highlight the differences between them with specific 
attention given to the pragmatic and explanatory nature of both (please see Chapter 6 for full 
details of the implementation study design). Each PRECIS-2 domain can be attributed a score 
from 1 to 5 according to how pragmatic or explanatory it is for a given trial (1=Very explanatory, 
2=Rather explanatory, 3=Equally pragmatic and explanatory, 4=Rather pragmatic, 5=Very 
pragmatic). These scores can be plotted onto a wheel to visualise how pragmatic or explanatory 
a given study is. Scores have been attributed to the PRECIS-2 domains for both the HeLP-
Diabetes RCT and implementation study and Figure 2-2 and Figure 2-3 present wheels for both 
studies to highlight the differences in the pragmatic/explanatory nature of them (it must be noted 
that the applicability of the PRECIS-2 is usually to RCTs only and thus may not transfer to the 
consideration of an implementation study as readily). 
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Table 2-1 Summary of the HeLP-Diabetes RCT and implementation according to domains of the PRECIS-2 framework 
PRECIS-2 
Domain 
Definition HeLP-Diabetes RCT HeLP-Diabetes implementation study 
Eligibility  The extent that the 
participants in the 
trial/study are 
similar to those 
who would receive 
the intervention if it 
was part of usual 
care.  
Eligibility criteria for patients were kept to a minimum in order to 
maximise generalisability. Participants were adults, aged 18 or 
over, with type 2 diabetes, registered with participating general 
practices.  People were excluded who were: unable to provide 
informed consent, e.g. due to psychosis, dementia or severe 
learning difficulties; terminally ill with less than 12 months life 
expectancy; unable to use a computer due to severe mental or 
physical impairment; unable to use the intervention due to 
insufficient mastery of spoken or written English; and those who 
were currently participating in a trial of an alternative self-
management programme.  Participants did not have to have 
home internet access or prior experience of using the internet to 
participate.  Participants with previous or current experience of 
self-management education were eligible to participate.  
 
Eligibility criteria for general practices included the practices 
having two nurses, the practice being interested in research, and 
committed to complex recruitment, data collection, and 
intervention delivery procedures. 
 
All patients over 18 who had type 2 diabetes were eligible to use 
HeLP-Diabetes. There were no exclusion criteria for use and 
staff at participating sites used their judgment to discern which 
patients to offer HeLP-Diabetes to.  
There were however exclusion criteria for patients taking part in 
the research to evaluate the implementation (see Chapter 6).  
 
There were no eligibility criteria for general practices other than 
the practices having to be part of the case study CCG.  
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Recruitment  How much extra 
effort is made to 
recruit participants 
over and above 
what that would be 
used in the usual 
care setting to 
engage with 
patients?  
A largely explanatory approach to patient recruitment was taken 
with registers of patients with type 2 diabetes screened, 
invitation letters sent to eligible patients, patients returning 
expression of interest forms, additional appointment at the 
practice with a research nurse. 
A very pragmatic approach was taken with patients offered use 
of HeLP-Diabetes within routine appointments.  
 
In a few practices a mail out was conducted to all patients with 
type 2 diabetes with an information leaflet (see chapter 7).  
Setting   How different is the 
setting of the 
trial/study and the 
usual care setting? 
Same as usual care Same as usual care 
Organisation   How different are 
the resources, 
provider expertise 
and the 
organisation of 
care delivery in the 
intervention arm of 
the trial and those 
available in usual 
In order to maintain staff blinding to the intervention that each 
patient received, participating practices were required to have 
two nurses to participate in the RCT, one nurse to act as a 
practice nurse (training participants in use of the intervention, 
providing routine clinical care) and one to act as a research 
nurse (blind to allocated intervention, collecting follow-up data). 
In some areas the PCRN had employed and trained research 
nurses.   
 
Service support costs were provided to all practices for their 
The delivery of HeLP-Diabetes relied on the resources and 
expertise of those available in routine care.  
It had been planned that I would assist practices to offer the 
intervention to patients, however this only happened in two 
practices (see chapter 7).  
Staff were provided with training on offering HeLP-Diabetes to 
patients.  
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care? participation in the RCT to reimburse staff time. 
 
Training was provided to practices nurses to deliver the 
intervention and to research nurses on the research procedures. 
 
Flexibility 
(delivery)   
How different is the 
flexibility in how the 
intervention is 
delivered and the 
flexibility likely in 
usual care? 
A detailed protocol for the delivery of HeLP-Diabetes was 
provided to practices. Patients had to be offered the intervention 
within a specific time period following randomisation. A training 
session was provided to patients which was a core part of the 
protocol. 
The details of how to implement HeLP-Diabetes was left up to 
individual practices/clinics to decide. Although the facilitation of 
patient use was encouraged this was left to practices to deliver 
or not.  
Flexibility 
(adherence)   
How different is the 
flexibility in how 
participants must 
adhere to the 
intervention and 
the flexibility likely 
in usual care? 
Follow-up phone calls were offered to support the patient in use 
of the programme.  Nurses and doctors in participating practices 
were asked to refer to the programme in consultations with 
participating patients and to integrate information from the 
programme into management plans. There were no measures in 
place to monitor patient adherence to HeLP-Diabetes.  
 
Although staff were encouraged to provide patients with ongoing 
encouragement to use HeLP-Diabetes within routine 
appointments this was left up to practices and clinics to 
implement or not. There were no measures in place to monitor 
patient adherence to HeLP-Diabetes.   
Followup   How different is the 
intensity of 
measurement and 
follow-up of 
Fairly intense follow up according to a strict protocol.  
Follow up data were collected at 3 and 12 months 
 
Standard operating procedures (SOPs) covered every aspect of 
No follow up 
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participants in the 
trial and the likely 
follow-up in usual 
care?  
data collection and nurses were trained in these procedures.  
Adherence to SOP was monitored.  Participants completed self-
reported questionnaires . The nurse recorded clinical outcomes 
and took blood for HbA1c and lipids..  
 
Primary 
outcome   
To what extent is 
the trial's primary 
outcome relevant 
to participants? 
HbA1C and diabetes related distress as measured by the PAID 
are of great relevance to patients. 
Uptake and use of HeLP-Diabetes were judged to be of less 
relevance to patients than the primary outcomes of the trial.  
Primary 
analysis   
To what extent are 
all data included in 
the analysis of the 
primary outcome? 
Pragmatic approach to the analysis using an intention-to-treat 
analysis using all available data. 
Data from all sites and registered patients included 
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Figure 2-2 PRECIS-2 scores and wheel for the HeLP-Diabetes RCT 
 
 
Figure 2-3 PRECIS-2 scores and wheel for the HeLP-Diabetes implementation study 
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In addition, the rationale for including an implementation study was that whether or not HeLP-
Diabetes itself proved effective in a trial, the policy and financial imperatives for introducing e-
health interventions to help patients improve their health are overwhelming; hence producing 
knowledge about how best to implement such interventions is useful for the NHS and other 
health care systems internationally. 
 
Finally, one of the over-arching aims of the NIHR Programme of Applied Health Research is for 
funded work to achieve benefits for the NHS.  Hence it was important to ensure that the 
programme of research generated all the data required to inform future implementation and use 
of HeLP-Diabetes throughout the NHS.  As part of the planning for this programme grant, the 
programme grant team thought about long term sustainability and maintenance.  It was clear 
that a revenue stream would be required for this, and that the most likely source of such 
revenue would be commissioning by NHS commissioners.  Commissioners need more 
information about a service than can be provided from trial data, including information about 
likely uptake and use, and the resources required for effective implementation.  This study was 
designed to address these needs as well as providing generalizable data of international 
relevance.  
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3 CHAPTER 3: FACTORS THAT INFLUENCE THE IMPLEMENTATION OF E-HEALTH: AN 
UPDATE OF A SYSTEMATIC REVIEW OF REVIEWS 
 
3.1 Chapter Summary 
This chapter presents a systematic literature review, which summarises and synthesises data 
from published reviews on the implementation of e-health in health services. A focus is placed 
on identifying factors that facilitate or hinder the implementation of e-health and strategies that 
promote implementation.  
 
3.2 Background 
As descried in Chapter 1, the use of technology in providing and delivering healthcare is 
pervasive worldwide (107, 108). The use of e-health, a term that describes the application of 
information, computer, or communication technology to some aspect of health or healthcare, is 
viewed as integral to solving problems facing healthcare systems(109) . Despite potential 
benefits of e-health, implementation of these systems is often reported as problematic (110). 
Barriers to implementation may arise at the individual, organisational and wider levels of the 
healthcare systems and interact in complex and variable ways (111, 112). Barriers may also be 
innovation- and context- specific. Recognising and understanding factors that influence 
implementation is crucial for devising strategies and interventions to improve the widespread, 
effective use of e-health and addressing blockages to implementation. 
 
However, as the e-health implementation literature is fragmented across multiple subspecialty 
areas, with a plethora of reviews on the implementation of different e-health technologies 
available, it may be difficult for anyone involved in implementing e-health systems to locate an 
appropriate body of evidence and to determine the relevance of that evidence to their specific 
circumstances (113). 
 
A systematic review of reviews by Mair et al. (113) synthesised the literature on the 
implementation of e-health interventions in healthcare settings published up until 2009. An 
update of this review was deemed timely given three factors: the increasing emphasis on e-
health solutions for healthcare services worldwide and the persistent problems with 
implementation; the changing context of e-health with more ubiquitous use and increased 
spending on e-health services and implementation; and the development of new e-health 
technologies.  
 
Since the reviews included in the first review were published, e-health has become increasingly 
viewed as essential for solving problems facing healthcare systems of increasing demand, due 
in part to an ageing population and improved treatments, and limited resources (114). 
Furthermore, the need to understand problems with implementation of e-health in healthcare 
settings has grown markedly.  There is an ongoing tension between the need to use health 
technologies to good effect and difficulties with implementation. For example, in the UK, the 
recent National Health Service (NHS) Five Year Forward View (54) states the need to make 
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better use of available health technologies and acknowledges that the NHS has previously 
failed to make best use of these because of difficulties in understanding how best to adopt and 
implement them. High profile implementation failures continue to be reported, such as  the 
failure of implementation of an e-health system in a major UK teaching hospital leading to 
reduced performance, demoralised staff, costs of £200 million and the Trust being put into 
special measures (115). This highlights the strong need for those undertaking the 
implementation of e-health within health systems to understand factors that influence 
implementation and be well equipped to devise strategies and interventions to improve the 
widespread effective use of e-health and address blockages to implementation.  
 
e-health, is emerging as one of the most rapidly growing areas in healthcare today (116) with 
the period since the last review seeing a rapid increase in the types, use and spending on e-
health. For example, in 2009, only 12 percent of U.S. acute care hospitals had adopted the 
Electronic Health Record, however by 2014 this had increased to 75% (117). More and more 
money is also being provided by healthcare services to facilitate the adoption of these 
technologies within healthcare systems. For example, NHS England has funded several 
schemes to support e-health implementation including The Integrated Digital Care Fund to 
facilitate the adoption of modern, safe standards of electronic record-keeping, the Nursing 
Technology Fund which provides grants to Trusts to buy digital services for nurses, and the 
NHS Innovation Accelerator scheme which funds fellows who have worked with industry and 
the third sector to develop health technologies (118). 
 
New e-health technologies and platforms have developed and been put into use in healthcare 
settings since the last review including smartphones, tablets, wireless technologies, wearable 
technologies, Apps, fibre optic broadband and Cloud computing technologies. Technologies 
such as websites and telemedicine that existed at the time of the first review but have evolved 
significantly in functional capabilities and scope of applicability (119). Therefore, given that: the 
use of e-health is rapidly growing and changing, the investments made by healthcare systems in 
e-health are increasing, and the importance of updating systematic reviews has been stressed 
(120), an update of the original review was deemed timely. 
 
As the focus of this review was to determine factors that are important to the implementation of 
e-health across multiple healthcare settings, I deemed a systematic review of reviews to be the 
most appropriate method, rather than a systematic review of the primary literature as the huge 
number of primary studies in the area would make synthesis potentially unworkable and very 
time consuming. A systematic review of reviews provides a summary of evidence from a variety 
of different levels, including the combination of different interventions, different populations and 
different settings (121) in a coherent and economical way (113). Conducting a systematic 
review of reviews allowed the findings of separate reviews to be brought together, compared 
and contrasted, with the aim of providing a comprehensive overview of factors that influence the 
implementation of e-health across settings and allowed factors common to all types of e-health 
interventions to be identified.  
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One criticism of implementation research is a lack of consistent terminology and definitions to 
describe factors that may impede or facilitate implementation of innovations (122). The use of a 
framework can facilitate the identification and understanding of the myriad of potentially relevant 
factors and how they may apply in a particular context. Normalisation Process Theory (NPT) (7, 
97) was employed by the Mair et al. review as a framework to code the data, and has been 
used in other sections of this thesis to understand the implementation of HeLP-Diabetes, it was 
not however deemed the most appropriate framework to use here. NPT focuses on social 
processes involved in the operationalization of new innovations within healthcare. However, 
many studies included in this review deal with factors that are important to implementation but 
are not directly related to social processes such as national and international policies and 
financial factors. Furthermore the authors of the original review stated that there were data 
within their review that could not be included in the analysis because it lay outside of the NPT 
framework, including data related to technical and attitudinal issues.  
 
For these reasons the Consolidated Framework for Integrating Research (CFIR) (122), which 
consolidates constructs from a broad array of theories and includes both process and non-
process factors, was selected as the framework to guide the coding of the data in this review. 
The CFIR is a meta-theory of implementation which was developed from a review and synthesis 
of existing implementation theories and offers a pragmatic organisation of constructs that are 
believed to (positively or negatively) influence implementation. The CFIR is composed of five 
major constructs (intervention characteristics, outer setting, inner setting, characteristics of 
individuals and process) that influence the implementation of innovations into practice (see 
Table 3-2). 
 
The intervention characteristics construct captures whether an innovation is simple or complex 
and its adaptability. The implementation setting is described as comprising an “outer context” 
that includes economic, political and social factors, and an “inner context”, including the 
organisational structure, culture and resources. The individuals involved in implementation 
include the various stakeholders (e.g., administrators, healthcare professionals, patients, etc.) 
and their characteristics, including attitudes about implementation (e.g., readiness/buy-in) and 
their roles in the organisational structure. Finally, the process of implementation addresses the 
stages in moving an innovation into full practice, including exploration/planning, 
installation/educating, initial/limited implementation, full implementation, innovation, and 
sustainability (including policy change) (122). One of the strengths of selecting this particular 
framework which has been used in many previous implementation studies is that it provides a 
consistent taxonomy, terminology, and definitions on which a knowledge base of findings across 
multiple contexts can be built and allows comparisons with other research.  
 
3.3 Aim 
The aim of this review was to update a systematic review of reviews in order to summarise and 
synthesise published reviews on the implementation of e-health in health services. A focus was 
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placed on identifying factors that facilitate or hinder the implementation of e-health and 
strategies that promote implementation.  
 
This review was conducted, in part, to inform the fieldwork components of this thesis. It was 
hoped that the findings from this review would provide guidance for the implementation of the 
HeLP-Diabetes intervention into NHS services and that the factors important for implementation 
reported by this review would provide a sensitising tool for potential barriers and facilitators to 
the adoption and use of HeLP-Diabetes. However, as I was conducting my PhD part time 
alongside my full time job to implement HeLP-Diabetes, the time scales were dictated by the 
needs of the wider programme grant. Therefore, the initial screening and reading of the 
literature was conducted while designing the implementation plan to implement HeLP-Diabetes 
into routine practice, however I was only able to update the citation search and systematically 
analyse the data after the fieldwork began. Therefore the learning from my reading of the 
reviews was applied to the development of the HeLP-Diabetes implementation plan, but the 
formal recommendations that arose from the results of this review were not available. The 
findings from this review are used to inform the discussion of the findings of this thesis (chapter 
11). 
  
3.4 Methods/ Design 
The protocol for this systematic review has been published (123) and registered with the 
Prospective Register of Systematic Reviews (registration number CRD42015017661).  
 
This is a systematic review of reviews which includes data collected from both qualitative and 
quantitative reviews. It largely replicates the methods for identifying and selecting studies 
described in the original review (113), but, as detailed, differs in the methods of data analysis. 
For reader clarity, henceforth the following terms shall be used to describe the reviews referred 
to: 
 Review: the current systematic review of reviews 
 Original review: the systematic review of reviews conducted by Mair et al. (113) 
 Studies/papers: the systematic reviews identified and synthesised in this review 
 
3.4.1 Reporting 
This systematic review is reported following the ENTREQ statement guidelines to enhance 
transparency in reporting qualitative evidence synthesis (124). 
 
3.4.2 Inclusion and exclusion criteria 
The eligibility criteria for study inclusion (replicated from the Mair review) were developed using 
the acronym PICOS (see Table 3-1) 
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Table 3-1 Eligibility criteria for study inclusion 
Criterion Description 
Population  Healthcare settings (including but not limited to: primary, intermediate, 
secondary, homecare). 
 All healthcare settings were considered.  
 Not limited by: clinical area, health concern; the type of patient receiving 
the e-health technology; the type of healthcare professional delivering care 
or country. 
Intervention e-health technologies (including: management systems, such as electronic 
health records that allow the acquisition, transmission and storage of patient 
data; computerised decision support systems including diagnostic support, 
alerts and reminder systems; communication systems such as 
telecommunication that act as an intermediary between users; and information 
resources such as the internet) 
Comparator This review was not limited to comparator studies. 
Outcomes Qualitative data on factors that inhibit or promote implementation of e-health. 
Study type Papers were included if they were: 
 Systematic reviews: where relevant literature had been identified by means 
of structured search of bibliographic and other databases; where 
transparent methodological criteria were used to exclude papers that did 
not meet an explicit methodological benchmark, and which presented 
rigorous conclusions about outcomes. 
 Narrative reviews: where relevant literature had been purposively sampled 
from a field of research; where theoretical or topical criteria were used to 
include papers on the grounds of type, relevance, and perceived 
significance; with the aim of summarising, discussing, and critiquing 
conclusions. 
 Qualitative meta-syntheses or meta-ethnographies, where relevant 
literature was identified by means of a structured search of bibliographic 
and other databases, where transparent methods had been used to draw 
together theoretical products, with the aim of elaborating and extending 
theory. 
And were excluded if they were;  
 Secondary analyses (including qualitative meta-syntheses or meta-
ethnographies) of existing data-sets for the purposes of presenting 
cumulative outcomes from personal research programmes. 
 Secondary analyses (including qualitative meta-syntheses or meta-
ethnographies) of existing data-sets for the purposes of presenting 
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integrative outcomes from different research programmes. 
 Discussions of literature included in contributions to theory building or 
critique. 
 Summaries of literature for the purposes of information or commentary. 
 Editorial discussions that argue the case for a field of research or a course 
of action. 
Where an abstract stated it was a review, but there was no supporting 
evidence in the main paper, such as details of databases searched or criteria 
for selection of papers (either on methodological or theoretical grounds), the 
paper was excluded. 
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3.4.3 Search strategy for identification of studies 
Comprehensive electronic searches of MEDLINE, EMBASE, CINAHL, PSYCINFO and The 
Cochrane Library (which include Cochrane Database of Systematic reviews, Cochrane Central 
Register of Controlled Trials, DARE, NHSEED (NHS Economic Evaluation Database), Health 
Technology Assessment Database) were conducted. 
 
The search strategy, which was replicated from the original review, was based on the following 
two concepts: e-health and implementation. The search strategy included a combination of 
medical subject headings and free-text words. The MEDLINE (Ovid) search strategy that was 
used to identify papers is presented in Appendix A. The two concepts of implementation and e-
health were combined, and then the search was limited by study type and date (up to 1.1.14). 
There was no limitation of language. Citation searches were carried out in ISI Web of Science in 
September 2015 and results were limited, in line with the search strategy, to studies published 
up until 1
st
 January 2014. Reference lists of all included studies were also screened for 
additional literature.  
 
The original review (113) was based on 37 papers published between 1995 and 31
st
 July 2009. 
The search strategy used in the original review was replicated to identify additional literature 
published from the 1
st
 August 2009 until 1
st
 January 2014. The 37 papers identified by the 
original review were also screened for inclusion in the current review. 
 
3.4.4 Selection of studies 
Search results were imported into EndNote reference management software and duplicates 
were removed automatically and manually double- checked. Titles and abstracts of all identified 
records were independently assessed by me and a second reviewer (Rosa Lau). Full text 
papers of references that were deemed potentially eligible were obtained and assessed for 
eligibility against the pre-specified inclusion and exclusion criteria. Any discrepancies between 
reviewers were resolved through discussion. Reasons for exclusion at this stage were recorded 
and are detailed in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) diagram (125) (see Figure 3-1).  
 
3.4.5 Study quality assessment 
Because the aim was to describe and synthesise a body of qualitative literature, and not 
determine an effect size, a formal quality appraisal of the included studies was not conducted as 
it would not affect the interpretive synthesis. However, an attempt to describe the quality of the 
reviews by focusing on certain key elements, such as searching methods and use or 
consideration of theory was made using items described in the PRISMA checklist as a guide 
(125). 
 
3.4.6 Data extraction 
All included studies were critically appraised during the data extraction stage. An Excel 
spreadsheet was created for the purposes of data extraction. This contained a row for each 
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included study and columns to describe the studies and classify the extracted data related to 
the implementation of e-health. I extracted data from the included studies and this data 
extraction and coding was checked by a third reviewer (Elizabeth Murray).  
 
3.4.7 Data synthesis 
The original review had used a thematic approach to analysing and synthesising the data, 
together with an analysis based on the NPT. In view of the large amount of new data, and the 
subsequent development of the CFIR, I decided to update the analytic approach to use meta-
ethnography for data synthesis, with the CFIR as an organising framework.  
 
As described in the background section, the CFIR is composed of five major constructs that 
influence the implementation of innovations into practice which comprise a number of 
components (see Table 3-2). The use of the constructs from the CFIR to organise data within 
the review provided a clear way to facilitate data synthesis from such a large data set. The use 
of the CFIR constructs also aided the transferability of the findings from this review to other 
implementation studies.  
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Table 3-2 Constructs and components of the CFIR 
Constructs Components 
Intervention 
characteristics 
 Intervention source 
 Evidence strength and quality 
 Relative advantage 
 Adaptability 
 Trialability 
 Complexity 
 Design quality and packaging 
 Cost 
Outer setting  Patient needs and resources 
 Cosmopolitanism 
 Peer pressure 
 External policy and incentives 
Inner setting  Structural characteristics 
 Networks and communications 
 Culture 
 Implementation climate (tension for change, compatibility, relative 
priority, organisational incentives and rewards, goals and feedback, 
learning climate, readiness for implementation, leadership 
engagement, available resources, access to knowledge and 
information) 
Characteristics 
of individuals 
 Knowledge and beliefs about the intervention 
 Self-efficacy 
 Individual stage of change 
 Individual identification with organisation 
 Other personal attributes 
Process  Planning 
 Engaging (opinion leaders, formally appointed internal 
implementation leaders, champions, external change agents, key 
stakeholders, innovation participants) 
 Executing 
 Reflecting and evaluating 
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Meta-ethnography, as described in depth by Noblit and Hare (126), focusses on interpretation 
and tries to ‘synthesise understanding’, unlike other approaches to qualitative synthesis, such 
as thematic analysis, which seek to summarise data (127). The phases involved in conducting a 
meta-ethnography described by Noblit and Hare were applied here in order to bring about new 
interpretations from the data within the studies. They were not used prescriptively, but rather as 
a systematic guide to the stages that can be considered in the synthesis of qualitative data. The 
following phases proposed by Noblit and Hare (126) to synthesising qualitative data informed 
the synthesis: 
 
Determining how studies are related 
This phase seeks to determine the relationships between the studies to be synthesized. Noblit 
and Hare suggest creating a list of the key concepts used in each account (126). For this 
review, I developed a data extraction form to extract key information and concepts from the 
included studies and to ease comparison between them. Data were firstly extracted to describe 
the type of study, including: publication date, e-health domain, healthcare setting, inclusion and 
exclusion criteria and methods used. Secondly, the main themes from each review relating to 
factors that influence implementation of e-health were extracted from both results and 
discussion sections of the included papers. Data from discussions were included as they often 
contained further interpretations from the authors, which offered important insights and 
enhanced the richness of the findings. A summary table created from this matrix, which includes 
key study details and the summaries of the main findings from each review, is presented in 
Appendix B. 
 
Translating the studies into one another  
This stage requires that the relationships between themes or concepts arising from the different 
studies are considered. I extracted detailed data related to the implementation of e-health from 
the studies into some initial broad codes, informed by the summary of main findings from each 
paper. These codes formed columns of the data extraction matrix, and a row for each study was 
created. The completion of this matrix for each study established that each concept in each 
paper was encompassed by one of the codes in the matrix and allowed the relationships 
between themes to be explored between studies. Cells within the matrix remained empty in 
cases where there were no relevant data in the paper concerned. As a way of remaining faithful 
to the meanings and concepts of each study, the terminology used in the original paper was 
preserved within the matrix. 
 
Next, after careful further reading, I decided that these broad codes, although useful for 
providing a sense of the themes within the papers, were not adequate for representing the 
nuances of the data within them. There was a considerable amount of data within each broad 
code that could be further explored. As such, data within the broad codes were extracted into 
further codes that were guided by the constructs of the CFIR (see Table 3-2). A category for 
data that did not fit into one of these constructs, or for data that warranted further discussion 
between reviewers was created. This ensured that data were not being forced into the 
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constructs where there was not a good fit, and allowed for the CFIR to be evaluated as to how 
well the constructs could account for the data from this review. A category was also created for 
the main explanations or theories arising from the authors’ interpretations that were relevant to 
the research question. Data were re-categorised from one construct to another and discussions 
about these categorisations continued between me and my supervisors (Professor Elizabeth 
Murray and Dr Fiona Stevenson) until I was confident that all data were coded into appropriate 
constructs or categories. 
 
Synthesising translations  
Noblit and Hare describe synthesis as making a whole into something more than the parts alone 
by analysing types of competing interpretations and translating them into each other. They 
identify three forms of synthesis: reciprocal, where concepts of one study encompass another; 
refutational, where concepts are contested across papers; and line of argument, where an 
overarching narrative is developed that summarises and represents the key findings of the 
papers. By reading the concepts and interpretations off the matrix, it was possible to establish a 
sense of the relationships between the studies. It became clear that the studies were not 
refutations of one another even when a particular concept was not identified in a particular 
paper (empty cells). Many themes occurred across studies from which a line of argument could 
be developed. Guided by the CFIR constructs, I constructed a narrative about the factors that 
are important for the implementation of e-health.  
 
Communicating the findings 
This thesis is one attempt to communicate the findings of the synthesis. The line of argument 
synthesis is described next in the results section, but also in the discussion section where the 
interpretations of the data are discussed. 
 
3.5 Results 
 
3.5.1 Search results 
In total 2812 unique citations were identified (see Figure 3-1). Of these, 2694 could be excluded 
on the basis of the title or abstract, leaving 118 citations where the full paper was needed before 
a decision could be made. Of the 118 full papers assessed, forty-four (128-171) met the criteria 
for inclusion and were included in this review (Appendix B gives details of all included reviews).  
 
3.5.2 Description of the included reviews 
All studies were published between 2003 and 2014. Fifteen studies originated from Canada 
(129, 138-142, 144-146, 149, 152, 154, 155, 157, 166), fourteen from the USA (130, 135-137, 
143, 148, 151, 153, 162, 165, 167-170), three from the Netherlands (130, 133, 147), three from 
the UK (150, 159, 164), two from Australia (128, 156), and one each from Germany (160), 
Sweden (163), Mexico (134), Malaysia (171), Kenya (158) and Israel (161). All papers were 
written in English.  
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Of the forty-four studies, twenty-five focussed specifically on one type of e-health technology. 
Five of these were concerned with electronic medical records (EMR) (131, 141, 149, 167, 168), 
six with clinical decision support systems (CDSS) (147, 153, 155, 156, 158, 161), five with 
telemedicine (133, 135, 144, 157, 164), and three with telehealth (130, 145, 146). Other studies 
focussed on electronic health records (EHR) (154), electronic personal health record systems 
(PHRs) (129), e-prescribing (140), handheld computers and personal digital assistants (PDAs) 
(151), and home telecare systems (132). Nineteen studies focussed on a collection of e-health 
technologies described as; information and communication technologies (ICT) (128, 136, 138, 
139, 148, 165), health information technologies (HITs) (150, 162, 169), healthcare information 
systems (HISs) (134, 143, 163, 171), information systems (159, 170), clinical information 
systems (CISs) (142), electronic health information systems (EHIS) (166) and health information 
exchange (HIE) (137). 
 
Twelve studies were focussed on one particularly type of healthcare setting including primary / 
ambulatory care (128, 137, 140, 141, 149, 152), hospital/inpatient/acute care (135, 142, 153, 
159) and homecare (132, 166). Twenty one studies focussed on the implementation of e-health 
in to two or more types of healthcare setting (134, 136, 138, 139, 143, 144, 146, 148, 150, 154-
158, 160, 162, 163, 165, 167-169). The remainder of the studies did not define a specific 
healthcare setting (129, 131, 133, 141, 147, 151, 161, 170, 171). 
 
Fifteen studies explicitly referenced and/or discussed a guiding theory or conceptual model for 
the categorisation of the data. There was a wide range of frameworks or existing classifications 
called upon including: The Clinical Adoption framework (CA) (149); human, organisation and 
technology-fit framework (HOT-fit) (147, 154); Technology Acceptance Model (TAM) (140, 154, 
170); Diffusion of Innovations Theory (140, 154); Promoting Action on Research in Health 
Services theoretical framework (PARiHS) (166); Expanded Systems Life Cycle framework 
(ESLC) (142); and the PRECEDE and PROCEED conceptual framework (148). 
 
When judged against the PRISMA checklist for reporting systematic reviews (125), many 
studies were methodologically poor. For example, three (143, 146, 171) did not give details of 
databases searched and seven searched only one database or source, such as the 
proceedings of a particular conference (132, 133, 140, 151, 157, 161, 167). Information about 
study selection criteria was also inadequate: Sixteen of the forty-nine studies did not specify the 
criteria for inclusion or exclusion (129, 130, 133, 135, 143, 145-149, 151-153, 161, 166, 169). 
Five did not detail the number of primary studies included in the review (135, 145, 153, 157, 
161). As this review was not concerned with numeric outcome measures, the PRISMA 
checklists for summary measures and result synthesis were not applicable.  
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Figure 3-1 PRISMA flow diagram of study selection 
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3.6 Factors that influence implementation  
By using the concepts of the CFIR to examine the data from within the reviews I developed a 
conceptual model specific to the implementation of e-health based on the most prominent 
constructs to arise from the synthesis of the studies. In developing this model I have moved the 
synthesis beyond just describing the data present in the reviews related to the constructs of the 
CFIR and have produced further interpretation from the data as to the factors that are important 
for the implementation of e-health. This conceptual model is presented in Figure 3-2 and 
described next. 
 
Figure 3-2 Conceptual model of factors that influence the implementation of e-health 
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3.6.1 Innovation Characteristics 
Adaptability  
An important factor in vendor and technology selection is the ability of the technology to be 
adapted to fit the local context (147, 152). Technologies that can have technical adjustments 
made to them to suit the constant modifications of the environment may have greater 
acceptance and adoption (131, 148, 154, 163, 171). End user input in the design and 
development of e-health technologies should be considered as a way of overcoming barriers of 
adaptability (141).  
 
Related to adaptability is the importance of the interoperability of systems (129, 131, 134, 135, 
137, 138, 141, 151, 161-163, 165, 166). To promote their acceptance and use, systems must 
be able to adequately interface with other IT systems and exchange information (131, 140, 
162).  
 
Complexity 
Complexity factors such as slow system performance (168), software and hardware problems 
(140), the need for extensive software modifications (165), the work involved in transferring 
records between two systems (131), the inability to provide real-time access (151), data 
handling, reliability, slow speed, unplanned downtime (154) and connectivity issues (162) 
influence implementation of systems in healthcare settings. Often issues of complexity are 
linked to health professionals being unable to master the technologies that are implemented 
(131, 141). Vendors of e-health systems should aim to make systems as user friendly as 
possible, involving end users in the design and development (166), providing guides to their use 
(147) and providing technical assistance (156).  
 
Cost 
The cost of e-health system and the costs associated with their implementation are extremely 
important for implementation success (128-132, 135-138, 140, 141, 143-146, 149, 151, 152, 
154, 156, 160, 162, 164-167, 170). Cost factors can relate to start-up costs, ongoing costs, 
costs related to a loss of revenue and savings. High set-up costs including purchasing and 
installation costs may act as barriers to the initial adoption of e-health systems (162) whereas 
financial incentives to adopt e-health systems from insurers and government agencies can 
facilitate adoption decisions (137, 150, 162).  
 
Concerns about ongoing costs act as barriers to adoption (130, 162). Evidence of cost-saving 
and returns on investment may be important for ongoing use of technologies (149, 152). 
Establishing cost-effectiveness through formal evaluations, financing of services on a bigger 
scale, redesigning business models and incentives are strategies that may help to overcome 
cost related barriers (133, 137, 164).  
 
3.6.2 Outer Setting 
External policy and incentives  
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An absence or inadequacy of legislation and policies and liability concerns may hamper the 
implementation of e-health systems at the organisational and health professional level (130, 
131, 133, 164).  There is a strong need for recognised standards for the provision of e-health 
systems (129, 131, 133, 141, 146, 149, 161, 162, 164). The creation of standards may serve to 
reduce health professionals’ concerns over patient data safety, professional liability (130, 146), 
and facilitate the exchange of electronic health information between systems (129) and 
organisations while maintaining data integrity (162).  
 
Incentives by government organisations and other external stakeholders may facilitate adoption 
by healthcare organisations (130, 131, 152, 161, 162). Financial incentives include the provision 
of initial funds to cover upfront costs (162), financial sponsorship (152), reimbursements for 
adoption (132, 143, 144, 149) as well as pay-for-performance initiatives (137, 149, 150, 162). 
 
3.6.3 Inner Setting 
Implementation climate 
Implementation climate includes the compatibility or general fit between the e-health 
intervention and the organisation (129, 136, 144, 146, 150, 159, 162, 172). The fit between e-
health systems and workflows seems particularly important for implementation success  (128, 
129, 131, 134, 136, 138, 140, 141, 149, 153, 154, 156, 160-163, 165, 168-171) with 
implementation failures occurring when systems do not fit well with work practices or daily 
clinical work (138). Health professionals’ perceptions that e-health systems disrupt workflows, 
and the delivery of care, are barriers to both the implementation and use of these systems (136, 
162, 165, 169, 170). When there is a good fit, or perceived fit, between e-health systems and 
workflows, and when systems positively influence workplace efficiency, this facilitates use (128, 
153, 154). Incorporating workflow analysis into system design (161, 168), the integration of 
systems into the usual process of care (128), user-friendly systems (153) and minimizing 
workflow interruptions during implementation (130) may minimise disruptions to workflow.  
 
Alterations to workflows created by the introduction of e-health systems may also disrupt 
established professional roles, responsibilities (129, 133, 138, 149, 168) and working styles 
(131). Physician resistance to e-health implementation may be related to fear of (131), 
dissatisfaction with (131), and uncertainty over (156, 160), new roles and responsibilities, 
created by the introduction of e-health systems (131). The quality of project management during 
the implementation period (131), careful study of the downstream effects of implementation on 
workflow (168), additional training (144, 168), the adaptability of technologies to fit with roles, 
tasks and workflows (150) and dedicated technical support staff (144) are strategies that may 
reduce barriers related to disruptions to workflow, roles and responsibilities that e-health 
implementation may bring.  
 
Readiness for implementation 
Leadership engagement at all stages of the development and implementation processes can 
help improve the effective implementation of e-health systems (156, 167, 169, 171) and a lack 
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of involvement can be a barrier to implementation (131, 166). Management support is also 
important for implementation success (138, 150, 163, 167).  
 
Available resources including the availability of suitable infrastructure are important for 
implementation success. Infrastructure features include electricity supply (164), available 
bandwidth (144, 164), access to reliable internet connectivity (158, 164), access to computers 
(147), electrical power (158), access to phone lines and mobile phones (158). The availability or 
lack thereof, of time to learn new e-health systems, implement them (138, 150, 166) and train 
staff to use them (162) is important for implementation, as is providing a period of transition in 
which end-users can become familiar with and learn how to use new systems (152, 163).  
 
Access to knowledge and information is also important for the implementation of systems 
across all e-health domains. Education increases staff acceptance of e-health systems (129, 
138, 154, 158) including education around anticipated benefits and when those benefits could 
be expected (167).  A lack of knowledge and a limited understanding of benefits afforded by the 
systems can act as a barrier to implementation (162, 165, 166). Training and support in relation 
to implementation and acceptance of e-health systems is of particular importance. Generally, 
access to appropriate, high quality, well-funded, and easily available training acts as a facilitator 
to implementation, whereas it is a barrier when it is non-existent, or existent but inadequate 
(128, 129, 131, 133, 136, 138, 141, 144, 150, 156, 158, 163, 164, 166-171). Similarly, access to 
ongoing support to use systems is important for system use (134, 138, 141, 144, 150, 152, 156, 
167) and a barrier to implementation when it is lacking (134).  
 
3.6.4 Individual Characteristics 
3.6.4.1 Knowledge and Beliefs 
Attitudes and beliefs act as both facilitators and barriers to implementation and acceptance of e-
health systems. Positive attitudes of practitioners toward e-health systems and their 
implementation increase acceptance and implementation (133, 134, 154, 157, 159, 162) 
whereas negative attitudes and staff resistance act as barriers (162, 165). Positive staff 
attitudes include beliefs that new systems will benefit patients (169), interest in the technologies, 
perceived usefulness, and motivation in working with the systems (134). Negative perceptions 
include beliefs that electronic systems disrupt the delivery of care (162), doubts that systems 
can improve patient care, clinical outcomes or improve the quality of medical practices (156), 
distrust in systems (150) and more general staff resistance to change (141, 145, 152, 154, 162, 
164-166). Strategies to challenge negative attitudes include fostering a culture of 
communication and cooperation, involving the eventual users of systems in the development 
and implementation (133, 162), leadership (169), friendly and context-aware user interfaces 
which promote perceived ease of use and usefulness (134), better education (160), and clearly 
and prospectively communicating intended benefits and realistic expectations for the system 
(167). The attitudes of colleagues (138, 154), and patients (138, 140, 154) also influence staff 
attitudes with regard to e-health acceptance as do staff demographic factors (136, 159, 169). 
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Specifically, fears over a loss of autonomy, (129, 131, 140, 147, 150, 152, 156) concerns about 
liability (129, 131, 135, 150, 156, 164), concerns over patient privacy and security being 
compromised (129, 131, 133, 136, 137, 140, 141, 143, 144, 146, 152, 154, 156, 158, 160, 162, 
164-166, 169, 170) and perceived threats to patient and health professional relationships (131, 
138, 140, 141, 144, 147, 150-152, 154, 156, 167, 170) through the introduction of e-health 
systems are barriers to use.   
3.6.4.1.1 Other Personal Attributes 
Healthcare professionals’ computer skills, abilities and experience influence implementation and 
acceptance of e-health systems (129, 131, 138, 141, 147, 149, 150, 154, 156, 165, 170). 
Training (138, 150, 156) and financial incentives (150) are strategies that can overcome skill- 
related barriers. Demographic factors such as age, education, sex, nationality, and clinical 
experience may influence healthcare professionals’ attitudes towards e-health systems (136, 
141, 159, 169, 170), however, no clear relationships between these characteristics and attitudes 
has been established (159, 169, 170).  
 
3.6.5 Process 
Planning 
Planning for implementation is important for success, whereas the lack of a strategic plan may 
be a barrier to e-health implementation (137, 140, 144, 157, 163). The work of planning includes 
the delineation of roles and responsibilities (156), securing time to invest system selection and 
procurement (131), evaluating other concomitant policy and process changes (153), needs 
assessment and analysis, development of a business plan (157), early identification and 
engagement of champions (144), involving end users (129, 140, 154, 164) establishing a 
guiding philosophy (146), testing organisational readiness (140, 145), development of incentive 
and innovation structures (140), communication of the strategy to all staff (163), development of 
protocols for using the system and for provision of training (144). Incremental implementation 
strategies where features are made available to users according to a plan are preferable to ‘big 
bang’ approaches to implementation within complex organisations (152, 162).  
 
Engaging  
The designation of champions (131, 133, 138, 142, 144, 145, 149, 150, 152, 164, 167, 171) and 
engagement of key stakeholders in the development and selection of e-health systems, and in 
the planning and execution of implementation processes may be important for implementation 
success (129, 133, 141, 142, 147, 154, 157, 162-164, 166-169, 171) by fostering a sense of 
ownership (133, 157, 164), confidence (141), acceptance (147), enjoyment and self- pride (133) 
towards the e-health system and increasing buy-in (167).  
 
Reflecting and Evaluating 
Evaluation is important to ensure system benefits (142, 161), to increase health professional 
acceptance through demonstration of benefits (144, 147, 154, 156) and to secure ongoing 
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funding (166), whereas a lack of evaluation and evidence may act as a barrier to 
implementation (166).  
  
 
3.7 Discussion 
This systematic review of reviews sought to synthesis available literature on factors that 
influence the implementation of e-health systems across a range of healthcare settings. 
 
By using the CFIR to examine the data within the systematic reviews included in this study, it 
was possible to develop a new conceptual model of the factors that are of most importance for 
the implementation of e-health within health systems. This model stresses:  the importance of 
the selection of an appropriate e-health system with the need for careful consideration taking 
into account system complexity, adaptability, compatibility with existing systems and work 
practices and costs; the importance of inclusion of key stakeholders and implementation 
champions as early as possible in the implementation process; the need for sufficient financial 
and legislative support in place to support implementation; that standards for technology may 
greatly improve acceptability and implementation of e-health systems and that planning 
implementation is a critical step which includes ensuring organisations are in a state of 
readiness. 
Using rigorous methods for the identification and selection of studies, this review identified forty-
four systematic reviews which met the inclusion criteria. These studies were focussed on a 
range of e-health systems including electronic health and medical records, clinical decision 
support systems, telemedicine and telehealth with several studies focussed on health 
information technologies in general. Twenty studies were published in the five years since the 
original search (1
st
 August 2009 until 1
st
 January 2014) reflecting a growing interest in the 
implementation of e-health.  
 
The findings suggest that issues around implementation are multi-level and complex. All the 
included reviews reported multiple factors that were important for implementation and no single 
factor could be identified as a key barrier or facilitator. Although different types of e-health 
systems have certain unique implementation factors, they nevertheless share many common 
factors. The factors that seem to have an important impact for all types of e-health systems, 
which were discussed by the majority of reviews are; evidence, strength and quality; relative 
advantage; complexity; cost; external policies and incentives (legislation, standards for 
technology and incentives); organisational culture; implementation climate (compatibility and 
goals and feedback); readiness for implementation (leadership engagement, available 
resources and access to knowledge and information); individuals’ knowledge and beliefs; 
planning; engaging (opinion leaders, formally appointed leaders, champions and key 
stakeholders); and reflecting and evaluating. Technological, external, organisational, individual 
and process factors were all important, and it appears to be the fit between these factors which 
is of critical importance for successful implementation.  
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The Consolidated Framework for Implementation Research (CFIR) (122) provided a framework 
to guide the categorisation of data within the identified reviews. The CFIR accounted very well 
for the data within the reviews; there were no data that could not be coded to one of the 
constructs. There were however, constructs of the CFIR for which little or no data in the 
included reviews was identified, suggesting either that these factors may not be as crucial for 
the implementation of e-health as they may be for other innovations, or that they have had 
insufficient attention paid to them in existing reviews. These were; trialability, patient needs, 
cosmopolitanism, peer pressure, implementation climate (tension for change, relative priority, 
learning climate), self-efficacy, stage of change, identification with organisation, engaging 
(external change agent, patients) and executing. This lack of data may also be a reflection of 
the type of data reported in systematic reviews as opposed to primary studies. For example, 
data on how implementation plans are executed would likely be described in individual primary 
studies, but would less likely to be synthesised in a systematic review that summarises barriers 
and facilitators from a number of studies.  
In comparing the findings of this review with the one it updates (113), it appears that many 
implementation factors are consistent over time, such as the prevailing focus on organisational 
issues including the way a new technology impacts on work practices, the need for adequate 
resources, particularly financial, training, policy support, standards and interoperability. Similar 
findings were also noted between the reviews in terms of the importance given to getting users 
engaged with new technologies and the recruitment of champions in order to legitimize 
participation in the implementation process.  Both reviews highlighted the importance of the 
ease of use of new technologies for health professionals and note a distinct absence of data on 
the ease of use for patients or other service users. These similarities suggest that although e-
health may be a rapidly changing field, many of the challenges of implementing systems within 
organisations remain constant over time.  However, some notable differences exist between the 
findings of the two reviews. The original review reported a concentration on organisational 
issues within the literature. Although also strongly present in this review, the use of the CFIR 
sensitised the focus of analysis to other factors as well including factors related to the 
innovation, outer context, individuals and the process of implementation. The original authors 
reported that very little attention had been paid to ensuring that the potential benefits of new 
technologies are made transparent through ongoing evaluation and feedback. In this review, 
there was focus given to the role of reflecting and evaluating which may represent an increased 
awareness of their importance in implementation. The original review reported that there was 
little coverage given to the ‘sense-making work’ undertaken when new e-health technologies 
are implemented (e.g. to determine whether users see it as differing from existing practice, have 
a shared view of its purpose, understand how it will affect them personally and grasp its 
potential benefits). In contrast one of the main factors to influence implementation in this review 
was the knowledge and beliefs that individuals held towards the new technology, particularly 
around the beliefs they had about potential benefits and the understanding of how technologies 
are likely to affect work practices. Finally, the original review reported that six percent of issues 
were unable to be coded because they fell outside of the coding framework used (NPT), this 
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means that issues that related to technical issues and attitudinal issues were not analysed and 
reported in the original review, whereas the more inclusive nature of the CRIF meant that all the 
data within the current review could be attributed to a CFIR construct.  
  
The results from this review are comparable to another large systematic review of reviews by 
Lau et al. which synthesised the literature on the barriers and facilitators to the implementation 
of complex innovations within primary care settings (173). Both reviews highlighted the 
importance of policies and incentives; adequate infrastructure and resources; engagement of 
key personnel; organisational readiness; individuals’ knowledge and beliefs; and the fit of 
innovations with workflows, processes and systems. As such it seems these factors are 
important for implementation across interventions and health care settings. Lau’s review found 
that the perceived benefits or harm of implementation such as expectations of more efficient 
workflow or lower productivity were only an important factor for the implementation of e-health 
interventions and was not present in the data for other types of interventions (guidelines or 
evidence-based practice, management of care, public health or preventative medicine, 
integration of new role or collaborative working). Adaptability and cost were only present in the 
data for e-health interventions and one other type of intervention. These factors were given a lot 
of focus in the current review thus suggesting that these factors may be unique or particularly 
relevant to e-health implementation.  
 
Conducting a systematic review of reviews, given the enormous literature reporting on the 
implementation of e-health, provided a useful and economical way to manage evidence across 
a broad topic area. The use of the constructs from the CFIR to organise data within the review 
provided me with a clear way to facilitate the data synthesis from such a large data set. This 
review allowed the findings of many separate reviews to be compared and contrasted and 
provided a summary of evidence from reviews which focussed on different e-health 
interventions and different healthcare settings. Although this review was rigorous, carefully 
executed and employed a robust methodological approach and guiding framework, it has 
limitations which require addressing. Systematic reviews, and also the studies included in them, 
may be subject to publication bias. This review was limited to reviewing what was published and 
in the public domain. It is possible, therefore, that some reviews were missed. There is the 
possibility that not all relevant primary research studies were captured by included reviews, so 
some findings may be missed by concentrating on reviews. Moreover, by only focusing on 
reviews, there is an inevitable time lag, with recent studies less likely to be reported in reviews. 
Other limitations include the fact that this review was dependent on the interpretations of 
primary data provided by the authors of included reviews. It was often not clear whether the 
data came from the primary studies or were subsequent interpretations by the authors of 
included reviews. Many reviews did not specify whether the data came from clinicians, nurses, 
other primary care healthcare professional or multidisciplinary teams, therefore it was not 
possible to differentiate the perspectives of specific roles (e.g. nurses).  
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3.7.1 Application of the findings 
The findings from this review were used to inform the implementation plan to implement HeLP-
Diabetes within routine practice (described in Chapter 5). Although as discussed earlier in this 
chapter the timing of the completion of this review and the development of the implementation 
plan did not fully align, the learning gained from undertaking the review was still able to be 
applied to the development of the plan (and the HeLP-Diabetes intervention). Table 3-3 
presents a summary of how the findings of this review were applied to the development of the 
HeLP-Diabetes implementation plan, which is described in detail in Chapter 5.  
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Table 3-3 A summary of how the findings of the systematic review were applied to the 
development and implementation of HeLP-Diabetes  
Factors important for e-
health implementation 
Application of findings to the HeLP-Diabetes implementation 
Innovation characteristics 
 Adaptability 
 Complexity 
 Cost 
Throughout the development phase of the HeLP-Diabetes 
intervention issues of adaptability and complexity were considered 
carefully. HeLP-Diabetes was designed to be user led so that there 
was great flexibility in the content that was accessed and the 
content was constantly being updated. A feedback button on the 
Homepage allowed any comments or suggestions to be sent to the 
research team in real time in response to any issues that might be 
encountered in practice. In addition, when HeLP-Diabetes was 
implemented within the case study CCG staff requested additional 
content and resources to be added to HeLP-Diabetes which I was 
able to do.   
 
Similarly, through the feedback function and the close contact that 
I had with practices in the implementation study, any issues related 
to complexity of HeLP-Diabetes could be dealt with quickly. Early 
development work with health professionals and patients ensured 
that HeLP-Diabetes was as user friendly as possible. In the 
implementation study guides were also provided to health 
professionals and patients on how to use HeLP-Diabetes.  
As part of a research study there were no financial costs to 
practices to implement and use HeLP-Diabetes. Practices were 
also informed that HeLP-Diabetes had the potential to be cost-
effective in the long term and that this was being established 
through the parallel RCT. Costs to practices in terms of staff time 
were considered and discussed with practices, and practices were 
reimbursed for staff time spent on research activities (as opposed 
to implementation activities), through Service Support Costs.  
 
Outer setting 
 External policies and 
incentives 
The use of NPT in the development phase of the HeLP-Diabetes 
intervention alerted the programme grant team to the importance 
of aligning HeLP-Diabetes with external policies and incentives. In 
the implementation study the presentation that I delivered to 
practices highlighted how HeLP-Diabetes aligned with external 
policies including the self-management agenda in the CCG, 
diabetes as an NHS priority area and the use of health 
technologies as an NHS priority area. During this talk, the potential 
of HeLP-Diabetes aligned with the Quality and Outcome 
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Framework (QOF) for diabetes education was also highlighted.  
The sponsorship of HeLP-Diabetes by the NHS was discussed in 
order to allay any fears about data safety or professional liability.  
Inner setting 
 Implementation 
climate 
o Compatibility 
 Readiness for 
implementation 
o Leadership 
engagement 
o Available 
resources 
o Access to 
knowledge 
and 
information 
The implementation plan aimed to be tested in a few pilot practices 
first in order to determine the fit between HeLP-Diabetes and work 
practices and that learning could be generalised from. It was 
initially thought that the use of HeLP-Diabetes within practices 
would be most compatible with the work of nurses and as such the 
training package was tailored to this group of professionals. 
Training aimed to allay fears over the disruption of workflows and 
highlight how HeLP-Diabetes could fit well into existing 
appointments and consultations.  
 
In order to assess readiness and to develop strategies to increase 
this I aimed to begin the implementation in a few practices which I 
thought, based on conversations with the CCG, would be good to 
use as pilot sites. The aim was to try out the implementation plan 
within these practices and learn from the experience, and respond 
to challenges that arose in these practices before moving on to 
more widespread implementation..  
 
The importance of leadership engagement led to me firstly trying to 
engage the GPs at each practice first by attending clinical 
meetings and presenting HeLP-Diabetes to them before asking 
them to suggest who else in the practices might be involved with 
implementing HeLP-Diabetes.  
 
I was sensitised to the fact that there would be limited resources 
within practices to implement HeLP-Diabetes and therefore as part 
of the implementation plan I worked with practices to determine 
what available resources they had and how they thought we could 
be apply them to the implementation of HeLP-Diabetes. I also 
offered my time to practices to help them initially set up HeLP-
Diabetes and to assist them with registering patients to use it.  
 
Access to knowledge and information about HeLP-Diabetes was 
incorporated into the implementation plan through the initial 
presentation to staff within practices, training session and materials 
provided to support staff with using it.  
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Individual characteristics 
 Knowledge and 
beliefs 
 Other personal 
attributes 
The presentation delivered in practices was specifically designed 
to align with core medical values and emphasis that HeLP-
Diabetes was designed to help patients. The presentation also 
emphasised that the development of HeLP-Diabetes had involved 
a large amount of input from health professionals and patients in 
order to ensure that it would fit well in routine practice, be easy to 
deliver and be useful to patients. Emphasising the evidence based 
nature of the content was also a priority of the presentation. 
Process 
 Planning 
 Engaging 
 Reflecting and 
evaluating 
The importance of planning the implementation of HeLP-Diabetes 
was highlighted by this review and considerable time and attention 
was devoted to developing a theoretically informed implementation 
plan (see Chapter 5).  
 
As part of the implementation plan I engaged commissioning 
officers, the CCG diabetes steering group, and patients in order to 
get the word out about HeLP-Diabetes and identify champions 
within the CCG who could help promote it. I gave talks at the CCG 
headquarters, the CCGs’ long term conditions group and patient 
involvement groups. I also engaged PPI members to spread the 
word about HeLP-Diabetes through patient networks.  
 
To promote positive reflection and evaluation of HeLP-Diabetes I 
planned to provide feedback to practices about the adoption rates 
within the CCG by services and by patients. The presentation 
given to practices also evolved during the study period to include 
quotes from health professionals and patients using HeLP-
Diabetes in order to disseminate the benefits that were being 
experienced through using HeLP-Diabetes.  
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4 CHAPTER 4: MODELS OF IMPLEMENTATION 
 
4.1 Chapter summary 
This chapter discusses and describes implementation theories, frameworks and models and 
presents the rationale for the selection of two of these to inform an implementation plan to 
implement HeLP-Diabetes into routine practice.  
 
 
4.2 Introduction 
Chapter 3 identified factors that can hinder or promote the implementation of e-health, and the 
synthesised reviews highlighted many examples of problematic implementation of health 
innovations into routine practice. The review findings suggest that well planned implementation 
may be crucial for implementation success. It is also understood that it may be important to use 
a theoretical and evidenced based approach to developing and operationalising implementation 
strategies to integrate interventions within their target settings (122, 174-177).  
 
There is now widespread recognition that implementation requires whole system change (178), 
implicating both the individual and organisation. However, despite a growing awareness that 
implementing innovations into routine practice is a complex, multi-faceted process, there 
remains a lack of knowledge about what methods and approaches are effective, for whom and 
in what contexts. The use of theory has been presented as a promising way to understand the 
‘black box’ of implementation, the premise being that if there is a better understanding of what 
happens when implementation activities are undertaken, then implementation will be more 
effective in the future (177). A greater use of explicit theory in order to understand barriers, 
design interventions, and explore mediating pathways and moderators has been advocated to 
advance of the science of implementation research (179). A systematic review of the use of 
theory in 235 evaluations of guideline dissemination and implementation (179) found that 
theories had been applied to the following areas of implementation research: guiding the choice 
of intervention; process assessment; exploring mediators and/or moderators of behaviour; 
exploring the effects of interventions; explaining the results of research and stimulating further 
discussion. Frameworks and models of implementation can be used as references to highlight 
the things to think about and pay attention to when undertaking implementation activities. The 
use of theory in implementation attempts also allows for easier replication of successfully 
implemented interventions. 
  
There are many theories of implementation in the literature and there is a lack of agreement on 
terminology, with the terms model, framework, and theory often used interchangeably. For the 
purpose of this thesis, Table 4-1, derived from work by Rycroft-Malone and Bucknall and Kitson 
et al. (177, 178), presents definitions for these three terms, draws distinctions between them, 
and highlights their applicability to implementation, although it is acknowledged that others may 
employ different definitions for these terms. 
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Table 4-1Definitions of implementation theories, frameworks and models 
Term Definitions How it may be applied to 
implementation 
Theory A theory is made up of concepts that 
characterise a particular phenomenon. Concepts 
are mental images of phenomena and 
propositions are statements about the concepts. 
 
A theory provides a logically coherent set of 
relationships. Theories can offer views on the 
causal relationships and seek to explain the 
phenomena, although from an interpretative 
perspective theories also play a vital role in 
offering explanations rather than causal 
relationships. Numerous theories may be 
consistent within the same framework. 
Theories can be used to 
describe, explain and 
predict implementation 
phenomenon.  
 
They can provide a guide 
to planning, intervention 
development, 
measurement/evaluation 
and for facilitating theory 
development 
Frameworks  A framework identifies a set of variables and 
relationships that should be examined in order to 
explain the phenomena. 
 
A conceptual framework is made up of sets of 
concepts and the propositions that integrate 
them into meaningful propositions. A conceptual 
framework need not specify the direction of 
relationships or identify critical hypotheses. 
 
 
Frameworks provide a 
heuristic for organising 
implementation efforts: 
what should be paid 
attention to, assessing 
barriers and facilitators, 
generating propositions, 
developing theory-based 
interventions, and facilitate 
a better understanding of 
what occurred during 
implementation 
Models Models represent a specific situation, are 
narrower in scope and more precise than a 
conceptual framework. 
 
The concepts within a model should be well 
defined, and the relationship between them 
specific.  
 
Models are representations of the real thing; they 
attempt to objectify the concept they represent.  
Models have much the 
same applicability to 
implementation as 
conceptual frameworks but 
are narrower in scope and 
situation and offer more 
precise representations 
and are more prescriptive.  
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A review by Tabak et al. (176) highlights the number and variety of implementation models (a 
term used by these authors to encompass both theories, frameworks and models) available. In 
their review they identified 61 models of implementation that have been designed specifically for 
use by researchers excluding models that are only focussed at national level implementation, or 
that apply only to individual behaviour change with no application to community or 
organisational levels.  
 
4.3 Selecting a theory, model or framework 
 
Given the large number of implementation theories, models and frameworks, it was important to 
articulate the rationale for the selection of one or more models to inform the implementation 
plan which was developed to implement the HeLP-Diabetes intervention into routine practice.  
 
It has been suggested that theory selection could be based upon whether a theory is robust, 
generalizable, stable, useful and appropriate (180, 181). However, in the implementation of 
complex interventions such as HeLP-Diabetes, it is likely that more than one theory will be 
required. Often the application of an overarching theoretical framework or model which 
encompasses more than one theory and often more than one model may be needed (177). For 
example a process model can be applied to how the implementation should be planned, 
organized and scheduled and impact models can be applied to hypotheses and assumptions 
about how implementation activities will facilitate a desired change, as well as the facilitators 
and barriers for success (182). 
 
In their review, Tabak and colleagues categorised implementation models by their construct 
flexibility, their focus on dissemination or implementation and their socioecological framework. 
Construct flexibility refers to whether the model is broad or operational in focus or somewhere in 
between. Broad models containing less well defined constructs allow greater flexibility in their 
application to an array of implementation activities and contexts. Operational models, on the 
other hand, provide more detailed and step-by-step constructs which are defined for particular 
activities and contexts. Models were also classified by where they fit on the continuum between 
dissemination and implementation (discussed in Chapter 1). The models were also categorised 
by the level at which they operate, for example, individual, organisation, community, systems 
and/ or policy levels.  
 
I used this categorisation as a tool for considering the selection of theories, frameworks and/or 
models to inform the HeLP-Diabetes implementation plan. The categories of construct flexibility, 
dissemination/implementation and socioecological framework were applied in turn to the context 
of the HeLP-Diabetes intervention and the implementation setting in order to select a theory, 
framework or model that was fit for purpose.  
 
Firstly, taking the category of construct flexibility, as this was the first time I had undertaken the 
task of implementing a new innovation I felt I needed to select a model that would help me to 
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consider the steps that needed to be thought through in order to successfully implement HeLP-
Diabetes. Therefore I selected an operational, step-by step model to assist me in the planning 
of the implementation plan. I also selected a broader theory of implementation that could be 
applied to the work of operationalising the plan, which helped with hypothesising about which 
implementation strategies might be effective in bringing about change and why, and to also 
provide an explanatory framework to consider barriers and facilitators that may arise.  
 
Secondly, applying the construct of dissemination vs. implementation led me to choose 
theories, frameworks and models that apply to implementation, rather than dissemination, as 
HeLP-Diabetes was a new intervention which was to be actively introduced into a specific 
setting.  
 
Thirdly, as the implementation of HeLP-Diabetes would involve changes in behaviour and 
practice at more than one socioecological level, including individual and organisational levels, 
theories, frameworks and models that applied at several levels were considered. 
 
As theories, frameworks and models of dissemination and implementation are derived from 
many disciplines including management, education and psychology, an additional criterion I 
included was that the selected theory, framework or model had previously been successfully 
applied to implementation planning in the healthcare setting. 
 
4.4 The selected model and theory 
Based on these criteria, I selected a model and a theory of implementation to inform the HeLP-
Diabetes implementation plan. Appendix D provides details of theories, frameworks and models 
which were not selected and the primary reasons for this. 
 
4.4.1 Effective Implementation: A Model  
Based on the above criteria the first model that I selected to guide the implementation of HeLP-
Diabetes was Grol, Wensing and Eccles’s model which they call “Effective implementation: a 
model” (2). This operational model has been developed to assist the implementation of change 
in healthcare and is applicable for planning change at several socioecological levels. This model 
provides a stepwise approach to guide the user through a series of deliberate steps in order to 
accomplish healthcare practice improvement.  
 
It provides a methodical process starting with the description of operational-change objectives 
and a thorough analysis of current practice, the target group, and the context where change 
should take place. The crucial step in the model, the development or selection of strategies, is 
facilitated by the previous steps. In this way, the model prevents the selection of standard but 
inappropriate solutions and facilitates better choices. Finally steps include operationalizing an 
implementation plan and the evaluation of both process and outcomes. The analytical approach 
to deliver a clear rationale for implementation is an essential feature of this model allowing it to 
be applied in a variety of settings. 
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This model describes the importance of selecting strategies to target change based on evidence 
or theory and urges the user to decide upon these through careful consideration of the target 
group, context, innovation and by using relevant evidence on barriers and facilitators and/or the 
selection of a suitable theory. As such, in order to hypothesize and make assumptions about 
how implementation activities facilitate the desired change, as well as the facilitators and 
barriers for success, I selected a theory of implementation (Normalisation Process Theory) to 
guide the choice of strategies to effect change and to understand arising barriers.  
 
4.4.2 Normalisation Process Theory 
 
Normalisation Process Theory (NPT) (7, 97) can be used to explain the processes by which an 
innovation becomes, or indeed fails to become, normalised into routine practice and offers a 
framework for assessing the conditions in which interventions become practically workable in 
healthcare. Normalization is defined as the embedding of a technology as a routine and taken-
for-granted element of clinical practice (183). This is different from decisions about diffusion or 
adoption as it focuses on the conditions of use and the behaviour of everyday users. Therefore 
this theory helps predict not only factors that may lead to an adoption decision, but what factors 
are important for something like HeLP-Diabetes to become sustained within the NHS. NPT may 
be operationalised at multiple socioecological levels including the individual, the organisation, 
the system and community. NPT has been applied as a theoretical framework in healthcare 
settings by several authors (184-187) and to the implementation of e-health (113, 188, 189).  
 
NPT, developed out of the Normalisation Process Model (190) is an action theory concerned 
with explaining what people do rather than their attitudes or beliefs. Action is categorised into 
four constructs representing the work that people do when they work around a new innovation, 
the four constructs, each of which comprise four sub-constructs are: Coherence, Cognitive 
Participation, Collective Action, and Reflexive Monitoring. Coherence is the sense-making 
work that people do individually and collectively when they are faced with operationalizing a 
new innovation. Cognitive participation is the relational work that people do to build and sustain 
a community of practice around a new technology. Collective Action is the operational work that 
people do to enact a new technology. Reflexive Monitoring is the appraisal work that people do 
to assess and understand the ways that a new innovation or set of practices affect them and 
others around them. Table 4-2 presents a description of NPT constructs and sub-constructs 
provided by the NPT online manual and toolkit (191).  
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Table 4-2 Constructs of Normalization Process Theory 
Construct Coherence Cognitive 
participation 
Collective action Reflexive 
monitoring 
Definition The sense-making 
work that people 
do individually and 
collectively when 
they are faced 
with the problem 
of operationalizing 
some set of 
practices. 
The relational 
work that people 
do to build and 
sustain a 
community of 
practice around 
a new 
technology or 
complex 
intervention. 
The operational 
work that people 
do to enact a set 
of practices. 
The appraisal 
work that people do 
to assess and 
understand the 
ways that a new set 
of practices affect 
them and others 
around them. 
Sub-
construct 
Differentiation Initiation Interactional 
workability 
Systematization 
Definition Sense-making 
work to 
understand how a 
set of practices 
and their objects 
are different from 
each other. 
Relational work 
to drive a set of 
practices 
forward.  
The interactional 
work that people 
do with each 
other, with 
artefacts, and with 
other elements of 
a set of practices, 
when they seek to 
operationalize 
them in everyday 
settings. 
Appraisal work to 
determine how 
effective and useful 
a set of practices 
are. This involves 
the work of 
collecting 
information in a 
variety of ways. 
Sub-
construct 
Communal 
specification 
Enrolment Relational 
Integration 
Communal 
appraisal 
Definition Sense-making 
work to build a 
shared 
understanding of 
the aims, 
objectives, and 
expected benefits 
of a set of 
practices. 
Relational work 
involved in 
collectively 
contributing to 
the work 
involved in new 
practices. 
 
The knowledge 
work that people 
do to build 
accountability and 
maintain 
confidence in a 
set of practices 
and in each other 
as they use them. 
Appraisal work to 
communally 
evaluate the worth 
of a set of 
practices. 
Sub-
construct 
Individual 
specification 
Legitimation Skill set 
workability 
Individual 
appraisal 
Definition Sense-making 
work to 
Relational work 
of ensuring that 
The allocation 
work that 
Appraisal work by 
individuals to 
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understand 
specific tasks and 
responsibilities 
around a set of 
practices.  
other 
participants 
believe it is right 
for them to be 
involved, and 
that they can 
make a valid 
contribution to it. 
underpins the 
division of labour 
that is built up 
around a set of 
practices as they 
are 
operationalized in 
the real world. 
appraise the effects 
on them and the 
contexts in which 
they are set.  
Sub-
construct 
Internalization Activation Contextual 
Integration 
Reconfiguration 
Definition Sense-making 
work to 
understand the 
value, benefits 
and importance of 
a set of practices. 
Relational work 
of participants to 
collectively 
define the 
actions and 
procedures 
needed to 
sustain a 
practice and to 
stay involved. 
The resource 
work. Managing a 
set of practices 
through the 
allocation of 
different kinds of 
resources and the 
execution of 
protocols, policies 
and procedures. 
Appraisal work by 
individuals or 
groups which may 
lead to attempts to 
redefine procedures 
or modify practices 
- and even to 
change the shape 
of a new technology 
itself. 
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NPT can be used as a heuristic tool to identify and explain factors that may inhibit the likelihood 
of a new innovation becoming normalised. NPT suggests that if an innovation can positively 
influence these constructs then it will be more likely to become part of routine practice than if it 
produces a negative effect. For example, with the construct of coherence, if healthcare 
professionals understand how a new technology is different to current ways of working, 
collectively agree about the purpose of the innovation, understand what the innovation requires 
of them and construct potential value of the innovation for their work the innovation is more 
likely to be embedded into practice than if they do not.  
 
With the cognitive participation construct, in order for an innovation to be embedded healthcare 
professionals must: agree that the innovation should be part of their work, buy in to the 
intervention, have a key individual(s) to drive the innovation forward and all continue to support 
the intervention.  
 
Positive appraisal of the collective action construct requires healthcare professionals to: perform 
the tasks required by the innovation and maintain their trust in each other’s work and expertise 
through the intervention. The work of the innovation must also be appropriately allocated to 
participants and adequately supported by its host organisation.  
 
Finally, to achieve positive reflexive monitoring healthcare professionals must access 
information about the effects of the intervention, individually assess the innovation as 
worthwhile, collectively assess the innovation as worthwhile and modify their work in response 
to their appraisal of the intervention (191).  
 
In the selection of specific strategies to effect change, NPT can be used as a sensitising tool to 
help in the assessment of whether a strategy is appropriate for the target group in the target 
setting. For example, when selecting a strategy to implement HeLP-Diabetes in routine practice, 
by considering the constructs of NPT I was able to question whether the target group 
understood what was being asked of them, whether it fitted with their skills and whether they 
reflected positively on it.  
 
4.5 Summary 
Implementation has been described as an active and systematic process of getting new 
evidence or innovations incorporated into routine practice (177) which involves identifying 
barriers to change and targeting strategies to promote change. In attempting to implement a 
complex intervention like HeLP-Diabetes I have suggested that it is necessary to consider the 
application of theory to the implementation process. Theories, frameworks and models of 
implementation can be applied to: implementation planning and organisation, forming 
hypotheses and assumptions about how implementation activities will facilitate a desired 
change; and to identifying and addressing the facilitators and barriers for success. 
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Using selection criteria derived from a systematic review of implementation models (176), I 
selected a planning model and a theory of implementation to inform the implementation plan for 
the implementation of HeLP-Diabetes into routine NHS practice. Grol, Wensing and Eccles’s 
model of effective implementation (2) was used when designing the approach to implementation 
and as a tool to guide thinking during the stages of planning. NPT has been selected as a 
theory by which to make theoretical assumptions about implementation strategies and was also 
used as a framework for assessing barriers and facilitators to the implementation that may arise 
and for evaluating the success of the implementation. 
 
In the next chapter the process for using this model and theory for developing the 
implementation plan for implementing HeLP-Diabetes into routine NHS practice is described. 
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5 CHAPTER 5: METHODS 1: DESIGNING THE IMPLEMENTATION PLAN FOR HELP-
DIABETES 
 
5.1 Chapter summary 
This chapter applies the implementation model and theory selected in the last chapter to the 
design of an implementation plan to implement the HeLP-Diabetes intervention into routine NHS 
practice. I present a detailed description of this plan here.  
 
5.2 Introduction 
In the last chapter, a model and theory of implementation were selected to inform the plan to 
implement HeLP-Diabetes into routine NHS practice. The use of theory in implementation can 
aid implementation planning and organisation and help form hypotheses and assumptions 
about how implementation activities will facilitate a desired change, as well as providing 
explanations to the facilitators and barriers that may be encountered (182). 
 
As described in Chapter 4, Grol, Wensing and Eccles’s model of effective implementation (2), is 
a planning model which provides a step-by-step guide to thinking about the implementation and 
the planning work that should be done before any attempt is made to implement an innovation 
in practice. The first part of this chapter outlines some of the main considerations raised by this 
model when thinking about implementing a new change in practice and how the model was 
applied to design an implementation plan for HeLP-Diabetes. In the second part of this chapter I 
will describe the specific approach that I took to implement HeLP-Diabetes in practice.  
 
5.3 Planning the implementation 
Grol, Wensing and Eccles’s model of effective implementation is designed to help plan and 
manage the change process. It provides a guide, in general terms, of how to set up a 
programme designed to introduce change in healthcare. The model includes a number of steps 
or processes to introduce change (Figure 5-1), the sequence of which and applicability depends 
upon the specific circumstances. The steps of the model to consider before the implementation 
takes place are described below, along with a description of how they have been addressed for 
the implementation of the HeLP-Diabetes intervention.  
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Figure 5-1 Stages for implementing change from Grol, Wensing and Eccles’s model of effective 
implementation 
 
 
 
5.3.1 Step 1: development of concrete proposals/ targets for improvement or change. 
The model suggests that innovations must be of good quality, fit in with the needs of the target 
group, be useable and easily available and be designed attractively. A good understanding of 
the characteristics of an innovation that are likely to affect its ultimate adoption is required. 
Characteristics may include: 
 The way the development has taken place- the quality and credibility of the process 
 Developers- the amount of support for the innovation 
 Design- it’s accessibility and attractiveness 
 Scope for adapting the innovation to suit the local situation 
 
As well as this stage’s emphasis on designing a fit for purpose, easy to use and accessible 
intervention (a discussion of which is outside of the scope of this thesis as it applies to the 
development stage of HeLP-Diabetes), this stage of the planning model stresses the need to 
have clear targets for the desired change. In developing an implementation plan the tasks that 
need to be undertaken by healthcare professional and the goals of implementation must be 
made clear (2).  
5.3.1.1 Step 1 applied to the implementation of HeLP-Diabetes 
The desired tasks required of healthcare professionals in order to implement HeLP-Diabetes 
within routine practice were to agree to adopt HeLP-Diabetes, recommend the use of HeLP-
Diabetes to patients, assist patients to register to use HeLP-Diabetes and facilitate patient use. 
How practices utilized HeLP-Diabetes with patients once they agreed to adopt it was governed 
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by some prescriptive requirements placed on use (including the need for patients to be 
registered to use it and complete an online registration form) but also, in order promote 
implementation, there was a high degree of flexibility and individuality in the way that HeLP-
Diabetes was offered to patients by each practice. In order to make sense of HeLP-Diabetes it 
was important for healthcare professionals (individual or groups or both) to decide how HeLP-
Diabetes best fitted in with their current practices including the way they worked with patients 
with type 2 diabetes and how they allocated resources. For example, some practices wanted to 
use HeLP-Diabetes as a tool at annual review, others saw it as a resource health care 
assistants could use with patients during routine appointments, others dedicated a Nurse to 
take the lead on offering HeLP-Diabetes to all type 2 patients.  
 
The desired targets for change were therefore for practices to adopt HeLP-Diabetes as an 
additional service for their patients with type 2 diabetes, which required providing resources 
(time, healthcare professionals, and space) to offer the website to patients. For healthcare 
professionals in the practices additional behaviours were required to recommend HeLP-
Diabetes to patients and to register the patients on the website. The desired behaviours from 
patients were to register to HeLP-Diabetes and use it.  
 
5.3.2 Step 2: analysis of performance, target group and setting 
The second step outlined by the model is to perform an analysis of the context within which 
changes in routines are to take place, the characteristics of the target group, the factors that 
stimulate and hamper change and the aspects of performance that show the greatest deviation 
from the proposed behaviour. Factors that determine whether the implementation is successful 
or not may be connected to the setting in which the change is to be implemented, the 
relationship between individuals within the setting, the goals of the implementation, the actual 
care provision proposed, the professionals who have to carry out the innovation, the patients 
who have to co-operate with the implementation, the resources available and the organisational 
or structural conditions for its effective introduction.  
 
Another analysis suggested within this step is to measure the current practice and compare how 
it matches to the desired practice. The measurement of current practice identifies where it does 
not match the patterns of care proposed by a guideline, best practice or new procedure. Based 
on this data it is possible to identify what changes in current practice are needed and which 
aspects of care the implementation plan should target. These may include:  
 To start a completely new routine, the use of a new technology 
 Stop a current routine 
 To reduce specific routines 
 To adapt specific routines  
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5.3.2.1 Step 2 applied to the implementation of HeLP-Diabetes 
Target group and setting: 
Although the HeLP-Diabetes intervention is designed to be used by patients, it is designed to be 
offered to patients as an NHS service and therefore the focus of this thesis is on the 
implementation of HeLP-Diabetes into the NHS where it will be offered to patients as a service 
by healthcare professionals. NHS services that could potentially offer HeLP-Diabetes to patients 
include GP practices, community clinics and hospital clinics. 
 
It was hoped that patients would be referred to HeLP-Diabetes during routine appointments and 
therefore the target groups of the implementation were those healthcare professionals involved 
in the delivery of routine appointments to patients with diabetes including GPs, nurses and 
health care assistants, consultants and psychologists. Target-group factors commonly found in 
healthcare settings that can stimulate or hinder the implementation of innovations include 
healthcare professional knowledge, skills, motivation, and social influence amongst colleagues 
(192). Healthcare setting factors that might influence the implementation include features of the 
organisation such as the available facilities and material and the structure such as protocols and 
routines.  
 
Different healthcare professional groups may be the target of strategies to promote 
implementation at different stages of the implementation process. It may be important to target 
interventions designed to engage healthcare professional and persuade them to adopt HeLP-
Diabetes at the GP and practice manager levels as these healthcare professional groups have 
the authority to agree to adopt a new service. Interventions that target changing behaviour to 
perform new tasks i.e. the work of offering HeLP-Diabetes to patients may be better targeted at 
nurses who are likely to be the group within practices who will offer HeLP-Diabetes to patients 
as they are the group who predominantly currently provide patients with referrals to diabetes 
education.  
 
Current practice: 
With the implementation of HeLP-Diabetes I aimed to introduce a new technology which was a 
completely new and additional routine (to register patients), but could also involve healthcare 
professionals adapting specific existing routines (such as diabetic appointments and referring 
patients to diabetes educational programmes) to fit the introduction of HeLP-Diabetes into 
existing practice. Box 5-1outlines the NICE guidelines related to offering education to patients 
with diabetes which was used as an indication of current practice.  
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Box 5-1 Healthcare professional guidelines for offering education to patients with type 2 
diabetes 
Healthcare professional guidelines for offering education to patients with type 2 diabetes 
The current healthcare professional guidelines for offering education to patients with type 2 
diabetes laid out by the National clinical guideline for management of type 2 diabetes in primary 
and secondary care (193) recommends NHS healthcare professionals:  
1.  Offer structured education to every person and/or their carer at and around the time of 
diagnosis, with annual reinforcement and review. Inform people and their carers that 
structured education is an integral part of diabetes care. 
2. Select a patient-education programme that meets the criteria laid down by the Department 
of Health and Diabetes UK Patient Education Working Group. 
 
However, prior to the start of the study, data from the National Audit Office suggested that only 
11.5% of people with type 2 diabetes were being offered structured education (194). This 
suggested that the majority of healthcare providers found it difficult to implement and resource 
quality education programmes that meet these standards and that there appeared to be an 
urgent need to ensure that all people with type 2 diabetes were offered high-quality structured 
education (193). This suggested that the work of referring patients to HeLP-Diabetes would be 
in line with what healthcare professionals were expected to do for patients with type 2 diabetes 
at that time, but that strategies may be needed to improve the referral rates. The additional work 
of having to register a patient to use the HeLP-Diabetes website may need additional strategies 
to bring about this behaviour in healthcare professionals.  
5.3.3 Step 3: selection of the implementation strategies 
Grol, Wensing and Eccles describe the stages of the implementation process as: 
 Orientation 
 Insight 
 Acceptance 
 Change and  
 Maintenance  
 
The model suggests that each stage may require a selection of different strategies. Strategies in 
the ‘Orientation’ phase must promote awareness of the innovation and stimulate interest and 
involvement, in the ‘Insight’ phase they must create understanding and develop insight into the 
routines of healthcare professionals, strategies in the ‘Acceptance’ phase should foster a 
positive attitude to the change and create positive intention or decisions toward change. In the 
‘Change’ phase strategies need to allow healthcare professionals to try the change out in 
practice and confirm benefit and value. Strategies in the ‘Maintenance’ phase need to facilitate 
the integration of the new practice into routines and embed the practice within the organisation. 
These stages will be used to guide the implementation plan set out in the next section.  
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5.3.3.1 Step 3 applied to the implementation of HeLP-Diabetes  
In this stage the factors I identified in the first two steps, along with other relevant information, 
were used to develop methods and strategies to implement HeLP-Diabetes. The selection of 
strategies to implement HeLP-Diabetes was based on: early development work with healthcare 
professionals (conducted as part of the programme grant); the knowledge gained from 
reviewing literature on the barriers and facilitators to implementing e-health; the understanding 
of target groups, setting and current practice; as well as NPT, which can be used as a 
sensitizing tool to think about how methods and strategies may impact on the work of healthcare 
professionals as well as a tool for understanding barriers and facilitators and for selecting 
appropriate strategies to target these.  
 
5.3.4 Step 4: development, testing and execution of an implementation plan 
In this stage, the methods and strategies are developed into a plan of action. Attention has to be 
paid to effective dissemination (to arouse interest and to guarantee sufficient knowledge) both 
to encourage the intervention’s acceptance (to foster a positive attitudes and willingness to bring 
about real behavioural change) and to promote the actual implementation and integration into 
normal working routines and care processes.  
5.3.4.1 Step 4 applied to the implementation of HeLP-Diabetes  
The development of the implementation plan (described in the next section) was an iterative 
process. Grol, Wensing and Eccles recommend starting on a small-scale and testing strategies 
on a modest sized motivated group, as what has been developed before implementation usually 
turns out differently when put into practice (2). Therefore, the intention was for the first iteration 
of the implementation plan to be tried out on a small group of GP practices. Following the 
implementation of HeLP-Diabetes in this first batch of practices, a staged roll out was then 
planned for the remaining services, whereby the implementation plan would be targeted at 
another few practices at a time, and then another few, as opposed to a widespread 
implementation targeted at all practices at once. The aim of the staged roll out was to learn from 
the experience of implementing on a small scale and apply this learning to adapting strategies 
for implementation at subsequent practices and to avoid implementing unsuccessful strategies 
across all practices.  
 
5.3.5 Step 5: evaluation and adaptions to the plan 
A final step in the model is to evaluate the results of the implementation. An evaluation will 
answer questions such as, have the goals been achieved? Has the desired change occurred? 
And where this is not the case, to consider what can be done to ensure better success. 
Evaluation should be a continuous process and may result in: 
 Adaptation of the plan 
 Supplementary analysis of stimulating or hampering factors 
 Further strategies and measures to bring about change 
 Revise the plan and conduct widespread implementation 
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5.3.5.1 Step 5 applied to the implementation of HeLP-Diabetes  
Chapter 6 outlines the methods selected to evaluate the implementation of the HeLP-Diabetes 
intervention within routine practice and Chapter 7 details the adaptations to the implementation 
plan which arose in response to identified challenges, barriers and facilitators.  
 
5.4 The HeLP-Diabetes Implementation Plan  
The first iteration of the HeLP-Diabetes implementation plan which was structured around the 
stages of the implementation process (Orientation, Insight, Acceptance, Change and 
Maintenance) outlined by Grol, Wensing and Eccles’s model is outlined in this section. This is a 
very linear description of the implementation plan for the purpose of presenting it easily in this 
thesis. Normalisation Process Theory was applied in the development of this plan to inform the 
selection of strategies to implement HeLP-Diabetes (as summarised in Table 7-3 on page 140).  
 
5.4.1 Orientation 
This part of the plan was designed to employ strategies that would raise awareness of HeLP-
Diabetes and stimulate interest. Healthcare professionals had to be made aware that HeLP-
Diabetes was available.  
 
Strategy:  
To create initial awareness of HeLP-Diabetes, an email was sent to GP practices. This email 
was designed to concisely inform healthcare professionals that there was a new tool available 
to support their patients with looking after their diabetes.  
 
The cost of a new technology was a common theme that arose from the systematic review on 
the barriers and facilitators to implementing e-health. In order to prevent any barriers related to 
costs of the technology itself, the email made clear that HeLP-Diabetes was a free tool being 
offered to practices.  
 
In order to build credibility about the source of the website and to waylay any barriers related to 
commercial websites (identified in early development work with healthcare professionals as a 
potential barrier to implementation), it was made clear that HeLP-Diabetes had been developed 
at a University as part of a research project.  
 
It was hoped that the issues of type 2 diabetes and self-management would be interesting to the 
GPs receiving the email, as these were current NHS areas of priority. The emails were sent to 
people identified by Elizabeth Murray as having an interest in diabetes within the practice.  
 
5.4.2 Insight 
The target group had to understand what HeLP-Diabetes involved and the arguments behind it. 
Care providers needed to know exactly what was expected of them and why it was important.  
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Strategy: 
NPT suggests, that in order for a new innovation to become routine in practice it must be 
coherent to those who will be working with it. Communal and individual specification are two 
components of the coherence construct of NPT that postulate that in order to operationalize a 
new innovation, shared and individual understanding of the aims, objectives and benefits of a 
set of practices must be built. Following the initial email contact made with practices, 
arrangements were made to set up a meeting with practices who had expressed an interest in 
finding out more about HeLP-Diabetes. The purpose of these meetings was to provide 
healthcare professionals with information about HeLP-Diabetes and the implications for their 
working practice to allow them to decide whether or not to adopt it in their practice.  
 
Specific strategies to engage healthcare professionals during these meetings included: 
presenting the evidence base behind the development and content of HeLP-Diabetes; outlining 
the potential benefits to the practice and patients of adopting HeLP-Diabetes; demonstrating 
how HeLP-Diabetes meets identified clinical needs; and through a live demonstration, showing 
the usability and attractiveness of HeLP-Diabetes.  
 
Following these meetings healthcare professionals were given time to ask questions and have 
queries answered. All of these questions were recorded and were proactively addressed in 
subsequent meetings with other practices. The intention was to use the learning gained from 
the questions and concerns that arose at these early meetings and apply it to future meetings. 
The intention was that if needed, additional strategies would be incorporated into the plan to 
address barriers that were identified at these early stages.  
 
Access to practice meetings was difficult to achieve and the length of time for the meetings was 
limited due to the busy nature of General Practice. In order to engage practices quickly and 
build credibility within these meetings Elizabeth Murray attended these meetings with me. This 
increased the NPT construct of coherence as her professional experience being a GP meant 
she could address concerns that arose at the practice meetings about the use of HeLP-
Diabetes in General Practice.  
 
5.4.3 Acceptance: 
Grol, Wensing and Eccles’s model suggests that at this stage healthcare professionals must 
gain: insight into exactly what is being recommended; an understanding of what is involved for 
them; acceptance, weighing up the advantages and disadvantages; and becoming convinced 
that the innovation is valuable, effective, useful or that it leads to saving time or money (2). 
Factors that may hinder a positive appraisal include healthcare professionals viewing HeLP-
Diabetes as unfeasible in their own work setting, if they doubt the scientific basis of the 
proposed change or if they doubt the credibility or expertise of those who developed HeLP-
Diabetes. The work required of healthcare professionals in order to implement HeLP-Diabetes 
is detailed in Box 5-2. 
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Box 5-2 The work of implementing HeLP-Diabetes required by healthcare professionals 
The work required of healthcare professionals in order to implement HeLP-Diabetes was 
to: 
 Identify patients who are suitable to use the website 
 Recommend the use of the website to the patients 
 Conduct a facilitation appointment with patients. This facilitation appointment was initially 
designed to take 40 minutes and achieve the following objectives:  
 
 Introduce patients to HeLP-Diabetes providing explanations of what it is, how it’s been 
developed, what it can be used for. 
 Register patients on HeLP-Diabetes so that they have a username and password to access 
the content. 
 Collect patient registration data on the online form including; contact details (name, email 
address, contact telephone number), socio-demographic details (date of birth, gender, 
ethnicity) questions about diabetes (date of diagnosis or duration of diabetes, how diabetes 
is managed, practice attended, areas of diabetes self-management that they would like help 
with) computer skills and internet access in order to tailor content and send engagement 
emails to patients and describe the type of patients who register.  
 Facilitate access: Once a patient has been registered healthcare professionals will 
demonstrate how to locate the website and how to login. 
 Facilitate use: Healthcare professional will show patients particular parts of HeLP-Diabetes 
that are of interest to the patient. The particular areas of interest can be gained from 
discussions with the patient, from responses to the question on the registration form about 
what help patients want or from knowledge of the patient. 
 Provide the patient with an activity booklet which is designed to be used at home. The 
booklet recommends specific activities that can be undertaken on the website and details of 
how to locate the relevant webpages 
 Encourage patient continued use of the website through discussions about it in routine 
appointments 
 
 
Strategy: 
One strategy to promote positive adoption decisions is to reduce the uncertainty an individual or 
a group may have about the new innovation. Grol, Wensing and Eccles state that an opportunity 
to try out the new innovation on a small scale is important to allow the target group to gain 
experience in using it and to learn the skills involved (2). This strategy also fits with NPT which 
holds that healthcare professionals must make sense of the new innovation and understand 
how it will fit in with existing practices. In order for healthcare professionals to try out HeLP-
Diabetes they were offered a username, password and the URL to access it so that they could 
explore the website themselves. The collective action construct of NPT refers to the operational 
work that people have to do to enact a new innovation, providing healthcare professionals with 
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access to HeLP-Diabetes allowed them to see how HeLP-Diabetes fitted with the skill sets of 
the healthcare professionals in the practice (skill set workability), what resources were needed 
to make it part of routine practice (contextual integration), what knowledge was needed to be 
confident with HeLP-Diabetes as a new way of working (relational integration), and the impact 
that HeLP-Diabetes would have on interaction with colleagues and patients (relational 
integration). 
 
In order to increase acceptance I had planned to work with practices individually to devise ways 
to ensure that HeLP-Diabetes worked well in their setting, with their healthcare professionals 
and patients. It was hoped that by allowing healthcare professionals the flexibility to use HeLP-
Diabetes in a way that fitted best with their current practices they would have more positive 
attitudes towards it.  
 
5.4.4 Change: 
Once a decision to adopt HeLP-Diabetes had been made by the practice, the overt work of 
implementing it into routine practice would begin. Grol, Wensing and Eccles suggest that 
specific training may be required at this stage and that the temporary help of experts can 
support people through this stage. In this stage healthcare professionals had to be convinced 
that HeLP-Diabetes delivered the anticipated advantages. Collecting data and providing 
feedback about the achievements and documenting any positive reactions from patients can 
support the motivation to continue during this phase.  
 
Strategy: 
Once a practice had decided to adopt HeLP-Diabetes, healthcare professionals were provided 
with a training session. As identified in the systematic review, training healthcare professionals 
on using a new innovation is a strategy that can facilitate implementation or impede it if not 
provided, or provided inadequately.  
 
Training was open to any healthcare professional, and the decision as to which healthcare 
professional(s) attended the training session at each practice was left up to the practices. In this 
way, the work of collective action was delegated to the practice who had to decide who would 
do the work of implementing HeLP-Diabetes (initiation) and how it would be organised 
(enrolment). It was important for the practice to make this decision, as they had knowledge 
about the availability of resources and what was likely to work best in their current routines. NPT 
suggests that it is important that new ways of working fit well with the specific skill sets of the 
people doing the work; the work of implementing HeLP-Diabetes appeared to align well with the 
skill set of nurses who work closely with patients with diabetes, have a good knowledge about 
which patients may benefit from HeLP-Diabetes, have frequent appointments designated to 
patients with diabetes, and have experience in dealing with self-management issues. As such, I 
planned to recommend to practices that nurses may be particularly suitable to attend the 
training sessions and use HeLP-Diabetes with patients.  
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The aims of the training session were to inform healthcare professionals about HeLP-Diabetes 
and to teach them how to use it. Specific objectives within the training were to:  
 Register healthcare professionals on HeLP-Diabetes so that they have a username and 
password to access the content. 
 Highlight core parts of the website and teach them how to access these. 
 Demonstrate how to register a patient on the system. 
 Provide an opportunity for healthcare professionals to role play the patient registration 
process. 
 Provide paper based resources. These were designed to act as aids to registering 
patients and demonstrating HeLP-Diabetes to patients. 
 Provide an opportunity for healthcare professionals to ask questions and discuss 
logistical aspects of using HeLP-Diabetes with patients. 
 
Once HeLP-Diabetes was being used by patients it was planned that I would collect feedback 
from them on their experiences of using the website and feed this back to practices to 
encourage them to continue offering the website to their patients.  
I planned to offer my time to practices during this stage in order to facilitate the change at the 
practice. It was intended that I would offer each practice help in doing the tasks required to get 
patients using the website, with a view to demonstrating the ease of the procedures and 
teaching healthcare professionals to do it themselves. The idea was that once they had 
observed me doing it they would feel confident to take over and to undertake these tasks 
themselves.  
 
5.4.5 Maintenance: 
Once a way of working with HeLP-Diabetes had been decided upon and was being used within 
a practice, strategies were needed to encourage its continued use and to facilitate these new 
working practices becoming part of routine practice. The NPT construct of reflexive monitoring 
describes the work that healthcare professionals do to assess a new innovation once in 
practice; systemization is the evaluation work that can be done either formally or informally to 
determine how effective or useful a new innovation is. Communal and individual appraisals take 
place which include discussions and interactions about the effectiveness and usefulness of the 
new innovation and appraisals about how the new innovation is impacting on individuals, work 
practices, patients and the context. Appraisal work may lead to reconfiguration where processes 
and innovations are modified to make them more workable in practice. 
 
Strategy: 
Implementation strategies including regular communication with practices, making frequent 
contact with individual healthcare professionals, and providing on-going support to problem 
solve and register patients were employed to facilitate positive reflexive monitoring, 
maintenance and continued use of HeLP-Diabetes. At this stage an adaptive approach was 
taken to addressing barriers that arose and further strategies were employed to tackle them as 
and when they were identified. It was planned that continued feedback would be provided to 
92 
 
practices about their progress in signing patients up to HeLP-Diabetes. Feedback, defined as 
returning information about their actions to professionals, practices or institutions to increase 
insight into these actions (2), is a common strategy in the implementation of innovations in the 
healthcare setting (195). Individual feedback was planned to be given to practices via email and 
telephone calls at regular intervals, especially to practices that were slow to sign patients up to 
HeLP-Diabetes. A newsletter was also sent to all practices which aimed to remind healthcare 
professionals about using HeLP-Diabetes and also contained figures on how practices were 
doing at signing patients up to HeLP-Diabetes.  
 
In order to keep patients motivated, engaged and informed about HeLP-Diabetes healthcare 
professionals were asked to regularly encourage patients’ use of HeLP-Diabetes. This could 
have been done by mentioning HeLP-Diabetes in consultations, asking patients how they were 
getting on with using it, setting reminders with patients to log on, posting out HeLP-Diabetes 
related information and giving patients quick follow up phone calls to check on their use of 
HeLP-Diabetes and provide any additional support required in using it. Newsletters and emails 
were also regularly sent to registered patients (see Chapter 2) that included links to content, 
suggestions of activities to complete, ways of connecting with other users, and contact details 
for support and suggestions. 
 
5.5 Discussion 
This chapter presents the first iteration of an implementation plan designed to assimilate HeLP-
Diabetes into routine NHS practice. This plan was constructed using a model and theory of 
implementation. The importance of planning implementation has been stressed by models of 
implementation which recommend that all steps in the implementation process are given 
attention before the implementation commences (2). In developing this implementation plan, 
Grol, Wensing and Eccles’s model of effective implementation was used as a guide to identify 
the important stages of the implementation process and to guide the selection of strategies at 
each of these stages to promote implementation. NPT was used to guide the selection of 
strategies by taking into consideration the work that individuals must do to make HeLP-Diabetes 
part of routine practice and by selecting strategies that promote the constructs of NPT that may 
increase implementation success.  
 
This plan was designed to be iterative and flexible and was expected to evolve over the course 
of the implementation period. In Chapter 7 changes that were made to the implementation plan 
are documented. 
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6 CHAPTER 6: METHODS 2: METHODS TO EVALUATE THE IMPLEMENTATION PLAN 
 
6.1 Chapter summary 
This chapter describes the methods selected to evaluate the implementation plan and provides 
details of the study design, methods, data collection and data analysis. 
 
6.2 Introduction 
The plan to implement HeLP-Diabetes into routine NHS practice was developed drawing on a 
model of effective implementation (2) to guide the different stages that an implementation 
process can take (see Chapter 5). The final stage of this model describes the need to evaluate 
the implementation plan. Grol, Wensing and Eccles et al (2) state that the results of an 
evaluation are needed to determine whether the energy that has been invested into the 
implementation planning has led to the desired change and, if not, consider what changes can 
be made. Evaluations of implementations may result in: adaptations to the proposal for change, 
for instance by revising the goals if these prove to be unrealistic; supplementary analysis of 
promoting or inhibiting factors; further strategies and measures to bring about change, or 
revisions to the plan or the conduct of the implementation. Grol et al stress that although 
evaluation is the final step in their model, it should not be the final step of an implementation 
project. Ideally, the evaluation should be conducted in parallel with implementation, with 
constant assessment of whether the desired change is being achieved leading to constant 
improvement and revisions of the processes and strategies of implementation. This approach 
lends itself to an iterative research methodology that allows adaptations to the intervention and 
the implementation plan to be made throughout the implementation phase in response to 
findings from the evaluation. 
 
As discussed in Chapter 1, there are several types of implementation studies described in the 
literature (90). The MRC describe implementation studies that establish the real-life 
effectiveness of interventions in unselected populations as Phase IV studies (196). The aims of 
these implementation studies include determining intervention effectiveness over the long term 
and identifying rare or long term adverse effects. In contrast, there are implementation studies 
that aim to determine how well interventions are taken up and used in unselected populations 
(197, 198). Researchers from the Veterans Association Quality Enhancement Research 
Initiative (VA QUERI) have argued for “hybrid” designs, which combine both types of research 
question (94). They have suggested a taxonomy for such “effectiveness-implementation hybrid 
designs” where type 1 tests effects of a clinical intervention on relevant outcomes while 
observing and gathering information on implementation; type 2 tests clinical and implementation 
interventions / strategies equally; and type 3 tests an implementation strategy while observing 
and gathering information on the clinical intervention’s impact on relevant outcomes  
 
This current study is of the latter type of implementation research (type 3) as its primary 
objective is to describe the uptake and use of the HeLP-Diabetes intervention in routine NHS 
practice.  The effectiveness of the HeLP-Diabetes intervention is being assessed in a separate, 
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parallel randomised control trial (199)) described in Chapter 2. Studies like this that describe the 
adoption and use of interventions in routine practice and the factors that influence their 
implementation are valuable as in order for interventions to be effective, they must be used (55). 
Data from these studies provide valuable additional data to data collected in even very 
pragmatic randomised control trials (discussed in Chapter 2) such as what happens in routine 
practice when interventions are made available, what actions and resources are needed for 
successful implementation, what actions and resources are needed in order to realise potential 
benefits of the intervention (94, 200). 
 
This chapter describes the methods that have been selected to evaluate the implementation of 
the HeLP-Diabetes intervention within routine NHS practice. A comparison between the 
methods of this implementation study and that of the RCT it was conducted alongside is 
presented in Chapter 2.  
 
6.3 Aims/objectives 
The aim of this evaluation was to evaluate the implementation of HeLP-Diabetes into routine 
National Health Service (NHS) practice.  
 
The specific research questions addressed were:  
 To what extent was HeLP-Diabetes adopted by NHS services? 
 To what extent was HeLP-Diabetes implemented within NHS services? 
 What was the uptake of HeLP-Diabetes by patients? 
 How was HeLP-Diabetes used by patients? 
 Were there any factors that predicted patient use of HeLP-Diabetes? 
 Were there any factors that predicted HeLP-Diabetes registration method?  
 What barriers and facilitators did staff identify to the adoption and implementation of 
HeLP-Diabetes by NHS services? 
 What barriers and facilitators did patients identify to the uptake and use of HeLP-
Diabetes? 
 
Please see the glossary on page 13 for definitions of the following terms related to the research 
questions: adoption, implementation, uptake and use. 
6.4 Study design 
The implementation of HeLP-Diabetes was evaluated using a multi-site case study approach 
using mixed methods. The evaluation was ongoing for a period of 26 months between July 2013 
and August 2015 and was iterative in nature. As such the procedures detailed in this section 
were adapted and modified over the duration of the study period. Changes to the 
implementation plan are detailed in Chapter 7 (section 7.4) and changes to the research 
protocol are described below in section 6.5.7.  
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6.4.1 Case study design 
A case study approach allows detailed, multi-faceted explorations of complex issues in their 
real-life settings and is a particularly useful approach when there is a need to obtain an in-depth 
appreciation of an issue, event or phenomenon of interest, in its real-life context (201). Case 
studies can be used to explain, describe or explore events or phenomena in the everyday 
contexts in which they occur (202). They address issues such as how interventions are being 
implemented and received on the ground, why one implementation strategy might be chosen 
over another and offer insights into gaps that exist in intervention delivery. An instrumental case 
study approach was selected for this study. In instrumental case studies the focus of the 
research is often known in advance and the study is designed around established theories or 
methods (203). As this study is driven by the research questions and has a theoretical 
underpinning (based on Normalisation Process Theory (NPT)), this type of case study was 
deemed most appropriate. The strengths of this design is that it allows an in-depth 
understanding and appreciation of a particular issue and offers thick description of a particular 
site (204) . The selected case for study was a whole Clinical Commissioning Group (CCG) 
which contained 37 General Practices, a community diabetes service and a Hospital Trust. 
 
Selecting an appropriate case is crucial to case study research. In selecting case sites the 
following issues should be considered. Sites should be open to allowing the research team 
access, which may include access to a group of individuals, the organisation, or processes. As 
the researcher needs to come to know the case study sites well and work cooperatively with 
them, selected case sites need to be hospitable to the inquiry if they are to be informative and 
answer the research questions (203). Access to sites is of importance and should be a key 
consideration (201). The CCG selected for this research study was chosen pragmatically: firstly, 
the CCG was familiar to the study team, it was local and therefore physical access to sites was 
easy; it was also known as being receptive to research and new innovations; in addition the 
CCG was in the process of introducing initiatives surrounding self-management and diabetes 
and were therefore considered to be receptive to an intervention which aimed to support patient 
self-management for people with diabetes.  
One major feature of case study methodology is that different methods are combined with the 
purpose of illuminating a case from different angles. In order to develop a thorough 
understanding of the case, data derived from multiple sources of evidence are collected, using a 
range of techniques. Approaching the same issue from different angles can help develop a 
holistic picture of the phenomenon (201). In this evaluation a mixed methods approach which 
employed qualitative and quantitative approaches to explore the implementation of HeLP-
Diabetes was taken.  
 
6.4.2 Mixed methods design 
The social sciences have traditionally been dominated by two opposing philosophical positions; 
positivism and constructionism. Positivism asserts the existence of ‘social facts’ that exist 
independently of the actions of researchers. Constructionism states that there are no ‘social 
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facts’, but rather, multiple forms of social reality, which are constructed by researchers and their 
participants. These issues are important, as they have implications for the methodological 
decisions that are made during a research study. For example, researchers who take a stance 
akin to positivism are concerned with objectivity and believe that the best way to investigate 
social phenomena is by applying the research methods adopted by the natural sciences, whilst 
researchers who adopt a constructionist stance query if objectivity is ever possible and instead 
embrace reflection upon the values, assumptions and objectives researchers bring to the 
research.  
 
In terms of methodological approach, quantitative methodologies tend to fit more readily with a 
positivist paradigm, whilst researchers who employ qualitative methods tend to fit more 
comfortably with a constructionist position. Advocates of the ‘incompatibility thesis’ state that 
qualitative and quantitative methods should not be mixed, because their underlying 
assumptions about the nature of knowledge are incompatible (205), with the suggestion 
researchers should situate themselves within one philosophical paradigm. In recent years 
however, particularly with the growth in applied research in areas such as health or social care, 
where researchers are interested in practical, rather than philosophical questions (206), there 
has been an increase in the number of studies which have adopted a mixed method approach. 
Mixed method researchers identify their concerns as primarily resting with selecting the best 
method for answering a research question, and so rather than aligning themselves with a 
particular ontological perspective, work across both positivist and constructionist worldviews 
(207). This is known as a pragmatic approach (208) and allows researchers to draw upon the 
strengths of both research paradigms. Philosophical issues about the nature of knowledge are 
still considered by pragmatists, but are used to inform, rather than dictate, their choice of 
methods.  
 
This PhD adopted a mixed methods approach with both quantitative and qualitative approaches 
used to describe the implementation, uptake and use of HeLP-Diabetes. The reasons that a 
mixed methods research design was selected for the current study were twofold. Firstly, within 
this thesis there were research questions that were addressed most suitably either with 
quantitative methods (for example: ‘What was the uptake of HeLP-Diabetes by patients?’) or 
through qualitative enquiry (for example: ‘What barriers and facilitators did patients identify to 
the uptake and use of HeLP-Diabetes?’). Secondly, there were research questions that 
benefited from the combination of both approaches in order to bring together a more 
comprehensive account (for example: ‘How was HeLP-Diabetes used by patients?’). 
In this thesis, quantitative and qualitative data were collected independently during the same 
time period of this study. The two approaches were given equal priority and were kept separate 
during data analysis. The two approaches were synthesised at the point of data interpretation in 
order to provide a more complete understanding of the research questions by obtaining and 
merging different but complementary data on the same topic. By comparing and synthesising 
the results in the discussion, conclusions and inferences could be drawn that reflected what was 
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learnt from illustrating quantitative results with qualitative findings and synthesising results to 
develop a more complete understanding of the research question (209).  
 
6.5 Methods 
6.5.1 Ethics and research governance 
Ethics and research governance approval for the study design, materials and procedures were 
obtained from the NRES Committee East Midlands-Leicester ref: 13/EM/0033, the local Trust 
(Islington) and the Whittington Hospital. Letters of access were issued by the Trust for the 
research to be conducted with primary care healthcare professional and patients at practices in 
their Trust. University College London was the study sponsor. 
 
6.5.2 Steering group 
Ongoing conduct of the study was monitored and guided by a multidisciplinary project steering 
group made up of two academic GPs (Elizabeth Murray and Kingshuk Pal), a GP with 
experience of implementing e-health (Brian Fisher), a medical sociologist (Fiona Stevenson), a 
consultant in diabetes (Maria Barnard) a consultant cardiologist with experience of 
implementation within the NHS (David Patterson), a Professor of Healthcare Innovation (Carl 
May), two statisticians (Michael Sweeting and Mohammed Huddah), a healthcare librarian 
(Richard Peacock), two Health Psychologists (Susan Michie and Lucy Yardley), two Health 
Economists (Steve Parrott and Jinshuo Li) and two user representatives (Bindie Wood and 
Malcolm Knox). The steering group met quarterly to review progress, advise on issues relating 
to recruitment and data collection and to discuss results. 
 
6.5.3 Recruitment 
6.5.3.1 Site recruitment 
The research was conducted in GP practices, community diabetes clinics and hospital based 
diabetes clinics within an inner city London Clinical Commissioning Group (CCG): There were 
37 GP practices, a community diabetes service and one hospital running diabetes clinics within 
this CCG at the commencement of this study. Each individual service, practice or clinic shall be 
referred to as sites throughout this chapter.  
 
As the implementation of HeLP-Diabetes was planned to take place in batches of sites at a time 
(see implementation plan in Chapter 5), I planned to start with sites within the CCG which were 
known to be research friendly, and then move on to offer HeLP-Diabetes and participation in the 
research to further batches of sites at a time. Research friendly sites were identified through the 
North and Central London Research Consortium (NoCLoR) (a partnership between Camden, 
Islington, Barnet, Enfield and Haringey Primary Care Trusts, Camden and Islington Mental 
Health and Social Care Trust, and Barnet Enfield and Haringey Mental Health Trust) which 
covers a large ethnically and socio-economically diverse area of London. Selection of the sites 
to approach first was guided by Elizabeth Murray who is a practicing GP in the CCG and a 
Research Engagement Consultant from NoCLoR who was responsible for promoting research 
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opportunities in GP practices in the CCG. The use of HeLP-Diabetes was offered to these sites 
free of charge for the duration of the study (26 months). Once sites decided they wanted to use 
HeLP-Diabetes they were asked to take part in the evaluation of the implementation study 
(Figure 6-1 presents the site recruitment procedure). However, as will be described in Chapter 7 
(section 7.4.2), the original batch roll out of HeLP-Diabetes changed to a widespread roll out to 
all sites and thus participation in the research study was also offered to all sites at a similar 
time.  
 
Figure 6-1 Site recruitment procedure 
 
6.5.3.2 Staff recruitment 
Staff at sites who agreed to take part in the research study were invited to take part in the 
research activities throughout the study period. 
6.5.3.3 Patient recruitment 
Once a site agreed to adopt HeLP-Diabetes they were able to offer HeLP-Diabetes to their 
patients. If the site had also agreed to participate in the research study eligible patients could be 
invited to participate. 
 
Eligible patients were invited to participate in the research study by me or a member of staff at 
the site. The inclusion and exclusion criteria for patients taking part in the research study were 
as follows: 
 
Inclusion criteria:  
 Aged 18 or above 
 Registered at a participating GP surgery, or attending a community diabetes clinic or 
hospital based diabetes clinic  
 Have a diagnosis of type 2 diabetes 
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Exclusion criteria:  
 Are unable to provide informed consent, e.g. due to psychosis, dementia or severe 
learning disabilities 
 Are terminally ill (life expectancy less than 12 months),  
 Are unable to use a computer due to physical or mental impairment 
 
6.5.4 Sample 
6.5.4.1 Sites 
Of the 37 general practices and the community and hospital based diabetes clinics in the CCG, 
based on what I estimated to be achievable within the study period, I aimed to offer HeLP-
Diabetes to up to 30 general practices and both the community and hospital based clinics. 
 
6.5.4.2 Patients 
As an implementation study the focus was on measuring uptake of HeLP-Diabetes when it was 
made available to an unselected population, therefore, a sample size calculation was not 
deemed appropriate for the patient uptake of HeLP-Diabetes. There were 9447 people (4.9 % of 
the population) with a recorded diagnosis of diabetes in Islington (210) at the time of the 
commencement of the study (July 2013). Globally, type 2 diabetes accounts for 90% of all 
diabetes cases and using these figures it was calculated that there were up to 8502 potential 
users of HeLP-Diabetes in Islington. However, the number of patients HeLP-Diabetes was 
actually made available to was dependent on the number of sites who adopted it and how many 
patients each site offered it to.  
 
Sampling for patient interviews aimed to recruit a purposive sample that reflected a range of 
participant characteristics that were thought, based on the literature, may influence perceptions 
and use of an internet intervention for diabetes self-management. Two factors that may 
influence participant’s perceptions of and engagement with the HeLP-Diabetes intervention are 
the digital divide and participants’ experience of illness. The digital divide, as described in the 
introduction is the gap between those with access to technologies such as the internet and 
those who do not; disparities are found to be associated with age, education and income (62, 
66). In order to address whether perceptions and use of the HeLP-Diabetes intervention are 
influenced by the digital divide participants were purposively sampled to include, older 
participants, a range of ethnicities, those with lower educational attainment, those without home 
internet access and those with basic computer skills. Another factor that may influence 
perceptions and use of HeLP-Diabetes is participants’ experience of illness. Patients’ 
perceptions of wellness, absence of complications and appraisal of current self-management 
have been found to influence attendance at DSME (37) and therefore may have similar 
influence on the use of an internet based intervention for self-management. Gender differences 
have also been observed in the prevalence of diabetes, diabetes control, self-management 
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(211) and accessing health information online (212). Participants were therefore sampled to 
include a range of self-management treatment methods, range of diabetes duration and both 
genders.  
6.5.4.3 Staff 
Sampling for staff interviews was purposive. As it was likely that different professional groups 
would have varying experiences with patients with type 2 diabetes and different perceptions of 
HeLP-Diabetes, it was important to capture the views of staff from different professional groups. 
As such, a range of staff including GPs, nurses, health care assistants, administrative staff, 
practice managers, commissioners and diabetes consultants were contacted throughout the 
duration of the study period and invited to take part in an interview. Healthcare professionals in 
practices and clinics that had agreed to adopt HeLP-Diabetes were sampled as were healthcare 
professional from sites that had either not adopted HeLP-Diabetes, or who had agreed to adopt 
it but had not offered it to any patients. This was in order to gain the perspectives of healthcare 
professionals from a range of sites with a range of engagement with HeLP-Diabetes. It was 
hoped that this may elicit a wider breadth of views on the barriers and facilitators to 
implementing HeLP-Diabetes within routine practice.  
 
6.5.5 Consent 
6.5.5.1 Patient consent 
All patients who registered on HeLP-Diabetes had to agree to accept the terms and conditions 
of use which included having anonymous data related to their use recorded including the 
number of unique registrations, the pages accessed and the temporal use of HeLP-Diabetes.  
 
Patients who were invited to take part in the research study were given a copy of the Patient 
Information Sheet (Appendix E) to read. There was an opportunity for them to discuss this and 
have any questions answered. They could take the information home and ask a family member 
to read it with them if desired.  
 
Those interested in participating were then asked to read the Patient Consent Form (Appendix 
F), and agree to 10 points (including their right to withdraw without giving any reason) listed on 
the form and sign to participate. Participants were given a copy of the signed Consent Form to 
keep for their own records. 
 
Participants who completed the Patient Consent Form were allocated a unique study ID number 
and asked to provide their email address, postal address and contact number for data collection 
purposes.  
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6.5.5.2 Staff consent 
Staff who agreed to take part in the research study were given a copy of the Staff Information 
Sheet (Appendix G) to read. There was an opportunity for them to discuss this with me and for 
them to have any questions answered.  
 
Those interested in participating were then asked to read a Staff Consent Form (Appendix H), 
and agree to 8 points (including their right to withdraw without giving any reason) listed on the 
form and sign to participate. Staff participants were given a copy of the signed Staff Consent 
Form to keep for their own records. 
 
6.5.6 Participant data and confidentiality 
Participants’ names, addresses, email addresses and contact telephone numbers were stored 
securely in a locked filing cabinet at UCL as were completed consent forms. Patient data 
collected by NHS staff were either collected by me from the sites or faxed to me securely. 
Patient data collected at the practice were stored securely in line with procedures followed in 
normal clinical practice. 
 
Participants in the study were informed that the information they gave throughout the study 
would be treated with the strictest confidence and used for the purpose of this research study 
only. The only exception where a breach of confidentiality might be required was if during an 
interview a participant disclosed information that I deemed potentially threatening or damaging 
to their health. Participants were informed that if this occasion arose I would discuss it with the 
participant and my duty of care would be explained before breaking confidentiality to the 
participants’ healthcare professional. However, this situation did not arise. 
 
6.5.7 Protocol and ethical amendments 
Nine months after the commencement of recruitment, in December 2013, I submitted a 
substantial amendment to the Research Ethics Committee to make several changes to the 
protocol to increase patient recruitment to the research study (at this time only 6 patients had 
been recruited). Two new models of implementing HeLP-Diabetes into routine practice had 
been proposed: a patient registration method and a peer facilitation model, for more details see 
Chapter 7 (section7.5). In light of these new models, and because at some sites it was proving 
very difficult for healthcare professionals to recruit patients into the research study because of 
limited time in consultations, I created an alternative online and automated study entry, 
participant information and consent procedure. 
 
I added a question to the HeLP-Diabetes registration form as follows: ‘We are asking patients to 
help us with some research about HeLP-Diabetes, would you be happy for us to contact you 
about this?’ The possible responses were ‘Yes’ or ‘No’. The following additional information 
about this question was provided in a hover over. ‘We (the research team who developed 
HeLP-Diabetes) are asking patients to help us evaluate and improve HeLP-Diabetes and the 
way it is offered to patients by the NHS. It won’t take much time, it would be a great help to us, 
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and saying yes at this stage does not commit you to anything. If you say yes you will receive an 
email or phone call from the HeLP-Diabetes research team’. If a patient ticked ‘Yes’ they would 
be sent an email automatically on completion of the online registration form which thanked them 
for their interest in the research study and gave them a link to the online study entry website 
which hosted online versions of the Participant Information Sheet and Patient Consent Form 
and a page to enter contact details. Once a participant had completed these I was sent an 
automatic notification that study entry had been completed and I could then contact patients 
about taking part in an interview. In essence this change allowed the participants to enter 
themselves into the research study without the need for healthcare professionals to conduct the 
research procedures. It was hoped that this would increase the number of participants being 
offered the opportunity to join the research study and reduce the burden on healthcare 
professionals’ time.  
 
Fourteen months after the commencement of recruitment in May 2014, I submitted an additional 
substantial amendment to alter the recruitment process for the patient interview part of the 
research study. Prior to this, using the existing procedures, I had only been successful in 
conducting an interview with one patient. These changes allowed me to contact any patient who 
had registered on HeLP-Diabetes by email and invite them to take part in an interview (apart 
from those patients who had explicitly opted out of being contacted about the research study by 
ticking ‘No’ to the question detailed above). This meant that I could contact all the patients who 
had registered on HeLP-Diabetes in the 9 months before the first substantial amendment who 
may not have been invited to participate in the research study because of the problems with 
staff not having time to recruit them. In addition I could also contact patients who had self-
registered (see Chapter 7, section 7.5 for details on this). 
 
Following the approval of this amendment I emailed all prior registered patients (and from that 
point onwards any newly registered patient who agreed to find out about the research study). 
This email gave a description of what was involved in taking part in an interview along with my 
contact details so any interested patients could contact me, via email or phone. When patients 
made contact they were emailed a copy of the Participant Information Sheet and asked to read 
it and confirm they were happy to take part, they could also ask any questions they had about 
the study, by email or phone. If they were happy to take part I arranged a date and time for 
interview. At the time of the interview I again checked that the patient had read and understood 
the Participant Information Sheet and allowed further opportunity for discussion and questions. 
Before the interview began consent was taken. This was taken verbally in the case of telephone 
interviews and was recorded on an audio recording devise. Consent was taken on a paper copy 
of the Consent Form in the case of face-to-face interviews. 
 
A summary of these amendments along with the patient recruitment rates throughout the 
duration of the study are presented in Table 6-1. 
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Table 6-1 Summary of patient recruitment to the research study 
Strategy Description Dates 
implemented 
Total 
number of 
patients 
registered 
to HeLP-
Diabetes 
Total 
number of 
patients 
completed 
study entry 
Number of 
interviews 
conducted 
Original 
recruitment 
strategy 
Staff would 
recruit 
patients and 
take consent. 
July 2013-
December 
2013 
30 6 0 
Amendment 1 Online and 
automated 
study entry, 
participant 
information 
and consent 
procedure 
January 2014-
May 2014 
60 8 1 
Amendment 2 Any patient 
who had 
registered on 
HeLP-
Diabetes was 
emailed and 
invited to take 
part in an 
interview 
June 2014- 
study close 
115 28 14 
Total   205 36 15 
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6.6 Data collection and analysis 
A summary of the research questions, data collected and analysis methods used in this 
evaluation is presented in Table 6-2 and then described in more detail below. 
 
Table 6-2 Summary of research questions, data collection methods and analysis 
Research question Data needed to 
describe: 
Sources of data Data analysis 
To what extent was 
HeLP-Diabetes 
adopted by NHS 
services? 
 
Number of diabetes 
services in the CCG 
 
Type of services 
 
 
 
 
 
 
Proportion of 
services who 
adopted HeLP-
Diabetes  
Communication with 
CCG officers 
 
QOF data 
Profromas 
GP practice websites 
Staff discussions 
 
 
 
Implementation 
spreadsheet 
Descriptive  
 
 
Descriptive analysis 
to describe the type 
of practice who 
adopted 
 
 
 
Descriptive analysis 
to describe 
proportion of 
services that adopted 
 
To what extent was 
HeLP-Diabetes 
implemented within 
NHS services? 
 
Number of patients 
registered 
 
Number of patients 
registered correlated 
with length of 
intervention 
availability 
 
How HeLP-Diabetes 
was implemented 
 
 
Patient online 
registration forms 
 
Patient online 
registration forms 
and implementation 
spreadsheet 
 
 
Research diary 
Descriptive analysis 
 
 
Correlation analysis 
 
 
 
 
 
Descriptive and 
explanatory using 
NPT 
What was the uptake 
of HeLP-Diabetes by 
patients? 
 
Number of registered 
patients 
 
Characteristics of 
Intervention software 
 
 
Patient online 
registration forms 
Descriptive analysis 
 
 
Descriptive analysis 
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registered patients 
 
How was HeLP-
Diabetes used by 
patients? 
 
Overall engagement 
with HeLP-Diabetes  
 
Number of patients 
who used HeLP-
Diabetes 
 
Temporal use of 
HeLP-Diabetes  
 
Content accessed 
 
Intervention software 
 
 
Intervention software 
 
 
 
Intervention software 
 
 
 
Intervention software 
Descriptive analysis 
 
 
Descriptive analysis 
 
 
 
Descriptive analysis 
and graphical 
presentation 
 
Descriptive analysis 
Were there any 
factors that predicted 
patient use of HeLP-
Diabetes? 
 
Characteristics of 
registered patients 
Overall engagement 
with HeLP-Diabetes 
Patient online 
registration forms 
 
Intervention software 
Univariate and 
multivariate 
multinomial logistic 
regression analyses 
Were there any 
factors that predicted 
HeLP-Diabetes 
registration method?  
 
Characteristics of 
registered patients 
 
Registration method 
Patient online 
registration forms 
 
Intervention software 
 
Univariate and 
multivariate binary 
logistic regression 
analyses 
What barriers and 
facilitators did staff 
identify to the 
adoption and 
implementation of 
HeLP-Diabetes by 
NHS services? 
 
Barriers and 
facilitators to NHS 
services uptake and 
use.  
 
 
 
 
Interviews with staff 
 
 
 
 
 
 
Qualitative thematic 
analysis 
 
Explanatory analysis 
mapping themes 
onto NPT 
 
 
 
What barriers and 
facilitators did 
patients identify to 
the uptake and use of 
HeLP-Diabetes? 
Barriers and 
facilitators to patient 
uptake and use. 
Interviews with 
patients with type 2 
diabetes 
Qualitative thematic 
analysis 
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6.6.1 To what extent was HeLP-Diabetes adopted by NHS services? 
 
In addressing this research question, data were collected and analysed to describe the number 
and type of services who adopted HeLP-Diabetes as a proportion of all the diabetes services 
within the CCG.  
6.6.1.1 Data collection 
Number of services that adopted HeLP-Diabetes  
To describe the proportion of NHS services that adopted HeLP-Diabetes it was necessary to 
collect data to describe the total number of diabetes services within the CCG. Data on the 
number of services within the CCG serving patients with type 2 diabetes were gained from 
communication with healthcare professionals working in the CCG. Additional information about 
the available services was also obtained from the CCG website and from interviews with 
healthcare professionals who took part in the research.  
 
Type of diabetes services 
To describe the type of diabetes services within the CCG data were collected from three 
sources. 
Data describing the GP practices within the CCG were available from the Quality and Outcomes 
Framework (QOF) publication provided by the Health and Social Care Information Centre (210). 
The Quality and Outcomes Framework (QOF) is a voluntary annual reward and incentive 
programme for all GP practices in England, detailing practice achievement results. Practice 
level data collected between April 2013 and March 2014 detailed the following information 
which was used to describe practices who adopted HeLP-Diabetes:  
 List Size 
 Number of registered patients with a diagnosis of diabetes 
 Overall QOF Achievement Score (Max 107) 
 The percentage of patients newly diagnosed with diabetes, on the register, in the 
preceding 1 April to 31 March who had a record of being referred to a structured 
education programme within 9 months after entry on to the diabetes register 
 
To collect data to describe the number of patients attending the hospital and community clinics, 
lead contacts at each site were asked to complete a proforma (see Table 6-3). In instances 
where this form could not be completed, data were collected from individual services websites 
and discussions with commissioning officers at the CCG. 
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Table 6-3 Hospital and community proforma 
Type Variable Response options 
Patient 
numbers 
Number of patients attending the 
clinic 
 
Free text 
Number of patients registered with 
type 2 diabetes 
 
Free text 
 
Implementation progress 
From the information collected about the number and type of diabetes services within the CCG, 
a spreadsheet was created which contained details of the names of GP practices, Hospital and 
Community clinics within the CCGs and the contact details for each service. This spreadsheet 
was then used to record all communication with each service regarding the adoption of HeLP-
Diabetes. Specifically, it recorded:  
 The number of services within the CCG that HeLP-Diabetes was offered to  
 Whether and how each site responded to initial contact about HeLP-Diabetes 
 If an initial meeting had been agreed, when it was, who was in attendance, what the 
outcome of the meeting was 
 Whether the site had decided to adopt HeLP-Diabetes 
 If and when a healthcare professional training session had been arranged and who was 
in attendance  
 When the site had started registering patients on HeLP-Diabetes 
 Whether a site was also taking part in the research study 
6.6.1.2 Data analysis 
Number of services that adopted HeLP-Diabetes  
A descriptive analysis based on the implementation progress spreadsheet was conducted to 
describe the proportion of diabetes services within the CCG who were offered HeLP-Diabetes, 
agreed to adopt HeLP-Diabetes or declined adoption.  
 
Type of services who adopted HeLP-Diabetes  
A descriptive analysis was conducted to describe the type of services that adopted HeLP-
Diabetes using data collected from QOF and healthcare professional completed proformas to 
describe: list size, number of patients with a diagnosis of diabetes, overall QOF achievement 
score, percentage of patients referred to diabetes structured education, number of patients with 
type 2 diabetes, length of time the services had access to HeLP-Diabetes.  
 
QOF data only provides details of the number of patients with diabetes at each practice, and 
does not distinguish between type 1 and type 2 diabetes. Based on the World Health 
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Organisations’ (213) estimation that 90% of all cases of diabetes are type 2 diabetes, an 
estimate of the prevalence of type 2 diabetes for each practice was calculated, based on the 
total number of patients with diabetes provided by the QOF data for 2013/4. A search of the 
hospital register was conducted by the lead consultant to provide the number of patients who 
attended diabetes clinics with type 2 diabetes. A search was also conducted by the manager of 
the community services for the number of patients with type 2 diabetes who were referred to the 
services in 2014/15.  
 
As services adopted HeLP-Diabetes at different points during the study, the length of time each 
service had access to HeLP-Diabetes was calculated. From the spreadsheets that documented 
implementation progress, the date that a service received training and/or materials (which from 
that point on would allow them to offer HeLP-Diabetes to patients) was used as the date HeLP-
Diabetes was available at the service. Using a round down method in Excel, with the date the 
study ended as the later date, it was possible to calculate the number of months each service 
had access to HeLP-Diabetes.  
6.6.2 To what extent was HeLP-Diabetes implemented within NHS services? 
 
In addressing this research question data were collected and analysed to describe the number 
of patients registered to use HeLP-Diabetes from each service as well as the way that each 
service implemented HeLP-Diabetes.  
6.6.2.1 Data collection 
Number of patients registered 
To describe the number of patients that each service registered to HeLP-Diabetes, information 
was extracted from the online patient registration form (see Appendix I) which recorded each 
patient registration along with the name of the service they were referred from.  
 
How HeLP-Diabetes was implemented 
To document how HeLP-Diabetes was being implemented at each site data were recorded in a 
research diary throughout the duration of the study. Research diaries facilitate the research 
process through recording observations thoughts and questions as they happen for later use by 
the researcher and to stimulate reflective thinking about the research (214). They can be used 
to “reach the parts that other methods cannot” (215). This diary was used to record detailed 
information gained from informal feedback, the experiences of supporting each practice to 
implement HeLP-Diabetes, personal reflections, discussions with staff during training sessions, 
email communication and ongoing feedback to detail how the implementation was taking place 
including;  
 how HeLP-Diabetes was responded to by staff during initial communication and at 
introductory practice meetings 
 who was in attendance at the practice/clinic meetings 
 what questions were raised by staff about HeLP-Diabetes 
 the level of engagement and enthusiasm about HeLP-Diabetes from individual staff 
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 what the adoption decision was and how this came about 
 who within the practice was responsible for implementing HeLP-Diabetes 
 how this decision came about 
 who attended training sessions 
 how the training sessions were received 
 what questions or concerns were raised during the training 
 any additional support provided to the site 
 email correspondences and other communication  
 reflections 
The notes that formed the research diary were recorded in a notebook during or directly after 
interactions with GP practices or diabetes clinics. These notes were then transferred to an Excel 
spreadsheet, which had a row for each site and columns to document the research notes 
including dates and locations. 
6.6.2.2 Data analysis 
Number of patients registered 
The number of patients registered to HeLP-Diabetes from each site was used to calculate 
whether a site made use of HeLP-Diabetes or not. Sites who registered one or more patients to 
HeLP-Diabetes were classed as having used it, whereas those who didn’t register any patients 
were classed as not using it.  
The number of patients from each service that signed up to HeLP-Diabetes was described as a 
proportion of all eligible patients at that service. The number of patients with type 2 diabetes at 
each service was used as the number of eligible patients. 
 
To determine whether the number of patients registered by each service was related to the 
length of time that the service had access to HeLP-Diabetes a test of correlation was 
conducted. As the number of patients registered was not normally distributed a Spearman’s 
non-parametric correlation was conducted. 
How HeLP-Diabetes was implemented 
The research diary was firstly analysed to create a description for each site of how the 
implementation had taken place at each site and specifically detailing:  
 which implementation models were employed at each site 
 how HeLP-Diabetes was introduced to each site 
 what training was given and who received it 
 the staff that were involved in implementing HeLP-Diabetes 
 how HeLP-Diabetes was incorporated into practices 
These detailed notes kept during the implementation were analysed and statements relating to 
factors influencing the implementation were extracted from the spreadsheet. These statements 
were then coded thematically to describe the data. As the themes were emerging from the data 
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it was clear from previous work in this thesis with Normalisation Process Theory (NPT) (7, 97) 
that there was strong resonance between the statements, emergent themes, and NPT 
constructs. Therefore, to extend the analytical process these themes were mapped onto the 
constructs of NPT.  
 
As described in detail in Chapter 4 (section 4.4.2), NPT is a theory which is concerned with the 
extent to which complex interventions (in particular new technologies) are implemented and 
embedded in healthcare and is useful in explaining observed variations in implementation 
processes rather than simply focusing on notions of barriers and facilitators. NPT is designed to 
be of practical value to researchers by enhancing understanding about the manner in which 
new innovations become embedded in healthcare systems (216). Table 6-4 (page 121) 
provides a summary of the constructs of NPT and a set of questions that have been derived 
from the constructs of NPT and applied to the implementation of HeLP-Diabetes. 
 
As described in more detail on page 117, operationalising NPT requires that its abstract core 
constructs are translated into a working model with real-world correlates (7). These then form a 
basis for the conceptual work of describing, explaining, making, and testing claims about 
observed phenomena. In order to operationalise NPT for the purpose of evaluating the 
implementation of HeLP-Diabetes, questions relating to each NPT constructs (and the four sub-
constructs of the Collective Action construct) were generated. The generation of questions in 
order to operationalise NPT has been used by several authors (8, 187). These questions were 
used to assist the mapping of the themes onto constructs of NPT. This method was first used 
for the analysis of the staff interviews within this thesis, and is therefore described in greater 
detail in that data analysis section (page 117). 
 
The mapping process was iterative, moving backward and forward between the emergent 
themes and the NPT definitions and questions. Coding was discussed with Elizabeth Murray 
and Fiona Stevenson until I was satisfied all the themes had been mapped correctly onto the 
constructs of NPT. This analysis using NPT moved the analysis from description to a 
theoretically supported analysis as to whether and how HeLP-Diabetes was implemented within 
the practices and clinics within the CCG. 
 
6.6.3 What was the uptake of HeLP-Diabetes by patients? 
 
In addressing this research question, data were collected and analysed to describe the number 
of patients registered to HeLP-Diabetes within the CCG and their characteristics.  
6.6.3.1 Data collection 
Number of patients registered 
The number of patient users of HeLP-Diabetes was recorded by HeLP-Diabetes software 
(Joomla). On registering, a unique ID for each patient was automatically assigned.  
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Characteristics of registered patients 
Data to describe the characteristics of patients who registered to use HeLP-Diabetes were 
recorded using a form I designed which was embedded into HeLP-Diabetes. Data collected with 
this form included: age, gender, ethnicity, educational attainment, duration of diabetes, diabetes 
management style, computer skills and internet access. Full details of the data collected by this 
form are presented in Appendix I. The registration process required each patient to complete 
this online form.  
6.6.3.2 Data analysis 
Number of patients registered 
The uptake of HeLP-Diabetes by patients was calculated by the number of unique registrations 
that were made to the website during the implementation period (01.07.2013-31.08.15) which 
were recorded on HeLP-Diabetes server and stored with a unique ID number.  
 
Characteristics of registered patients 
Descriptive statistics were conducted to describe the characteristics of patients who joined 
HeLP-Diabetes from data captured in the online registration form which were downloaded from 
HeLP-Diabetes software into Excel spreadsheets and then transferred into SPSS for analysis.  
 
Educational attainment was a question that was introduced to the patient registration form later 
than the other variables, and as such there was only education data for 122 patients (59.51%). 
Educational attainment was introduced in order to address the research question around 
whether different patient registration methods could reduce the digital divide. Educational 
attainment was used as the proxy measure for the digital divide (as well as computer skills and 
ethnicity variables) as it was easier to complete on an online form than occupation and less 
sensitive than household income. Originally this variable was not included on the online form 
when patient registration to HeLP-Diabetes was completed in practices and clinics by 
healthcare professionals and this information could not be easily obtained by staff without 
patients being present to ask. This variable was therefore introduced as soon as the patient 
registration method had been introduced. There were also missing data for computer skills 
(n=21), computer access (n=19), management of diabetes (n=10), duration of diabetes (n=5) 
and age (n=3) due to errors in registering patients by healthcare professional in participating GP 
practices. 
 
6.6.4 How was HeLP-Diabetes used by patients? 
 
In addressing this research question, data were collected and analysed to describe the number 
of patients who used HeLP-Diabetes, the amount patients used HeLP-Diabetes, temporal 
patterns of use and HeLP-Diabetes content accessed 
6.6.4.1 Data collection 
Use of HeLP-Diabetes by patients 
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Details of all logins made (time and date) to HeLP-Diabetes and pages viewed by patients who 
were stored under each patient’s unique ID number were automatically recorded on HeLP-
Diabetes server. At the end of the study period, this data was exported from HeLP-Diabetes 
server into an Excel spreadsheet. Each row represented a page view and columns provided 
data on participant ID, data, time, and the URL of the page. A technical problem with 
intervention software meant that patient use of HeLP-Diabetes was only recorded from 
01.01.2014, meaning that the first six months of data were not captured.  
6.6.4.2 Data analysis 
Overall engagement with HeLP-Diabetes  
The number of days a patient visited HeLP-Diabetes following their registration date was used 
as the main measure of engagement with HeLP-Diabetes (alternative measures of engagement 
that were considered but discounted are described in Box 6-1). As each patient visited HeLP-
Diabetes in order to register to use it (either alone or with assistance from a healthcare 
professional), only logins made on days after the date of registration were counted as actual 
intervention use to avoid someone who only registered (with no subsequent use) being counted 
as someone who used HeLP-Diabetes. This measure of engagement was calculated for each 
participant by counting the number of separate dates they accessed HeLP-Diabetes and 
discounting their date of registration.  
Box 6-1 Alternative measures of engagement considered 
The number of unique logins to HeLP-Diabetes was also considered as a measure of overall 
engagement with HeLP-Diabetes, however this measure was deemed to be less reliable as 
there were cases observed during testing phases where patients did not log out following the 
end of a visit and on their return to HeLP-Diabetes were not required to log back in, in these 
cases the number of visits to HeLP-Diabetes may not have been accurate.  
 
The number of pages each patient viewed was also calculated for the data, but was not 
selected as the main measure of engagement as it did not reflect the frequency of intervention 
use. For example a patient may have looked at a hundred pages on their first visit to HeLP-
Diabetes but subsequently made no further visits, in this case, using number of page views as a 
measure of engagement they may be classed as engaging a lot with HeLP-Diabetes, when in 
fact they only used it once. It is also not possible to determine whether participants looked at a 
lot of pages because they were engaging in a meaningful way with HeLP-Diabetes, or because 
they could not find what they were looking for.  
 
Number of patients who used HeLP-Diabetes 
The proportion of patients who used HeLP-Diabetes again following registration was calculated 
using the measure of overall engagement. Patients who did not make use of HeLP-Diabetes 
again following registration were classed as ‘non users’ whereas those who did make use of it 
again were classed as ‘users’.  
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Temporal use of HeLP-Diabetes  
The date and time stamps for each page view were used to determine the times of day and the 
days of the week that HeLP-Diabetes was used. Days of the week were calculated in Excel from 
the dates of each page view, and this data was imported into SPSS software where it was 
plotted graphically in order to give a visual representation of the temporal patterns of use.  
 
Content accessed 
The URLs of HeLP-Diabetes pages that were accessed were sorted by the frequencies with 
which they were requested by patients. Views of the registration pages and lost password 
pages were excluded as they were not classed as intervention content. The remaining URLs 
were sorted so that the pages viewed most frequently were at the top and those least frequently 
at the bottom. From this the top 20 most visited pages were described by the page title (rather 
than URL) and are presented with the frequency of views and the percentage of overall views 
each page accounted for.  
 
6.6.5 Were there any factors that predicted patient use of HeLP-Diabetes? 
 
In addressing this research question, data were collected and analysed to describe the use of 
HeLP-Diabetes by patient characteristics.  
6.6.5.1 Data collection 
Characteristics of registered patients 
It was hypothesised that there may be differences in intervention use according to certain 
patient characteristics such as age, gender, educational qualifications, computer access, and 
computer skills have been found to be important in determining patterns of internet use, the 
prevalence of diabetes, diabetes control, self-management (211) and accessing health 
information online (212). Also of interest was ethnicity and educational status, as discussed in 
Chapter 1, as these have been found to be important in determining between those who have 
access to technologies and those who do not. Several clinical factors might also be plausibly 
associated with use of HeLP-Diabetes. For example, recent diagnosis of diabetes may increase 
patients’ need for and interest in self-management information and support. As described in 
Chapter 7 (section 7.5), different registration models were developed throughout the study 
period. It was of interest to explore whether the method by which patients were registered to 
HeLP-Diabetes had any effect on their use of HeLP-Diabetes. 
As described above, data to describe the characteristics of patients who registered to use 
HeLP-Diabetes were recorded by a form I designed which was embedded into HeLP-Diabetes 
(Appendix I). 
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Overall engagement with HeLP-Diabetes  
As described above, data were collected by HeLP-Diabetes software which allowed a variable 
to be created to describe the overall level of engagement each patient had with HeLP-Diabetes.  
6.6.5.2 Data analysis 
Recoding variables 
Four patient characteristic variables (ethnic group, duration of diabetes, education and how 
diabetes is managed) had to be recoded in order to provide enough cases for statistical analysis 
to be conducted. Appendix J presents this recoding. 
 
Logistic regression of predictors of intervention use 
Number of days using HeLP-Diabetes was selected as the measure of intervention use for the 
analysis. This variable was highly positively skewed, with a floor effect that meant attempts to 
transform the data would be unlikely to achieve normally distributed data. The distribution of the 
data did not improve when those who had never used HeLP-Diabetes following registration 
were removed (see Appendix K for histograms representing the distribution of intervention use). 
As a result HeLP-Diabetes use data were not suitable for use as a dependent variable in linear 
regression analysis. Instead, ordinal categories of intervention use were coded from number of 
days using HeLP-Diabetes data and a logistic regression analysis was conducted.  
 
Dependent variable: Level of intervention use  
Two categories of intervention use were coded from the total number of days visits were made 
to the intervention: those patients who made 0 visits to HeLP-Diabetes following registration 
were categorised as having made no use of HeLP-Diabetes; those participants who had visited 
HeLP-Diabetes on ≥ 1 day following registration were categorised as having made use of HeLP-
Diabetes. 
 
Predictor variables: 
Based on the rational provided in the data collection section, the predictors selected for 
inclusion in analyses predicting intervention use were:  
 age (years)  
 gender (male/female) 
 Ethnicity (white British/other ethnicities) 
 Educational qualifications (none orschool leaver with no further educational 
qualifications/A levels or higher)  
 Duration of diabetes (less than a year/1-5 years/5-10 years/more than 10 years) 
 Diabetes management (lifestyle alone/tablets/insulin or other injectables) 
 Computer skills (Basic/Intermediate /Advanced) 
 Registration method (staff registration/ patient registration) 
Computer access was not included as a predictor variable as there were too few cases of public 
internet access to include in the analyses. 
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Analyses conducted 
Separate univariate and multivariate logistic regression analyses were conducted predicting 
intervention use.  
 
Analyses were conducted for all complete cases of data (n=114). Ninety one cases were 
removed due to missing data on one or more of the following variables; age (n=3), duration of 
diabetes (n=5), management of diabetes (n=10), computer skills (n=21) and education (n=84, 
41%).  
 
6.6.6 Were there any factors that predicted intervention registration method? 
 
In addressing this research question, data were collected and analysed to describe the method 
by which patients were registered to HeLP-Diabetes and the characteristics of patients 
registered by each method.  
 
As described in more detail in Chapter 7 (section7.5), a natural experiment arose during the 
research study, with practices adopting one (or a combination) of two different registration 
methods to register patients to HeLP-Diabetes (staff registered/patient registered). This 
research question explores whether certain types of patients were more or less likely to have 
assistance from a member of staff in registering to HeLP-Diabetes and whether staff assisting in 
the registration might be important for overcoming barriers to accessing internet interventions 
for some groups. 
6.6.6.1 Data collection 
Characteristics of registered patients 
Data to describe the characteristics of patients who registered to use HeLP-Diabetes were 
recorded by a form I designed which was embedded into HeLP-Diabetes (see Appendix I). Data 
were collected to describe the age, gender, educational qualifications, computer access and 
skills of patients as these have been found important in patterns of internet use (211) and 
accessing health information online (212). Also of interest was ethnicity and educational status, 
as discussed in Chapter 1, these have been found to be important in the digital divide between 
those who have access to technologies and those who do not. 
 
Registration methods 
Patient registration data was recorded and stored separately for each registration method by the 
use of separate registration URLs. This allowed the number of unique registrations to HeLP-
Diabetes to be analysed by the different registration methods as well as collectively. 
6.6.6.2 Data analysis 
Recoding variables 
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As above, four patient characteristic variables (ethnic group, duration of diabetes, education and 
how diabetes is managed) had to be recoded in order to provide enough cases for statistical 
analysis to be conducted. Appendix J presents this recoding. 
 
Logistic regression of predictors of registration method 
In order to explore whether any patient characteristics could predict which registration method 
was used to register to HeLP-Diabetes, a logistic regression was conducted. 
 
Dependent variable: Registration method: 
The way that patients were registered to use HeLP-Diabetes was recorded by the URL used for 
registration and was coded as either ‘healthcare professional registered’ or ‘self-registered’. This 
categorical variable was selected as the dependent variable.  
 
Predictor variables: 
The predictors selected for inclusion in analyses predicting registration method were therefore:  
 age (years)  
 gender (male/female) 
 Ethnicity (white British/other ethnicities) 
 Educational qualifications (none orschool leaver with no further educational 
qualifications/A levels or higher) Computer skills (Basic/Intermediate/Advanced)As 
above, computer access was not included as a predictor variable as there were too few 
cases of public internet access to include in the analyses. 
 
Analyses conducted: 
Separate univariate and multivariate logistic regression analyses were conducted predicting 
registration method. Analyses were conducted for all complete cases of data (n=117). Eighty 
eight cases were removed due to missing data on one or more of the following variables; age 
(n=3), computer skills (n=21) and education (n=84, 41%).  
 
6.6.7 What barriers and facilitators did staff identify to the adoption and implementation of 
HeLP-Diabetes by NHS services? 
 
6.6.7.1 Data collection 
Qualitative data was collected to explain the adoption, implementation and use of HeLP-
Diabetes by NHS services and healthcare professional. 
 
Interviews were conducted face to face, generally in the health professionals’ consulting rooms. 
Semi-structured interviews were selected as the most appropriate type of interview to conduct 
(see discussion on page 123 for justification). All interviews were one to one and lasted for 
between 30 minutes and an hour, with the exception of one focus group that I conducted with 
117 
 
three Nurses and a Health Care Assistant from the same general practice. This focus group 
arose opportunistically from an offer from one of the nurses to invite her colleagues to join in the 
interview I had arranged with her. This focus group took place in the Nurse’s consultation room 
over their lunch break.  
 
All healthcare professional participants completed a data collection form to describe 
demographic characteristics, professional characteristics and internet experience (see Appendix 
L for full details of the data collected). All interviews, with participants’ consent, were audio 
recorded using a digital voice recorder.  
 
The topic guides for the staff interviews were informed by Normalisation Process Theory (NPT) 
(7, 97), a theory which identifies factors that promote and inhibit the routine incorporation of 
complex interventions into everyday practice and offers explanations as to how interventions 
work (or fail to) in routine practice, looking not only at early implementation, but beyond this to 
the point where an intervention becomes so embedded into routine practice that it ‘disappears’ 
from view (i.e., it is normalised) (see Chapter 4, section 4.4.2 for a detailed description of this 
theory). The main concepts of NPT: collective action, coherence, collective action and reflexive 
monitoring (see Table 4-2 page 77, for definitions of these constructs) were used as a guide to 
develop questions that focused on: the way that HeLP-Diabetes was being conceptualised by 
staff; the work that was being conducted at sites to incorporate HeLP-Diabetes into practice, 
how well HeLP-Diabetes was being embedded and how staff appraised and reflected upon the 
implementation. These questions were also designed to elicit data on the barriers and 
facilitators to the implementation.  
 
The topic guide evolved and developed over time in response to themes that emerged in 
individual interviews (see Appendix M for the original staff’ topic guide). Topic guides were also 
tailored to specific staff groups; e.g. the questions asked to GPs, receptionists and 
commissioners were tailored to reflect the different roles these groups had in implementing 
HeLP-Diabetes and the differences in the ways they may have worked with it. 
6.6.7.2 Data analysis 
Data collection and analysis were conducted concurrently, with analysis starting as soon as 
early interviews were transcribed. Audio recordings were transcribed verbatim by Way With 
Words transcription service and I checked each one against the original interview recordings for 
accuracy and to anonymise the transcripts by removing names of people and places. Corrected 
transcripts were loaded into Atlas.ti software ready for coding.  
 
A two stage process to the analysis was taken whereby data were firstly analysed thematically 
and then the emergent themes were mapped onto the constructs of Normalisation Process 
Theory (NPT). This two stage method has been utilised by other authors exploring the uptake of 
interpreting services by GPs (216), and nurse’s experiences and views of home telecare 
services (217). The strength of the NPT framework to interpret the data is that it enhances 
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understanding about the implementation interventions, in this case HeLP-Diabetes and provides 
a conceptual tool that moves the analysis beyond description. However, there are concerns 
about applying pre-determined conceptual frameworks to data and the risk of forcing data into 
pre-determined categories (218). Employing this two stage process enabled the emergent 
themes from the interviews to be data driven (although it is acknowledged that the use of the 
NPT to develop interview topic guides influenced the emergent themes), and meant that the 
robustness of NPT in explaining the data could be tested against the themes during this 
mapping process. This process ensured that any data that could not be mapped on to NPT 
would still be captured and would form the basis of a critique of the scope of NPT in explaining 
this data. 
 
Firstly, each transcript was read and summaries of the main themes and impressions from each 
transcript were written to generate a feeling for each of the interviews and as a quick reference 
point for each interview. The themes that were identified in this initial analysis were discussed 
with Elizabeth Murray and Fiona Stevenson who had read all 21 corrected interview transcripts. 
In order to obtain other interpretations of the data from a range of perspectives these themes 
were presented to the project’s multidisciplinary steering group where the themes were 
discussed in terms of how they could inform the ongoing project. In addition to the steering 
group, a data clinic was held in order to explore the rigor and reliability of the themes that were 
emerging from the initial thematic analysis. Qualitative researchers from a range of disciplines 
were invited from the department of Primary Care and Population Health to attend this clinic. 
Eight researchers from sociology, psychology and epidemiology research disciplines attended 
the data clinic in April 2015. Prior to the clinic an interview transcript was selected for circulation 
to the attendees. This particular transcript was a HCP interview with a GP which had been 
chosen because it included data on nearly all of the themes that were emerging from the staff 
data set as a whole. The transcript was independently read by each researcher and they were 
asked to identify themes for discussion at the clinic.  
 
An introduction to the research questions was provided to the group at the beginning of the 
clinic and then each member was asked to give their general impressions of the interview 
transcript and briefly describe any themes that they had identified. Following this, a more 
focussed discussion was held with the whole group that centred on the themes that emerged 
from the individual impressions. These discussions brought to light alternative view points and 
interpretations of themes that had already been identified, as well as suggestions for new 
themes to explore and additional questions that could be asked in future interviews.  
 
All discussions in the data clinic were audio recorded with the consent of the participants and 
this recording was drawn upon several times during the analysis phase to keep the discussions 
in mind. Notes from the data clinic were made under the following headings: Other 
questions/issues to explore in further interviews; interpretations of themes already identified; 
and new themes to explore. Following the data clinic, all interview transcripts were reread and 
119 
 
the themes were refined and additional ones created. Once all the transcripts had been read 
and initial themes had been developed the second stage of analysis began using NPT.  
 
Firstly, questions relating to each of the constructs of NPT were generated in order to apply 
NPT to the context of the implementation of HeLP-Diabetes. Although NPT provides general 
definitions of the constructs, the study-specific meaning of the constructs is not predetermined 
and can only be determined by the specifics of each study setting including the staff involved, 
the nature of their work, the innovation being introduced, the immediate clinical context, and the 
wider organisational context in which implementation is taking place (216). May and Finch 
describe the need to operationalise NPT by translating its abstract core constructs into a 
working model with real-world correlates which allows researchers to undertake the conceptual 
work of describing, explaining, making, and testing claims about observed phenomena (7). 
 
Creating questions of the NPT constructs as applied to the implementation of HeLP-Diabetes 
increased confidence in the fact that data from the HCP interviews were not being forced into 
predetermined categories but instead the analysis was benefitting from NPT as a conceptual 
framework to enhance the understanding of the issues arising from the data.  
 
The questions developed to apply to the NPT constructs for the staff interviews developed 
naturally from the general descriptions of the constructs provided in the literature and the NPT 
online manual and toolkit which breaks the constructs down into a series of general questions 
that can be applied to individual settings and contexts (191). Once developed, these questions 
were talked through with Elizabeth Murray and Fiona Stevenson and at a meeting with two 
implementation researchers familiar with NPT (Rosa Lau and Susanna Dowrick). In these 
meetings the questions were discussed and refined. Table 6-4 presents the definitions of the 
NPT constructs and the questions developed to apply NPT to the implementation of HeLP-
Diabetes.  
 
Originally it was planned that data would be mapped to the sub-constructs of NPT; however it 
became clear during the coding of the first few transcripts that choosing between sub-constructs 
was problematic as there was often a lot of overlap and uncertainty. The decision was therefore 
made to map themes to the main NPT constructs of coherence, cognitive participation, and 
reflexive monitoring. However, for the construct of collective action mapping remained at the 
sub-construct level (interactional workability, relational integration, skill set workability, 
contextual integration) as the collective action sub-constructs are the most well defined and 
widely used aspect of NPT and the distinction between these for these data appeared more 
pronounced. The collective action construct was also the basis for the original Normalisation 
Process Model (NPM) and has been used widely by other researchers to explain their 
implementation research findings (see (219) for a review of studies that have applied NPT and 
NPM) and has been applied specifically by authors to explain the implementation of e-health 
interventions (189, 220). As such, mapping to the sub-constructs of collective action allowed for 
the possibility of comparing study’s findings with other research. 
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The method of mapping themes on to NPT suggested by Macfarlane and O’Reilly-de Brun (216) 
was used to guide this process. This involved using my understanding of the themes and the 
NPT constructs and determining ways in which they related to each other. This was achieved 
through suspending my understanding of the themes as they were formulated in the thematic 
analysis and applying the questions related to the constructs of NPT to them. Where the themes 
appeared to be related to constructs of NPT, illustrative quotes from the raw data were drawn 
upon to demonstrate this relationship. Of equal importance in this process was the identification 
of themes that did not map neatly on to the constructs of NPT. These data were used to critique 
the applicability of NPT for explaining these data.  
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Table 6-4 Definitions and questions relating to each of the constructs of NPT 
Construct/sub construct Definition* 
 
Questions that NPT poses 
of the implementation of 
HeLP-Diabetes? 
Coherence The sense-making work that 
people do individually and 
collectively when they are 
faced with the problem of 
operationalizing some set of 
practices 
How is HeLP-Diabetes 
conceptualised by staff? 
What is the work of 
implementing HeLP-
Diabetes?  
Cognitive participation The relational work that 
people do to build and sustain 
a community of practice 
around a new technology or 
complex intervention 
How do staff come to engage 
with HeLP-Diabetes? 
How do they decide on 
engagement and the purpose 
that it serves? 
Collective action The operational work that 
people do to enact a set of 
practices 
How do staff enact HeLP-
Diabetes?  
How are their activities 
structured and constrained? 
Interactional workability The interactional work that 
people do with each other, 
with artefacts, and with other 
elements of a set of practices, 
when they seek to 
operationalize them in 
everyday settings 
How does HeLP-Diabetes 
affect interactions between 
people and practices?  
Relational Integration The knowledge work that 
people do to build 
accountability and maintain 
confidence in a set of 
practices and in each other as 
they use them 
How does a HeLP-Diabetes 
relate to existing knowledge 
and relationships? 
Skill set workability The allocation work that 
underpins the division of 
labour that is built up around a 
set of practices as they are 
operationalized in the real 
world 
How is the current division of 
labour affected by HeLP-
Diabetes? 
Contextual Integration The resource work. Managing 
a set of practices through the 
How does HeLP-Diabetes 
relate to the organisation in 
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allocation of different kinds of 
resources and the execution 
of protocols, policies and 
procedures 
which it is set? 
Reflexive monitoring The appraisal work that 
people do to assess and 
understand the ways that a 
new set of practices affect 
them and others around them 
How do staff appraise HeLP-
Diabetes? 
What are the effects of 
appraisal? 
How are they mediated? 
*Definitions taken from the online NPT toolkit (191) 
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6.6.8 What barriers and facilitators did patients identify to the uptake and use of HeLP-
Diabetes? 
 
6.6.8.1 Data collection 
Qualitative data were collected to explain the adoption and use of HeLP-Diabetes by NHS 
patients and to identify barriers and facilitators to initial and ongoing use.  
 
All eligible patients were contacted to participate in interviews. As described earlier, recruitment 
to interviews took place purposively in order to capture the views of patients from a range of 
ethnic backgrounds, ages, educational attainment, length of time with diabetes, treatment types, 
and associated complications as well as experience with computers and the internet and use of 
HeLP-Diabetes. Interviews were conducted with all patients who agreed to be contacted about 
participation. 
 
As the implementation of HeLP-Diabetes was an iterative process and adoption at practices 
happened at different times throughout the study period, recruitment of patients took place on 
several occasions during the study period in order to recruit patients from a range of 
practices/clinics, and not just from those sites who were first to adopt HeLP-Diabetes. 
 
Interviews with patients were conducted both face to face and over the telephone. All interviews 
were one to one and lasted approximately 30 minutes to an hour. Data were collected to 
describe the characteristics, diabetes related information and internet use and experience (see 
Appendix H for details of variables collected by HeLP-Diabetes registration form) of patient 
interview participants. All interviews, with participants’ consent, were audio recorded using a 
digital voice recorder.  
 
The topic guides for patient interviews explored themes including; experience with having 
diabetes, self-management, current NHS care, information seeking and use, the use of the 
internet, the introduction of HeLP-Diabetes, use (or non-use) of HeLP-Diabetes, barriers and 
facilitators to signing-up and use, and recommendations for improvement of HeLP-Diabetes and 
the way it was introduced to them. An iterative approach was taken, where the interview data 
helped develop and refine the topic guide and informed analysis based on emerging ideas (for 
original topic guide see Appendix N).  
 
The implementation of the HeLP-Diabetes intervention into routine practice took place from July 
2013. Interviews were conducted with patient users of HeLP-Diabetes between April 2014 and 
February 2015, therefore the interview participants varied in length of exposure to the HeLP-
Diabetes website and recency of visit.  
 
Given the aim of this study was to explore patients’ experience with and perceptions of an 
internet based self-management intervention for people with type 2 diabetes, a qualitative study 
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design using semi structured interviews was employed. Semi structured interviews allow the 
researcher to pose specific questions in order to address pre-defined research questions, at the 
same time giving the interviewee the opportunity to provide open responses in their own words. 
They allow for the discovery or elaboration of information that is important to participants but 
may not have previously been thought of as pertinent by the research team (221). Moreover 
they facilitate individual experiences of having diabetes, self-management and accessing DSME 
which may influence the perception of and use of HeLP-Diabetes. Thus semi-structured 
interviews were selected over in-depth interviews which attempt to avoid any preconceived 
ideas and are led by the participants agenda to a greater extent (221). Semi-structured 
interviews were selected over more consensus building approaches such as focus groups. 
Semi-structured interviews with multiple participants allow a range of perspectives to be 
captured and differences and similarities between accounts to be explored. As the way in which 
people engaged with and used HeLP-Diabetes as part of their daily lives was of interest, as 
were factors related to non-use and non-engagement with HeLP-Diabetes, semi-structured 
interviews provided the most appropriate way of exploring these issues. An alternative 
approach, used during the development phase of HeLP-Diabetes, would have been to observe 
participant use of HeLP-Diabetes and conduct ‘think aloud’ interviews. However, as I was 
interested in how participants would actually make use of HeLP-Diabetes by themselves in their 
own time without the presence of a researcher which may influence how they used the 
intervention, this approach was deemed unsuitable.  
 
Semi-structured interviews were initially conducted over the telephone. Telephone interviews 
are increasingly used in health services research as they allow a geographically wider range of 
participants to participate, can be more time and cost effective compared to face to face 
interviews, may be more acceptable to participants because they take less time to complete 
(222) and place less burden on participants compared to face to face interviews where travel 
and other arrangements may have to be made. As has been shown with accessing face to face 
DSME, accessibility issues are a barrier to attendance for people with type 2 diabetes who have 
caring responsibilities, who work or who have other physical health problems. It was hoped that 
by conducting interviews over the telephone the range of participants able to take part would be 
optimised. The first eight (of 15) interviews were conducted over the telephone with participants. 
Although the majority of these interviews produced valuable data, there were some cases 
where I felt the data were a little sparse and there were topics that had not been elaborated on 
as much as I had hoped and which I wanted to explore in more depth. In order to test out 
whether the data were sparse in these cases because of the topic area or because of the data 
collection method, I conducted the rest of the interviews face to face with participants. It has 
been suggested that responses to telephone interviews may be shorter with less information 
divulged than might be during a face to face interview where visual cues are present to aide 
probing and to encourage the participant to continue with answers. Factors such as perceived 
confidentiality and the relative impersonality of telephone interaction may also impact on the 
nature and length of the discussions (222). After conducting all of the interviews I felt that the 
ones conducted face to face did indeed provided richer data and allowed me to explore issues 
125 
 
in more depth than the telephone interviews had, suggesting that the method of data collection, 
rather than the topics I was exploring had contributed to the less rich data collected in the 
telephone interviews.  
 
The face to face interviews were conducted either at UCL or at the participant’s General 
Practice according to the participant’s preference. At the start of all interviews, my role as a 
researcher from UCL was reiterated before the commencement of the interview. Socially 
desirable responses to interview questions, whereby participants may distort their answers to 
questions in order to present themselves as having more socially desirable or respectable 
characteristics or behavioural histories (223), are a concern in qualitative research. As the 
professional background of the interviewer has been found to influence interviewing (224, 225), 
I felt it was important to clarify my role, especially in the face to face interviews which were 
conducted in an environment (GP practices) where participants’ may be used to a different kind 
of interview with healthcare professionals. As I would be asking question about participants’ 
diabetes, self-management, and their perceptions of healthcare, I felt it important to remind 
participants that; I was not part of their healthcare team, I was not affiliated with the GP practice 
or NHS, that I did not have a clinical background and that the purpose of the interviews was to 
elicit views on the HeLP-Diabetes intervention.  
 
My role as a researcher who had worked on the development of the HeLP-Diabetes intervention 
was also made clear to participants. Although my role as a developer of HeLP-Diabetes had the 
potential to elicit socially desirable responses to questions about it, this did not appear to be the 
case. Many participants did not seem to make the connection that HeLP-Diabetes that they had 
been provided with through the NHS had been developed at UCL (despite being told again at 
the beginning of the interviews) with many perceiving it to have been developed by the NHS. 
Before interviews, participants were informed that the findings would be used to develop and 
improve HeLP-Diabetes and the way that it was offered to patients; thus giving participants’ 
permission to be critical or negative. Indeed, many participants’ were very forthcoming about 
their non-engagement with HeLP-Diabetes and with their perceptions (good and bad) of HeLP-
Diabetes, suggesting that participants felt comfortable giving honest accounts. 
6.6.8.2 Data analysis 
Unlike the staff interview data that lent itself well to a two phase approach to data analysis, with 
a secondary analysis of the data being conducted through an NPT lens, data from the patient 
interviews did not. There was limited data on the ‘work’ involved in implementing HeLP-
Diabetes in the patient interviews which made it difficult to develop definitions using the 
categories outlined in NPT. It was therefore decided not to pursue this line of analysis with the 
patient interviews, and instead the data were analysed using a detailed thematic analysis (226). 
This process began by familiarisation with the data by reading the transcripts and listening to 
the interview recordings several times and noting down areas of interest and potential codes. 
Initial codes were generated for as much as the data as possible and applied systematically to 
the corresponding text in the transcripts using Atlas.ti software to assist with the organisation of 
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the data. Once the entire dataset was coded, data extracts were collated under each of these 
codes. The codes were then organised into broader themes and sub-themes (see Chapter 10). 
All transcripts were read by Elizabeth Murray and Fiona Stevenson, and discussions around my 
coding of the data were held with them. This helped refine the codes and resulted in additional 
themes. An inductive approach to analysis was taken with themes directly linked to the data (i.e. 
data-driven). Themes were reviewed by re-examining corresponding data extracts and un-
coded, outlying data were examined for disconfirming evidence. An iterative process was taken, 
where the transcripts were revisited throughout the process of coding, theme allocation and 
written presentation. 
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7 CHAPTER 7: METHODS 3: CHANGES TO THE HELP-DIABETES IMPLEMENTATION 
PLAN  
 
7.1 Chapter summary 
This chapter describes how the implementation took place in the case study CCG. Firstly a 
description of the CCG is presented detailing the CCG as a whole and the diabetes services 
provided within it. Secondly, the changes that occurred to the original implementation plan 
(described in Chapter 5) since its introduction into practice are described. Finally, all the 
strategies that were employed to implement HeLP-Diabetes into practice are brought together 
and presented graphically as the final implementation plan to implement HeLP-Diabetes into the 
CCG.  
 
7.2 Introduction 
Grol, Wensing and Eccles (2) describe the evaluation of implementation efforts as an ideally 
continuous process rather than the final stage of an implementation project, as such the 
changes to the implementation plan described below were made iteratively during the 
implementation period (July 2013-August 2015), in response to feedback from staff, emerging 
barriers and facilitators and attempts to problem solve.  
 
Adaptive implementation methodologies hold that the implementation of new innovations can be 
improved by processes that enable initial plans to be adapted to unfolding events and decisions 
(227). Adaptive implementation plans allow research sites that are not responding to an initial 
implementation plan to receive an augmented version (228). Due to the large number of 
potential barriers to the implementation of HeLP-Diabetes that may be site specific, an adaptive 
approach to implementation was deemed most appropriate. As this research is concerned with 
addressing how best to implement an intervention in real world settings, it was also important 
not to persist with an implementation plan that was proving ineffective, and instead to identify 
solutions that could facilitate the implementation.  
 
Drawing from principles of action research, which is an iterative process in which researchers 
and practitioners act together in the context of an identified problem to discover and effect 
positive change (229), problems that arose with the implementation plan were addressed. 
Action research involves participatory, pragmatic, democratic processes to explain social 
situations and implement change. Although not true action research, the concepts of 
collaborative working between researchers and those intended users of interventions and 
iterative problem solving were applied to the HeLP-Diabetes implementation plan. Working 
collaboratively with those tasked with implementing HeLP-Diabetes in practice enabled the 
implementation plan to be tailored to the specific needs that arose at different sites. This also 
meant that effective strategies that were developed in collaboration at one site could be applied 
at other sites with the aim of developing a refined and effective overall implementation plan.  
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In this Chapter, the implementation context, adjustments that were made to the implementation 
plan, problems identified with the implementation plan and strategies employed to address them 
are presented.  
 
7.3 Implementation context  
 
7.3.1 Islington CCG and the wider NHS 
The borough of Islington is the most densely populated in the United Kingdom, with just under a 
quarter of a million people (230) living in an area under six square miles, which as the CCG 
website reports, brings unique challenges to healthcare (231). The area of London that the CCG 
serves is multi-ethnic, with more than half of residents being of non White British (230). Islington 
is the fifth most deprived Borough in London and 14th most deprived in England. Islington has 
the highest percentage (6.4%) of people reporting they are in bad or very bad health among 
London boroughs and it is higher than both the London and England averages (5.0% and 5.5% 
respectively) with 24% of households having a person with a long term health problem or 
disability (230). It is estimated that 9,747 have a diagnosis of diabetes, with many more living 
with the condition undiagnosed (232).  
 
Islington CCG established an Integrated Care programme in 2013 to develop new ways of 
commissioning and delivering healthcare. This programme involved (amongst others) changes 
to the management of long term conditions, including new pathways of care for people with long 
term conditions. For diabetes care, the aims of this approach were to enhance the management 
of diabetes and those at risk of developing diabetes in primary care, and increase the number of 
people who are able to self-manage their health.  
 
During the period of time that HeLP-Diabetes was being implemented into Islington CCG (July 
2013- August 2015), several major changes were taking place in the way that diabetes care 
was provided. The CCG was beginning the early stages of implementing the Integrated Care 
diabetes care pathway (described above). In addition, in February 2013 the diabetes locally 
commissioned service (LCS) was launched. The aim was to provide every person with diabetes 
with an enhanced care plan, created through an extended collaborative consultation with their 
clinician, who had been trained in motivational interviewing, coaching and behavioural change. 
The LCS also offered identification of patients at high risk of developing diabetes with proactive 
follow up and recall for annual review; regular review of patients with history of gestational 
diabetes; implementation of enhanced care planning with a “Year of Care” (233) approach (an 
approach which uses care planning as a central component to drive a proactive process of care 
designed to improve patient involvement, provide a more personalised approach and support 
self-management of diabetes and other long terms conditions) to all patients with diagnosed 
diabetes; and a medicines management audit around metformin prescribing. It aimed to provide 
every GP and practice nurse in Islington with Year of Care (YOC) training by April 2016. 
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HeLP-Diabetes was designed as a service to support people with type 2 diabetes to self-
manage their condition, and as such, it appeared to have real synergy with the priorities of 
Islington CCG, a borough that was also demonstrating their capacity to implement new 
innovations into existing practice. It was therefore hoped that this would be an ideal case study 
for the implementation of HeLP-Diabetes. However, the implementation of HeLP-Diabetes took 
place between July 2013 and August 2015, a time of great flux in the NHS due to the Health 
and Social Care Act 2012. The Guardian described this time as “the biggest reorganisation of 
the NHS in England since it was created” (234). The changes brought about by this act, 
including the abolition of primary care trusts and the establishment of new statutory bodies 
came into effect on 1 April 2013 in Islington (235), with HeLP-Diabetes being made available in 
July 2013. In recent years NHS general practice has become increasingly under strain, and 
concerns have increased that primary care is overwhelmed (236) with the NHS being in the grip 
of the biggest crisis in its history (237). Complexity in patient cases, reduced workforces, 
reduced primary care budgets, an increase in resources being spent on contractual and 
regulatory requirements such as the Quality and Outcomes Framework (QOF) and enhanced 
services, GP time being spent on duties other than care giving, and political and public pressure 
on GPs and practices for increased access to GPs over extended hours and seven day 
working, have all contributed to a fatigued system (236-239). This is exemplified by the closure 
of many GP practices. In 2014 there were 7,875 general practices in England, a decrease of 87 
(1.1%) on 2013 (240). Since April 2013, it was reported that 22 London GP practices have 
closed (241). Three of these London practices were based in Islington CCG which closed down 
during the implementation of HeLP-Diabetes (July 2013-August 2015) (as reported by the 
Islington CCG Clinical Commissioning Officer) placing additional pressure on remaining local 
NHS services. These factors all contributed to a very strained NHS context within which to 
introduce a new intervention.  
 
In addition there was evidence during this time that referrals to diabetes education were not 
optimally delivered. Although patient self-management of diabetes was a key NHS priority, 
during the time of the implementation of HeLP-Diabetes, calls were made for GPs to do more to 
ensure that patients have access to diabetes education. In the first all party parliamentary 
meeting for diabetes in June 2014, experts called for GPs to do more to refer patients to 
diabetes education services. The report suggests that reasons for the lack of referrals by GPs 
include: healthcare professionals not valuing, or being unaware of, the benefits of education 
programmes; GPs being too busy to refer people to education; and the very few incentives to 
encourage healthcare professionals to develop services in this way (242).  
 
7.3.2 Diabetes services in Islington 
Within the CCG there were three main tiers of diabetes services: primary care, intermediate 
care and secondary care. Primary care services were delivered by staff in GP practices. 
Intermediate care is provided to those patients with enhanced clinical need and was delivered 
through the community based intermediate diabetes services located in a Primary Care Centre. 
Secondary care for diabetes was a consultant led specialist multi-disciplinary service, delivered 
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through hospital based clinics and aimed at patients with complex needs requiring specialist 
input. 
 
7.3.2.1 Primary care 
In Islington there were 37 GP practices at the time the implementation began, however, as 
described earlier, during the course of the implementation, three of these closed down, with 
their patient registers being absorbed by other GP practices within the CCG. Within general 
practice, a range of staff contribute towards the care of people with diabetes including GPs, 
practice nurses, healthcare assistants and practice managers, administrators and reception 
staff. The majority (n=29) of GP practices in Islington were group practices, run by several GPs. 
There were fewer (n=8) single-handed practices, with just one GP in charge. All of the practices 
that closed down during the implementation period were single-handed practices.  
 
Within general practice, certain diabetes care processes, recommended by the National 
Institute for Health and Care Excellence (NICE) for diabetes are incentivised through the Quality 
and Outcomes Framework (QOF) (243). The QOF is a voluntary incentive scheme for GP 
practices in the UK, rewarding them for how well they care for their patients, and helping them 
target resources for where they are most needed. It consists of groups of indicators against 
which practices score points according to their level of achievement. The diabetes indicators 
include ensuring patients receive a number of clinical checks and tests as well as being referred 
to a structured education programme (there are no points awarded for the number of patients 
who actually attend structured education).  
 
7.3.2.2 Intermediate care 
The diabetes intermediate care service in Islington is comprised of a team of diabetes specialist 
nurses, diabetes specialist dietitians, diabetes psychologists with support from a diabetes 
consultant, based primarily in one of the Primary Care Centres in the borough. Group education 
and self-management are key components of the service. The intermediate service runs 
DESMOND (diabetes education and self-management for ongoing and newly diagnosed) (32) 
for people with type 2 diabetes. Also available to patients is Co-creating Health (244), a seven 
week self-management programme. Co-creating Health aims to help participants build skills, 
knowledge and the self-belief needed to effectively manage their diabetes. 
 
7.3.2.3 Secondary care 
Diabetes secondary care is located primarily in hospitals, with the Whittington being the main 
hospital to serve the borough of Islington, although Islington patients may attend clinics at other 
hospitals in neighbouring boroughs. A team comprised largely of diabetes specialist nurses, 
consultants and junior doctors at the Whittington hospital run diabetic clinics which provide 
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services including: outpatient clinics, specialist paediatric endocrinology clinics, follow-up phone 
clinics and self-management programmes for patients with type 2 diabetes.  
 
7.4 Adjustment to the implementation plan 
In this section changes that were made to the implementation plan throughout the course of the 
implementation and the reasons for these changes are described. 
 
7.4.1 Changes to target group and setting 
Initially, the plan had focused on General Practice only. However, during an early steering group 
meeting, it was decided that in order to fully integrate HeLP-Diabetes into routine NHS care it 
should be made available to patients through a range of settings. The target settings were 
therefore extended to include hospital and community diabetes clinics (as well as GP practices). 
In making HeLP-Diabetes available across settings it was hoped that this would: act as a 
strategy to raise awareness of HeLP-Diabetes, with patients being exposed to HeLP-Diabetes 
in the GP practice and hospital and community clinics; raise the credibility of HeLP-Diabetes as 
an NHS service being promoted throughout the range of services that provide diabetes care; 
increase the communication around HeLP-Diabetes between services and promote a buzz 
which would encourage more practices and clinics to adopt HeLP-Diabetes.  
 
7.4.2 Changes to staged roll out 
Through networking, a slot was made available for HeLP-Diabetes to be presented at one of the 
CCG’s diabetes steering group board meetings in December 2012 before the implementation 
had begun in the borough. This was a very important meeting to raise awareness of HeLP-
Diabetes as it was attended by Commissioning Officers, Consultants from the local hospitals, 
local GP’s with a specialist interest in diabetes, specialist Nurses, Practice Managers and 
patient representatives. The outcome of this meeting was extremely positive with the CCG 
offering to support and promote the roll out of HeLP-Diabetes across the borough. The 
involvement from the CCG changed the planned batch roll out of HeLP-Diabetes as the CCG 
wanted HeLP-Diabetes to be made available to as many practices as possible as quickly as 
possible. The justification of this from the CCG point of view was that if they were to endorse 
HeLP-Diabetes as a service to its patients, it had to be available to all patients and not just 
those from a few practices. The implications of this were that rather than targeting a few 
practices at once, the commissioning officer from the CCG sent a blanket email to all practices 
in the borough introducing HeLP-Diabetes and urging all GPs and Practice Managers to set up 
practice meetings to find out more.  
 
As discussed in the systematic review in Chapter 3 (section Error! Reference source not 
found.), the identification and engagement of a key figure or opinion leader is a well-recognised 
strategy for facilitating implementation. Having the support and influence of the Commissioning 
Officer from the beginning of the implementation process was highly beneficial in terms of 
providing access to the target setting, raising awareness of HeLP-Diabetes throughout the 
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borough and enhancing credibility. Hence, overall, I welcomed this involvement, although it did 
mean that I lost control of the process.  
 
7.4.3 Changes to facilitating integration within practices 
Initially, when a batch roll out of HeLP-Diabetes to practices and clinics was planned it was 
intended that I would provide support to individual practices at the start of implementation. It 
was envisaged that I would work closely with each practice, training staff and demonstrating 
how to register patients. It was planned that I would spend a few weeks within each practice 
helping to register patients while staff observed and learnt the process. It was then hoped that 
the staff would feel confident and able to take over this role and register all future patients. This 
strategy was employed in two practices, however, when all practices were offered HeLP-
Diabetes at once, it became impossible to offer this service to all practices. Therefore, this 
strategy continued in the practices that had already been offered it, but it was not subsequently 
offered to any further practices.  
 
7.5 Addressing barriers to implementing HeLP-Diabetes  
Throughout the implementation phase, barriers to the implementation were identified by staff 
within practices and clinics through informal discussions and qualitative interviews. As an 
iterative study, in cases where it was possible, these barriers were tackled by making 
adjustments to the implementation plan. Below is a description of the barriers reported by staff 
towards the implementation and the adjustments made to the implementation plan and/or 
strategies employed to address these. These are summarised in Table 7-1. 
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Table 7-1 Summary of the problems encountered during the implementation and the 
adjustments made to the implementation plan to address them 
Barrier Adjustment/Strategy 
Constraints on time within 
consultations  
Reduced the time needed to offer HeLP-Diabetes to 
patients 
Workload Alternative patient registration methods created 
 Patient registration method 
 PDF leaflets 
 Paper registration forms 
 Peer supported registration 
Staff forgetting to 
recommend HeLP-Diabetes 
Integrating with practice templates to prompt 
recommendations 
Access to patient medical 
records perceived as 
controversial 
Removal of feature 
 
Lack of patient awareness of 
HeLP-Diabetes 
Additional patient focussed advertising: 
 TV screen adverts 
 Patient self-management groups 
 Diabetes UK events 
 Practice newsletters 
 Mail out 
Lack of staff awareness of 
HeLP-Diabetes 
Additional staff focussed advertising: 
 Locally Enhanced Services 
 Map of medicine  
 Staff education events 
 GP bulletin. 
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7.5.1 Barrier: Appointment time 
Several consistent barriers to implementation were observed across practices during the 
implementation process. Two interrelated barriers were time and workload. Practice staff stated 
they did not have enough staff time or staff availability to conduct the patient registration 
appointments. To tackle this barrier, several alternative implementation strategies were devised. 
These were offered and introduced to sites pragmatically based on discussions with practice 
staff and took into account what staff believed would work best in their services.  
 
Strategy: Reducing time needed to offer patients the intervention 
As described in Chapter 2 (page 34), HeLP-Diabetes was designed to be offered to patients by 
a member of staff who would provide facilitation to use it. It was initially estimated that it would 
take staff about 10 minutes to sign patients up to HeLP-Diabetes and an additional 30 minutes 
to take them through the website and help them to complete an activity on the site. However, it 
was identified by staff during initial practice meetings, that 40 minutes per patient would be 
unworkable in current GP practice. Subsequently, the registration process was streamlined so 
that it could be completed in 5 minutes and the facilitation aspect of the appointment (showing 
patients the website and taking them through an activity) was made into an optional (but 
encouraged) extra.  
 
7.5.2 Barrier: Workload 
As HeLP-Diabetes was being offered as a NHS service, patients needed to complete an online 
registration form and create a username and password to access it (see page 34). The need for 
patients to be registered by staff remained a barrier to offering HeLP-Diabetes to patients in 
many practices even after the reduced time of the registration and facilitation appointments. 
Staff cited competing demands on their workloads as reasons for not being able to register 
patients. In response to this several alternative methods of patient registration were devised and 
offered to practices. 
 
Strategy: Alternative patient registration methods 
 
Patient registration method: 
A separate registration URL was created so that patients could register themselves on HeLP-
Diabetes. Staff in practices using this model would identify suitable patients to give information 
leaflets to. These leaflets included details of how to access the HeLP-Diabetes online 
registration page and contained an individual access code (see Appendix O). These codes 
allowed patients access to the website and ensured that only the intended patient could access 
the site. Each code was linked back to the practice/clinic that gave the patients the leaflets so 
that the effectiveness of this strategy could be monitored.  
 
PDF leaflets: 
The patient registration leaflets had originally contained individual access codes (one code per 
patient) due to limitations of the software. However, by April 2015, with help from HeLP-
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Diabetes software company, I had been able to develop a system that allowed multi-use access 
codes to be generated. This meant that each practice could be provided with just one code for 
all of their patients and would still allow me to monitor where each patient had registered from. 
This also meant that rather than batches of individual paper leaflets having to be created and 
sent to each practice, each practice could just have one leaflet. This could be emailed to the 
practice in a PDF format, shared with all staff in the practice, printed whenever needed and 
readily stored on desktop computers which, it was hoped, would make offering HeLP-Diabetes 
to patients much easier. 
Paper registration forms: 
A strategy that was tried initially in one practice was to provide paper copies of the online 
registration form which could be used in the following ways: staff could promote HeLP-Diabetes 
to patients during consultations and interested patients could be given a copy of the paper 
registration form to complete in reception after their appointment and before leaving the 
practice. Or practices could mail out a copy of this registration form to all patients with type 2 
diabetes. Patients could then return the completed forms to a member of the practice team who 
could add all the completed forms to the online system at a convenient time. This method was 
used in one practice. 
 
Peer supported registration: 
In order to support practices to register patients a peer tutor was trained to help with the 
registration process within practices. This peer tutor was a member of the study steering group 
who had type 2 diabetes. She was trained by me on the registration process and to facilitate 
patients’ access to HeLP-Diabetes. It was envisaged that she would work within practices, 
where patients identified by staff would meet with her to be registered to HeLP-Diabetes and 
taken though the content. It was hoped that a peer approach to this would engage patients, and 
also provide them with more time to explore HeLP-Diabetes than would be possible with a staff 
given the time constraints of appointments. This idea was discussed with the CCG who were 
positive about the approach. Following the training of the peer tutor, all practices were 
contacted and offered this service. Despite continued offers, email and newsletter 
correspondence about the availability of a peer tutor, no practices took up the offer. Informal 
feedback from one GP within a practice suggested that the reason for this lack of uptake was 
due to the fact that it would still involve additional work for practices to set the peer tutor up 
within the practice and to refer patients to her.  
 
Therefore the two main ways in which patients were registered to HeLP-Diabetes during the 
study were by staff registering patients and patients registering themselves with an access 
code. These registration methods are summarised in Table 7-2. 
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Table 7-2 Ways in which patients registered to HeLP-Diabetes  
 Staff registration Patient registration 
Online registration form 
completed by? 
Member of staff with patient 
usually present 
Patient once they had left the 
practice/clinic 
Assistance provided to 
make first login? 
Yes No 
HeLP-Diabetes 
demonstrated to patients by 
staff? 
Yes (usually but optional) No 
 
7.5.3 Barrier: Staff forgetting to recommend intervention 
Informal feedback from staff suggested that a barrier to offering HeLP-Diabetes to patients was 
staff forgetting about it during appointments with patients.  
 
Strategy: Integrating with practice templates 
During a meeting with a practice nurse in February 2015, the nurse mentioned that she had 
been able to create a tick box on the diabetes EMIS (Electronic patient record systems and 
software used in GP practices in the CCG) template which prompted her to offer patients 
access to HeLP-Diabetes during routine appointments with patients with diabetes. She had also 
uploaded the patient leaflet PDF to the template for ease of access. I suggested this strategy to 
other practices as a way of increasing patient registrations to HeLP-Diabetes and it was 
implemented in three practices. A lack of technical support in other practices prevented this 
from being more widely implemented.  
 
7.5.4 Barrier: Access to patient medical records 
Another barrier to adoption raised at an initial practice meeting by a GP was in relation to a 
specific feature of HeLP-Diabetes. HeLP-Diabetes was designed to allow patients to access 
summary data from their electronic health records. This access would have to be agreed by the 
practice and the individual patient. However, this feature had been subject to delays and was 
not functional at the time of initial practice meetings, but staff were made aware that it might be 
available in the future. One GP was uncomfortable with this possibility and would not consider 
adopting HeLP-Diabetes until HeLP-Diabetes had been approved by the Local Medical 
Committee. 
 
Strategy: Removal of feature 
In order to address this, advice from the commissioning officer for the CCG was sought. The 
officer offered to raise this issue at the IT working group for the borough. It was also 
recommended that in the meantime, until approval was granted, this feature of the website was 
not promoted at future practice meetings. Based on this recommendation, the fact that the CCG 
IT working group never gave approval and the continued delays with the functionality of this 
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feature; this feature was turned off and no longer formed part of the HeLP-Diabetes intervention 
offered in the CCG. 
 
7.5.5 Barrier: Patient awareness of HeLP-Diabetes 
Originally, the strategy to raise awareness of HeLP-Diabetes amongst patients relied on staff to 
promote HeLP-Diabetes during routine appointments and the use of posters and leaflets in 
practices and clinics. As these strategies alone were not attracting much interest from patients, 
the following additional strategies were developed and implemented.  
 
Strategies: 
 TV screen adverts 
I created an advert to be displayed on the TV screens within GP practice waiting rooms 
which advertised HeLP-Diabetes to patients and provided information on how they 
could find out more about it.  
 
 Patient self-management groups 
I was invited by several practices during the implementation to attend events that they 
had arranged at the practices. These included patient self-management evenings where 
all the services within the practice to support patient self-management were discussed, 
and patient evenings for patients with diabetes. At these sessions I presented HeLP-
Diabetes, gave a live demonstration, answered patient questions and then registered 
interested patients then and there.  
 
 Diabetes UK events 
I was invited to attend an event hosted by Diabetes UK which aimed to raise awareness 
of diabetes services for patients within the borough. This was attended by over 100 
patients with diabetes. I held an exhibition stall and provided live demonstrations of 
HeLP-Diabetes as well as providing patients with literature and information on how to 
register to use HeLP-Diabetes. 
 
 Practice newsletters 
Several GP practices produced their own regular newsletters for patients and HeLP-
Diabetes was often included in these to raise awareness with patients. 
 
 Mail out 
The hospital within the CCG conducted a mail shot of patient registration leaflets to the 
1000 patients with type 2 diabetes that it serves. This was conducted in February 2015.  
 
7.5.6 Barrier: Staff awareness of HeLP-Diabetes  
To further promote HeLP-Diabetes among staff the following strategies were devised and 
implemented. 
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Strategies: 
 Locally Enhanced Services 
HeLP-Diabetes was included by the CCG as one of their Locally Enhanced Services 
(LES) for type 2 diabetes in November 2014. This raised the profile of HeLP-Diabetes, 
consolidated the CCG backing of HeLP-Diabetes and raised awareness of it through 
the LES documentation. The intervention was seen by the CCG to support the following 
aspects of the diabetes LES and theses features of HeLP-Diabetes were promoted to 
staff:  
o Supporting care planning by allowing patients and staff to share a common 
record and by the provision of a care planning component within HeLP-
Diabetes which uses the Islington care planning document.  
o enabling patients (of practices that use EMIS) to access their investigation 
results (e.g. in advance of the 2
nd
 care planning appointment);  
o encouraging patients to obtain and record the “9 essential processes” 
recommended by NICE;  
o Providing education and support to enable patients to self-manage. 
 
 Map of medicine  
Following the integration of HeLP-Diabetes into the diabetes LES, HeLP-Diabetes was 
added to the Map of Medicine system used by GP practices in the CCG. This map 
displays care pathways and referral guidance within the CCG so that staff can readily 
access relevant information at the point of care and save forms within patient records. 
 
 Staff education events 
I was invited by the CCG to attend GP educational events on several occasions during 
the implementation. At these events I held an exhibition stall with a laptop to 
demonstrate HeLP-Diabetes, and produced promotional materials including posters, 
flyers, mugs and pens to attract interest. At these events I talked to GPs and promote 
HeLP-Diabetes, took details of interested GPs and followed up interest with an offer of 
me attending a practice meeting to give them more information.  
 
 GP bulletin 
The intervention was frequently advertised in the CCG’s bulletin to GPs informing them 
of its availability and giving my contact details for further information. 
 
7.6 Barriers that could not be addressed 
There were several barriers to the implementation identified by staff which were beyond the 
scope of this research to address. These were: 
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7.6.1 Barrier: Change in staffing 
In several cases staff who had been trained to offer HeLP-Diabetes subsequently left the 
practice or clinic and no other members of staff continued to advocate HeLP-Diabetes to 
patients. Despite me offering to attend practice meetings and provide training to alternative staff 
to try and engage new staff, these were not responded to.  
 
7.6.2 Barrier: Closed practice 
During the implementation, as described in the context section above, three practices in the 
CCG closed down and had their patient lists absorbed by other neighbouring practices. This 
meant that HeLP-Diabetes could not be implemented within these practice, but also that the 
additional strain on the neighbouring practices hindered the implementation of HeLP-Diabetes 
there.  
 
7.6.3 Barrier: Non responsive practices 
There were eight practices who, despite continued efforts by the CCG’s Commissioning Officer 
and I to establish contact, did not respond to any correspondence about HeLP-Diabetes. 
Through discussions with the Commissioning Officer during our regular meetings potential 
reasons for the non-engagement by these practices were ascertained. The most common 
reason was that the practice was a single handed practice (with only one GP working there) 
which meant that there was no additional capacity to take on new interventions and implement 
them. Other reasons provided by the Commissioning Officer included GP’s disinterest in 
diabetes and long term conditions, GP’s being off work due to long term sickness, practices 
facing difficult times financially and the closure of practices.  
 
7.7 Other uses for HeLP-Diabetes  
Teaching aid for health care assistants 
HeLP-Diabetes was also used in an unanticipated way by the lead Diabetes Specialist Nurse 
within the CCG as an educational tool to teach health care assistants about care planning, goal 
setting and behaviour change for patients with type 2 diabetes. The videos within HeLP-
Diabetes were played during these training days to increase the health care assistants’ 
knowledge about diabetes and the goal setting and action planning tools were demonstrated. 
The health care assistants were also provided with login details for HeLP-Diabetes so that they 
could use it with patients in routine practice.  
 
7.8 The final implementation plan 
 
Table 7-3 presents a summary of the implementation strategy and its components in 
generalizable terms.   
Figure 7-1 summarises the result of this iterative implementation plan and displays the different 
ways which were devised during the study for practices and clinics to offer HeLP-Diabetes to 
patients within routine practice.  
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Table 7-3 Summary of the HeLP-Diabetes implementation plan 
Stages of 
implementation 
process and 
goals of 
strategies at 
this stage. 
NPT constructs 
to target 
HeLP-Diabetes implementation plan 
Orientation: 
Raise 
awareness of 
HeLP-Diabetes 
and stimulate 
interest 
 
At this stage the 
plan needed to 
start to build a 
sense of 
coherence 
towards HeLP-
Diabetes.  
An email was sent to all practice/clinic managers and 
lead GPs/consultants for diabetes to inform them that 
there was a free new tool available to support their 
patients with looking after their diabetes. In order to 
increase coherence the email emphasised that HeLP-
Diabetes was an online programme thus different from 
other self-management programme, that it was free to 
use and had been developed by a university.  
Insight:  
Create 
understanding 
of what HeLP-
Diabetes is and 
what was 
expected of 
staff. 
 
At this stage, staff 
coherence was 
further targeted.  
Meetings were arranged with services who had 
responded to initial emails.  The purpose of these 
meetings was to provide healthcare professionals with 
information about HeLP-Diabetes and the implications 
for their working practice to allow them to decide 
whether or not to adopt it in their practice. 
  
Specific strategies to engage healthcare professionals 
during these meetings included: presenting the 
evidence base behind the development and content of 
HeLP-Diabetes; outlining the potential benefits to the 
practice and patients of adopting HeLP-Diabetes; 
demonstrating how HeLP-Diabetes meets identified 
clinical needs; and through a live demonstration, 
showing the usability and attractiveness of HeLP-
Diabetes. 
Acceptance: 
foster a 
positive 
attitude 
towards HeLP-
Diabetes and 
create positive 
intention or 
The collective 
action construct 
was targeted at 
this stage to 
demonstrate that 
the operational 
work needed to 
implement HeLP-
Services were provided with login details in order to try 
out HeLP-Diabetes before they made a decision to 
adopt.  
Trying out HeLP-Diabetes allowed staff to see how 
HeLP-Diabetes fitted with the skill sets of the healthcare 
professionals in the practice (skill set workability), what 
resources were needed to make it part of routine 
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decisions to 
adopt. 
 
Diabetes was 
achievable.   
practice (contextual integration), what knowledge was 
needed to be confident with HeLP-Diabetes as a new 
way of working (relational integration), and the impact 
that HeLP-Diabetes would have on interaction with 
colleagues and patients (relational integration). 
  
Change: 
confirm benefit 
and value of 
HeLP-Diabetes 
once a service 
had agreed to 
adopt it.  
 
The cognitive 
participation 
construct was 
targeted at this 
stage to promote 
a sense of 
willingness to 
take part amongst 
staff in services.  
Once a service had decided to adopt HeLP-Diabetes, 
healthcare professionals were provided with a training 
session.  
This training session provided the opportunity for staff 
to understand the actions and procedures needed to 
sustain HeLP-Diabetes in practice and to be convinced 
that HeLP-Diabetes could deliver the anticipated 
advantages. The majority of training was with groups of 
staff which allowed the opportunity for them to discuss 
and decide how the work of implementing would be 
shared.  
Maintenance: 
Encourage 
HeLP-Diabetes 
continued use 
and facilitate 
new working 
practices 
becoming part 
of routine 
practice. 
 
At this stage 
reflexive 
monitoring 
construct was 
targeted to create 
positive 
appraisals of the 
worth of 
undertaking the 
work of 
implementing 
HeLP-Diabetes. 
Ongoing support and communication was provided to 
each service who adopted HeLP-Diabetes in order to 
problem solve and maintain awareness.   
Feedback was provided to service to promote positive 
reflexive monitoring. Feedback included details of how 
many patients were using HeLP-Diabetes, how each 
service was performing and feedback from patients 
using HeLP-Diabetes.  
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Figure 7-1 The Final Implementation Plan 
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8 CHAPTER 8: RESULTS 1: ADOPTION, UPTAKE AND USE OF THE HELP-DIABETES 
INTERVENTION BY NHS SERVICES AND PATIENTS. 
 
8.1 Chapter summary 
This is the first of three chapters presenting the results of the study. The results presented in 
this chapter address the adoption, uptake and the use of HeLP-Diabetes by NHS services and 
patients. Findings related to interviews conducted with staff and patients that explore factors 
important for the adoption, uptake and use of HeLP-Diabetes are presented in Chapters 9 and 
10.  
 
8.2 Introduction 
In this chapter, the main findings which relate to the following research questions are presented.  
 
 To what extent was HeLP-Diabetes adopted by NHS services? 
 To what extent was HeLP-Diabetes implemented within NHS services? 
 What was the uptake of the HeLP-Diabetes by patients? 
 How was HeLP-Diabetes used by patients? 
 Were there any factors that predicted patient use of HeLP-Diabetes? 
 Were there any factors that predicted HeLP-Diabetes registration 
 method?  
To aid interpretation, definitions of terms from the glossary (page13) used throughout this 
chapter are provided again in Table 8-1. A description of how these terms specifically apply to 
the implementation of HeLP-Diabetes is also provided.  
 
Table 8-1 Definition of terms 
 Definition Operationalisation of 
definition 
 
Adoption A decision to make full use of an 
innovation as the best course of action 
available. 
 
The decision made by NHS 
services to take on HeLP-
Diabetes as a tool to offer to 
their patients. 
 
Implementation The active process of putting to use or 
integrating evidence-based interventions 
within a setting. 
Staff making use of HeLP-
Diabetes within practices and 
clinics 
 
Uptake  The action of taking up something that is 
available 
 
The decision by patients to 
register to HeLP-Diabetes and 
the act of registering 
144 
 
 
Use The action of or making use of 
something that is available 
Patients making use of HeLP-
Diabetes again after 
registering. 
 
8.3 To what extent was HeLP-Diabetes adopted by NHS services? 
 
8.3.1 Number of services that adopted HeLP-Diabetes  
There were 37 GP practices, a hospital and a community service running diabetes clinics in the 
CCG. Of the 37 GP practices, twenty two (59.5%) practices agreed to adopt HeLP-Diabetes as 
did the hospital and community clinics.  
 
Six (16.2%) GP practices expressed initial interest in HeLP-Diabetes but then did not respond to 
further correspondence regarding the process of implementing it within their practice. It was not 
possible to establish any contact with eight (21.6%) GP practices despite efforts from both me 
and the CCG, and one (2.7%) GP practice explicitly declined to adopt HeLP-Diabetes. As 
described in detail in Chapter 7 (page 136), this practice declined to adopt HeLP-Diabetes 
based on concerns the GP had about the potential link HeLP-Diabetes was offering to patients 
electronic health records. In an effort to resolve this, this specific function feature of HeLP-
Diabetes was removed from HeLP-Diabetes. However, despite communicating this back to the 
GP, this practice still decided not to adopt HeLP-Diabetes. This practice was one of the ones 
which closed down during the implementation period (July 2013- August 2015). The other two 
practices which closed were ones with whom it had not been possible to establish any contact 
with regarding HeLP-Diabetes.  
 
8.3.2 Type of diabetes services 
A description of the twenty two GP practices (ordered by the number of patients registered to 
use HeLP-Diabetes) and the hospital and community clinics is provided in Appendix P. 
 
The list sizes of these twenty two practices ranged from 2,101 to 12,941 and the practices 
collectively served 5,117 patients with type 2 diabetes. The services had access to HeLP-
Diabetes for varying amounts of time (ranged between 3 and 25 months) depending on when 
they adopted it during the implementation period. QOF scores for the diabetes indicator for 
these practices ranged from 76% (of total achievable points for the indicator) to 100% with 
higher scores reflecting better achievement and thus greater financial reward for practices. 
 
8.4 To what extent was HeLP-Diabetes implemented within NHS services?  
 
8.4.1 Number of patients registered 
Of the twenty two GP practices that decided to adopt HeLP-Diabetes, eighteen (81.8%) 
implemented it, as did the hospital and community clinics. Implementation was defined as a 
practice or clinic registering one or more patient to use HeLP-Diabetes.  
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The number of patients registered to use HeLP-Diabetes ranged greatly between GP practices, 
between 1 and 40 patients per practice, with a median value of 3. The number of patients 
registered to HeLP-Diabetes by these practices comprised approximately 3.4% of their 
potentially eligible patients (see Chapter 6 page 98 for eligibility criteria and Appendix P for 
details of the percentage of eligible patients registered by each service). The hospital registered 
30 patients and the community clinic registered one patient (As shown in Appendix P the 
community clinic adopted HeLP-Diabetes much later than the other services).  
 
Four practices did not implement HeLP-Diabetes (did not register any patients from their 
practices to use it). It was not possible to tell in these cases if HeLP-Diabetes had been offered 
to patients but not taken up by them, or whether the practices simply had not offered HeLP-
Diabetes at all. Therefore, of the 37 GP practices, 48.6% (n=18) adopted HeLP-Diabetes and 
made use of it. The hospital clinic and the community clinics were both classed as having used 
HeLP-Diabetes as patients from both services were registered to use HeLP-Diabetes.  
 
In order to explore whether differences in the number of patients signed up to HeLP-Diabetes 
was related to the length of time a practice had provided patients access to HeLP-Diabetes, a 
one-tailed Spearman’s test for correlation between these factors was conducted but revealed a 
non-significant relationship between these variables (r=0.32, n=18, p=0.98), suggesting that 
other factors than length of time were important for actually putting HeLP-Diabetes to use.  
 
8.4.2 How HeLP-Diabetes was implemented 
As described in detail in Chapter 6 (section 6.6.2.1), a research diary (Appendix Q) was kept 
during the research to document the implementation progress at each site. The data in this 
diary (collected from informal feedback from staff, personal experience of supporting the 
implementation at each site, discussions with staff during training sessions, email 
communications and ongoing feedback from staff) were coded into descriptive themes and then 
mapped onto constructs of NPT in order to explain how HeLP-Diabetes was implemented into 
practice.  
 
As a reminder, and to aid the reader’s interpretation, definitions of NPT and questions relating to 
each of the constructs which were used to facilitate the mapping process (described in Chapter 
6, section 6.6.2.2) are provided again in Table 8-2. Table 8-3 presents descriptive themes, 
illustrative examples and the NPT constructs that themes were mapped to.  
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Table 8-2 Definitions and questions relating to each of the constructs of NPT 
Construct/sub construct Definition* 
 
Questions that NPT poses 
of the implementation of 
HeLP-Diabetes? 
Coherence The sense-making work that 
people do individually and 
collectively when they are 
faced with the problem of 
operationalizing some set of 
practices 
How is HeLP-Diabetes 
conceptualised by staff? 
What is the work of 
implementing HeLP-
Diabetes?  
Cognitive participation The relational work that 
people do to build and sustain 
a community of practice 
around a new technology or 
complex intervention 
How do staff come to engage 
with HeLP-Diabetes? 
How do they decide on 
engagement and the purpose 
that it serves? 
Collective action The operational work that 
people do to enact a set of 
practices 
How do staff enact HeLP-
Diabetes?  
How are their activities 
structured and constrained? 
Interactional workability The interactional work that 
people do with each other, 
with artefacts, and with other 
elements of a set of practices, 
when they seek to 
operationalize them in 
everyday settings 
How does HeLP-Diabetes 
affect interactions between 
people and practices?  
Relational Integration The knowledge work that 
people do to build 
accountability and maintain 
confidence in a set of 
practices and in each other as 
they use them 
How does a HeLP-Diabetes 
relate to existing knowledge 
and relationships? 
Skill set workability The allocation work that 
underpins the division of 
labour that is built up around a 
set of practices as they are 
operationalized in the real 
world 
How is the current division of 
labour affected by HeLP-
Diabetes? 
Contextual Integration The resource work. Managing 
a set of practices through the 
How does HeLP-Diabetes 
relate to the organisation in 
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allocation of different kinds of 
resources and the execution 
of protocols, policies and 
procedures 
which it is set? 
Reflexive monitoring The appraisal work that 
people do to assess and 
understand the ways that a 
new set of practices affect 
them and others around them 
How do staff appraise HeLP-
Diabetes? 
What are the effects of 
appraisal? 
How are they mediated? 
*Definitions from (191) 
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Table 8-3 Descriptive themes, illustrative examples and mapping to constructs of NPT 
Theme Illustrative Examples NPT Construct 
Available 
Resources/Training 
Time constraints to offer 
intervention 
Contextual Integration 
Lack of space to register 
patients privately 
Contextual Integration 
Lack of computers to conduct 
registration 
Contextual Integration 
Very old computers and very 
slow internet connection 
Contextual Integration 
Healthcare professional training  Skill Set Workability 
Compatibility Intervention fitted well into 
existing extended appointments 
designated for people with 
diabetes 
Interactional Workability 
Competing pressures with many 
other services to implement 
Cognitive Participation 
Complexity of 
intervention 
Perceptions of the ease and 
difficulty of the patient 
registration process 
Interactional Workability 
Tasks associated with the 
research study perceived as 
overwhelming 
Cognitive Participation/ 
Interactional Workability 
Healthcare professional 
unconfident with 
computers/internet 
Skill Set Workability 
Feedback Positive feedback received from 
patients using it. 
Reflexive Monitoring 
Feedback from me on numbers 
of patients being registered. 
Reflexive Monitoring 
Fit for purpose Practice nurse did not think 
many patients would have 
computer/English language 
skills to use it 
Cognitive Participation 
Practice nurse thought 
intervention was better aimed as 
an educational tool for 
healthcare professional  
Cognitive Participation 
Receptionist thought 
intervention wasn’t appropriate 
Cognitive Participation 
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for the age of the patients she 
saw 
Fit with external 
policies/priorities 
Strong push from the CCG to 
implement HeLP-Diabetes 
Contextual Integration 
Intervention incorporated into 
LES for the CCG 
Contextual Integration 
Perceived fit with CCG policies 
and intervention 
Contextual Integration 
Implementation 
process 
GP involvement in driving 
intervention forward 
Cognitive Participation 
Assisting patient registration Interactional Workability/ 
Skill Set Workability 
Ongoing communication and 
support 
Relational Integration 
Provision of materials Relational Integration 
Intervention source Credibility given to HeLP-
Diabetes because it was 
developed at a University  
Coherence & Cognitive 
Participation 
The lack of commercial affiliation 
was viewed as a positive  
Coherence & Cognitive 
Participation 
Strong academic evidence base 
for HeLP-Diabetes  
Coherence & Cognitive 
Participation 
Perceptions of the 
value of HeLP-Diabetes 
GP had a strong interest in 
diabetes and self-management 
and saw value in HeLP-Diabetes 
Cognitive Participation 
Healthcare professional could 
see value in intervention over 
group based education for some 
patients  
Coherence & Cognitive 
Participation 
Comparisons with other existing 
websites  
Coherence & Cognitive 
Participation 
Healthcare professional 
roles and 
responsibilities 
Only the GP took ownership of 
HeLP-Diabetes and did not 
communicate about it with other 
staff  
Contextual Integration/ 
Relational Integration 
HCA’s enjoying feeling upskilled 
by undertaking new role 
Skill Set Workability 
Healthcare professional who 
were responsible for 
implementing were not always 
Relational Integration 
150 
 
those who had agreed to adopt 
Staff and stability Large healthcare professional 
turnover 
Contextual Integration 
Reliance on agency healthcare 
professional 
Contextual Integration 
Problems with estate forcing 
practice to close down 
temporarily 
Contextual Integration 
Support for HeLP-
Diabetes 
Teams of healthcare 
professional all interested in 
intervention 
Cognitive Participation 
Competing organisational 
pressures 
Cognitive Participation 
Lack of support from senior 
healthcare professional 
Cognitive Participation 
Strong support and push for 
intervention by lead GP 
Cognitive Participation 
Support for intervention among 
healthcare professional 
Cognitive Participation 
Lack of replacement healthcare 
professional to carry intervention 
forward  
Contextual Integration 
Tailoring Positive feedback received from 
patients using it. 
Reflexive Monitoring 
Feedback from me on numbers 
of patients being registered. 
Reflexive Monitoring 
Addition of local services 
information  
Reflexive Monitoring 
Teamwork and 
communication 
Big nurse/NCA team who 
worked closely together  
Relational Integration 
Intervention had not been well 
communicated by GPs to the 
nurses/HCAs 
Relational Integration 
Intervention was not well 
communicated to other 
healthcare professional in 
practice  
Relational Integration/ 
Interactional Workability 
Tensions between healthcare 
professional within the practice  
Relational Integration 
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8.4.3 Explaining the implementation using Normalization Process Theory 
 
The data are now presented using an NPT lens to describe the work involved in implementing 
HeLP-Diabetes and to identify barriers and facilitators to implementation.  
 
Coherence: The sense making work that healthcare professional perform around HeLP-
Diabetes 
 
In most cases during practice meetings it was clear that the value, benefits and importance of 
HeLP-Diabetes was understood by staff. The fact that HeLP-Diabetes had been developed by 
academics with input from healthcare professionals and patients with type 2diabetes at a 
university, and was evidence -based served to distinguish it from other available websites and 
increase staff perceptions of its value. HeLP-Diabetes was clearly distinguishable from current 
resources available to patients, such as group based education, which was mentioned by 
several staff as unsuitable for certain patients. Self-management was a clear priority throughout 
the CCG and as such many staff commented on how useful a tool to help patients self-manage 
was perceived to be, as it would help them to achieve the goals of supporting self-management. 
The demonstration of HeLP-Diabetes during clinical meetings and the opportunities for practice 
staff to ask questions around what would be involved in implementing it served to increase both 
individual and shared understandings of what the work involved in implementing HeLP-Diabetes 
would be. 
 
Cognitive participation: The relationship work that staff perform around HeLP-Diabetes 
 
Despite a strong sense of coherence around understanding the value and potential benefits of 
HeLP-Diabetes, in many practices and clinics there appeared to be little cognitive participation 
to embed HeLP-Diabetes in routine practice. Although these practices had signed up to adopt 
HeLP-Diabetes it did not emerge as a priority and failed in the majority of practices and clinics 
to normalize within routine practice. Staff within practices were working to a set of tasks which 
were dictated by practice priorities such as ensuring that financially incentivised targets set out 
by the QOF were reached. HeLP-Diabetes, as a non-incentivised task, was not prioritised over 
other work and therefore was often not carried out in favour of other incentivised tasks.  
 
Another barrier to cognitive participation arose around staff not feeling that HeLP-Diabetes was 
a legitimate part of their work due to the limitations they perceived of HeLP-Diabetes. In their 
coherence work some staff had concluded that HeLP-Diabetes would not be suitable for certain 
patients and therefore decided against putting the required effort in to implementing it. In a few 
cases during practice meetings concerns were expressed that as an internet intervention written 
in English there would be certain patients who would not be able to use HeLP-Diabetes, and 
therefore questioned its effectiveness and suitability. It was frequently asked whether HeLP-
Diabetes was available in other languages. At some practices staff perceived the content of 
HeLP-Diabetes as too complex for many of their patients and viewed HeLP-Diabetes as a tool 
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that would be better suited for healthcare professionals. Indeed in three cases, HeLP-Diabetes 
was used in a different way than intended. It was used by two health care assistants to teach 
themselves more about diabetes, and used by a diabetes specialist nurse who had 
responsibility for training all the health care assistants in the CCG about providing self-
management support to patients with long term conditions (especially around using goal setting 
and action planning). In other cases staff expressed concerns that the age of the population 
with type 2 diabetes would preclude them from using technologies to access self-management 
support.  
 
The responsibility of supporting self-management of diabetes in general, as well as for the 
delivery of HeLP-Diabetes, seemed to be passed down the chain. Pressures from wider NHS 
policies for self-management of long term conditions were passed on to the CCG, who then 
placed this responsibility for patients better managing their conditions onto GPs practices. GPs 
within practices delegated the responsibility of self-management to nurses, who in turn placed it 
onto the patients. As described in Chapter 7, HeLP-Diabetes was originally designed to be used 
collaboratively with staff and patients during appointments however, in many practices this 
interaction around HeLP-Diabetes was reduced to the handing out of a leaflet and as such, 
patients had to undertake the work of registering themselves to use HeLP-Diabetes.  
 
However, there were a smaller number of practices and clinics where the work of implementing 
HeLP-Diabetes did become part of routine practice. In cases where there were key individuals 
to drive it forward and to engage other staff, HeLP-Diabetes was taken up by more patients than 
in practices and clinics where there were no such individuals. However, this was not common, 
and in the majority of practices and clinics the work of implementing HeLP-Diabetes was the 
responsibility of one or two staff who received little support from the wider practice or clinic 
team. Some staff expressed the opinion that HeLP-Diabetes should not be delivered through 
primary care and that patients should just be able to search for it online like services like 
Diabetes UK; thus suggesting that they did not think the delivery of HeLP-Diabetes was a 
legitimate part of their work.  
 
Collective action: The operational work that people do to enact a set of practices. 
 
Interactional workability 
In their attempts to enact HeLP-Diabetes within practices many staff viewed the logistics of 
giving patients’ access to HeLP-Diabetes by registering them and introducing them to it as 
problematic. A number of options were developed (as discussed in Chapter 7) in order to ease 
the work of operationalising HeLP-Diabetes within practices including printable forms, patient 
registration leaflets, peer supported registration as well as the original staff registration method. 
However the majority of practices lacked the impetus to consider change, or immediately 
dismissed the possibility of engaging in the work needed to adjust routines in order to register 
patients. This was largely as a result of their concerns about workload and time pressures.  
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Handing out leaflets which allowed patients to sign themselves up to HeLP-Diabetes rather than 
the staff registration method was viewed as more desirable a method to implement. Handing out 
leaflets presumably fitted more readily into existing ways of working as staff are used to doing 
this. In this way leaflets proved minimally disruptive and were more acceptable than the staff 
registration method.  
 
Some practices did however enact the work of offering HeLP-Diabetes to patients, and were 
able to integrate the staff registration method within the practice. This was a result of a small 
team or an individual nurse/HCA changing their work practices and having the support of the 
practice to make these autonomous decisions over changing their way of working. However, in 
a couple of cases where this had occurred, when the healthcare professional who had taken the 
lead on the implementation left the practice, the use of HeLP-Diabetes within the practice 
ceased as it was not incorporated into the wider practice and there was no one else available or 
willing to take over this role.  
 
Relational Integration 
In many cases there was a lack of communication between staff around the implementation of 
HeLP-Diabetes. Adoption decisions were often made by GPs and practice managers during 
initial clinical meetings that I attended to demonstrate HeLP-Diabetes. However, in most cases 
it was practices nurses, healthcare assistants and receptionists who were identified as having 
the specific skills, time and opportunity to deliver HeLP-Diabetes. There was a discord between 
who was accountable for the implementation of HeLP-Diabetes and who was responsible for 
carrying out the work of implementing it within practice. The staff who were identified (usually by 
GPs) to deliver HeLP-Diabetes were often not involved in the decision to adopt it, and in some 
cases when I arrived to deliver training to these healthcare professionals they had no 
knowledge of HeLP-Diabetes or the work expected of them. 
 
Skill set workability 
Training sessions proved valuable in engaging staff tasked with doing the work of implementing 
HeLP-Diabetes. In an environment where practices and clinics are overwhelmed by competing 
priorities, having the opportunity to view HeLP-Diabetes and interact with it increased staff 
confidence in their ability to use it and in HeLP-Diabetes itself as a worthwhile tool to promote to 
patients (Cognitive Participation). In addition, the ongoing support available I provided to staff, 
and the hands-on assistance I provided in some practices at the beginning of implementation 
were viewed as helpful to allow staff to gain confidence in the processes. 
 
In some practices where receptionists and health care assistants were enacting the work of 
implementing HeLP-Diabetes they informally reported to me a positive impact of this work on 
their role identity. Undertaking training, being provided with HeLP-Diabetes which provided 
them with an information resource and using it with patients provided a sense of taking on 
additional responsibilities which they valued and perceived as fitting well with their career 
aspirations as several were in the process of taking on additional clinical responsibilities.  
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Contextual integration 
HeLP-Diabetes had strong support from the CCG and fitted well with its priorities. The CCG 
offered support in implementing HeLP-Diabetes through contacting practices, raising it as an 
agenda item at diabetes steering group meetings with clinicians and by incorporating it into the 
LES for the CCG. However, no resources were provided to practices and clinics to implement 
HeLP-Diabetes. This lack of resource arose as the main challenge for practices to implement 
HeLP-Diabetes, with a lack of staff, staff turnover, time pressures, limited physical space and 
old and slow computers described as barriers by staff during clinical meetings and ongoing 
communication. In contrast, in practices where I undertook the work of implementing the 
intervention by registering patients and facilitating their access, this additional resource seemed 
to make the work of registering patients possible.  
 
Reflexive monitoring: The appraisal work that is performed around HeLP-Diabetes 
In cases where staff were given feedback from patients using HeLP-Diabetes, this helped to 
confirm that it was a worthwhile intervention to promote, however due to the low number of 
patients signed up by practices and clinics this was uncommon and this lack of feedback served 
to undermine the perceived value of HeLP-Diabetes. I provided practices and clinics with 
regular updates on the number of patients that were being registered to HeLP-Diabetes from 
their practices in order to help them appraise the worth of continuing with implementing it. There 
were several examples of staff making changes to HeLP-Diabetes to make it more workable in 
practice. One nurse asked for more content to be added around sexual dysfunction as she 
found this a challenging area in her discussion with men with diabetes and believed HeLP-
Diabetes could help her address this. A GP asked for a page to be created for pre-diabetes as a 
lot of his work was with this patient group and he believed HeLP-Diabetes would be useful in 
this area too. 
 
 
8.5 What was the uptake of HeLP-Diabetes by patients? 
 
8.5.1 Number of patients registered 
In total 205 patients registered to use HeLP-Diabetes from the 18 GP practices, hospital and 
community clinics during the implementation period (July 2013 to August 2015).  
 
The majority (n=143, 69.3%) were registered to HeLP-Diabetes via the staff registration method 
with a further 62 (30.7%) patients using the patient registration method. It was not possible to 
determine how many patients were actually offered use of HeLP-Diabetes but decided against 
using it, as it was not feasible due to time constraints and workload for the staff at participating 
sites to record the number of patients they offered HeLP-Diabetes to.  
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8.5.2 Characteristics of registered patients 
The intervention attracted a wide range of patient users including a range of ages, ethnicities, 
educational attainment and computer skills. Over half (n=107, 52.2%) of registered users were 
male and 47.3% (n=97) were from non-white British backgrounds, with African, Caribbean, 
Bangladeshi, Indian and other ethnicities represented (see Figure 8-1). The sample contained a 
wide spread of ages, from nineteen to eighty-one years, and represented a range of educational 
levels, with 15.1% (n=31) with no formal education and a further 16.1% (n = 33) being school 
leavers (see Figure 8-2). Participants ranged with regards to the duration of their diabetes, 
including patients who had been diagnosed for less than a year to those who had had diabetes 
for more than twenty years, with the majority (n=119, 58%) having diabetes for less than five 
years (see Figure 8-3) . The majority of patients managed diabetes through lifestyle modification 
and medication, with a smaller proportion (n=26, 12.7%) taking insulin (see  
Figure 8-4). Although the majority of patients who registered to use HeLP-Diabetes had home 
internet access (n=177, 86.3%), over a third (n=79, 38.5%) described their computer skills as 
basic, and 31% (n=65) as intermediate skills (see Figure 8-5). Table 8-4 presents a full 
description of the characteristics of the patient users of HeLP-Diabetes.  
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Table 8-4 Characteristics of patients registered to HeLP-Diabetes 
Variable Response options Number 
of 
patients 
(n=205) 
% of all 
patients 
Age Range 19-81  
Mean (standard deviation) 56.8 
(11.8) 
 
Gender Male 107  52.2 
Female 98 47.8 
Ethnic Group White - English/Welsh/Scottish/Northern 
Irish/British 
 98 47.8 
White - Irish 7 3.4 
White - Other 16 7.8 
Black or Black British - African 20 9.8 
Black or Black British - Caribbean 11 5.4 
Black or Black British - Other 3 1.5 
Asian or Asian British - Bangladeshi 8 3.9 
Asian or Asian British - Chinese 1 0.5 
Asian or Asian British - Indian 8 3.9 
Asian or Asian British - Other 5 2.4 
Asian or Asian British - Pakistani 1 0.5 
Mixed - White and Asian 1 0.5 
Mixed - White and Black African 1 0.5 
Mixed - Other 1 0.5 
Other ethnic group - Arab 3 1.5 
Other ethnic group - Other 11 5.4 
Prefer not to say 10  4.9 
Highest 
educational 
attainment 
None 31 15.1 
School leaver (e.g., CSE, GCSE, O-
Level, NVQ1-2) 
33 16.1 
A-level or vocational equivalent (e.g. NVQ 
3) 
16 7.8 
Degree or NVQ 4, HND or similar 20 9.8 
Post-graduate degree or NVQ 5 22 10.7 
Not stated 14 6.8 
Not asked at registration* 69 33.7 
Duration of 
diabetes 
<1 year 53 25.9 
1-5 years 66 32.2 
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5-10 years 37 18.0 
10-20 years 35 17.1 
>20 years 9 4.4 
Not answered 5 2.4 
How diabetes is 
managed 
Lifestyle alone (i.e. diet and physical 
activity) 
40 19.5 
Lifestyle and tablets 128 62.4 
Lifestyle tablets and insulin 26 12.7 
Other injectables 1 0.5 
Not answered 10 4.9 
Internet access Home 177 86.3 
Public 9 4.4 
Not answered 19 9.3 
Computer skills Basic 79 38.5 
Intermediate 65 31.7 
Advanced 40 19.5 
Not answered 21 10.2 
Implementation 
model 
Patients registered by healthcare 
professional 
142 69.3 
Patients self-registered 63 30.7 
NHS service type GP practice 175 85.4 
Hospital 30 14.6 
Community clinics 1 0.5 
*As discussed in Chapter 6, the question about educational attainment was not added to the 
online patient registration form until March 2014 and therefore was not asked of patients who 
registered before this time 
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Figure 8-1 Ethnicity of patients registered to HeLP-Diabetes 
 
 
Figure 8-2 Educational attainment of patients registered to HeLP-Diabetes 
 
 
Figure 8-3 Duration of diabetes of patients registered to HeLP-Diabetes 
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Figure 8-4 Diabetes management of patients registered to HeLP-Diabetes 
 
 
Figure 8-5 Computer skills of patients registered to HeLP-Diabetes 
 
 
8.6 How was HeLP-Diabetes used by patients? 
 
8.6.1 Number of patients who used HeLP-Diabetes 
 
Overall, 104 (50.7%) patients were classed as having used HeLP-Diabetes.  
 
As described in Chapter 6 (section 6 6.6.4.2), a recorded login on a date other than the date of 
registration was the measure of patient use of HeLP-Diabetes.  
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8.6.2 Days of use and page views 
 
Excluding patients who did not make use of HeLP-Diabetes again following registration (n=101, 
49.3%), the number of days patients visited HeLP-Diabetes ranged between one 1 and 77, with 
a median of 2 days of use per patient.  
 
 
The total number of pages visited by individual patients ranged from 1 page to 271 pages with a 
median value of 15.5 page views per patient.  
 
Using the number of days following registration that a patient visited HeLP-Diabetes, it was 
calculated there were 439 visits in total to HeLP-Diabetes by patients and during these visits a 
total of 3,221 page views were recorded for all patients.  
 
8.6.3 Temporal use of HeLP-Diabetes  
 
8.6.3.1 Time of day 
51.2% (n=1,651) of all page views occurred outside of working hours (9am-5pm) suggesting 
HeLP-Diabetes may be more accessible for some than face-to-face education which is held 
during working hours (see Figure 8-6).  
 
Page views were recorded for every hour of the day, suggesting that patients took advantage of 
the fact that as an internet intervention, it was available 24 hours a day. Peaks of pages viewed 
were recorded between 12pm and 1pm (290 page views, 9.0%) and between 5pm and 6pm 
(364 page views, 11.3%), which could reflect patients viewing HeLP-Diabetes during lunch 
breaks and at the end of the working day. 
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Figure 8-6 Percentage of page views by time of the day 
 
8.6.3.2 Days of the week 
Mondays and Fridays were the days that HeLP-Diabetes was accessed the most with 76 
(17.3%) and 77 (17.5%) of the 439 visits to HeLP-Diabetes recorded on these days 
respectively. There were less visits to HeLP-Diabetes at the weekend with 42 (9.6%) visits on 
Saturday and 46 (10.5%) visits on Sunday (see Figure 8-7). 
 
Figure 8-7 Percentage of visits to HeLP-Diabetes by day of the week 
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8.6.3.3 Monthly use  
 
In any given month, the number of patients accessing HeLP-Diabetes did not go above 20% of 
the number of registered users. Figure 8-8 presents the number of registered users and the 
number of registered users making use of HeLP-Diabetes for each month of the study. 
 
Despite the number of patients registered to HeLP-Diabetes increasing cumulatively each 
month, the percentage of registered patients actually using HeLP-Diabetes did not change 
markedly from month to month. October 2014 had the lowest percentage of registered users 
making a visit to HeLP-Diabetes with 3.0% (n=4) of registered users visiting HeLP-Diabetes (on 
one or more occasions). May 2014 saw the highest percentage of registered users using HeLP-
Diabetes (20% n=18).  
 
This relatively consistent pattern of use suggests that patients may have stopped using HeLP-
Diabetes over time, otherwise a more upwards trend of percentage of registered users making 
use of HeLP-Diabetes might be expected.  
 
Figure 8-8 Number of registered users and the percentage making use of HeLP-Diabetes each 
month 
 
 
8.6.4 Content accessed 
Patients viewed a total of 396 (68.9%) of the 574 HeLP-Diabetes pages, suggesting a wide 
range of content was of interest to patients. The most frequently viewed pages are displayed in 
Table 8-5. Apart from the homepage, pages on food (62 views), common diabetes questions 
(54 views), care planning (43 views) and the forum (42 views) were accessed the most 
frequently.  
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Table 8-5 Most frequently viewed HeLP-Diabetes pages 
Title of page accessed Frequency of 
page views 
Percentage of all page 
views 
Homepage 520 16.1 
Food 62 1.9 
Common diabetes questions 54 1.7 
My diabetes care plan 43 1.3 
Help Diabetes Forum  42 1.3 
How my body can be affected 39 1.2 
My health profile 39 1.2 
Eating & drinking 35 1.1 
Exercise videos 32 1.0 
My test results 32 1.0 
Understanding diabetes 32 1.0 
Staying healthy 28 .9 
My appointments 22 .7 
Understanding my moods 22 .7 
How is type 2 diabetes treated? 21 .7 
Living & working with diabetes 20 .6 
Physical activity 20 .6 
Looking after yourself 19 .6 
My health record 19 .6 
Snacks and desserts 19 .6 
My health tracker 17 .5 
Practical diet advice 17 .5 
Quick guides 17 .5 
Sexual problems 17 .5 
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8.7 Were there any factors that predicted patient use of HeLP-Diabetes? 
 
Univariable and multivariable regression analyses predicting overall HeLP-Diabetes use (no use 
compared to use) were carried out. Multivariable analyses were conducted on all complete 
cases of data (n=114).  
 
Registration method was shown to be a significant predictor of HeLP-Diabetes use (see Table 
8-6).  
 
8.7.1 Univariable results 
Univariable logistic regression analyses found that relative to no HeLP-Diabetes use those who 
made use of HeLP-Diabetes were more likely to have advanced computer skills (OR=2.46, 95% 
CI=1.12, 5.40)  (OR=2.07, 95% CI=1.14-3.74) and be registered via the patient registration 
method (OR=5.54, 95% CI=2.80-10.96).  
 
8.7.2 Multivariate results 
Multivariate logistic regression analysis found that relative to no HeLP-Diabetes use those who 
made use of HeLP-Diabetes were more likely to be registered by the patient registration method 
(i.e. registered themselves to use HeLP-Diabetes) (OR=5.91, 95% CI=2.84-12.31).  
 
Despite being a significant predictor in the univariable analysis, advanced computer skills did 
not significantly predict HeLP-Diabetes use in the multivariable analysis (OR=3.15, 95% 
CI=0.81, 12.21). 
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Table 8-6 Univariable and multivariable logistic regression for predictors of some usage of HeLP-Diabetes 
 Univariable Multivariable 
N=114 
Characteristics associated with some use of HeLP-Diabetes N Odds Ratio 
(95% CI) 
p-value Odds Ratio  
(95% CI) 
p-value 
  
Age (years)  202 1.01 (0.99, 1.04) 0.23 0.99 (0.95, 1.04) 0.74 
Sex:  
Male 
Female 
205  
1.00 
0.75 (0.43, 1.29) 
0.30  
1.00 
1.34 (0.53, 3.42) 
0.54 
Ethnicity: 
White British 
Non-white British 
205  
1.00 
0.61 (0.35, 1.06) 
0.08  
1.00 
0.61 (0.25, 1.50) 
0.28 
 
 
Education: 
None/School leaver 
A-level or higher 
122  
1.00 
1.96 (0.93, 4.12) 
0.08  
1.00 
1.30 (0.47, 3.65) 
0.62 
Duration of diabetes: 
<1 year 
1-5 years 
5-10 years 
>10 years 
200  
1.00 
0.62 (0.30, 1.28) 
1.17 (0.50, 2.73) 
1.42 (0.63, 3.19) 
0.17  
1.00 
0.65 (0.15, 2.87) 
1.38 (0.25, 7.73) 
1.00 (0.15, 6.65) 
0.73 
Management of diabetes: 
Lifestyle alone 
Lifestyle and tablets 
Lifestyle, tablets and insulin 
195  
1.00 
1.03 (0.73, 5.50) 
2.00 (0.73, 5.50) 
0.31  
1.00 
1.11 (0.23, 5.45) 
0.53 (0.05, 5.04) 
0.59 
Computer Skills: 184  0.046  0.19 
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Basic 
Intermediate 
Advanced 
1.00 
1.86 (0.96, 3.61) 
2.45 (1.12, 5.40) 
1.00 
2.08 (0.70, 6.17) 
3.15 (0.81, 12.21) 
Registration model: 
Staff registered 
Self-signup 
205  
1.00 
5.54 (2.80, 10.96) 
<0.0001  
1.00 
5.21 (1.83, 14.82) 
0.0020 
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8.8 Were there any factors that predicted HeLP-Diabetes registration method?  
 
Univariable and multivariable binary regression analyses predicting registration method (staff 
registered or patient registered) were carried out. Multivariable analyses were conducted on all 
complete cases of data (n=117).    
 
Education was found to be a significant predictor of registration method (see Table 8-7).  
 
8.8.1 Univariable results 
Patients who registered themselves to HeLP-Diabetes were more likely to have A-level 
qualifications or higher (OR=4.52, 95% CI=2.10, 9.75), and have advanced computer skills 
(OR=2.76, 95% CI=1.25, 6.12). 
 
8.8.2 Multivariable results 
Patients who registered themselves to HeLP-Diabetes were more likely to have A-level 
qualifications or higher (OR=3.90, 95% CI=1.59, 9.57). 
 
Despite being a significant predictor in the univariable analysis, advanced computer skills did 
not significantly predict self-sign up in the multivariable analysis (OR=3.50, 95% CI=(1.06, 
11.31). 
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Table 8-7 Univariable and multivariable logistic regression investigating the association between patient characteristics and the likelihood of patient self-registration 
 Univariable Multivariable 
N=117 
Characteristics associated with self-registration N Odds Ratio 
(95% CI) 
p-value Odds Ratio  
(95% CI) 
p-value 
  
Age (years)  202 1.01 (0.98, 1.03) 0.56 1.00 (0.97, 1.03) 0.95 
Sex:  
Male 
Female 
205  
1.00 
0.62 (0.34, 1.14) 
0.12  
1.00 
1.43 (0.59, 3.46) 
0.42 
Ethnicity: 
White British 
Non-white British 
205  
1.00 
0.84 (0.46, 1.52) 
0.57  
1.00 
0.62 (0.27, 1.44) 
0.27 
Education: 
None/School leaver 
A-level or higher 
122  
1.00 
4.52 (2.10, 9.75) 
0.0001  
1.00 
3.90 (1.59, 9.57) 
0.0030 
Computer Skills: 
Basic 
Intermediate 
Advanced 
184  
1.00 
1.23 (0.59, 2.54) 
2.76 (1.25, 6.12) 
 
0.037  
1.00 
1.60 (0.61, 4.16) 
3.50 (1.06, 11.31) 
0.12 
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8.9 Discussion 
HeLP-Diabetes was adopted by two thirds of the GP practices within the CCG, and by both the 
hospital and community clinic. Taking into account that it was not possible to establish any 
contact with eight GP practices about HeLP-Diabetes, HeLP-Diabetes was adopted by three 
quarters (75.9%) of practices who had received information about it. Only one practice explicitly 
declined adoption. 
 
As there are relatively few other studies describing adoption of an internet intervention within 
routine care by health services, it is hard to draw comparisons between the rates of adoption 
seen here with rates in other studies. Many other implementation studies focus on patient rates 
of uptake of interventions from services that have opted to take part in research. For example, a 
recent study by Aarts et al. (220) explored the implementation of an internet based fertility 
website in a clinic that had agreed to act as a research site, and thus not representative of 
everyday routine care. Generalizing from these studies is difficult because organisations that 
participate in research may differ in systematic ways to those that do not (245). They may 
exhibit greater readiness to change and usually receive advice and support to implement 
interventions. Participation in research may also give interventions greater salience than they 
might otherwise receive. For practices implementing interventions into everyday routine care, 
the interventions must compete with other priorities without the help of compensating factors 
provided through participation in research (245). The current study, where adoption of HeLP-
Diabetes was not contingent on participation in research, adds valuable information on rates of 
adoption of an internet intervention by NHS services, which has not been explored previously. 
More studies of this nature are needed as patient access to interventions delivered by the NHS 
and other health services is dependent on gate keepers such as these adopting them. 
 
Half of the GP practices in the CCG (48.6%) implemented HeLP-Diabetes to some degree. 
Implementation was defined as a practice registering (or a patient self-registering) one or more 
patients to use HeLP-Diabetes. Both the hospital and community clinic also implemented HeLP-
Diabetes. The number of patients registered to HeLP-Diabetes from each practice or clinic 
ranged from 1 to 40. There was no correlation between the time that a service had access to 
HeLP-Diabetes and the number of patients they registered suggesting that the extent to which 
HeLP-Diabetes was used by services was not related to how long it had been available. Four 
practices who had decided to adopt HeLP-Diabetes did not implement it (did not register any 
patients).  
 
A research diary was kept during the study. Analysis of this using Normalization Process Theory 
(NPT) (7, 97) suggested that the high rates of adoption of HeLP-Diabetes was related to good 
coherence and cognitive participation, however, the low use of HeLP-Diabetes by practices and 
clinics was related to collective action. In other words, those practices and clinics were generally 
willing to participate but the reality of putting the work in to implement HeLP-Diabetes was too 
much for many of them. This had a negative impact on reflexive monitoring as few patients were 
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registered, which in turn led to reduced cognitive participation (i.e. reduced desire to 
participate).  
 
Previous studies have reported that implementing diabetes management strategies can be 
challenging for primary care practices (187, 245-247) and the NHS context in which HeLP-
Diabetes was being implemented (discussed in Chapter 7) likely played a considerable role in 
the ability of practices and clinics to implement it. During the time HeLP-Diabetes was being 
implemented, the NHS was in the grip of the biggest crisis in its history (237, 248). Complexity 
in patient cases, reduced workforces, reduced primary care budgets, an increase in resources 
being spent on contractual and regulatory requirements such as the Quality and Outcomes 
Framework (QOF) and enhanced services, GP time being spent on duties other than care 
giving, and political and public pressure on GPs and practices for increased access to GPs over 
extended hours and seven day working, have all contributed to a fatigued system (236-239). 
The fact that three practices within the CCG closed down during the study period suggests that 
practices were under a high degree of stress. 
 
Many previous studies of the implementation of innovations within healthcare settings have 
pointed to the influence of context (249). The systematic review conducted as part of this thesis 
found that the implementation of e-health initiatives can be affected by financial, legislative and 
policy factors and by the availability of resources to enable implementation. A systematic review 
of the causes of the evidence to practice gap in primary care (the delay of translating new 
innovations into everyday clinical practice) stresses the importance of external contextual 
factors such as policies and legislation, economic climate, incentives, and the specific context 
into which interventions are being embedded (250). A systematic review of challenges in 
primary care relating to the delivery of diabetes care describes clinicians facing multiple 
challenges in the management of diabetes including struggling to meet evolving treatment 
targets within limited time and resources (246). Similarly a systematic review of barriers to 
diabetes management found that over-stretched primary care services and a myriad of 
competing tasks act as barriers to diabetes care (247). Work from the NPT literature often 
points to issues of contextual integration as inhibiting the implementation of initiatives. A study 
by Kennedy et al. (187) evaluating the implementation of self-management support for type 2 
diabetes within primary care found that competing priorities such as incentivised targets 
stopped a new intervention from becoming prioritised. A study of the implementation of a care 
co-ordination model by nurses in general practices was hindered by the lack of time available to 
allocate to the task and the fact that time to implement the intervention was not considered 
feasible in busy general practices (251).  
 
205 patients were registered to use HeLP-Diabetes from the eighteen GP practices and the 
hospital and community clinics which implemented HeLP-Diabetes. This comprised 
approximately 3.4% of the eligible patients attending these services.  
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There is limited evidence from previous research about the rates of patient uptake of internet 
interventions within routine primary care. One other study identified explored the patient uptake 
of a web-based alcohol misuse service that was implemented within routine practice in one 
primary care trust. Low rates of uptake were also reported with only thirty-one patients referred 
to the service in a twelve month period (252). The authors suggest that low rates of referral 
were due to reluctance on the part of health professionals to discuss alcohol with their patients 
and difficulty in remembering the existence of the new service. Uptake of non-internet based 
diabetes interventions delivered through NHS services report similarly low rates of patient 
uptake. As discussed in Chapter 1, group based, face-to-face diabetes education to which 
patients are referred as part of routine care is attended by only 5.3% of patients in England (35). 
In order to understand the potential of internet interventions like HeLP-Diabetes that are 
intended to be delivered to patients through healthcare services, there is a real need for more 
studies that address uptake into everyday routine practice in order to help identify interventions 
most likely to have a meaningful impact on population health and to fit local settings and 
priorities. Diabetes interventions measured as part of trials consistently report higher rates of 
patient uptake than found in the current study. For example, two computer based diabetes 
health behaviour change programmes, the Diabetes Priority and Diabetes Health Connection 
were reported to reach (defined as the patient participation rate) 50% and 38% respectively of 
all patients in participating practices with type 2 diabetes (253). Results like this are unlikely to 
reflect rates of adoption by patients outside of research trials in which services have opted to 
participate and deliver the interventions and where patients who participate are often self-
selecting and self-motivated (254).  
 
A wide range of patients registered to use HeLP-Diabetes. A third (31.2%) of patients who 
registered either had no education or basic education, just under half (47.5%) were from non-
white British ethnic backgrounds, and 38.5% had basic computer skills. The users of HeLP-
Diabetes appeared to be representative of the Islington population as a whole in terms of 
ethnicity and education. Office for National Statistics census data from 2011 (230) reported that 
48% of Islington residents were white British and 51% were from other ethnic backgrounds 
including white other (20%), Black/African/Caribbean/Black British (13%), Asian/Asian British 
(9%) and other and mixed ethnicities (9%). Grouping users of HeLP-Diabetes into these 
categories shows a very similar distribution: White British (47.8%), white other (11.2%), 
Black/African/Caribbean/Black British (16.7%), Asian/Asian British (11.2%) and other and mixed 
ethnicities (8.4%). Census data shows that 17% of Islington residents had no education, 16% 
had basic education, 9.8% had A-level qualifications and 48.1% had a university level 
qualification. Categorising HeLP-Diabetes users in this way reveals a similar picture with the 
exception of higher education, for which there was not as high a proportion of HeLP-Diabetes 
users with university level qualifications as in Islington as a whole (15.1% had no education, 
16.1% had basic education, 7.8% had A-level qualifications and 20.5% had a university level 
qualification). Patients registered to HeLP-Diabetes had exactly the same proportion of home 
internet access as the UK average (86%) (45).  
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Arguments have been made in the literature that participants in studies of internet interventions 
are not generally representative of wider populations (255). It has been reported that 
participants in internet intervention research tend to be more highly educated, with a high 
percentage having a university degree (256), and in the UK tend to be White British (257, 258). 
This research is the only (to my knowledge) to explore uptake of an internet intervention within 
routine practice, where use of the intervention was not dependent on enrolment into a research 
study or limited by any eligibility criteria other than diagnosis. Overall the patients who have 
registered to use HeLP-Diabetes seem representative of the wider CCG population in terms of 
education and ethnicity and the UK population in terms of home internet access.  
 
Overall use of HeLP-Diabetes varied considerably between participants. Just under half (49.3%) 
of registered users made no further use of HeLP-Diabetes following the day they were 
registered. Of those who did go on to make further use of it (50.7%) there was great variability in 
the amount of use. Although the median number of days using HeLP-Diabetes was two, actual 
use ranged from patients who used it on one further day to those who used it on 77 further 
days.  
Comparisons of HeLP-Diabetes use with other internet interventions for type 2 diabetes is 
complicated by the fact that many studies of internet based diabetes interventions do not 
provide details of the use of the intervention (259-263), and for those that do, the differences in 
analyses of usage data and study design make direct comparisons difficult. In comparison to 
studies that report different measures of usage, relatively low use was made of HeLP-Diabetes 
by patients (38, 264-266). However, many of the interventions in these comparison studies also 
crucially differed to HeLP-Diabetes, as in HeLP-Diabetes patient use was not prescriptive or 
regularly encouraged by staff. The interventions in other studies either provided specific 
components for patients to complete over a certain time period, introduced tailored content at a 
certain time point after registration to increase patient engagement or provided consistent staff 
encouragement of patient use. Commonalities between use of HeLP-Diabetes and use of 
interventions in these studies were however observed in terms of patient attrition to the 
interventions. The proportion of registered users using HeLP-Diabetes on a monthly basis did 
not increase incrementally as the number of registered patients increased throughout the study. 
This suggests that registered users did not continue to make ongoing regular use of the 
intervention over long periods of time, or that use was sporadic. A declining pattern of use is 
commonly reported with internet interventions (68, 266). 
 
A potential advantage of internet interventions for supporting self-management is their 
availability for use at any time of day or night, and it was notable that use of HeLP-Diabetes was 
recorded for every hour of the day. One of the most commonly reported barriers to attendance 
at group based diabetes education is accessibility (37, 39, 41) and the fact that these courses 
are usually held during working hours and are therefore not convenient for people who work. 
Over half of all page views were conducted outside of working hours suggesting that HeLP-
Diabetes may fit well into peoples’ lives, being used at the most convenient times for them.  
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The most commonly accessed HeLP-Diabetes pages included those containing information 
about food, common diabetes questions and complications of diabetes (‘How the body is 
affected’); pages that allowed patients to input their own data (‘My diabetes care plan’, ‘My 
health profile’) and understand test results; the forum and exercise videos. These pages reflect 
the wide range of tasks that someone living with diabetes has to engage with in order to 
manage their condition. Previous studies have found that the most important information for 
people with diabetes is information on diet, complications of diabetes and exercise (267) which 
seems to be reflected in the use of HeLP-Diabetes. The diversity of content viewed is in keeping 
with the range of areas of diabetes management identified in the HeLP-Diabetes development 
work with people with type 2 diabetes (268). Patients taking part in those focus groups reported 
wanting a wide range of content that included details of the biomedical aspects of the disease 
and covered practical aspects of living with type 2 diabetes such as dietary advice, physical 
activity and information about health services.  
 
An area of concern for delivering healthcare through the internet is the issue of the digital divide. 
The digital divide refers to the gap between those who have access to information technologies 
such as the internet and those who do not (66). For people with diabetes, it is often those who 
experience the higher burden of diabetes who are also most likely to lack access to the internet, 
as older age, lower educational status and income are negative predictors of diabetes outcomes 
and internet use (62). However, the characteristics which have previously been reported to 
influence the digital divide (age, ethnicity, computer skills and education) did not appear to 
affect the level of use patients made of HeLP-Diabetes. The lack of association of age, ethnicity, 
computer skills and education with use of HeLP-Diabetes supports other studies of engagement 
with internet based interventions. A study of diabetes self-management education delivered via 
the internet indicated that patients with a variety of education, age, income levels, ethnic 
backgrounds, socio-demographic, psychosocial, and clinical characteristics were able to use the 
intervention. Moreover, older patients, ethnic minority patients as well as those with a higher risk 
of diabetes complications, lower health literacy, and little experience of computers were as 
engaged with the intervention as other participants (38). There was no association with gender 
and HeLP-Diabetes use which is in contrast to previous studies which have found that females 
are more likely to engage in self-management education than males (42) and have observed 
gender differences in self-management (211) and accessing health information online (212).  
 
There were also no differences in use of HeLP-Diabetes by the duration that patients had had 
diabetes for and diabetes management style. Some models of chronic illness have argued 
against the notion that patient information and support needs are determined by the length of 
time that a person has had a condition. For example, the Shifting Perspectives Model of Chronic 
illness (269) suggests that needs are determined by patients’ perceptions of wellness and 
illness which continually change throughout a lifetime and which may be influenced by social 
context and life events rather than just the duration of their condition. This has implications for 
diabetes education (as will be discussed in Chapter 11) which is traditionally targeted at newly 
diagnosed patients.  
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However, patients who made most use of HeLP-Diabetes registered using the patient 
registration method and patients who registered themselves to HeLP-Diabetes (rather than 
being registered by a member of staff) were more educated. Those less education were more 
likely to be registered by a member of staff. Being registered by a member of staff was likely to 
have facilitated access for uneducated patients and thus helped to bridge the digital divide in 
accessing this internet based intervention, especially as education was not a predictor of level 
of use. A study of patient factors associated with non-uptake of group based structured 
education also did not find an association with patient education and uptake (42).The findings 
from the current study suggest that if patients with basic education are given support to access 
internet interventions this may bridge the digital divide so that their ongoing use of the 
intervention is comparable to patients with higher educational attainment.  
 
Facilitating access to internet interventions has been found to promote engagement with 
internet based health interventions (270). A review of factors that influence user engagement in 
internet-based behavioural interventions for chronic illness found that interventions with the 
lowest attrition rates included features such as professional feedback, social networking and the 
ability to make contact with a health care professional. A previous study of a diabetes self-
management internet intervention investigated the effects of adding tailored self-management 
training or peer support components to a basic information-focused comparison intervention. 
Intervention usage was reported as greater at all points during the study for participants who 
received the additional tailored self-management training or peer support components 
compared to those not receiving these interventions (68).  
 
The implications that these findings have for practice, policy and research are discussed in the 
overall discussion chapter (Chapter 11), as are the methodological strengths and weaknesses 
of the studies in this thesis.  
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9 STAFF PERCEPTIONS OF AND EXPERIENCES WITH THE IMPLEMENTATION OF 
HELP-DIABETES 
 
9.1 Chapter summary 
This chapter presents the findings from the analysis of semi-structured interviews conducted 
with staff. The interviews explored the adoption and implementation of the HeLP-Diabetes 
intervention within routine NHS practice in order to address the following research question:  
 
 What barriers and facilitators to the adoption and implementation of HeLP-Diabetes by 
NHS services did staff identify? 
 
9.2 Introduction 
As described in detail in Chapter 1, the referral of patients with type 2 diabetes to self-
management education is now an incentivised part of routine NHS diabetes care. However, 
patient attendance at group based education is not incentivised and uptake is extremely low. 
HeLP-Diabetes, an internet based self-management programme, offers an alternative to group 
based structured education and has been developed to be delivered through the NHS by staff 
(see Chapter 2).  
 
Studies suggest that health professionals may influence patient uptake of group based diabetes 
education (37). However, little is known about what healthcare staff think about self-
management support for diabetes, including group based diabetes education. In addition, to my 
knowledge, no studies have explored the views of staff towards an online structured education 
intervention for type 2 diabetes, designed to be delivered to patients through NHS services.  
 
A detailed implementation plan to integrate HeLP-Diabetes into routine practice was developed 
(see Chapter 5) and put into practice in one CCG in London between July 2013 and August 
2015. In order to understand why or why not something is implemented it is important to 
understand the views of those doing the work of implementation (187). The implementation of 
innovations like HeLP-Diabetes requires a change in professional behaviour which in turn 
requires an understanding of the context in which they work and the values which they espouse. 
In order to identify insights and experiences that can usefully shape the future direction 
of HeLP-Diabetes implementation and other web-based services within routine NHS care, this 
qualitative study explores the perceptions of staff towards delivering diabetes care and their 
views as to how an intervention like HeLP-Diabetes, designed to support patient self-
management, can be best implemented within routine care. 
 
9.3 Aim 
To investigate, from the perspective of those implementing it and using it in practice, aspects of 
the HeLP-Diabetes implementation plan that succeeded, the aspects that were less successful, 
176 
 
the barriers and facilitators to adoption and widespread implementation and future directions to 
improve adoption of HeLP-Diabetes. 
 
9.4 Results 
 
9.4.1 Interview subsample 
 
Twenty one members of practice and clinic staff took part in seventeen interviews and one 
focus group (with four staff from the same GP practice). The interview sample represented a 
diverse range of professional roles including GP partners (3/21), a salaried GP (1/21), a practice 
manager (1/21), diabetes specialist nurses (2/21), practice nurses (6/21), an advanced nurse 
practitioner (1/21), healthcare assistants (3/21), receptionists/administrators (3/21) and a 
commissioning officer (1/21). There were fewer male participants (6/21) than female (15/21) and 
the sample was predominantly white British (16/21) with other staff representing Irish (1/21), 
White/Black Caribbean (1/21), Sri Lankan (1/21), Indian (1/21) and New Zealand/USA (1/21) 
ethnicities. The majority of staff described their skills with the internet as ‘Experienced’ (e.g. 
used or currently use the Internet regularly) (19/21), with the remainder (2/21) describing 
themselves as ‘Expert’ (e.g. work is to do with the Internet). Staff tenure in their current role 
ranged from less than a year to 20 years’ experience.  
 
The majority of staff worked in GP practices (18/21), with a further two based in the hospital 
clinics and one at the CCG headquarters. Unfortunately, no member of staff from community 
clinics participated. Most of the staff worked in services where HeLP-Diabetes had been 
adopted and implemented to some extent (19/21). The number of patients registered to HeLP-
Diabetes from these services ranged from 1 to 40. One participant worked in a GP practice 
where adoption of HeLP-Diabetes had been declined and another worked in a GP practice 
where HeLP-Diabetes had been adopted (adoption agreed), but hadn’t actually been 
implemented (no patients registered). Table 9.1 presents details of the characteristics of the 
interview sample.  
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Table 9-1 Characteristics of the staff participants 
ID Age 
range 
Gender Professional Role Service setting Years 
in 
current 
role 
Ethnic 
background 
Internet 
experience 
Practice/clini
c 
implementati
on status 
Number 
of 
patients 
register
ed  
ST1: 35-44 Male GP Partner GP practice 11 White British Experienced Adopted and 
implemented 
40 
ST2: 55-64 Female Diabetes Specialist 
Nurse 
Hospital 12 White British Experienced Adopted and 
implemented 
30 
ST3: 45-54 Male Commissioning Officer N/A 2 White British Expert Adopted N/A 
ST4: 25-34 Female Practice Nurse GP practice 2 White British Experienced Adopted and 
implemented 
28 
ST5: 45-54 Female Health Care Assistant GP practice 10 White British Experienced Adopted and 
implemented 
40 
ST6: 35-44 Male GP Partner GP practice 3 Indian Experienced Adopted and 
implemented 
8 
ST7: 35-44 Female Receptionist/Admin GP practice 9 White British Experienced Adopted and 
implemented 
40 
ST8: 18-24 Male Receptionist/Admin GP practice 1 White and Black 
Caribbean 
Experienced Adopted and 
implemented 
11 
ST9: 55-64 Female Advanced Nurse 
Practitioner 
GP practice 4 White British Experienced Adopted and 
implemented 
3 
ST10: 35-44 Male Practice Manager GP practice 7 White British Experienced Not adopted 0 
 
ST11: 35-44 Female GP Partner GP practice 17 White British Experienced Adopted and 15 
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implemented 
ST12:* 45-54 Female Practice Nurse GP practice 4 White British Experienced Adopted and 
implemented 
11 
ST13:* 45-54 Female Practice Nurse GP practice 9 White British Experienced Adopted and 
implemented 
11 
ST14:* 35-44 Female Health Care Assistant GP practice <1 Sri Lankan Experienced Adopted and 
implemented 
11 
ST15:* 25-34 Female Practice Nurse GP practice 8 White New 
Zealand/USA 
Experienced Adopted and 
implemented 
11 
ST16: 55-64 Female Diabetes Specialist 
Nurse 
Hospital 1 White British Experienced Adopted and 
implemented 
30 
ST17: 45-54 Female Health Care Assistant GP practice 7 White British Expert Adopted and 
implemented 
40 
ST18: 25-34 Female Receptionist/Admin GP practice 5 White British Experienced Adopted and 
implemented 
1 
ST19: 45-54 Male Salaried GP GP practice 1 White Irish Experienced Adopted and 
implemented 
11 
ST20: 65-74 Female Practice Nurse GP practice 17 White British Experienced Adopted but 
not 
implemented 
1 
ST21: 55-64 Female Practice Nurse GP practice 20 White British Experienced Adopted and 
implemented 
3 
*staff who took part in the focus group 
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9.4.2 Results of thematic analysis 
Presented below are the findings from the thematic analysis of the interviews with staff. The 
main themes that emerged from the data related to: 
 Diabetes care within the CCG and the self-management agenda 
 Staff roles in diabetes management 
 Staff perceptions of self-management 
 Current self-management resources 
 Staff perceptions of HeLP-Diabetes 
 Adoption and implementation of HeLP-Diabetes 
 
To help interpretation, these themes and the subthemes within them are presented in Figure 9-
1. Also for ease of interpretation, participant ID numbers and the participant’s professional role 
are provided with each illustrative quote. In instances where questions I have asked are 
presented I am referred to as R (researcher). 
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Figure 9-1 Themes and sub themes identified from the analysis 
 
Diabetes care within the CCG and 
the self-management agenda 
 The role of different services 
 The push towards self-
management 
 Patient challenges to diabetes 
care 
 
Staff roles in diabetes 
management 
 Responsibilities to patients 
 Power, control and frustration 
 Team approach 
Staff perceptions of self-
management 
 Value of the self-management 
approach to diabetes care 
 One size fits all? 
Current self-management 
resources 
 Awareness 
 The role of structured education 
 Barriers to patient attendance at 
diabetes education 
 Readiness to engage 
 Staff roles in referrals to diabetes 
education 
Staff perceptions of HeLP-
Diabetes 
 Fit of intervention with/in 
current practice 
 Relative advantage 
 Suitability for target 
population 
 
Adoption and implementation of 
HeLP-Diabetes 
 Evidence and endorsement  
 Trialability, training and 
support 
 Responsibility for 
implementation 
 Awareness and engagement  
 Impact on roles and work 
practices 
 Availability of resources 
 Suggestions for improving 
the implementation 
Diabetes care 
Self-management 
HeLP-Diabetes intervention 
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9.4.3 Diabetes care within the CCG and the self-management agenda 
 
The role of different services 
There was a clear distinction made by staff as to the role of primary and secondary care 
services in the treatment of patients with type 2 diabetes within the CCG. GP practices provide 
the majority of care to people with diabetes and those with more complex problems are 
escalated through intermediate and secondary care services. 
ST3: we have primary care service, of course, which is basic GMS contract 
services looking at just basic diabetes care with no major complications. 
Anything slightly complicated gets escalated into the intermediate service and 
then into a secondary care if they become particularly complex, or have multiple 
co-morbidities. 
(Commissioning Officer) 
 
The care of patients with diabetes within General Practice, was recognised by staff as still 
relatively new, but had become very central to the role of being a healthcare professional within 
General Practice. 
ST1: When I started in general practice diabetes was still, you know, it was a 
Secondary Care thing, but we did a little bit in general practice. Now it’s very 
much, you know, type 2 diabetes is, I would say, very much the bread and 
butter of what we do as GPs 
(GP partner) 
 
The aim within the CCG was for patients to be discharged back to primary care services as 
soon as possible.  
ST3: even if they have multiple co-morbidities the idea is that ultimately a 
patient with diabetes should be treated in primary care and that’s our aim in 
[Name of Borough] certainly. 
(Commissioning Officer) 
 
However, it was recognised that this was not always the case, and that patients may remain 
being treated in secondary care services for longer than desired.  
ST16: we see more complex type two patients so people with perhaps heart 
problems, difficult to control hypertension, foot problems, renal problems, 
people who are needing multiple therapies to control their diabetes so they are 
not the straightforward patients. That having been said there are a number of 
people who perhaps could be discharged if that was the ethos of the clinic 
which it doesn’t seem to be. 
(Diabetes Specialist Nurse) 
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The importance of these different services within the CCG working together in order to provide 
the best possible care for people with diabetes was mentioned often. It was a particular aim of 
the CCG to make the care pathway for patients with diabetes as seamless as possible.  
ST3: it's about integrating services so that the patient is unaware, should be, 
theoretically, unaware of however many people involved in his care, they just 
follow it pathway. And that's all that they need to think about, you know, and 
that's the aim for what we've all been working for. 
(Commissioning Officer) 
The push towards self-management  
 
Staff described how there had been a recent shift in emphasis towards an increased focus on 
self-management within the CCG, driven by the introduction of care planning for all patients with 
long term conditions.  
ST3: One of the things that [Name of Borough] was committed to when we 
became CCG was implementation of care planning into all patients, all 
management of patients with long term conditions  
(Commissioning Officer) 
 
The drive from the CCG to promote the Year of Care (an approach which uses care planning as 
a central component to drive a proactive process of care designed to improve patient 
involvement, provide a more personalised approach and support self-management of diabetes 
and other long terms conditions) and make patient self-management of diabetes a priority was 
felt by the majority of staff within the CCG. They all reported receiving training on care planning 
recently and were aware of the increased focus on long term condition management. This new 
focus had created a change in practice.  
ST10: before people would just come in and then you would respond to what 
they were presenting with, you know? They'd say, oh, you know, you'd do your 
blood test and then you'd say, okay, oh, looks like your control's gone a bit high, 
you know, Mrs. Biggins, whatever, so, you know, what's changed, you know? 
And then just dealing with it like that. But now, it's, like, a bit more, kind of, 
proactive I suppose is the word which people might use. 
(Practice Manager) 
 
Although generally received positively by staff, there were some staff who presented resistance 
to the changes necessary in order to meet the new demands of the Year or Care. One nurse 
discussed the difficulty that she has experienced changing the focus of consultations to fit in 
with the Year of Care approach.  
ST9: It’s been a huge change for me because, I mean, I've been a nurse for 40-
odd years, and it was always that we advise patients or we empower patients... 
We’re now trying to get the patients to change their way of thinking, and for 
them to actually identify ways of addressing their problems, setting goals, how 
they’re going to do it... And it’s quite hard for me to take on. 
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(Advanced Nurse Practitioner) 
 
Staff discussed the conflicts within time limited appointments to achieve the new approach to 
diabetes care advocated by the Year of Care whilst also providing a personalised service to 
patients. 
ST21: We’re trying to follow the Year of Care format, but time pressure is 
huge…you’re supposed to be asking open questions and helping the person to 
find their own solutions… when they’ve also got the, sort of, whilst I’m here, I’d 
like you to look in my ears, I’d like you to look at this wound on my leg, I’d like 
you to tell me how I can get the housing people to sort out my heat or whatever. 
(Practice Nurse) 
 
In particular, the ever increasing demand for staff to work through a designated list of Quality 
and Outcomes Framework (QOF) targets within the appointment time led to frustration by some 
that individualised care was being missed, or pushed to the end of appointments. staff 
expressed a tension around being able to deliver different measures of quality of care. 
Contrasts were drawn between achieving measurable outcomes defined by the QOF and being 
able to provide a level of service to patients that they perceived to be quality care.  
ST20: it’s not just about earning GPs money, it’s about quality of care, and 
advice, that you’re giving to people. And I very often say to them, sorry, you’re 
sitting there, and I’ve got to keep turning away from you to the screen, to tick all 
these boxes. 
(Practice Nurse) 
 
Time pressures within consultations proved a constant source of frustration for many staff, who 
reported feeling constrained by time and workload pressures which impacted on their ability to 
provide the level of care to patients with type 2 diabetes that they desired. Many recognised that 
the care they were able to provide was not optimal because of these constraints.  
ST13: within that time there are practical things to do: foot checks, filling out 
various forms and referrals for things that they… if they haven’t had their eye 
screening and things like this. So, you’re packing it full of things to do: blood 
pressures, heights and weight and stuff, so there isn’t a huge amount of time 
within that for a lot of conversation 
(Practice Nurse) 
 
Patient challenges to diabetes care 
Patient related factors also influenced the level of care that could be optimally delivered. Staff 
often described co-morbidities associated with diabetes as having an impact on the care that 
could be delivered. These challenges were often described as outside of the control of staff. 
ST2: I think a major barrier to caring for people with type 2, by the time they get 
into the secondary care system, so these are people far down the line, maybe 
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they’ve got complications, they’ve ended up on very complex treatment 
regimens. 
(Diabetes Specialist Nurse) 
 
In many of the interviews patients’ socio-economic and occupational circumstances were 
discussed as barriers to staff being able to engage patients with diabetes care. Language 
barriers and educational limitations were most frequently mentioned, and the demographic 
characteristics of the CCG was often contrasted with other areas of the country, with this CCG 
often described as ‘challenging’  
ST20: … it’s the poor starting point that you have with a lot of the patients 
clinically, if I’m honest. As I say, we know that with deprivation goes an awful lot 
of this…they’re victims of their own lifestyle. Poor lifestyle, one way and 
another. 
(Practice Nurse) 
 
Discussion around the challenges of providing care to patients who didn’t speak English arose 
frequently. Often staff expressed frustration that they were unable to provide adequate care in 
these situations.  
ST6: Understanding, whether that is by the patient, for the patient. Language 
barrier. A lot of… our population’s quite diverse so the language barrier’s quite 
difficult. 
(GP Partner) 
 
Unsurprisingly, in such a diverse, multi-faith and multi-ethnic CCG, issues of culture in providing 
care to patients were often mentioned. Some staff talked about the way culture gave rise to 
patients having a fatalistic approach to diabetes care which impacted on their motivation to 
engage with looking after their condition. 
ST2: that fatalistic, cultural approach, God will take me when it’s my time 
anyway so it doesn’t matter what I do. So all those things make it difficult to get 
through to people with type 2 
(Diabetes Specialist Nurse) 
 
One clinician described frustration with patients who returned to their countries of origin for long 
periods of time, during which they took breaks from looking after their diabetes, only to return 
having very poor glycaemic control. In this example, this GP expresses frustration with the 
ability to provide ongoing care when patients are away and ‘opt out’ of treatment for part of the 
year. This represents a mismatch between a western model of care which focusses on the idea 
of continuity of care on the part of the HCP and patient and patients’ lifestyle and cultural 
constraints.  
ST6: a lot of our Bengali patients seem to disappear and go to Bangladesh for 
six months. They only take three months’ worth of medication with them. They 
don’t bother getting their medication while they’re over there and then they 
185 
 
come back, they do their… say, I’ve been away, can I have a blood test? Do 
the blood test, you’re like, oh my God. So, you have to start from scratch again. 
And then they do that every year. So, it’s really difficult. 
(GP Partner) 
 
9.4.4 Staff roles in diabetes management 
 
Responsibility to patients 
Staff presented their role in the care of patients’ diabetes differently. Many viewed themselves 
as a partner in the management of diabetes, with a responsibility to collaborate successfully 
with patients in order for them to manage their condition.  
ST1: working with patients, and being responsive to patients’ needs, so more of 
a partnership working with patients  
(GP partner) 
 
Others however, recognised limitations in what they could achieve with patients and suggested 
that it is ultimately up to patients to take on the responsibility of managing their condition. This 
view point was often associated with the acknowledgement that staff simply did not have 
adequate time to provide the amount of care they might ideally like to be able to give to patients.  
ST20: you see a healthcare professional for about three hours a year, and the 
remaining, I don’t know, I forget how many hours it is, you’re out there, I’m not 
saying we’ve thrown you to the wolves, but you’re out there looking after 
yourself. 
(Practice Nurse) 
 
Some staff talked about a desire to be able to do more for patients, whereas others were 
resigned to the fact that there was only so much they could do.  
ST16: when they come to us they don’t want to make changes and if people 
don’t want to make changes there is little that we can do. We can’t force 
people; we’re only here to support guidance if they want to make those 
changes 
(Diabetes Specialist Nurse) 
 
Many staff described a large part of their role as trying to engage patients with their diabetes, 
and reported having to spend a considerable time convincing patients of the benefits of looking 
after their diabetes and encouraging them to undertake actions of self-care.  
ST1: I think there is a medical side to it, and it is important to address the 
medical factors, but that needs to be tailored with the patient, and actually is 
part of the engaging of the patient to realise that is an important aspect of it. 
(GP Partner) 
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Power, control and frustration 
Staff members’ own sense of responsibility for patient’s diabetes was reflected in concerns that 
without guidance and follow up patients might lose enthusiasm for managing their condition, use 
medications incorrectly, avoid seeking help when needed and not continue to follow advice. 
ST9: And they may go through this honeymoon period where they’re willing to 
do everything. They’ll try. But you can tell when you bring them back, you know, 
you may say to them, okay, let’s go through what your diet’s like. You know, 
what have you had for breakfast, lunch and dinner yesterday. And then you can 
tell by what they’re telling you that they’ve perhaps not looked at food labels 
and they’ve not really taken on-board 
(Advanced Nurse Practitioner) 
 
Others discussed a perceived lack of control with regards to knowing what their patients were 
doing to self-manage. One nurse described having to take on the role of ‘detective’ to uncover 
the ‘truth’ of what her patients were actually doing to self-manage. 
ST2: they don’t necessarily share with you the truth of what they’re doing. So 
you don’t really know whether people are actually taking all their medications, 
you might suspect… often they will tell you what they think you want them to 
say rather than what is actually true. And so a lot of the time it’s like being a 
detective 
(Diabetes Specialist Nurse) 
 
Clinicians reported experiencing a range of often negative emotions in dealing with diabetes, 
especially around patient adherence to management plans.  
ST20: I do feel a bit defeated sometimes, I must admit. Because, the usual 
suspects, and you think oh, blimey. Put on another couple of kilos. 
(Practice Nurse) 
 
A tension was described between staff feeling frustrated at patients’ non-adherence and 
concern that they are pestering patients with their continued efforts to get patients to engage. 
ST11: So there’s quite a few of our 20 to 30 year olds who aren’t seen at 
hospital, because they never turn up, so we have to see them and we have to 
chase them, and make them come in for prescriptions, and one feels a bit of a 
nag, really. 
(GP Partner) 
 
The responsibility to self-manage diabetes can result in patients being more ‘expert’ about their 
condition than their healthcare professionals. The majority of staff viewed patients becoming 
more knowledgeable about their condition positively and recognised that given the restrictions 
on the care staff are able to provide to patients, the more expert the patient in looking after their 
condition the better. 
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ST16: in a year so much of the time they are their own experts, we’re not here 
for them, they have a very limited amount of time with a healthcare professional 
so self-management is pivotal to caring I guess for all long term conditions 
(Diabetes Specialist Nurse) 
 
One GP reported an experience of an informed patient challenging his knowledge. In this 
extract an irritation with the patient is evident under the surface, suggesting that there may be a 
tension between self-management and the possibility that patients may begin to challenge 
accepted medical thinking and question what they have been told. This could be viewed as the 
opposite side of self-management to those patients described earlier who did not want to take 
control of their diabetes at all, and leaves staff in a situation where they may have to manage 
potentially challenging interactions.  
ST1: the sort of informed person, who likes to think he’s… thinks he’s very 
informed. He’ll come in and he likes to challenge a bit, he likes to sort of throw a 
few things out there, and sometimes it’s like… And I don’t see it as authority, 
but if you like, challenging the authority of, you know, the doctor, and therefore 
this sort of perceived wisdom. And that’s cool, that’s fine 
(GP Partner) 
 
Team approach 
Having a well organised and engaged team within the GP practice was also considered 
important in promoting providing adequate support to patients with diabetes. 
ST19: having the practice, the GPs as a team organising themselves so that 
they've got appointments that are suitable, that they can go into the depth that 
you can't go into in a ten minute appointment. 
(Salaried GP) 
 
Other staff perceived that having the right mix of staff and good communication between team 
members was crucial to staff being able to support patients with diabetes. 
R: it's quite a big practice, isn't it? Do you think that makes a difference when it 
comes to caring for people with diabetes? 
ST5: No. I don't think that the size of the practice matters, I just think if you've 
got the right staff to do it. Yes. And I think education about it. Obviously as a 
receptionist, or even as a healthcare assistant, you only need to know so much, 
but we always have regular updates in meetings. 
(Health Care Assistant) 
9.4.5 Staff perceptions of self-management  
 
Value of the self-management approach to diabetes care 
Self-management of diabetes by patients was recognised by staff as necessary given the 
pressure on finances in the NHS and the increasing prevalence of people living with long term 
conditions, making more traditional models of care unfeasible.  
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ST2: Well, because of the context of the times that we’re in, you know, and 
limited resources that we’ve got to deal with the increasing number of people 
who have long term conditions. So it’s economic, isn’t it? It makes sense.  
(Diabetes Specialist Nurse) 
 
As well as the economic necessity reported, self-management of diabetes was generally viewed 
as a positive approach to the management of diabetes by the majority of GPs and nurses, who 
valued patients being involved in the management of their health.  
ST16: The emphasis should be on self-management. People need to be able to 
make informed decisions themselves and they need to have the confidence and 
skills to do that. 
(Diabetes Specialist Nurse) 
 
Using self-management as an approach was discussed as a way of enabling patients to take 
responsibility for their condition, preventing complications of diabetes, empowering patients and 
achieving better clinical outcomes.  
ST4: Hopefully people eventually will be more inclined to take responsibility, 
because they feel like they’re achieving something for themselves, and 
hopefully they’ve decided that they want to make those changes and so more 
likely to stick to them, rather than being told this is what you need to do, and 
then probably less likely to follow it. 
(Practice Nurse) 
 
One size fits all? 
It was recognised that patients’ desire and capacity to managing their own condition ranged 
greatly between individual patients, and that the emphasis on self-management might not be 
appropriate for all. Staff spoke of patients who wanted to be told what to do, rather than having 
to take responsibility and self-manage their diabetes.  
ST9: The main challenges are… some patients prefer to be told what to do. 
(Advanced Nurse Practitioner) 
 
Some GPs related patients’ resistance to the notion of self-managing their condition to cultural 
differences. It was noted that patients from cultures where a doctor led approach to disease 
management prevailed found it more difficult to understand and engage with the responsibility 
to self-manage diabetes, and the lack of input from staff was perceived as ‘neglect’. 
ST16: I suppose for some people… some people their health beliefs, they 
believe, particularly from our ethnic minority groups believe the doctors should 
be telling them what to do. And they feel that if we encourage them to look after 
themselves and self-manage more that we’re neglecting them so that can be an 
issue. 
(Diabetes Specialist Nurse) 
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Some reported that as a relatively new concept in healthcare, patients, especially of an older 
generation, may need time to adjust to the new role that self-management places on them in the 
management of their diabetes.  
ST12: …it’s a really new concept for them, and it takes… it probably will take a 
while for many of them to buy into that idea 
(Practice Nurse) 
 
Some staff also recognised that patients might experience emotional barriers to being able to 
take on the role of managing their own condition.  
ST17: …a lot of them, once they're told they're diabetic, they get a bit scared. 
And some of them don't sort of really want to take it on board and manage it. 
(Health Care Assistant) 
 
Staff spoke about the need to recognise that placing the responsibility for diabetes management 
on the patients was not possible in all cases. It was suggested that staff had to retain majority 
responsibility for patients’ diabetes care in some cases, for example where people had mental 
health problems or learning difficulties.  
ST11: you still have to, if you like, retain responsibility as a professional a bit 
more for some of these hard to reach people, all the learning difficulties people, 
and the people with schizophrenia. And I think it’s important not to throw the 
baby out with the bathwater, and say, oh, diabetes is all about the patients’ 
responsibility…but one has a professional responsibility to try and enable the 
best care to be available to people. 
(GP Partner) 
 
Others suggested that there were patients for whom self-management was made very difficult 
because of a lack of education and a lack of cognitive ability to grasp the tasks required of 
them. 
ST2: And it’s understanding, it’s cognition and it’s, you know, sort of level of 
health literacy, you know, knowing who to go to, when, for help, and so, and 
intelligence. Many of our patients have had no formal education. 
(Diabetes Specialist Nurse) 
 
There was recognition that people have priorities other than diabetes. Many staff acknowledged 
that self-management of diabetes was often low down on the list of priorities for patients facing 
a range of social, financial and other health problems. Some expressed concern that adding the 
responsibility for managing diabetes alongside other challenges was too much for many 
patients.  
ST16: Yeah lots of people who are struggling really who are typically perhaps 
elderly who don’t have English as a first language, who are on a very low 
income, perhaps their housing isn’t very good and they’ve got diabetes on top 
of it. It’s tough and it’s a huge challenge. 
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(Diabetes Specialist Nurse) 
 
9.4.6 Current self-management resources  
One of the QOF targets to be achieved for diabetes is that people diagnosed with type 2 
diabetes should be referred to structured education within six months of diagnosis. Within the 
CCG several self-management programmes were available for patients, the two main ones 
being DESMOND and Co-creating health. This theme discussed HCP’s views on this self-
management education. 
 
Awareness 
Most staff were aware of the self-management programmes available to their patients in the 
CCG. The perceived difference between these two resources were that DESMOND focused on 
information provision and Co-creating health on learning to put information into practice. 
ST2: DESMOND, it’s more about information giving at the beginning of your 
condition and what do you need to do to look after yourself…co-creating health 
is much more about, okay, well, we’ve got the basic information, now how do 
you put that into practice? How does diabetes impact on you, on your social life, 
your emotional life, your work life, how does it all balance?  
(Diabetes Specialist Nurse) 
 
In general staff perceived these resources as very valuable for their patients. GPs in particular 
highlighted the benefit of gaining knowledge and sharing experiences with other patients.  
ST1: it’s a way of just being able to put down some, not ground rules, but sort 
of, a good foundation for someone’s understanding of their diabetes…You’ve 
got a group that meets up regularly, for a period of time, and there’s a very 
powerful thing about being in a group and the support you get from that 
(GP Partner) 
 
Some staff however reported not being sure what the structured education entailed, and that the 
information they had about the content was gleaned from patients feeding back to them. 
ST4: I haven’t been to one, but from what patients have told me it, sort of... I 
think they do have access to a dietitian, looking at type 2 diabetes, I guess what 
causes it, and then lifestyle changes, so I guess exercise, diet and then, I 
guess, where they might go from there. 
(Practice Nurse) 
 
The role of structured education 
 
Many staff viewed this education as an important addition to the care that patients received in 
consultations. Recognising the limitations of providing care in time pressured consultations, staff 
believed this education allowed patients more time to address important issues and gain further 
knowledge.  
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ST2: I think that you don’t have enough time, one-to-one, to do the information 
giving, which you do need to do and the self-management support. And so you 
can see that when people go on programmes, they come back so much better 
informed and, you know, they know what they’re doing much better. 
(Diabetes Specialist Nurse) 
 
One GP suggested that the peer nature of the support gained from group based education gave 
patients permission to admit to engaging in behaviours not conducive to diabetes management 
in a supportive, non-judgmental way, as well as support to then move forward to change this. 
ST1: And the fact that someone sitting next to you admits to eating too many 
cakes, and then that gives you the permission to actually admit to yourself, yes, 
actually, I eat too many cakes as well. But it’s okay to have that, because that’s 
nature, we all like eating cakes. It’s just that the difficulty is now this is 
something that I need to address, and the group can help with that.  
(GP Partner) 
 
The group based nature of currently available diabetes education was also perceived as 
beneficial to patient learning through the sharing of experiences and working together. Several 
staff highlighted the value of the experiential knowledge that was shared in groups.  
ST2: it gives you just so much more benefit than one-to-one work, partly 
because people are working together, problem solving together, seeing all the 
sorts of problems that others have, picking up tips from each other and so forth. 
And lots of time to reflect and practice. 
(Diabetes Specialist Nurse) 
 
 
Barriers to patient attendance at diabetes education 
There was a widespread concern, that despite the perceived benefits of structured education 
courses, the courses were not suitable for all patients. Problems identified included patients’ 
busy lives which made attending a programme that lasts several days and is held during 
working hours difficult for those in full time work or with caring responsibilities.  
ST1: younger people’s lives can be more complicated, with childcare, and work 
commitments, and what have you, and often people are travelling a lot through 
their work. You know, they can’t commit to a DESMOND type programme, or 
even, the self-management programme is actually seven weeks, which is quite 
daunting 
(GP Partner) 
 
Other issues related to the group based nature of the courses such as patients feeling 
embarrassed to ask or answer questions and feeling anxious within a group setting. 
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ST9: I had one lady who had anxiety, she just couldn’t be there with all those 
people, even though it’s... I think the group’s only six or eight, isn't it? She felt… 
She was overwhelmed by it, so… 
(Advanced Nurse Practitioner) 
 
Staff also referred to the fact that patients who could not speak English could not attend these 
groups. 
ST11: I know that we have quite a lot of Turkish and Bengalis who we are not 
allowed to refer which is a great shame 
(GP Partner) 
 
Readiness to engage 
 
There was discussion about when structured education should be provided to patients. Several 
staff believed that there was an optimal time period in which to engage patients with their 
diabetes, and after which time patients lose the initial impetus to engage.  
ST3: if you get diagnosed and somebody refers you onto a programme and you 
start within two weeks then you’re most likely going to do it. If it's six, eight, 12 
weeks, even beyond as it was at one point, almost four months, people have 
lost the immediate anxiety of learning that they've got a long term condition. 
(Commissioning Officer) 
 
One Advanced Nurse Practitioner referred to this as the ‘honeymoon period’, which occurred 
shortly after diagnosis, when patients would be willing to try things to help them manage their 
diabetes 
ST9: they may go through this honeymoon period where they’re willing to do 
everything 
(Advanced Nurse Practitioner) 
 
It was reported that problems with long waiting lists to attend these courses resulted in patients 
losing interest or feeling that they no longer needed to take up the education when it became 
available. 
ST9: They’ve got a long waiting list. Then by the time the patient was actually 
approached, they didn’t feel that they needed it. 
(Advanced Nurse Practitioner) 
 
There was also a large cohort of patients within the CCG who had missed out on attending any 
education for their diabetes because they were diagnosed before the education was available. 
ST13: DESMOND is relatively new. So, some people have been sent to it later 
along the line because they never did go at the beginning. And some people, I 
think, probably never did go on it. 
(Practice Nurse) 
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Staff roles in referrals to diabetes education 
Many staff had no idea how many of their patients actually attended these programmes after 
they had provided them with a referral to attend. Follow up with patients regarding attendance 
was very rarely reported.  
ST4: We offer them to all newly diagnosed patients, they’re all meant to be 
offered the programme, and I would say a lot of them probably don’t go  
(Practice Nurse) 
 
Staff felt that their role in getting patients to attend the education courses ended with the 
handing out of referrals. 
ST6: We can only give them the form, I mean, there’s no… I can’t walk them up 
there. 
(GP Partner) 
 
Some staff reported giving patients an initial referral but not following this up with patients. 
ST20: So, I do… I’m really terribly bad at reinforcing it. I tend to offer it de novo, 
and then not again, which is a fault of mine, really. 
(Practice Nurse) 
 
A few staff suggested that patient engagement with self-management was dependent on the 
level of interest of staff and their skills in encouraging patients with self-management. 
ST19: one of the biggest barriers to self-management is GPs, and one of the 
biggest potential solutions as well… so how GPs can help, so one is actually 
being interested in self-management, having the skills to be able to get the 
patient on board with or at least establish where a patient is at with that 
(Salaried GP) 
 
One diabetes specialist nurse alluded to the fact that referring patients to structured education 
had not yet become fully part of routine practice in the CCG and suggested that staff need to 
improve the way it is marketed to patients to get them engaged.  
ST2: I think we don’t have an expectation that people will need to do that as, 
you know, as a normal next step; get diagnosed and then everybody does it. 
You know like how everybody, every woman, expects to have a smear 
test?…So I think that that is something that needs to be created and it’s how it’s 
marketed, how it’s sold, because a lot of people will be ambivalent, I imagine, 
about going to it. So it’s about pushing people. 
(Diabetes Specialist Nurse) 
 
9.4.7 Staff perceptions of HeLP-Diabetes  
Staff generally perceived HeLP-Diabetes very favourably and described how it would fit well 
within current practice helping to fill gaps in knowledge and information provision resulting from 
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time pressured consultations. HeLP-Diabetes was perceived to have several advantages over 
group based education and other formats of information provision, although mention was made 
of people with certain characteristics for whom staff did not think it would be suitable for.  
 
 
Fit of HeLP-Diabetes with current practice 
Overall, HeLP-Diabetes was viewed positively by staff in the CCG. 
ST16: I had look at it before … and I think it’s great, it’s fabulous. 
(Diabetes Specialist Nurse) 
 
HeLP-Diabetes was viewed as having synergy with the policies and priorities of the CCG and 
therefore fitted well with what staff were trying to achieve with patients with diabetes.  
ST15: … it fits in with the practice of, sort of, Year of Care and encouraging 
people to self-manage, which is quite positive. 
(Practice Nurse) 
 
The majority of staff perceived HeLP-Diabetes to be a complimentary resource to offer to their 
patients. Having a menu of options available to patients seemed particularly important as many 
staff spoke about one type of diabetes education not fitting all.  
ST3: I think if you’re going to do self-management courses you have to have a 
menu of options, because there’s nothing, you know, one size doesn't fit all so 
there's no way that everybody's going to want to do DESMOND. 
(Commissioning Officer) 
 
Staff perceived that HeLP-Diabetes would fit well into the current care that they provided to 
patients, addressing some of the barriers that currently exist to patient information seeking. It 
was recognised that patients might sometimes feel embarrassed asking multiple questions of 
staff and was suggested that HeLP-Diabetes allowed patients to bypass the traditional routes to 
information, allowing patients to access information by themselves. 
ST5: … I mean, you can't keep going back to… you feel embarrassed when 
you keep going back to talk to your doctor or the hospital. Maybe not for the 
serious, you know, but for general… I wonder if I could eat that really. I wonder 
if I… okay, so I'm putting on weight. How can I lose weight? And you can put it 
all in on there [HeLP-Diabetes] and find that out.  
(Health Care Assistant) 
 
Some staff talked about patients potentially feeling bombarded by information when they are 
first diagnosed, and that HeLP-Diabetes could be used as and when needed by patients to 
access information.  
ST4: it just gives them a basis in their own time, rather than being bombarded 
with information, especially when they’re maybe newly diagnosed and they 
don’t want to hear about everything at once understandably. 
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(Practice Nurse) 
 
Many staff talked about the fact that currently the majority of information is provided to people 
with diabetes all at once at the time of diagnosis. Staff perceived that at diagnosis people might 
not know all the questions that they will eventually have about their diabetes, and having a 
resource that patients can keep going back to was perceived as very useful.  
ST14: I think because when they come to us they only have a certain time, 
sometimes they might not have all the questions on the top of their head…so 
when we give them website information, they are free to use anything of the 
available information…I think it’s really helpful. 
 (Health Care Assistant) 
 
With the focus within the CCG on providing education to those patients who are newly 
diagnosed with diabetes, staff recognised that patients who have had diabetes for a longer time 
and who may not have had any form of diabetes education might be particularly suited to using 
HeLP-Diabetes. 
ST4: we’ll see patients that have been diagnosed maybe for ten years, so you 
don’t know what information they got at the beginning or what they may have 
forgotten, so it’s quite nice that they can go back and look over maybe why we 
are doing some of the things we’re doing. 
(Practice Nurse) 
 
It was also suggested that there might be some diabetes related issues that patients might find 
more comfortable finding out about via the anonymity of the internet rather than from a 
healthcare professional. 
ST14: Sometimes they would hesitate to discuss certain things. For example, 
when we ask, do you suffer from a erectile dysfunction…if they have resources 
available, like, when they go home it would be better, yes. 
(Health Care Assistant) 
 
HeLP-Diabetes was perceived positively in terms of having the potential to relieve time 
pressures within consultations with patients. Many staff reported that being able to offer such a 
comprehensive resource for patients to use following appointments took the pressure off them 
having to cover all necessary areas in details within time limited appointments and that patients 
could use HeLP-Diabetes to continue their learning and information seeking after appointments. 
ST4: I think giving them time to look at the areas that they want to look at, 
rather than us, sort of, trying to cover everything in a 20 minute or 15 minute 
appointment, maybe trying to pick out a few bits and let them have a bit of time 
to read about it. 
(Practice Nurse) 
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ST8: …the website’s very good, clear, concise, everything’s in one place, it’s, I, 
I could only see it reducing the GP’s workload in the long run. 
(Receptionist/Admin) 
 
HeLP-Diabetes was perceived by most staff to be a useful tool that patients could use to 
supplement the information they received from staff, and could be used in between 
appointments.  
ST4: It’s quite nice to just remember that they can just focus on one area and 
then we can see them in between. 
(Practice Nurse) 
 
ST5: I think they'd still need their regular checks, but I just think that for in 
between questions and things, and to keep a chart, as well, of their weight and 
their HbA1C, I think that's really good. 
 (Health Care Assistant) 
 
The use of technology to deliver care to patients was viewed by many staff as the future of the 
healthcare, and many spoke about the positives of technology for the management of long term 
conditions. Staff viewed the use of technology within practice as a way to make services more 
accessible to patients. 
ST8: Well, I think it’s amazing, I mean, I mean, we’re living in a technological 
age, things are only going to get more that way in the future, so, it’s good that 
people can just manage themselves if they, if they want to. 
(Receptionist/Admin) 
 
Many staff were already familiar with recommending websites in their consultations, and the use 
of the internet in general with patients was viewed positively.  
ST21: I think it’s good and I think it’s the way forward. The number of people 
who come in and they’ve already looked something up on the website, on a 
website, and it’s something, well, I’m getting more used to doing it. 
(Practice Nurse) 
 
However, there were some patients that staff didn’t perceive would ever feel the need to use an 
online intervention like HeLP-Diabetes as they were satisfied with the way their current care 
was handled.  
ST18: They come in and see the doctor and obviously if they’ve got any 
questions then they come in and make another appointment so I think a lot of 
patients are quite happy in that routine already and some, yes, some people 
don’t like change. 
 (Receptionist/Admin) 
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Relative advantage 
The problems that were identified with current face-to-face group based education available in 
the CCG provided a strong sense of need among staff for alternative forms of education that 
could be offered to patients. Views of HeLP-Diabetes were generally presented in contrast with 
group based education.  
 
The main advantages of HeLP-Diabetes compared to existing services were reported to be 
related to accessibility. Accessibility was described in terms of the simplicity and clarity of the 
information provided as well as the fact that HeLP-Diabetes was accessible at any time, as 
often as patients liked. 
ST1: I think, as I said, because it’s a resource that patients can… You know, it’s 
a resource with a lot of very relevant, patient accessible information that, yes, 
that people can access, sort of, online. 
(GP Partner) 
 
HeLP-Diabetes was viewed as much more accessible for certain groups of patients than current 
face-to-face education. Staff perceived that their younger patients, those who worked, those 
with caring responsibilities and those who travelled a lot would particularly benefit from an 
online resource compared to a face-to-face resource. 
ST4: I think again people can tailor it or get the information that they want out of 
it. In terms of timing they can access it whenever they want, rather than having 
to miss work, which is obviously quite a big issue for these patients. 
(Practice Nurse) 
 
However, there were certain features of face-to-face education that staff thought could not be 
replicated or delivered via an online resource.  
ST8: Well, I suppose with things like Desmond, it’s good because it’s obviously 
a community activity, you are actually physically there with other people, which 
can be hugely important for some people, so, it’s just, essentially for the elderly. 
It’s good because there’s a little bit of, you get to have a chat and see some 
people and stuff like that. 
(Receptionist/Admin) 
 
As well as staff perceiving HeLP-Diabetes as being distinct to current face-to-face diabetes 
education, it was also perceived as different to other online resources that are available to 
patients. Staff drew comparisons with Diabetes UK online resources, and perceived HeLP-
Diabetes to have advantages over this because of its interactivity.  
ST1: I think that, particularly, the accessibility of this, yes, and I suppose also 
pointing out to people that it is very different to Diabetes UK. Although there are 
a lot of resources in Diabetes UK, this is more interactive 
(GP Partner) 
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ST7:  Well, I think the website is more on a personal level, whereas I think 
the Diabetes UK is more clinical whereas the Help Diabetes it’s more personal.  
R: And you think that’s better in a way? 
ST7: Yes. A hell of a lot better because I think people can relate to it more. 
(Receptionist/Admin) 
 
Staff perceived patients using HeLP-Diabetes as preferable to general searching on the internet 
for diabetes related information. The fact that HeLP-Diabetes is a dedicated website, specific to 
one condition was seen advantageous as was the potential of HeLP-Diabetes to be tailored to 
the needs of patients. 
ST4: I think again people can tailor it or get the information that they want out of 
it. 
(Practice Nurse) 
 
Some staff talked about information and guidelines constantly changing which often rendered 
more traditional forms of information resources such as leaflets and booklets obsolete after a 
short time. The online format of HeLP-Diabetes allows regular updates to help overcome this 
problem. 
ST21: …it’s constantly updated whereas you give them a booklet and then a 
year later, the Department of Health has said as a diabetic, you mustn’t have 
five fruit, you’ve got to have one fruit and four vegetables or something. 
(Practice Nurse) 
 
Suitability for target population 
There were certain groups of patients identified by staff as not being able to benefit from HeLP-
Diabetes. Language barriers to use arose frequently, as well as people who were unable to use 
a computer. 
ST16: A lot of the patients we see are elderly frail, as I’ve said, perhaps don’t 
have English, and mostly importantly don’t have a computer at home or are 
computer literature. 
(Diabetes Specialist Nurse) 
 
Although some suggested that HeLP-Diabetes could be used by patients with support from 
English speaking relatives. 
ST13: I mean, we can ask them, have they got people in the family that would 
show them it? You know, link them in with it at home. Perhaps a grandson can 
come and click the right buttons and get them going. 
(Practice Nurse) 
 
ST1: I suggested HeLP-Diabetes to, not so much for her but more for the 
family, and they can maybe sit with her, and they can actually… And the great 
thing with the Internet is, you can play this video on diabetes, and all the keys 
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going in [animation used to explain diabetes], and actually press pause and 
explain it in Bengali, and then it’s there. 
(GP Partner) 
 
Due to the perceived level of literacy needed to use the internet to access HeLP-Diabetes, there 
was the perception by some that HeLP-Diabetes, like the other existing services in the CCG, 
was only suitable for patients who were literate with some degree of motivation to self-manage.  
ST19: So yes, the basic is that a patient has to be motivated to do it. Then they 
have to be able to use the internet as well. They have to have the intellect, 
the... a connection of the internet. 
(Salaried GP) 
 
There was a concern that within the CCG, there were still no adequate solutions to engage 
patients deemed as ‘hard to reach’ with diabetes education. 
ST1: I think, one of the things we’ve been discussing in the steering group is 
how do we reach the hard to reach groups. Because, actually, the way I look at 
the challenge, and particularly with diabetes, we haven’t quite. 
(GP Partner) 
 
Other staff however, recognised that these ‘hard to reach’ patients were the ones for whom 
face-to-face input was the most valuable. Whereas perhaps for some patients, interventions 
such as HeLP-Diabetes could do some of the work that staff would traditionally do, for others 
there was no substitute for healthcare professional input. 
ST11: …I don’t think DESMOND or HeLP makes a difference to the hard to 
reach people. I think that you have to chip chip away, build a relationship, you 
know, and try to gradually keep them on board. And they are the people, if you 
like, who often take up the most time, and we spend the most time to do, 
because you’re still trying to find what will help get them on board. 
(GP Partner) 
 
The age of diabetes patients was raised as a concern for the use of an online intervention like 
HeLP-Diabetes with staff perceiving that the older age of the diabetes population might prevent 
them from engaging with online resource. 
ST18: because it’s computer based more than anything. I mean, it’s kind of like 
trying to teach an old dog… old dog new tricks kind of thing. You do have 
patients who are set in their ways. I mean like electronic prescribing, a lot of our 
elder patients hate it. 
(Receptionist/Admin) 
 
It was suggested by some that the use of HeLP-Diabetes may increase over time as the 
diabetes population gets younger and computer skills become more ubiquitous in older 
populations.  
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ST6: as time goes on, you’re going to find more and more people using the 
internet, aren’t you? So, they’ll prefer it. 
(GP Partner) 
 
 
9.4.8 Adoption and implementation HeLP-Diabetes  
Even though HeLP-Diabetes was generally viewed favourably by the staff, there was not 
widespread use of it. Here I describe how HeLP-Diabetes was actually used within routine 
practice and the factors that were identified as facilitating or inhibiting its use. 
 
Evidence and endorsement 
HeLP-Diabetes had very strong support from the CCG from the outset. The Commissioning 
Officers at the CCG held the expectation that HeLP-Diabetes would become a service that 
would gradually become embedded in practice. The CCG recognised that this could take years 
because of the many competing priorities placed on staff.  
ST3: …we're anticipating that it would be…second nature within practices. And 
that's going to take a long time because these things take two to three years to 
bed in, realistically, no matter how much buy-in you have because there are so 
many other things to think of you know. But I think once it gets to that stage, you 
know, I think it would just be offered alongside all the other things straightaway, 
you know, on diagnosis. 
(Commissioning Officer) 
 
The CCG actively helped to promote HeLP-Diabetes by incorporating it into diabetes nurses’ job 
descriptions and making it part of the diabetes Locally Enhanced Services (LES).  
ST3: … We're trying to put it into the service spec for the diabetes nurses and 
into the long term conditions LES. It’s mentioned in there as one of the options 
in self-management which we're promoting. 
(Commissioning Officer) 
 
This support from the CCG was important for many staff in their decision to adopt HeLP-
Diabetes. The support gave HeLP-Diabetes a sense of credibility and encouraged staff to feel 
that this was a service that they should be offering to their patients. 
ST1: …being validated by an organisation that you respect. So it’s …the CCG, 
or the steering groups saying this is a good thing 
(GP Partner) 
 
Staff also thought the fact that HeLP-Diabetes aligned with current CCG policies facilitated their 
use of it. 
ST12: And the fact that most of it had the same action plan as Year of Care 
facilitated because it’s, sort of, in line with what you’re learning. 
(Practice Nurse) 
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Apart from the endorsement that HeLP-Diabetes received from the CCG, staff talked about 
different types of evidence being important in their decisions to adopt HeLP-Diabetes.  
 
For many, the fact HeLP-Diabetes had a strong evidence base and came from a university was 
extremely important in the decision to take it on. 
ST3: We wouldn't have taken it on if it wasn't evidence-based. We really 
wouldn't. And we’re pioneers now so we are creating the evidence, but for 
something like this, you know, the fact that it was validated and evidence-
based. That really just underscored everything. 
(Commissioning Officer) 
 
Others talked about generating the evidence they needed to continue implementing HeLP-
Diabetes by taking it on, trying it out and obtaining feedback from patients to evaluate its worth.  
ST6: I suppose it’s just trying it out and seeing if people go on it and if people 
like it and then any sort of… informal, sort of, feedback is good. I haven’t had 
any complaints and people said… a couple of people said some nice things 
about it so, I, you know… if people find it helpful, then obviously we need to 
look at it ourselves and see, you know, what’s the information like? Is it 
reputable and so on and so on? 
(GP Partner) 
 
Other staff gained evidence of the ease of implementing HeLP-Diabetes from the experience of 
other practices that had adopted it. One GP discussed how the need for staff to register patients 
to HeLP-Diabetes was an initial barrier to their adoption, but hearing from other practices that 
this had been done successfully had changed their mind to adopt. 
ST11: Well, initially, I think I remember we weren’t one of the first adopters. 
Which is unusual for us for diabetes… and then…there was one of those 
education sessions, and a GP and [Name of Commissioning Officer] talked 
about how their patients had found it useful, and they’d managed to do it as a 
practice, I thought, oh, well, we’d better get on, and not be laggards, so you 
know, we then did it 
(GP Partner) 
 
Before agreeing to adopt HeLP-Diabetes, one practice nurse had conducted her own research 
to provide evidence that there would be suitable patients to use HeLP-Diabetes at her practice. 
She had a preconceived notion that none of her patients with type 2 diabetes would use a 
computer and therefore didn’t think HeLP-Diabetes would be suitable.  
ST20: I did a fantastically huge piece of research, a hundred patients. I got the 
girls, the receptionists, to ring round 100 of our type 2 patients. I should actually 
have fiddled it, and said only the ones that are over 70, or something like that. 
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And, I was quite surprised, because of the 100, 54 or 56 did use a computer, 
which surprised me. 
(Practice Nurse) 
 
 
Trialability, Training and Support 
The demonstration of HeLP-Diabetes to staff during practice meetings and the training sessions 
held with staff on how to offer HeLP-Diabetes to patients were perceived very favourably by 
staff.  
ST12: And I think perhaps the fact the partners invited you [researcher] in to 
come and present about HeLP-Diabetes gave great weight to it as a 
programme, and because we obviously respect their judgement and they felt 
this was a good service and something important to promote in the practice. 
(Practice Nurse) 
 
In some cases there was a sense of trepidation about taking on another new initiative in 
practice. However, when staff saw HeLP-Diabetes and were trained to use it they reported 
feeling pleasantly surprised by it, and it was at these times that staff reported becoming 
engaged with HeLP-Diabetes.  
ST7: … it was mentioned before by the practice manager and I think one of the 
doctors, and we were like, well, what’s all this about? And to be honest with you 
it was a case of, oh, here we go, another one of these things that’s... not going 
to take off. It’s going to be a five minute wonder and that’s why when you came 
in and you trained us up, it was just such a shock to what we’ve... to what other 
ones we’ve been on. It was more useful than what... 
(Receptionist/Admin) 
 
Having the opportunity to try out HeLP-Diabetes and become familiar with it before deciding to 
adopt it also proved useful for staff. 
ST5: I think because we signed up ourselves and we sort of like got to know 
the website ourselves, so then we could... because it’s no use selling 
somebody something if you don’t know what the product’s going to do. 
(Health Care Assistant) 
 
In two practices, I helped staff to register patients during the initial stages of implementation. 
The support that I was able to offer to these practice to implement HeLP-Diabetes was viewed 
as very helpful for staff within the practices, and it was these two practices that went on to 
register the most patients.  
ST4: I would say it was really nice having you here... we were quite slow, you 
know, just getting used to it. So I think having you here... I think it would be 
really helpful to have you there for a few sessions and one beforehand to go 
through it like you did with us, to show us to show us how to login and 
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everything. Then maybe have you there for a few sessions seeing the patients. 
And then I think it’s been nice when we’ve had... been able to email you so with 
questions and if we did need you to come in 
(Practice Nurse) 
 
Responsibility for implementation 
In the original implementation plan it was perceived that the role of facilitating patient access to 
HeLP-Diabetes would be a role best suited to nurses who traditionally take on the majority of 
self-management work with people with long terms conditions like diabetes and who have the 
opportunity to introduce HeLP-Diabetes to patients during routine consultations. However, there 
were mixed perceptions amongst staff as to whether this role was actually a good use of nurse 
time.  
 
Some staff agreed that nurses had the necessary access to patients and that during 
consultations would be the easiest way to register patients to HeLP-Diabetes. 
ST15: … you almost have to seize the moment, really. So, in that sense, it 
would probably be easier done in the appointment with the nurse 
(Practice Nurse) 
 
However, it was called into question by some GPs and nurses whether the task should be 
undertaken by nurses, as it was not perceived to be a good use of clinical time. Instead it was 
suggested that other staff such as health care assistants and receptionists within the practices 
might be better suited to this role. 
ST1: Actually, I would argue it shouldn’t be done by the nurse because, you 
know, it’s quite a low-key IT thing...I would rather our practice nurses spend 
their time, you know, doing the clinical work that they are most skilled at doing, 
and you can have someone else. 
(GP Partner) 
 
In the majority of practices the role of offering HeLP-Diabetes to patients actually ended up 
being taken on by health care assistants and receptionists, with nurses and GPs only 
undertaking the role in a few practices. The role was perceived as particularly suited to health 
care assistants and reception staff as they were described as IT literate, willing to help out with 
other tasks, and keen to learn new skills, and importantly, perceived to have more time to 
undertake the role.  
ST12: Or, in our case, having [Name of receptionist]…he was very willing to 
drop whatever he was doing and come and chat to people. He was IT literate 
and very personable. So, I think you had… he was a very good, sort of, face of 
HeLP-Diabetes. And nothing was a problem and, oh just sign up here, fantastic. 
And he would just appear and swoop people off and sort it out, and it was 
magic. So, actually having that combination of someone who’s quite 
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keen,…who feels confident about doing it and… can stop whatever they’re 
doing and just come and take over. 
(Practice Nurse) 
 
Awareness and Engagement 
Between practices there was much variation in awareness of HeLP-Diabetes and the level of 
involvement of practice staff. In the practices that signed up the most patients to HeLP-
Diabetes, HeLP-Diabetes was known by the majority of staff who all worked together to offer 
HeLP-Diabetes to patients.  
ST7: GPs and nurses, they’re sort of…100% behind it and I think that does 
make a difference…you go to a GP and they say to you, well, there’s this 
programme you can do... and then send them to either me or (HCA’S name) 
and we can explain it to them more then. 
(Receptionist/Admin) 
 
In this case, the buy in to HeLP-Diabetes by the GPs in the practice gave the receptionist 
confidence in using HeLP-Diabetes with patients and gave HeLP-Diabetes an approval that was 
perceived as necessary in order to offer it to patients. 
 ST7: if they weren’t behind us and they went into one of the GPs and said, oh, 
your HCA or your admin assistant has just given me this leaflet for this, what do 
you think, if they’re not behind you they’re just going to say, oh, don’t worry 
about it, just throw it away, do you see what I mean? But when they’re behind 
you, it does... yes. 
(Receptionist/Admin) 
 
However, in practices where HeLP-Diabetes wasn’t being offered to many patients, there was a 
perceived lack of buy in from GPs and other staff within the practices. 
ST20: I kind of have to hoe my own row. He’s [GP partner] not obstructive, but 
he’s got a very clear idea of what he thinks is important, and what isn’t. It’s not 
always easy. 
(Practice Nurse) 
 
Some staff reported difficulties in trying to engage other staff with HeLP-Diabetes. The lack of 
involvement was frequently attributed to other staff being too busy to engage. 
ST21: In an ideal world, I would have liked to get reception more involved…I 
half mentioned it and it was very clear at the time that there weren’t the 
resources 
(Practice Nurse) 
 
The pressure of all the existing services that nurses had to deliver acted as a barrier to them 
becoming engaged with HeLP-Diabetes which was perceived as yet another new initiative to 
take on and implement.  
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ST1:…neither of our nurses were really in to it…they said they can’t cope with 
the new LES, and all of the new templates, and everything else. And I said, now 
there’s a great new IT tool, and they said, go away, we’ve got enough to be 
getting on with 
(GP Partner) 
 
Impact on roles and work practices 
There was a strong perception from many staff that the work involved in offering HeLP-Diabetes 
to patients would be too time consuming and too difficult to take on. This was described as the 
main barrier to HeLP-Diabetes being implemented successfully within practices after the 
decision to adopt had been made. 
ST11: And the barrier was this notion that we’d got to get the receptionist 
trained to fill in a form, and to go online. That all sounded like a bit of a 
nightmare 
(GP Partner) 
 
However, in stark contrast to this were the views of staff within practices where HeLP-Diabetes 
had been implemented who were actually doing the work of registering patients. There was a 
clear sense from those doing the work successfully that the task of registering patients was not 
a difficult or time consuming one. This suggests a mismatch between the fear of HeLP-Diabetes 
being time consuming before it is adopted (as in the quote above) and the reality of the time 
implications.  
ST8: I would register patients as they, as they came, and then maybe at the 
end of the week, send a list of the people we’ve registered. So, yes, it would be 
ten, ten minutes out of my day here and there… It wouldn’t be a massive, 
massive burden, no. 
(Receptionist/Admin) 
 
Some staff described the work of registering patients to HeLP-Diabetes as fitting in well within 
their current practices, and in some cases using HeLP-Diabetes with patients during 
consultation was reported to be time saving. 
ST4:…if the patient has identified something or if we identify something, you 
know, if the HbA1c’s gone up or the patient’s identified that they want to, I don’t 
know, lose weight, then we can use that as a resource. So it’s quite good, 
because it probably does save us time 
(Practice Nurse) 
 
In addition, in some cases, the staff doing the work of registering patients felt that this new task 
was adding something to their job satisfaction and adding a new skill to their set.  
ST7: Yes, and then a patient could phone up and just sort of like you don’t... I 
don’t have to then wait to speak to a doctor. I can either offer them that facility 
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to look up on the Help Diabetes or I can look it up for them and explain it to 
them and then... 
(Receptionist/Admin) 
 
One receptionist who was allocated the task of registering patients perceived it as a position of 
responsibility and felt pleased that it had been designated to her.  
ST18: It felt nice that the doctors thought they could trust me with that 
responsibility so that was quite nice. 
(Receptionist/Admin) 
 
Two health care assistants, from practices where HeLP-Diabetes was being offered 
successfully to patients, distinguished the new way of working with HeLP-Diabetes to previous 
ways of working. From using HeLP-Diabetes the health care assistants now had more 
knowledge about type 2 diabetes and felt more able to help patients with their queries. Before 
the use of HeLP-Diabetes these health care assistants did not feel confident enough to answer 
questions about diabetes and had referred the patients straight on to a GP. In this way the use 
of HeLP-Diabetes helped these staff to transcend their traditional roles and also gave patients 
access to information more quickly than if they had had to wait to have their queries answered 
by a GP.  
ST5: Yes, yes, yes. Yes. I mean, obviously I'm not diabetic. I'm not an expert on 
the subject. I only know bits and pieces. But I'll say to them, well, look, if I don't 
know the answer, we'll ask the doctor, but let's have a look first and we'll see if 
the answers are on the site, you know. 
(Health Care Assistant) 
 
For practices that did not implement HeLP-Diabetes due to the perceived workload implications 
of staff having to register patients, alternative strategies were introduced to help them overcome 
this problem, including the introduction of patient registration leaflets (see Chapter 7 for more 
details of alternative implementation strategies).  
 
The patient registration strategy was perceived favourably by many staff as it took much of the 
workload implications of offering HeLP-Diabetes away from them. 
ST12: Because now we have new leaflets there’s a number that they type in 
where they can join. So, I think that’s really taken out the middleman and forms 
getting lost, and things not… access not working and that. So, I think that’s 
really been a big step forward 
(Practice Nurse) 
 
Some staff viewed their role in the offering of HeLP-Diabetes as unnecessary, as in the quote 
above, this nurse referred to the role as that of a ‘middleman’, suggesting that she viewed this 
as a redundant step.  
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However, other staff recognised the value of staff supporting patients to register, showing 
patients what HeLP-Diabetes is and its ease of use. 
ST13: Well, I think it’s really important to actually put it on screen in front of 
everyone, and click through it and just show how easy it is to use.  
(Practice Nurse) 
 
Availability of resources 
Although perceived favourably, HeLP-Diabetes was often reported to be forgotten in 
consultations when staff felt under pressure to complete lots of other tasks within the time. In 
this way, HeLP-Diabetes had not become a priority in comparison to the other tasks that are 
required within time limited consultations. 
ST6: you do forget, I forget. I see diabetic patients and I go… after they’ve left, I 
go doh, I should have given them the leaflet. But, you know, you just forget 
because there’s a million things and a million questions. 
(GP Partner) 
 
In other practices and clinics there were more practical barriers to implementing HeLP-Diabetes. 
In one small practice it was reported that they lacked the physical space to register patients to 
HeLP-Diabetes.  
ST6: Well, for us, it [HeLP-Diabetes] was great but it was going to be really 
difficult to implement in our surgery because of staffing- no space for 
receptionists to go off and talk to the patients and log them in and stuff. 
(GP Partner) 
 
And in the hospital clinics, offering HeLP-Diabetes to patients was described as almost 
impossible because of the very old computer systems that staff had to work with. 
ST16: Well we’re working with Windows 2003 I think, we don’t have Google 
Chrome, I have kind of slightly overcome it, I’ve inherited a very ancient laptop 
which is like a museum piece but it has been loaded with some newer software 
on there. But it’s locked in the drawer and realistically I’m not going to get it out 
and fire it up between patients in the clinic. 
(Diabetes Specialist Nurse) 
 
Suggestions for improving the implementation 
Several suggestions to improve the implementation plan in order for HeLP-Diabetes to become 
more widely used within routine practice were described by staff. Feedback on how individual 
practices were performing with regards to registering patients was suggested as a way to 
motivate staff to register more patients.  
ST11: You know, GPs, like everybody, feel slightly competitive and if they see 
only five of theirs have enrolled, and somebody else has got 100, it makes you 
think. 
(GP Partner) 
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Feedback from patients on their views of using HeLP-Diabetes was also suggested as a way to 
encourage staff to continue to offer HeLP-Diabetes as they could use patient feedback as a tool 
to promote HeLP-Diabetes to other patients. 
ST5: I have asked some of them to get back in touch and let me know how they 
find it…because it would be interesting to know, and then I could say to other 
patients, well, actually patients have found this really helpful, you know. 
(Health Care Assistant) 
 
Many staff thought that if HeLP-Diabetes was simply searchable on the internet then it would be 
much easier to implement within practice and would have many more patients using it.  
ST1: …it would be nice if it could be as easy as possible…if you could just be 
told, there is this great tool out there, have a look at it, and you could just type 
in www.helpdiabetes, whatever. 
(GP Partner) 
 
There were other places that staff suggested that HeLP-Diabetes should be introduced to 
patients including at group based structured education, at pharmacies, in centres for older 
people, in supermarkets and local libraries.  
 
Identifying a champion at each practice was advocated by some staff who thought this would be 
the only way of pushing HeLP-Diabetes through in each practice. 
ST1: HeLP-Diabetes is part now of the nursing dialogue. It’s what we want to 
try and do, but again, as I said, there’s so many other initiatives going on it gets 
a bit lost. But I think the key is having the champions in the practice, and just, 
sort of getting the word out there. 
(GP Partner) 
 
Some staff talked about the need for HeLP-Diabetes to be incentivised by becoming part of the 
QOF. Some staff suggested that this would make it much more of a priority for staff.  
ST6: You need to be part of … the QOF. It needs to be part of that. If it’s part of 
that, it will be done. 
(GP Partner) 
 
Similarly, staff suggested that if practices received money for referring patients to HeLP-
Diabetes then this would boost the rates of patient signups. 
ST8: a cash incentive for signing people up, yes, yes, something like that, I 
mean, it’s a, you know, a bit heartless to say that, but unfortunately, that would 
make the GPs refer people, and it would make the nurses refer people. 
(Receptionist/Admin) 
9.4.9 Applying concepts of Normalization Process Theory to the data 
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Analysing the data thematically provided an overview of staff views on the implementation of 
HeLP-Diabetes. Normalisation Process Theory (NPT) is now used as a lens through which to 
reanalyse the data focusing on the ‘work’ participants report engaging in in relation to the 
implementation and normalisation of HeLP-Diabetes in practice.  
 
As described in detail in Chapter 6, the constructs of NPT that the themes (see Figure 9-1) were 
mapped to were: 
 ‘Coherence’ which refers to the extent to which HeLP-Diabetes makes sense to staff.  
 ‘Cognitive participation’ which concerns the commitment and collective engagement of 
staff towards HeLP-Diabetes.  
 ‘Collective action’ which refers to the relationships and the work required for HeLP-
Diabetes to be taken up in practice and to identify the factors that serve as barriers to 
implementation and embedding. As this was of particular interest the four sub-
constructs of ‘Collective action’ were considered:  
o interactional workability, ways in which HeLP-Diabetes helps or hinders care for 
patients with diabetes.  
o relational integration, confidence in worth and safety of offering HeLP-Diabetes;  
o skills set workability, the allocation of the work and fit with routine;  
o contextual integration, how well HeLP-Diabetes is supported by infrastructure 
and culture in the practices and clinics;  
 ‘Reflexive monitoring’ which holds that successful embedding of HeLP-Diabetes in 
everyday practice relies upon a continuous process of evaluation that can feedback into 
refining the process of implementing HeLP-Diabetes  
The mapping of each theme onto constructs of NPT is presented in Table 9-2 followed by the 
analysis of the data through the lens of NPT.  
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Table 9-2 Mapping on themes onto constructs of NPT 
Theme 
Sub-theme 
NPT construct 
Staff perceptions of HeLP-Diabetes 
 
Fit of intervention with/in current practice Contextual integration 
Interactional workability 
Relative advantage Coherence 
Suitability for target population Cognitive participation 
Interactional workability 
Adoption and implementation of HeLP-Diabetes 
 
Evidence and endorsement  Cognitive participation 
Reflexive monitoring 
Contextual integration 
Trialability and training and support Coherence 
Skill set workability 
Interactional workability 
Responsibility for implementation 
 
Relational integration 
Skill set workability 
Awareness and engagement  
 
Relational integration 
Cognitive participation 
Contextual integration 
Impact on roles and work practices  Interactional workability 
Skill set workability 
Contextual integration 
Cognitive participation  
Availability of resources 
 
Contextual integration 
Cognitive participation 
Suggestions for improving the implementation 
 
Reflexive monitoring 
Contextual integration 
Cognitive participation 
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Coherence (the extent to which HeLP-Diabetes makes sense to staff)  
The way that staff described HeLP-Diabetes demonstrated a strong sense of coherence 
towards the value and benefits that it could offer. It was described as accessible and updatable 
with excellent content.  
 
All staff demonstrated that they understood what HeLP-Diabetes was and could distinguish 
HeLP-Diabetes from their current ways of working; it was commonly discussed in contrast to the 
group based education and to other websites that they currently recommended to patients.  
ST1:  what HeLP-Diabetes does is it gives people that information that they 
can access at any time, because it’s on the computer.  
(GP partner) 
 
The demonstration of HeLP-Diabetes during the practice meetings where it was introduced to 
staff was described as particularly useful to enable the sense making work around the potential 
benefits to take place.  
ST12: you took the time to come in to talk to us about it that you took the time 
to come. And, yes, I think it really promoted it well  
(Practice Nurse) 
 
However, there were some staff who although could see the potential benefit for some patients, 
didn’t think that the patients they encountered would benefit from it. 
ST6: Those with background retinopathy or if they can’t really see or they’ve 
got language issues, can’t read, write, illiterate people, then yes they would 
struggle. 
(GP Partner) 
 
Cognitive participation (the commitment and collective engagement of staff towards HeLP-
Diabetes) 
 
Despite strong coherence towards HeLP-Diabetes, staff in the majority of practices and clinics 
struggled to build and sustain a set of practices around HeLP-Diabetes in order to implement it. 
This was contributed to in part by the view that although HeLP-Diabetes was seen to be of 
potential benefit for some patients, there were many groups for whom staff did not think would 
benefit which impacted on their willingness to invest the required time and effort into 
implementing it.  
ST20: I must admit, I did think it… it did seem to me more, that it was for, it was 
for staff. I know it’s supposed to be for people with diabetes, some of the people 
on my list, I don’t think we… and I’m not being defeatist now, we wouldn’t get 
past the gate.  
(Practice Nurse) 
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Whereas there were other staff, who although recognising that it might not be suitable for 
everyone were determined to make sure everyone had the opportunity to use it.  
ST5 A lot of them are basic, yes. They know they can go to www dot. Some 
of them are not too sure of it, and I say to them, just look, you won't break it. 
Just play with it, you know. Yes, but even the… as I say, even the elderly ones, 
the non-English speaking. 
(Health Care Assistant) 
 
The fact that HeLP-Diabetes was created at a university and promoted by the CCG was 
influential in staff decisions as to whether they wanted to take part in implementing it, providing 
a sense of credibility and reassurance that that HeLP-Diabetes was worthwhile.  
ST3: We wouldn't have taken it on if it wasn't evidence-based. We really 
wouldn't. 
(Commissioning Officer) 
 
Some staff reported undertaking the work of generating their own evidence. They sought out 
evidence of how likely HeLP-Diabetes was to be of benefit to their patients which factored into 
their decision about whether HeLP-Diabetes was something worthwhile to invest in.  
ST20: I did a fantastically huge piece of research… I want to kind of get round 
the mythology, that nobody over 60 uses a computer, 
(Practice Nurse) 
 
The importance of cognitive participation from other members of staff was also discussed. Buy-
in to HeLP-Diabetes from senior staff was viewed as important for nurses and healthcare 
assistants in order to feel that it was a worthwhile task to take part in.  
ST12: And I think perhaps the fact the partners invited you in to come and 
present about HeLP-Diabetes gave great weight to it as a programme, and 
because we obviously respect their judgement and they felt this was a good 
service and something important to promote in the practice 
(Practice Nurse) 
 
Some staff talked about the difficulty in engaging other staff in the work of implementing HeLP-
Diabetes which made it difficult to enact the work of implementing within the practice. 
ST20: I don’t think [Name of GP] took it on board at all, unfortunately. And 
that’s… and I really haven’t myself, I’m ashamed to say 
(Practice Nurse) 
 
The task of registering patients to HeLP-Diabetes was often not perceived to be a suitable use 
of time and resources, and staff questioned why this had to be part of the work of implementing 
HeLP-Diabetes.  
ST15: Or for patients to do it themselves with the leaflet; that would be perhaps 
the best option.  
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(Practice Nurse) 
 
However, other staff could see the value in registering patients and allocated resources to 
carrying out the registrations.  
ST13: Well, I think it’s really important to actually put it on screen in front of 
everyone, and click through it and just show how easy it is to use.  
(Practice Nurse) 
 
Suggestions by staff to improve the implementation of HeLP-Diabetes often centred on 
strategies to increase cognitive participation. The incentivisation of the work and the 
identification of a champion were described as having the potential to increase the prioritisation 
that was attributed to HeLP-Diabetes and to increase buy-in. 
ST1: …priorities get lost, and so to successfully implement, be it HeLP-
Diabetes, be it Year of Care, you need a champion at each step of the way.  
(GP partner) 
 
Collective action (the relationships and the work required for HeLP-Diabetes to be taken up in 
practice and to identify the factors that serve as barriers to implementation and embedding) 
 
Interactional workability  
HeLP-Diabetes was perceived by staff in practices where it was being implemented as having a 
positive impact on consultations with patients. 
 
There was the perception by some that offering HeLP-Diabetes was beneficial to consultations 
as it provided additional information to patients that staff might otherwise struggle to deliver due 
to time constraints in consultations.  
ST13: it’s a brilliant website that patients can access really good quality 
information at home, and take their time over it. Because when they come in to 
the doctors, sometimes we give information really rapidly and we’re always 
under time pressure. So, they can actually take their time. They can look things 
up. They can advance their knowledge about their condition, which a lot of 
patients would be very interested in, because it is their condition. 
(Practice Nurse) 
 
One GP reported that his use of HeLP-Diabetes had changed the way in which he explained 
certain diabetes related concepts to patients in consultations.  
ST1: In fact, I’ve found I’ve got a whole different language of explaining what 
diabetes is to patients, having seen the video that’s on there, explaining what is 
diabetes. I think the whole thing of the keys is really good, and that sort of 
visual…  
(GP partner) 
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The use of HeLP-Diabetes also helped some staff to answer question that they might not 
otherwise have been able to. For example, the information provided on HeLP-Diabetes allowed 
healthcare assistants to feel confident in providing clinical advise to patients.  
ST5: I'll say to them, well, look, if I don't know the answer, we'll ask the doctor, 
or let's have a look and we'll see if the answers are on the site, you know.  
(Health Care Assistant) 
 
Some staff reported that because their patients had been using HeLP-Diabetes, this had 
changed the patients’ understanding of their condition and this had changed the nature of 
subsequent consultations as patients were now more informed. 
ST5: It just gives them a little bit more, sort of, insight into what their illness is 
because it also explains if it’s within the normal range. They then have a 
subsequent appointment with the doctor, which then, it means if any questions 
come out of that, you know, transpose specifically, they’ll have had time to 
consider them as well.  
(Health Care Assistant) 
 
Some staff perceived that referring patients to HeLP-Diabetes through the patient registration 
method was very much in line with current work practices 
ST7: Yes. No, I think... for me and (HCA’S name) it is more of a routine 
because it’s sort of... because (HCA’S name) does it every day and I’ve sort of 
like... if I ain’t sending letters, I’ve got people phoning up to change 
appointments and whatever. I think it’s just something else that we do on a daily 
basis.  
(Receptionist/Admin) 
 
It was not perceived to impact on consultations negatively as it could be incorporated easily into 
the parts of the consultations that were already dedicated to providing patients with diabetes 
resources.  
ST6: If I’m going to talk to them about Desmond, it doesn’t really take much 
more to talk to them about HeLP. 
(GP Partner) 
 
Similarly staff reported already being used to the work of recommending internet resources to 
patients during consultations and had now replaced the recommendations that they had 
previously made with recommendations of HeLP-Diabetes because of the perceived additional 
benefits that HeLP-Diabetes could offer to patients.  
ST7: If they mention Diabetes UK we say to them, no, you should look at this. 
I’ll give you the leaflet for the Help Diabetes. There is a lot more information on 
there. 
(Receptionist/Admin) 
 
215 
 
Some staff reported having changed the way they offered HeLP-Diabetes to patients in order to 
make it operationalise better in practice. There were examples of staff who offered HeLP-
Diabetes to a patient’s relative because the patient didn’t speak good English. Several staff also 
recommended that patients should use HeLP-Diabetes with family members if they didn’t have 
good computer skills or had trouble understanding English.  
ST5: Well, I've had one woman who didn't speak a word of English. Her 
granddaughter came with her. And as I was doing it… it took a long time 
because as I'm showing, the granddaughter's then explaining it to the Nan. But 
we got there and she seemed quite enthusiastic. And the young girl said, my 
Nan hasn't got an email, but we'll use mine.  
(Health Care Assistant) 
 
However, there were a few cases where HeLP-Diabetes was perceived to have negatively 
impacted on consultations and current practice. This largely centred on time, with the referral to 
HeLP-Diabetes perceived as taking away from valuable time within consultations.  
 
There were several staff who reported wanting to be able to make HeLP-Diabetes easier to 
offer to patients. 
ST9: the most difficult thing when we were trying to incorporate it… was really 
the time factor of registering the patients on it, that process, selling it and then 
registering it. And I... so that didn’t really work particularly well for us. 
(Advanced Nurse Practitioner) 
 
Relational integration  
HeLP-Diabetes was introduced to practices and clinics during clinical meetings, and following 
these meetings the decision whether to adopt it was made. In some cases all staff within a 
practice or clinic were in attendance, however, most often these meetings were held only with 
GPs. This resulted in the decision to adopt HeLP-Diabetes being made by those who then did 
not take responsibility for implementing it, as the work of implementing was passed on to either 
nurses, healthcare assistants or receptionists. 
 
In some practices it was reported that there had been minimal, if any, communication around 
HeLP-Diabetes before these staff were expected to take up the role. 
ST5: I was just called in to the meeting, and I didn't know nothing about it. And I 
just got told this is what we're going to do and we thought you'd be good. Okay, 
fine. Because I suppose I do both things. I have the contact with the people on 
the desk, but I also have a clinic as well 
(Health Care Assistant) 
 
 
The work of engaging of staff to undertake the work of implementing HeLP-Diabetes was in 
some cases very opportunistic. One GP had tried to delegate the work to the nurses within the 
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practice who were proving resistant to taking on this responsibility, and so instead the GP 
approached the receptionist who was put on the spot to take on the responsibly.  
ST1: we sat them [practice nurses] down, and we said, look, this is it, and they 
said, oh, yes, that would be a good idea but she didn’t have time to do it. At 
which point I ran out and got hold of [NAME OF RECEPTIONIST] 
(GP partner) 
 
Once the task of enacting the work of implementing HeLP-Diabetes had been delegated, there 
was little evidence of GPs checking on how the staff charged with this responsibility were 
getting on with delivering it to patients. 
ST19: I don't know what quantities there are. I'm not sure the last time she 
[receptionist] registered anybody. You might want to have a quick word with her 
on the way out.  
(Salaried GP) 
 
However, there were other practices where staff reported that there was good communication 
and commitment from the whole team around implementing HeLP-Diabetes. Healthcare 
assistants in one practice described how they would work collaboratively towards ensuring that 
all patients were offered the chance to use HeLP-Diabetes.  
ST17: Most of the doctors are aware of it. So if they feel that they [patients] 
need sort of help with the website, they'll email myself or [Name of receptionist], 
and then we'll go through it with them. 
(Health Care Assistant) 
 
And nurses in another practice discussed how the decision to adopt had been made 
collaboratively.  
ST4: I think [Name of nurse] and I were keen for it, keen to use it and because 
we see all the diabetic patients and the doctors were quite happy and they liked 
the sound of it as well, so it was, sort of, a... we all agreed 
(Practice Nurse) 
 
The relational work between senior staff and health care assistants helped to provide 
legitimation to health care assistants that this work was worthwhile to be undertaken.  
ST5: Yes. I think it has to come from practice managers, partners, and then 
down. And are they willing to, you know, allocate a person or two people to do 
this, you know, whether it's just to register, like me, or whether it's the nurses 
or… yes, I just think it needs… I couldn't take it upon myself to say do this, do 
that. It has to come from [GPs]… 
(Health Care Assistant) 
Skill Set Workability 
Although nurses were originally assumed (see implementation plan in chapter 5) to be the most 
appropriate group of staff to deliver HeLP-Diabetes as they do the majority of self-management 
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work with patients, it was often health care assistants and receptionists who undertook the work 
within practices. As the facilitation of patient use of HeLP-Diabetes became optional (see 
chapter 7), the work of implementing HeLP-Diabetes changed in nature and became much 
more of a clerical task rather than a clinical one and thus was not perceived as suitable for 
nurses who were perceived as over qualified for the role.  
 
There was the perception that the work of registering patients to HeLP-Diabetes and (optionally) 
demonstrating some content was particularly suited to healthcare assistants. 
ST2: Practice nurses might be a lot more interested in it. The HCAs were. 
R: Yes, why do you think that is? 
ST2 Because, do you know… Jamie, they’re more keen. They’re more sort 
of… they’re more impressionable, if you like, and they want to extend their 
roles, a lot of them. They’re not stuck in their ways and, to them, it’s all new and 
exciting, you see. 
(Diabetes Specialist Nurse) 
 
Receptionists were another group of staff who were identified as being able to deliver HeLP-
Diabetes due to their computer skills.  
 
In practices, the role of implementing HeLP-Diabetes was reported to add to healthcare 
assistants and receptionists’ job satisfaction. One receptionist reported feeling honoured to 
have been given the responsibility of offering HeLP-diabetes to patients.  
ST18: It felt nice that the doctors thought they could trust me with that 
responsibility so that was quite nice. 
(Receptionist/Admin) 
 
As described earlier, the work of implementing HeLP-Diabetes was reported as work that was 
developing the skills and knowledge of health care assistants. Using HeLP-Diabetes with 
patients allowed some staff to transcend their traditional roles and provide more clinical advice 
to patients. 
 
Training on using HeLP-Diabetes was viewed as very important in increasing the confidence of 
those doing the work of implementing HeLP-Diabetes in their ability to deliver it correctly.  
ST13: You did a little bit on motivational training when you came. It was quite 
helpful because that was fairly new to all of us at that time. So, I think that kind 
of value added…it seemed doable. 
 (Practice Nurse) 
 
Contextual integration 
HeLP-Diabetes was supported by the CCG through endorsement, promotion and 
encouragement of staff within practices and clinics to offer it. However, there was no resources 
made available by the CCG to help integrate HeLP-Diabetes within practices and clinics. 
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It became evident during the implementation that it was crucial to have a dedicated person to 
support the implementation. When I undertook this work at two practices it was perceived to be 
extremely valuable, and it is likely that this initial support was one of the key reasons that these 
two practices went on to be the ones to register the most patients to HeLP-Diabetes.  
ST4 I would say it was really nice having you here... we were quite slow, 
you know, just getting used to it. So I think having you here... I think it would be 
really helpful to have you there for a few sessions and one beforehand to go 
through it like you did with us, to show us to show us how to login and 
everything.  
(Practice Nurse) 
 
ST16: I think it would be helpful even if somebody could just come occasionally 
(Diabetes Specialist Nurse) 
 
The lack of cognitive participation by some practices and clinics with the intervention was likely 
due to a lack of available resources in terms of time but also in terms of physical space and 
adequate computers which made it difficult for practices to implement HeLP-Diabetes.  
ST6: Well, for us, it was great but it was going to be really difficult to implement 
in our surgery because of staffing - no space for receptionists to go off and talk 
to the patients and log them in and stuff. 
(GP Partner) 
 
With such limited time within consultations and a large number of competing priorities staff had 
to decide upon the priority of delivering HeLP-Diabetes.  
 
Reflexive monitoring (process of evaluation that can feedback into refining the process of 
implementing HeLP-Diabetes)  
In order to be able to appraise whether HeLP-Diabetes was worth the effort and was bringing 
about the perceived value, staff talked about engaging in work to try and gain feedback from the 
patients that they had offered HeLP-Diabetes to.  
ST5: I have asked some of them to get back in touch and let me know how they 
find it…because it would be interesting to know, and then I could say to other 
patients, well, actually patients have found this really helpful, you know. 
(Health Care Assistant) 
 
Assessing whether HeLP-Diabetes was benefiting patients was the main source of feedback 
that staff reported seeking in order to make decisions as to whether the investments they had 
made in implementing HeLP-Diabetes were worth it.  
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ST10: there’s two decision you need to make… no, two factors if you like that 
will lead to a decision and one is that, is it worth it financially? Right. And then 
the second thing, really more important, is it worth it for the patients?  
(Practice Manager) 
 
9.4.9.1 Degree of normalization 
The degree to which HeLP-Diabetes had become integrated within practices varied greatly. 
There were practices who had integrated it, using the staff registration method where it had 
become part of routine practice. 
ST7: The thing is it’s so... because it’s not hard work, it just slots in. It’s easy to 
sign someone up, it’s not... it doesn’t drag it out, it’s not a lot of rigmarole in 
answering this question and that question. It’s simple, it’s sort of idiot proof 
really. And then even working your way round the website, it’s... I think it’s easy. 
(Receptionist/Admin) 
 
There were practices that having failed to integrate the staff registration method had begun, 
more successfully, to integrate HeLP-Diabetes using the patient registration method.  
ST12:…now we have new leaflets…that’s really taken out the middleman and 
forms getting lost, and things not… access not working and that. So, I think 
that’s really been a big step forward. 
(Practice Nurse) 
 
And there were practices where HeLP-Diabetes had failed to become part of practice and 
provided a good example of the difference between adoption and normalization.  
R: So in terms of how it’s worked in this practice?  
ST18: It hasn’t if I’m being honest. 
(Receptionist/Admin) 
 
9.5 Discussion 
 
Interviews with staff suggest that the high rate of adoption of HeLP-Diabetes from services 
within the CCG was driven by a strong sense of the value and benefit that it could bring. Staff 
perceived HeLP-Diabetes as being able to plug gaps in the provision of information due to time 
constraints within appointments. HeLP-Diabetes was also perceived to be able to address 
barriers to the use of group based education including it not being suitable for people who work 
and people who might dislike being in groups. The findings from the systematic review (Chapter 
3) also suggest that staff being able to see the relative advantage of a new innovation over 
current ways of working is important for the decision to adopt and implement new technologies.  
 
The endorsement of HeLP-Diabetes by the CCG and buy in to HeLP-Diabetes by senior staff 
within practices was important for adoption and the work of implementing HeLP-Diabetes. Staff 
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described the importance of feeling supported to undertake the work and the importance of a 
collaborative team approach to implementing HeLP-Diabetes. The endorsement from the CCG 
and engagement of the whole team increased the sense that HeLP-Diabetes was important and 
legitimate to engage with. Previous studies of the implementation of e-health have also reported 
that in order for e-health implementations to be successful there must be participation and 
collaboration amongst all staff within an organisation (135, 150, 163) as collaboration may help 
to: combat health care professionals’ resistance to the implementation of e-health systems 
caused by the perception that the new technologies will disrupt delivery of care (162); create a 
more positive image of e-health as an integral component of routine health care; and bring 
together the latest IT expertise and practical clinical expertise in the organisation (146). A lack of 
collaboration around the use of HeLP-Diabetes within practices resulted in some staff feeling 
overwhelmed by the responsibility to implement HeLP-Diabetes. Often the role of offering HeLP-
Diabetes was delegated to members of staff by GPs without discussions or prior agreement. 
Ongoing encouragement and support for this role by GPs following the delegation of the task 
was rarely reported, which contributed to staff feeling that this may not be a task worth 
prioritising over others.  
 
When HeLP-Diabetes was implemented and used within services it was reported to have 
beneficial effects on consultations with patients. Staff perceived it as a useful resource to offer 
to patients which could supplement the information they were able to provide within 
consultations. Two health care assistants reported that being able to use HeLP-Diabetes as an 
information resource had allowed them to help patients through the provision of information that 
they otherwise would not have had access to. Other staff reported that HeLP-Diabetes had 
provided them with a simpler way of explaining some of the complex diabetes information to 
patients in consultations. As such HeLP-Diabetes was generally perceived to fit well with the 
current work of the health professionals using it. A systematic review of the implementation of 
innovations into primary care stresses the importance of the fit between interventions and 
different levels of context in order for them to become successfully implemented. How well 
interventions fit with existing work practices, daily work as well as professional beliefs and 
attitudes has an impact on the degree of implementation (250).  
 
The role of implementing HeLP-Diabetes and registering patients fitted particularly well with the 
skills of health care assistants and receptionists. HeLP-Diabetes allowed them to support 
patients with self-management, provide clinical advice which increased the remit of their usual 
roles and the use of technology to do this was seen as beneficial rather than undermining. 
Several staff reported feeling that the role was not suitable for GPs or nurses. A possible 
explanation for this may be that for more highly skilled staff the use of HeLP-Diabetes to support 
self-management and address patients’ questions within consultations could be perceived as 
undermining knowledge and skills. Technology use in routine care has been suggested to have 
the potential to hamper individuals’ creativity and undermine their pride in their knowledge and 
skills and ability to solve problems creatively, removing their freedom to act in ways they 
consider most appropriate. This, in turn, diminishes individuals’ sense of control over their work 
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(271). For staff such as GPs and nurses who are used to drawing on their own knowledge to 
address patient problems, the use of HeLP-Diabetes as a tool to do this may not have been 
perceived as necessary or desirable. However, for less knowledgeable staff, HeLP-Diabetes 
provided them with the opportunity to help patients in a way they previously couldn’t. This has 
important implications for who might best be targeted to deliver future internet interventions to 
patients in practice.  
 
HeLP-Diabetes was not however, implemented successfully in the majority of services that 
adopted it. Difficulties arose with staff mobilising time and effort to do the work required to make 
HeLP-Diabetes integrated into practice. Some staff reported feeling that HeLP-Diabetes 
wouldn’t be suitable for many of their patients including non-English speaking and older patients 
which impacted on their willingness to invest resources to implement it. This was not however 
supported by the quantitative data (reported in Chapter 8) as no differences were observed in 
use of HeLP-Diabetes by patients’ ethnicity or age. Being able to feed these results back to staff 
could have been a useful strategy in promoting their views of the suitability of HeLP-Diabetes; 
however, the timing of the data analysis did not permit this.  
 
The registration process was one of the most widely reported barriers to more widespread use 
of HeLP-Diabetes. There was a lack of agreement by staff as to whether this was a legitimate 
part of their role with some reporting that it wasn’t a suitable use of time or resources. Some 
staff described a negative impact of registering patients to use HeLP-Diabetes as taking time 
away from other important tasks to be achieved within consultations. In such a resource tight 
context, staff were reluctant to take on any more work on top of all the other incentivised tasks 
they had to perform. Other studies have reported that time and resource limitations impact upon 
health care professionals’ ability to provide diabetes care (246), and the need to perform 
incentivised tasks as part of the QOF has been reported to impact on the willingness of staff to 
take on any additional diabetes self-management support work (187). This raises important 
considerations for the future of non-incentivised interventions within routine practice with regard 
to the prioritisation that they are given by health professionals. Some staff suggested that if 
HeLP-Diabetes could become part of the QOF then the registration of patients would get done. 
Although there was support from the CCG through promotion and endorsement work, there 
were no resources in terms of finance or extra personnel provided to services to implement 
HeLP-Diabetes.  
 
The implications that these findings have for practice, policy and research are discussed in the 
overall discussion chapter (Chapter 11), as are the methodological strengths and weaknesses 
of the studies in this thesis.  
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10 CHAPTER 10: RESULTS 3: PATIENT PERCEPTIONS OF THE IMPLEMENTATION OF 
AN INTERNET INTERVENTION TO SUPPORT SELF-MANAGEMENT OF TYPE 2 
DIABETES 
 
10.1 Chapter summary 
 
This chapter presents the findings from the analysis of semi-structured interviews conducted 
with patients which explored the uptake and use of HeLP-Diabetes in order to address the 
following research question: 
 
 What barriers and facilitators did patients identify to the uptake and use of HeLP-
Diabetes? 
10.2 Introduction 
As described in detail in Chapter 1, effective self-management of type 2 diabetes by patients 
can improve glycaemic control and reduce diabetes related complications (30); but optimal self-
management is often difficult to achieve. Diabetes self-management education (DSME) has 
emerged as a resource to assist individuals to actively participate in their diabetes care, 
however, data from the UK National Diabetes Audit suggests attendance rates at DSME are low 
only 5.3% of patients attending (35). Non-uptake of DSME by patients is associated with poorer 
health outcomes (36) and as these programmes are of considerable cost to the NHS (37), non-
uptake by patients reduces the cost-effectiveness for health services.  
 
As argued in Chapter 1, delivering DSME over the internet may also reach a broader population 
and prove to be cost-effective (55). Recent evidence demonstrates that internet based DSME 
interventions have the potential to improve clinical, behavioural, psychological, emotional, and 
psychosocial outcomes in patients with type 2 diabetes. However, what is lacking from the 
literature is an insight into patients’ experiences of using internet interventions that gauges 
whether these interventions meet user needs. Patient perceptions of internet interventions have 
been found to influence use (272), and intervention use is crucial for actualising potential 
benefits. Although the relationship between level of engagement and outcomes of internet 
programs is unclear, a threshold level of involvement is necessary to obtain benefit (38). It is 
therefore important to understand how patients with type 2 diabetes perceive, make use of and 
evaluate internet DSME interventions when they are made available in routine practice and to 
understand factors that may influence engagement.  
 
10.3 Study aim 
This study explored patients’ experiences and perceptions of an internet based DSME 
programme for type 2 diabetes (HeLP-Diabetes) which was made available to an unselected 
patient population as part of routine NHS care. The aim is to understand the role of internet-
based interventions such as HeLP-Diabetes in helping people self-manage and to determine 
the specific barriers and facilitators of use and continued engagement with HeLP-Diabetes.  
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Specific objectives were to:  
 Explore how HeLP-Diabetes is perceived by patient users 
 Explore how HeLP-Diabetes is used by patients 
 Identify barriers and facilitators to use 
 
10.4 Results 
 
10.4.1 Interview subsample 
As described in chapter 6 (section) sampling for the patient interview was designed to be 
purposive and interviews were conducted with all patients who consented. The participants’ who 
took part in the interviews (n=15) represented a reasonably diverse sample. There were fewer 
female participants (4/15) than male (11/15), however, there was a good range of age (43-76 
years), and ethnicity represented. Sixty percent of participants’ were white British (9/15), but 
Black or Black British- African, Black or Black British- Caribbean and Other (Turkish, Italian and 
mixed) ethnicities were represented. The length of time since participants were diagnosed with 
diabetes ranged from less than a year to between 10 and 20 years. Treatment modalities 
included participants who managed their diabetes through diet only and participants who 
managed through diet and medication. Unfortunately, no participants managing their diabetes 
with insulin or other injectable medication participated. A range of educational attainment was 
represented in the sample including those with no educational qualifications, school leavers, 
degree and post-graduate degree level qualifications. Participants with a range of computer 
skills were sampled with basic (4/15), intermediate (6/15) and advanced (5/15) computer skills 
represented. Home internet access was all but universal, with only one participant reporting 
public internet access as their main way of connecting to the internet. A full description of the 
characteristics of each interview participant is presented in Table 10-1. 
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Table 10-1 Characteristics of patient interview participants 
ID Gender Age Ethnicity Duration of 
diabetes 
Diabetes management 
style 
Computer skills Internet 
access 
Highest educational 
attainment 
PT1 Male 58 White British 5-10 years Lifestyle and tablets Advanced Home A-level or vocational 
equivalent (e.g. NVQ 3) 
PT2 Male 63 White British 10-20 years Lifestyle and tablets Advanced Home Degree or NVQ 4, HND 
or similar 
PT3 Male 59 White-Other (Turkish) 1-5 years Lifestyle and tablets Advanced Home Degree or NVQ 4, HND 
or similar 
PT4 Female 43 Black or Black British- 
African 
1-5 years Lifestyle and tablets Basic Home School leaver (e.g., 
CSE, GCSE, O-Level, 
NVQ1-2) 
PT5 Male 76 White British 1-5 years Lifestyle Intermediate Home Post-graduate degree or 
NVQ 5 
PT6 Male 58 White British 1-5 years Lifestyle and tablets Intermediate Home None 
PT7 Female 68 White British 5-10 years Lifestyle and tablets Intermediate Home School leaver (e.g., 
CSE, GCSE, O-Level, 
NVQ1-2) 
PT8 Male 68 White British 10-20 years Lifestyle and tablets Intermediate Home Post-graduate degree or 
NVQ 5 
PT9 Male 66 White British <1 year Lifestyle Basic Home None 
PT10 Male 67 Mixed-Other 5-10 years Lifestyle and tablets Intermediate Home Degree or NVQ 4, HND 
or similar 
PT11 Male 46 White British 10-20 years Lifestyle and tablets Advanced Home Degree or NVQ 4, HND 
or similar 
225 
 
PT12 Female 52 White British <1 year Lifestyle Basic Public Degree or NVQ 4, HND 
or similar 
PT13 Male 52 White-Other (Italian) <1 year Lifestyle and tablets Intermediate Home A-level or vocational 
equivalent (e.g. NVQ 3) 
PT14 Male 56 Black or Black British- 
Caribbean 
1-5 Years lifestyle Advanced Home A-level or vocational 
equivalent (e.g. NVQ 3) 
PT15 Female 58 Other-(Turkish Cypriot) 1-5 years lifestyle Basic Home None 
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10.4.2 Findings from the thematic analysis  
 
Presented below are the findings from the thematic analysis of the interviews with patient users 
of HeLP-Diabetes. The main themes that emerged from the data related to: 
 The experience of diabetes 
 Perceptions of diabetes 
 Self-management 
 Self-management education and support 
 Diabetes information  
 Perceptions of HeLP-Diabetes 
 Use of HeLP-Diabetes 
To help interpretation, the connections between these themes which will be discussed next 
have been presented graphically in Figure 10-1. Also for ease of interpretation, participant ID 
numbers, age, gender and experience with computers is provided after each illustrative quote. 
In instances where questions I have asked are presented I am referred to as R (researcher).  
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Figure 10-1 Themes identified from the analysis and connections between them 
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10.4.2.1 Participants’ experiences and perceptions of diabetes 
 
The experience of having diabetes influenced all the other themes present in the interview data. 
Through influencing perceptions of diabetes and self-management, the experience of having 
diabetes indirectly affected participants’ perceptions and use of HeLP-Diabetes.  
 
Factors in this theme include the duration of time participants’ had had diabetes for, whether 
participants took medications to manage their condition, and the presence or absence of 
symptoms, side effects and diabetes related complications. These factors were presented as 
linked to participants’ perceptions of diabetes in terms of their acceptance of diabetes and the 
extent to which they perceived diabetes to be a serious condition that demanded attention and 
prioritisation which influenced participants’ self-management of diabetes. In turn, perceptions of 
diabetes and self-management factors influenced whether participants viewed HeLP-Diabetes 
(as a tool to support self-management) as valuable, and determined in part, the extent to which 
they engaged with it. In this section the experience of diabetes and the way it influenced 
participants’ perceptions of diabetes and self-management is presented.  
 
Diabetes often does not initially present with symptoms and side effects and several participants 
reported not having experienced any symptoms which heavily influenced the way in which they 
perceived diabetes. An absence of symptoms led to feelings of surprise and shock at being 
diagnosed with diabetes and influenced how well participants had come to terms with having 
diabetes; with some participants with no symptoms reporting being unable to accept the fact 
that they have diabetes. 
PT13: Well, at the beginning obviously it was quite difficult to accept it, 
especially because I had no symptoms 
(52 year old male, intermediate computer skills) 
 
At diagnosis, it is usual for healthcare professionals to recommend patients try to manage 
diabetes through lifestyle changes first before the introduction of medications. For some 
participants, the fact that they had been advised to control their diabetes through dietary and 
lifestyle changes alone; without prescribed medications, made it difficult to accept that they had 
diabetes. This highlighted an association that was held by several participants between being 
unwell with the taking of medications, or being well and the absence of medications. 
PT9: I do not feel that I’ve got diabetes. I don’t feel, you know… I mean, I don’t 
take no medication. I don’t take nothing at all. I don’t test myself, because I’m 
not on medication. 
(66 year old male, basic computer skills) 
 
As well as influencing acceptance of diabetes, the presence and absence of symptoms and 
medication influenced perceptions of seriousness. Participants made judgments about the 
seriousness of diabetes by forming comparisons with other conditions and treatment methods.  
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PT7: I went in to see my doctor…and she said by the way, you’ve got diabetes, 
and I just went, oh, right. Okay, whatever. And in a way I didn’t, I mean she said 
type two, so not having to take insulin or anything 
(68 year old female, intermediate computer skills) 
 
In this quote, the participant presents the moment she was given the diagnosis by her 
healthcare professional as something that occurred almost flippantly ‘by the way, you’ve got 
diabetes’ which she constructs as influencing how seriously she perceived the diagnosis to be 
‘Okay, whatever’. Also she describes the fact that she did not have to use injectable 
medications like insulin to manage her condition as a factor in her judgement that her condition 
is less serious than type 1 diabetes. 
 
Other participants reported having experienced a range of symptoms and complications 
associated with diabetes including tiredness, erectile dysfunction, wounds not healing and 
frequent urination. These participants were more likely to perceive diabetes as a serious 
condition because of their experiences with the complications. One participant who had 
experienced several complications of diabetes wanted to urge others to take it more seriously 
from the beginning because of the potential for future complications, highlighting the 
progressive nature of diabetes.  
PT2: they don't realise until something like osteomyelitis or heart failure or 
retinopathy or whatever else comes along that it's not a joking matter. It's an all 
over shroud of illness that you live under 
(63 year old male, advanced computer skills) 
 
Acceptance of diabetes and perceptions of its seriousness influenced the way that participants 
reported engaging with self-management activities. A fear of disease progression and a desire 
to prevent future complications and worsening of health was a main priority for participants 
engaging with self-management. Participants who had witnessed the seriousness of the 
disease or who were concerned about it were more likely to see the value in self-management. 
This participant who was motivated to make lifestyle changes in order to manage his condition 
reported being motivated by having witnessed the serious complications that can arise if self-
management isn’t taken seriously.  
PT14: I think my biggest motivation is that my dad and all of his brothers bar 
one have all died from diabetic related diseases, like strokes, stuff like that, and 
they talk the talk, but they never did any exercise, and they were still drinking 
their rum like every two or three days 
(56 year old male, advanced computer skills) 
 
Medication was viewed by many participants as a marker for seriousness. As the progressive 
nature of diabetes means the taking of medications is inevitable for most people, having to take 
medication symbolised a worsening of diabetes for some participants.  
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PT5: Well, I really don't want to be a diabetic and I certainly don't want to reach 
a level where I... where I have to take medication. 
(76 year old male, intermediate computer skills) 
 
Some participants reported that being able to avoid or delay the taking of medication was a 
reason that motivated them to engage in self-management of their diabetes.  
R: You don’t take any tablets at the moment?  
PT9: Not at the moment. If I’ve got to I will take them, right? But I think, at the 
moment…if I can lose a lot a lot of weight it might stop me going on tablets. 
(66 year old male, basic computer skills) 
 
A few participants were motivated to engage with having diabetes because they felt as though 
doing so enabled them to have a sense of control over their condition and the disease 
trajectory. 
PT10: …I think the thing about self-management, it also implies being 
proactive, it means not sitting there and waiting for something to happen, but 
being preventative about it, so that’s, that to me, is the key bit.  
(67 year old male, intermediate computer skills) 
 
10.4.2.2 Self-management  
 
Participants’ perceptions and experience of self-management were important in their 
engagement with HeLP-Diabetes. This relationship was complex and multifaceted. In general 
participants who reported engaging with self-management of their diabetes were more likely to 
see benefit and value in HeLP-Diabetes than those participants who were not. There was much 
variation reported by participants with regard to how well they perceived themselves to be 
managing their diabetes. For some, self-management activities to control diabetes were 
perceived to be easy to undertake and therefore interventions such as HeLP-Diabetes to 
support self-management were not perceived necessary. For others who perceived themselves 
to be managing their diabetes well, HeLP-Diabetes was perceived positively as an additional 
and useful resource to support this. Similarly, these differences in the perceptions of the value 
of HeLP-Diabetes were present among those participants who reported not self-managing well. 
For some, it was perceived to be useful in providing support and information that they had not 
gained elsewhere; however, others craved a type of support that they did not feel they could 
gain from HeLP-Diabetes, being an online intervention. Factors related to participants’ self-
management are described here.  
 
As described in depth in Chapter 1 self-management tasks for people with diabetes may involve 
taking medications, attending appointments, modifying behaviours such as eating and physical 
activity, managing the impact of diabetes on relationships with others and learning to manage 
the emotions associated with having a long term condition. In order to undertake the self-care 
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tasks required of managing diabetes, a level of engagement with the idea of self-management 
and the activities required of it must be present.  
 
Engagement with self-management of diabetes by participants varied greatly in terms of 
whether or not they had initiated self-management activities and if so, the extent to which they 
had made lifestyle modifications. Factors that influenced participants’ engagement with self-
management were related to four main factors; self-efficacy, readiness, the relative prioritisation 
of self-management vis-à-vis the rest of their lives, and perceived responsibility for self-
management. 
 
As described in the literature, people with diabetes often find it difficult to achieve the lifestyle 
modifications required to self-manage diabetes. Participants in this study varied markedly in 
terms of how well they perceived they were engaging with these self-management activities. 
Engagement with making lifestyle modifications was often related to the participants’ self-
efficacy in their ability to perform the tasks. Some participants who reported having not engaged 
with self-management activities described feeling overwhelmed by the tasks required of them 
and expressed a lack of confidence in their ability to achieve the changes necessary to manage 
their diabetes.  
PT15: I know, like, when you say, like, lifestyle changes, I know, like, diet, 
exercise. I mean, I know it all but it is can I really do it all? That is the hard thing 
for me. 
(58 year old female, basic computer skills) 
 
Conversely, there were participants who had engaged with self-management activities who 
reported feeling confident in their ability to undertake these tasks.  
PT10: …swimming, and walking…I just sort of embraced that. So, I was very, 
completely religious about the medication, of course I took it, and… I sort of 
also took seriously, the diet issue, and the exercise, so yes, I didn’t have any 
difficulty with that, at all 
(67 year old male, intermediate computer skills) 
 
Although the majority of participants reported that they had embarked on some self-
management activities, there were participants who reported having not started to address their 
diabetes and self-managing their condition due to not yet being ready to do so.  
PT12: It’s basically something that I have to address, that’s on my mind a lot, 
but I’m finding excuses not to deal with it 
 
(52 year old female, basic computer skills) 
 
For some, engaging in self-management activities would make diabetes, and moreover the 
possible future complications of diabetes, feel real. Some participants reported that they were 
not yet ready to engage with the fact that they had diabetes as this would place a burden on 
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them in terms of the work that they would feel obliged to undertake in order to control their 
condition, which they were not ready to undertake yet.  
PT11: …I don’t deal with that sort of thing otherwise I’ll be… I mean, I’m a 
worrier anyway and that would just be another thing just to… I’ve, kind of, put 
my head in the sand about the long term. 
(46 year old male, advanced computer skills) 
 
In some cases, not being ready to engage in self-management was related to not being ready to 
make lifestyle changes that may disrupt the participants’ sense of leading a normal life. 
Although, the medical literature suggests that undertaking tasks to achieve optimal self-
management of diabetes is of upmost importance for diabetes outcomes, in many cases 
participants described the strain that undertaking these self-management activities placed on 
them. Undertaking these activities, which are intended to improve diabetes outcomes, actually 
disrupted participants’ everyday lives and placed great burden on them. 
PT4: Tired. I get so tired very easily… as I say, I have to watch all of the time, 
you know, what I eat, for example, I have to watch what I eat and I have to 
watch my toes, my feet, I have to look after them. Whereas before I never did 
that, I just got on with everything, I think, but now, you know, especially you 
have to know about your sugar levels, if they’re up, if it’s down, so all that, it 
affected me, naturally.  
(43 year old female, basic computer skills) 
 
PT2: …it's a pain having to go to all these appointments and clinics and such 
like 
(63 year old male, advanced computer skills) 
 
A dissonance between the goals of self-management for the medical profession and the goals 
of self-management for patients was apparent. Whereas, adherence to medication, attending 
appointments, achieving glucose control are reported in the literature as clinical goals of self-
management; participants’ described their priorities as being able to lead a normal life and to 
not feel as if they are unwell. People reported feeling a tension between making changes in 
order to self-manage and being able to maintain a normal life, with decisions about which of 
these had priority being regularly weighed up. One participant reported that taking her 
medications as prescribed in order to control her diabetes was having a detrimental effect on 
her daily life as she was experiencing awful side-effects from the drugs. In this instance she had 
tried to solve this dissonance by taking the prescribed amount of medication at different times 
than were recommended. 
PT7: I’m on Metformin now, medication and I hate it. I’m supposed to take four 
pills a day and I can’t do that unless I’m near a toilet….I just get complete 
diarrhoea…I find that a bit disturbing, to be honest with you. 
(68 year old female, intermediate computer skills) 
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Social situations seemed to be a particular trigger for this tension between adhering to self-
management activities and maintaining a normal life, particularly in relation to dietary changes. 
For some, the tasks of self-managing were put on hold when they had the potential to impact on 
others. Maintaining the appearance of being ‘normal’ was also important to participants in social 
situations and therefore tasks involved in managing diabetes such as dietary changes were 
sometimes placed on hold in the presence of others in order to maintain a sense of being like 
everybody else.  
PT6: if I was at somebody’s and they put old potatoes on I wouldn’t make a 
comment about it, I would just get on and eat it…I mean, I make the changes in 
as much as I can in my own life, but that doesn’t affect people.  
(58 year old male, intermediate computer skills) 
 
PT12: …I went for a long walk with a friend …she said will you share a cake 
with me, and I thought, well, I really shouldn’t do this… well, I said yes to it … 
basically it’s down to me again, it’s not her fault. If I don’t talk about it and make 
an issue of it and, you know, make it part of our relationship, you know, to 
discuss it then, you know, these things happen. 
(52 year old female, basic computer skills) 
 
Despite the burden that undertaking self-management activities often placed on participants, in 
general, there was a sense among respondents that self-management was the best way for 
their diabetes to be managed. The majority of participants shared the view that caring for their 
diabetes was largely their responsibility. There was a sense of guilt expressed by some about 
having diabetes; which led to them feeling that they were to blame for having it and therefore 
responsible for managing it.  
R: whose responsibility do you think it [managing diabetes] is? 
PT11: Oh, it’s absolutely 100% mine. If my… it’s my fault I got into it, it’s 
nobody else’s because I wasn’t born with it….this is purely my fault because I’m 
fat. 
(46 year old male, advanced computer skills) 
 
Others indicated a feeling of responsibility for looking after their diabetes because they felt that 
if they did not look after their diabetes then no one else would do it.  
PT9: … if I didn’t do it, I can assure you nobody else is going to do it, you know. 
(66 year old male, basic computer skills) 
 
Several participants however, reported wanting more involvement from healthcare professionals 
in controlling their condition, suggesting that perhaps they did not agree with the large 
responsibility for their diabetes that the notion of self-management places on them. 
PT15: I think I want a more practical... I wish there was somewhere where I 
could go where I could get help and support 
(58 year old female, basic computer skills) 
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10.4.2.3 Self-management education and support 
Participants’ perceptions of self-management education and support were influenced in part by 
how good they judged their control of their diabetes to be, their perceptions of the responsibility 
for diabetes management and the extent to which they had unmet needs with regard to 
information provision and support. Participants’ perception of the education and support that 
was currently on offer was important in their perceptions and use of HeLP-Diabetes. Those who 
believed they were receiving adequate education and support from elsewhere had less of a 
need for an additional source of education and support than those who felt they hadn’t received 
the amount or the type of education and support they needed. For some the internet offered a 
different format of education and support which was better suited to their needs and wants than 
more traditional formats such as group based education. Factors related to participants’ 
perceptions of the support and education they receive for their diabetes are described here. 
For most participants, the main source of healthcare professional input for their diabetes came 
through primary care services, specifically appointments with GPs and nurses in their GP 
surgeries. The GP practice also provided access to hospital services for specific diabetes 
related tests and checks, appointments with dieticians and group based DMSE. There were 
strong opposing feelings about the care and support participants were getting from their GP 
surgeries for their diabetes. Some reported feeling very satisfied, whereas others thought that 
their care was minimal and that more should be on offer to support their self-management.  
R: How would you describe the care that you receive from the NHS? 
PT6: From my doctor it is absolutely top notch excellent. 
(58 year old male, intermediate computer skills) 
 
 
PT14: I see someone every six months, for the six month blood sugar test, and 
that’s the only time they see me. I think I should go more often. 
(56 year old male, advanced computer skills) 
 
Often these views were influenced by how well participants’ perceived themselves to be self-
managing their diabetes, with those who held more positive appraisals of their own diabetes 
management expressing more satisfaction with the care from the NHS compared to those who 
felt that they were struggling with self-management.  
PT5: …as for the national health, I'm quite impressed, actually…it sort of went 
up a click when I reached my 75th birthday… and I'm chased up fairly regularly, 
and in quite a fierce way, which is very useful. 
(76 year old male, intermediate computer skills) 
 
Specific shortcomings of current care provided by the NHS were reported in relation to time and 
continuity of care. Several participants reported that they felt they did not have enough time with 
healthcare professionals during consultations to cover all the issues that they wanted to 
discuss. And others reported a frustration that it was difficult to see the same healthcare 
professional each time they had an appointment which made it difficult to build relationships. 
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This also increased the burden on participants, as they had to repeat answers to questions with 
each new healthcare professional they encountered.  
PT13: …I had to wait a long time to get an appointment, and then not with the 
doctor I wanted…I should wait months before I get appointment with him 
(52 year old male, intermediate computer skills) 
 
PT2: Well, I carry, because you have to answer from healthcare professionals 
these same questions time after time after time, I carry in my wallet a detailed 
list of all my meds. 
(63 year old male, advanced computer skills) 
 
Participants’ judgments of who should be responsible for the care of their diabetes also 
influenced perceptions of the adequacy of care provided by the NHS. Those participants who 
believed that responsibility for managing diabetes was largely theirs had more positive 
appraisals of the level of care they were receiving than those participants who wanted the 
responsibility to be more shared. 
 
PT12: I think it’s as much as they should be giving really. I mean, I think it 
should be down to me – there’s only so much they can do 
(52 year old female, basic computer skills) 
 
PT1: …there is no social support, is there?...There is no social support. We 
can’t go to an AA meeting for sugar addiction; it doesn’t exist. There’s nothing 
for diabetics 
(58 year old male, advanced computer skills) 
 
There were certain expectations that participants held with regard to the role of their healthcare 
professionals in managing their diabetes. Participants’ perceived a distinction between tasks 
that were the responsibility of healthcare professionals to undertake and tasks that they 
perceived as their responsibility. In general, the role of healthcare professionals in the 
management of diabetes were perceived to be the provision of information, the prescription and 
adjustments of medications, and performing medical tests and checks whereas the participants’ 
roles included being informed, following advice, attending appointments and making changes to 
diet and exercise.  
PT15 Well, the GP, obviously, they, like, do all your bloods and stuff like that 
and then once a year I go around there, they check your feet…the clinical side 
of it, yes, like, obviously the GP but everything else is down to me, you know. I 
try and look after myself the best way I can like knowing what to eat, how to eat, 
when to eat. 
(58 year old female, basic computer skills) 
 
Not all participants reported having been offered access to group based structured diabetes 
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education when they were diagnosed or subsequently. This was particularly true of those 
participants who had been diagnosed with diabetes a long time ago when education may not 
have been available or recommended. Of those offered access, there were several barriers 
reported to attending the groups including the fact that they were held during working hours 
making it difficult for those in paid employment to attend. Others reported feeling that they were 
too busy to attend a course that lasted several hours.  
PT13: I couldn’t attend because I had to go to work at the time there, so I 
couldn’t do it. 
(52 year old male, intermediate computer skills) 
 
PT10: I think things… my life is so busy, I’m not sure I have the time to go and 
have a chat to other people, who’ve got diabetes, do you know what I mean? 
(67 year old male, intermediate computer skills) 
 
For those participants who did attend a group education session, their evaluations of the 
sessions varied greatly. Group based education was particularly suited to participants who 
reported feeling alone with their diabetes as it provided an opportunity for them to connect with 
other people with diabetes and helped to alleviate feelings of isolation. Others found the 
support-group like nature important in encouraging and motivating them in their self-
management efforts. 
PT4: ... first of all, when you go to a meeting you realise you’re not alone. And, 
second of all, you think again that you are the only one who goes through it, but 
when you go there you meet other people, share the experience and you 
realise that other people go through the same thing again and it helps you to 
cope. 
(43 year old female, basic computer skills) 
 
PT1: The class was set up to encourage you… you had to make a sort of 
promise every week that you wouldn’t do anything and you would do a certain 
thing and then come in the next week and see how you’d got on with that, 
which was excellent. 
(58 year old male, advanced computer skills) 
 
However, there were several negative appraisals of the group based education from 
participants. One of the biggest criticisms noted was that the courses hadn’t lived up to 
participants’ expectations which centred on gaining information and gaining motivation to 
manage diabetes. Participants who reported feeling like they had a good level of diabetes 
related knowledge to begin with expressed disappointment that the courses were aimed at a 
more basic level of knowledge, and did not cater for those who might want more complex issues 
addressed.  
PT7: I go to these I sort of know all the stuff that they’re telling me, but at least 
it’s three hours without chocolate. 
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(68 year old female, intermediate computer skills) 
 
A lack of tailored information provision due to the group based nature of the courses was a 
criticism by many who felt their specific issues were not addressed or that they did not have 
time to raise their own concerns. 
PT4: I think because the group, you know, you have limited time and a lot of 
people are there and everybody wants to... they all have to be answered, you 
know, so you don’t get time, as much time as you’d like, to answer everything, 
what you want 
(43 year old female, basic computer skills) 
 
Others felt that despite being provided with the information they needed, the course hadn’t been 
successful in motivating them to act upon it and make changes. 
PT12: …it was mainly about diet, and I felt that I knew most of the stuff. My 
problem is to do with motivation, it’s not that I don’t know 
(52 year old female, basic computer skills) 
 
Other participants’ experienced difficulties with the group based education due to interactions 
with other attendees. In one case a participant reported that the group was disruptive which 
obstructed her learning. Another participant who had hearing difficulties found the group 
interactions challenging to follow.  
PT3: I don’t like the groups things personally. 
PT12: There were problems with that. There were people in the group who 
were basically a bit cynical about the group and they kind of dominated, so it 
was a little bit difficult. 
(52 year old female, basic computer skills) 
 
PT3: The thing for me is I can’t catch the conversation because I have a 
hearing problem. If I don’t see someone else speaking them I am losing it. 
Sometimes the language also affects my understanding of things. 
(59 year old male, advanced computer skills) 
 
10.4.2.4 Diabetes information  
 
Central to whether and for what purposes participants accessed HeLP-Diabetes were 
perceptions of the need for information about diabetes and self-management. Information wants 
and needs were influenced by participants’ appraisal of current sources of information provision 
and diabetes related factors. Perceptions of the value and usefulness of HeLP-Diabetes were 
influenced by whether participants desired information about diabetes, and whether they 
perceived the internet to be an acceptable way of providing this information. 
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As already mentioned, information provision was viewed as a core responsibility of healthcare 
professionals in providing diabetes care to participants. Many participants regarded having 
access to accurate and clear information about diabetes and how to manage it as crucial to 
being able to self-manage effectively, particularly for those participants who were newly 
diagnosed. Participants who were given information that they did not understand reported this 
as a barrier to their being able to control their diabetes.  
PT4: … I think it’s very important for someone with diabetes to look after 
themselves and to take in any... what can I say? To get more, as much 
information as you can from the GP, from the books, anything which can help 
you get the information for the diabetes. 
(43 year old female, basic computer skills) 
 
PT1: …I’m not managing it very well and I just feel that the information we get is 
a bit hit and miss. I hear different things off of different people, supposedly 
diabetic experts. 
(58 year old male, advanced computer skills) 
 
Many participants reported experiencing a lack of consistent and trustworthy information 
provision from their healthcare professionals and the NHS in general. Concerns were expressed 
by participants around being provided with information that was conflicting, did not make sense 
to them, and some even questioned the knowledge of their healthcare professionals. 
PT8: I find that the medical advice sometimes, you know, it changes quite 
drastically sometimes. 
(68 year old male, intermediate computer skills) 
 
PT1: Well, I don’t feel that the GPs and I’m not blaming… my doctor is a very 
good doctor, but he’s just not up on diabetes. … And I just feel that they’re not 
really in touch. 
(58 year old male, advanced computer skills) 
 
Appraisals of current information provision and need for additional information were influenced 
by how long participants had had diabetes for. Information needs changed over time with those 
who were newly diagnosed reporting a greater need for information than those who had had 
diabetes for longer. Length of time with diabetes was linked to feeling more confident in being 
able to deal with diabetes and being able to seek out the relevant information and help if it was 
needed. 
PT13  Well, to be honest, you know, at the beginning you look, look, look, but 
now I don’t look very much. 
(52 year old male, intermediate computer skills) 
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PT10: …I do get enough information. I mean, I’m getting it, I’m getting the 
information. And I know where to go, if I need to, if something happens. And 
nothing has happened yet, touch wood. I know where to go for that. 
(67 year old male, intermediate computer skills) 
 
In addition to length of diabetes, information seeking behaviour seemed to be influenced by how 
well participants had come to terms with their diabetes and their engagement with self-
management. A few participants reported actively avoiding diabetes related information 
because of a fear of confronting the condition. Whereas other participants’ sought out 
information because they associated being well informed with being able to better self-mange 
and prevent the worsening of diabetes.  
R: You say you haven’t really engaged with any information on diabetes 
because of the way you’re feeling about it? 
PT12: …I would say the bottom line is that … there is a kind of fear of 
confronting it which is sort of holding me back a bit. 
(52 year old female, basic computer skills) 
 
PT4: …I used to look on, you know, the exercise, what to eat, how I should take 
care of myself in general, to prevent my diabetes getting worse, yes. 
(43 year old female, basic computer skills) 
 
All participants reported supplementing the information they received from healthcare 
professionals about diabetes and self-management by seeking information on the internet. One 
of the main reasons the internet was chosen by participants over other sources of diabetes 
related information was accessibility. Participants reported being able to access the internet 
whenever they needed and enjoyed being able to take their time over information seeking, 
which was viewed in contrast to information provided by their healthcare professionals which 
was often reported as difficult to access and time limited. 
PT4: …you don’t get time, as much time as you’d like, to answer everything, 
what you want, whereas if you go on a website you can read about it…You can 
get more information and in your own time, you know; there is no rush  
 (43 year old female, basic computer skills) 
 
Despite the acceptability of the internet for diabetes related information and the unanimity 
among participants in accessing information this way, there were several concerns raised by 
participants about using the internet for health information. Most commonly expressed was a 
worry about the reliability and trustworthiness of information on the internet. Participants were 
concerned that some of the information they encountered online could not be trusted and thus 
tended to seek out information from sources that they deemed to be authoritative and well 
recognised, websites with an absence of advertising, and websites from England which were 
deemed as markers of credibility. 
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PT5: Well, put it this way, I wouldn't... I wouldn't even look at Wikipedia, in that 
I'd pay, you know, attention to a NHS-backed website, or something, you know, 
the Royal College does, or something of that sort. 
 
(76 year old male, intermediate computer skills) 
 
Another issue for participants seeking information online, which was similar to one of the 
reported limitations of group based education, was that the internet could not provide 
personalised information. Participants expressed concerns that online information could only 
cater to a general audience and that it might not apply to them specifically, given their 
individualities.  
PT10: …the trouble with it, is diabetes is always in the context of other things, 
you see. Witness my inability to exercise, because I had arthritis. So… it may 
not necessarily be the right thing for you. 
(67 year old male, intermediate computer skills) 
 
 
10.4.2.5 Perceptions of HeLP-Diabetes 
 
As discussed briefly above, participants perceptions of HeLP-Diabetes were influenced by 
several factors; acceptance of diabetes, appraisal of self-management, burden of illness, 
satisfaction with current diabetes care and education and information wants and needs. 
Participants’ perceptions of HeLP-Diabetes and how these factors influenced these perceptions 
are discussed in more detail in this theme. 
 
Acceptance of diabetes was influential in whether or not participants had engaged in actively 
controlling their diabetes through self-management activities and also whether they engaged 
with HeLP-Diabetes. Participants who reported having not yet fully engaged with having 
diabetes perceived that using HeLP-Diabetes may force them to become more aware of the 
condition and possible future complications which they were not yet ready to do.  
PT12: … my life has been blessed with good health and it’s only recently that 
due to hospitalisation I’ve put on weight and then became diabetic, but 
generally I’ve not had to think about my health in my life and it’s just basically I 
want that to continue 
(52 year old female, basic computer skills) 
 
PT11: …I did log on, I have signed up to it but I think that would mean 
everything becomes a bit more real. At the moment stabbing myself every so 
often and doing my long term count. I don’t want to look at something knowing 
that it’s going to be bad 
(46 year old male, advanced computer skills) 
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Some participants (as exemplified in the quote above from participant PT12), when talking 
about their health, used language which suggested that they had never taken agency over their 
health but that using HeLP-Diabetes may force them to take account of it, which they did not 
want to do. This participant uses the phrase ‘blessed with good health’ which suggests a lack of 
personal influence over her health and she describes ‘never having had to think about my 
health’. Using HeLP-Diabetes would involve thinking about her health which she describes as 
not wanting to do.  
 
There were also participants who were confident in their current self-management who did not 
perceive a need for HeLP-Diabetes. These participants reported being satisfied with their 
current self-management behaviours and had achieved a level of diabetes control that they 
were happy with. As such, they reported little need or use for HeLP-Diabetes at present.  
PT2: Well, the reason I don't use it, as I explained, I feel I'm sort of self-
managing it, so I'm not looking at it because I don't need advice 
(63 year old male, advanced computer skills) 
 
For participants who reported experiencing burden from living with diabetes and undertaking 
self-management activities, the reminders and prompts to use HeLP-Diabetes were perceived 
as increasing this burden. Participants’ reported a feeling of just wanting to be able to get on 
with their lives instead of having to think about the fact that they have diabetes all the time. 
Email reminders and newsletters designed to prompt use of HeLP-Diabetes were perceived 
negatively by these participants because they provided a reminder of their diabetes and along 
with other forms of reminders, resulted in participants feeling bombarded with information about 
their diabetes.  
PT7 Yes, I get very pissed off actually…you know, it’s in the back of my 
mind. I’m completely conscious of it. I don’t need reminding, and there are 
times when I go, I know!...sometimes I think you don’t get time to even think 
about what you’re doing.  
 
(68 year old female, intermediate computer skills) 
 
Participants’ appraisals of their current information and support needs influenced judgements of 
the benefits of HeLP-Diabetes. Participants varied with regard to how much information they 
had about diabetes and how much they wanted which influenced their reasons for using or not 
using HeLP-Diabetes. The majority of participants reported a desire for information about 
diabetes and described information seeking from a range of sources on a regular basis. The 
internet was viewed by many as a resource which enabled them to keep up-to-date with current 
diabetes information, and HeLP-Diabetes was viewed as an additional resource which was 
used for information seeking. 
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PT6: …when I first had it I read everything I possibly could, absolutely 
everything; and I looked up everything on the web about it…But anything that 
says something about diabetes I do read it, to be honest. 
(58 year old male, intermediate computer skills) 
 
There were participants however, who felt that they had a good level of knowledge about their 
diabetes who did not perceived HeLP-Diabetes to be useful for them as they felt it did not offer 
anything that they did not already know or have access to.  
PT5: the information on it I'm already up to speed on…there's nothing on it, as 
far as I can see, that's new or different. 
(76 year old male, intermediate computer skills) 
 
As described, HeLP-Diabetes was perceived to be a good source of information about diabetes. 
As well as information, HeLP-Diabetes offers behaviour change tools, emotional management 
tools, self-monitoring tools and social and peer support features, however, the majority of 
participants’ described it purely for its information content, rather than any of these other 
features. This may have been due to expectations of what websites usually provide and how 
participants’ typically use the internet for diabetes related support; the presence of these tools 
are less common on standard information websites. 
 
The reported strengths and benefits of HeLP- Diabetes often reflected shortcomings in other 
sources of diabetes self-management support. Participants who reported experiencing 
difficulties with attending or benefitting from group based education perceived HeLP-Diabetes to 
be incredibly useful in addressing some of these issues. Many made reference to HeLP-
Diabetes’ accessibility and convenience as well as the privacy that it afforded people to look up 
information on their own and at their own pace.  
PT12: Well, the DESMOND group for me, because my memory is not brilliant it 
means that… and if they give you a lot of information in one go it’s hard to sort 
of assimilate it all, whereas if there’s a site you can take in as much as you 
want, you know, at certain times. 
(52 year old female, basic computer skills) 
 
PT7: … this is a very private thing and…because you can go on to the website 
in the privacy of your own space and look things up. Some people don’t like to 
put their hand up at a group thing, they’re a bit shy about that, they hope 
someone else is going to ask the question 
(68 year old female, intermediate computer skills) 
 
However, there were other participants, particularly those who valued the social interaction that 
they gained from group based education who did not perceive HeLP-Diabetes to be able to 
meet their needs for social support as they craved interaction and support from other people.  
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PT15 It's okay but... I just thought to myself, like, what's the point? What's the 
point of it really? You're there just looking at a computer screen, like, answering 
questions, doing stuff like that and, to me, that is not enough, you know. I'd feel 
better, you know, like, having somebody to actually talk to. I think that would be 
better for me, you know. 
(58 year old female, basic computer skills) 
 
Perceptions of and satisfaction with current diabetes care was an important factor in 
perceptions of HeLP-Diabetes. Those participants who were satisfied with their current care 
from their healthcare professionals and who were confident that their needs were being met 
elsewhere often did not perceive the need to use HeLP-Diabetes.  
R: Is there anything missing from HeLP Diabetes?  
PT7:…I don’t think so, because actually I’ve never really had a huge question to 
ask…I have a really good GP and a very good health centre and they, you 
know, run a service that if I wanted to speak to a doctor and I couldn’t get an 
appointment then the doctor would phone me. 
(68 year old female, intermediate computer skills) 
 
However, other participants who reported dissatisfaction with their healthcare perceived HeLP-
Diabetes to be beneficial in being able to supplement and even corroborate or check 
information that they had been provided with by healthcare professionals which they did not 
trust or understand. In this way HeLP-Diabetes was seen by some as a resource that allowed 
them to transcend traditional knowledge boundaries, and allow them access to information that 
they may otherwise not have been privy to.  
PT14: biggest problem I find with the GP, is when I was first diagnosed...didn’t 
like his attitude: you’re a diabetic, you will be on your medication, you will have 
one tablet a day… no talk of exercise whatsoever… so I had to go online, and 
say, what’s the best thing, diet and exercise? 
(56 year old male, advanced computer skills) 
 
HeLP-Diabetes was perceived by some as a more trustworthy source of information than 
information from their healthcare professionals. Often distrust of the information from healthcare 
professionals was linked to previous negative experiences that participants had encountered 
with the information provided to them by healthcare professionals. HeLP-Diabetes was used as 
a second opinion to check information provided by healthcare professionals.  
PT2:…twice I've been let down by healthcare professionals in prescribing 
medication, which has led to other things…so from now on every time I get a 
drug, I check it and I look at the side effects and I ask what are these going to 
do? 
(63 year old male, White British, advanced computer skills) 
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Despite participants concern over the credibility of online information in general, HeLP-Diabetes 
was perceived as a trustworthy and authoritative source of information. This was largely due to 
the affiliations HeLP-Diabetes has with the NHS and University College London whom 
participants reported trusting and respecting thus giving it credibility and authority.  
PT5: It was a project started by Whittington and the University College, which 
are my two favourite hospitals, and, I think, the Royal Free as well, I'm not 
sure... the, sort of, local connections, you might say, so it must be all right. 
(76 year old male, intermediate computer skills) 
Another important factor in participants’ judgements of the credibility of HeLP-Diabetes was the 
fact that it was offered via their GP practice or hospital clinic. Having HeLP-Diabetes introduced 
to them through these services with a recommendation from a healthcare professional seemed 
of central importance in participants’ decisions to register and use HeLP-Diabetes. Many spoke 
of the importance of the endorsement from healthcare professionals which set HeLP-Diabetes 
apart from other online resources. 
R: Was it important to you that it was a website recommended through your GP 
practice? 
PT7: Yes, absolutely.  
R: Why is that? 
PT7: Well, because you feel it has been researched. You feel that some of the 
information on it has come from experience and I’m more likely to go onto that 
website because it was recommended by a place I’ve been going to for ten or 
more years. 
(68 year old female, intermediate computer skills) 
 
The majority of participants were registered to HeLP-Diabetes through the staff registration 
method where a healthcare professional at their GP practice or diabetes clinic assisted 
participants to access and register on HeLP-Diabetes (for more details on the different 
registration methods please see Chapter 7). In addition, some practices offered a degree of 
facilitation to participants which included staff introducing HeLP-Diabetes and showing 
participants parts of it. Participants described this registration and facilitation process positively 
and suggested that this was a key factor in influencing them to engage with HeLP-Diabetes.  
PT14: That was the only reason I signed up, because it was recommended, 
plus they had a person there to show me what it was like 
(56 year old male, advanced computer skills) 
 
The facilitation from staff to access and register on HeLP-Diabetes seemed to be particularly 
important in order to overcome issues of the digital divide. Participants with basic computer 
skills and those for whom English was not their first language (PT3) seemed to particularly 
benefit from the assistance of staff in initially accessing HeLP-Diabetes. Being able to register 
on HeLP-Diabetes with support and being shown how to access and use it was helpful in 
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building participants’ interest in HeLP-Diabetes and their confidence in being able to access and 
use it alone. 
PT9: The secretary, a lady called (name of receptionist), very helpful. And she 
set it up for me and, you know, logged me in and you know, you’ve got a 
password and everything. 
(66 year old male, basic computer skills) 
 
Not all participants received this additional facilitation to access HeLP-Diabetes. One participant 
with basic computer skills, who hadn’t received any support in accessing HeLP-Diabetes 
suggested that facilitation by a healthcare professional would have helped her discover the 
content that she was interested in.  
PT4: …if you go on a website I think they should show you…For example... 
how to fast, how to take care of your feet, how to... exercising. I think there 
should be like something like that 
(43 year old female, basic computer skills) 
 
The other way in which participants accessed HeLP-Diabetes was through the patient 
registration method. In these cases, staff would recommend HeLP-Diabetes, but would not 
facilitate registration or access. Instead, participants were given a patient registration leaflet with 
details of how to register themselves. Most participants who accessed HeLP-Diabetes in this 
way reported this process as straightforward. However, all the participants in this interview 
subsample who joined via the patient registration method described themselves as intermediate 
or advanced computer users and were therefore probably adept at accessing websites and 
online registration forms. This suggests that the patient registration method may not have been 
utilised by participants with lower levels of computer skills and stresses the importance of staff 
facilitation in overcoming issues of the digital divide between those who can access healthcare 
online and those who can’t.  
PT10: Oh, the doctor told me. The doctor, so he gave me a leaflet, and a 
number, and I signed up for it, yes.  
R: And how did you find the signing up process? 
PT10: Yes, yes, absolutely, no I didn’t have any problem with that, at all. No, 
no. 
(67 year old male, intermediate computer skills) 
 
10.4.2.6 How HeLP-Diabetes was used 
 
Participants with a range of computer skills reported that accessing and using HeLP-Diabetes 
was straightforward and unproblematic. The navigation and design of the website appeared to 
be conducive for participant use, with participants reporting the website to be clear, easy to 
navigate and well laid out.  
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PT5: … it looks... I mean, it looks very attractive and interesting and well laid 
out 
(76 year old male, intermediate computer skills) 
 
Surprisingly, the only participants who expressed having difficulty with accessing content on the 
website were those who were advanced computer users who expressed difficulty in finding 
specific content.  
PT1: I know the information’s there on the website that you’ve created, but …I 
find the website not confusing, but hard to access. 
(58 year old male, advanced computer skills) 
 
Some issues with accessing HeLP-Diabetes were encountered when participants attempted to 
access it from mobile phones, for which it was not optimised. These participants were those 
who reported not having home internet access and this will be an important issue to consider in 
the future with regards to issues of the digital divide, especially as use of the internet on devices 
such as smartphones is rapidly increasing. 
PT12: Well, I like the idea of the website – I did like the idea of it. In reality, it’s 
not been practical for me because I’ve only got a smartphone, I don’t have a 
computer. So, I did like the idea of that because that meant that I could revisit it 
again and again until I sort of learn things. And so, yes, unfortunately it hasn’t 
worked out because it’s been very difficult with my phone, you see. 
(52 year old female, basic computer skills) 
 
For those participants who could access HeLP-Diabetes, patterns of use were extremely varied. 
Some participants reported not using HeLP-Diabetes again after their initial registration, 
whereas others reported using it weekly and in some cases daily. Frequency of use appeared to 
be determined by the reasons that participants used HeLP-Diabetes and the tasks that they 
performed on it. 
 
Those participants who perceived HeLP-Diabetes as an information resource were more likely 
to be sporadic rather than regular users. These participants’ used HeLP-Diabetes in response 
to particular scenarios, such as being prescribed new medications or to look up a news story 
that had recently been reported in order to gain further information. Often these participants 
were those who reported managing their diabetes well and had a low perceived need for 
additional help and support. In some cases, these participants reported attrition to HeLP-
Diabetes because they had used it to answer a specific question and hadn’t returned as that 
need had been met.  
PT6: …If I hear something about diabetes on the news I will invariably go and 
check it up online and see exactly what it is they’re saying 
(58 year old male, intermediate computer skills) 
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In contrast, there were participants who accessed information on HeLP-Diabetes regularly in 
order to try and control their diabetes better. These participants returned more often and 
accessed more of the content of the website including the tools. Participants who used HeLP-
Diabetes to input their own data in order to self-monitor and track their progress were more 
likely to return to the website regularly and viewed usage as part of their self-management 
regime.  
PT3: I try checking regularly like a job, duties, not every day, sometimes a week 
or sometimes a month especially if I get new things like results of a blood test 
or eye scan or something like that 
 (59 year old male, advanced computer skills) 
 
For some participants their use of HeLP-Diabetes was prompted by the regular emails and 
newsletters that were sent from the website (see Chapter 2). These prompts served to remind 
participants about HeLP-Diabetes and certain topics grabbed their attention and encouraged 
them to log on.  
PT14: …I kept getting these regular emails and …I’ve actually looked on the 
website and it’s okay 
(56 year old male, advanced computer skills) 
 
However, a few participants reported ceasing to use HeLP-Diabetes because of these email 
and newsletter prompts which were perceived as annoying.  
PT6: I dreaded it because I seem to get emails every second second from 
them, and in the end I just stopped, you know, it was just a nuisance. 
(58 year old male, intermediate computer skills) 
 
Overwhelmingly the content on HeLP-Diabetes to do with food, weight loss and medication 
were reported as the most accessed by participants. These were also the areas to do with self-
management that participants reported having found particularly difficult to understand with 
regards to their self-management, with many reporting having received conflicting information 
about these topics from other sources. HeLP-Diabetes served to provide clearer information on 
these and fill existing gaps in participants’ knowledge.  
R: And has it [HeLP-Diabetes] helped you with any specific aspects of looking 
after diabetes?  
PT4 I think the main one was what I should and shouldn’t eat, yes. And 
sometimes they show in little videos, click on it, it’s exercises and you see, you 
know, how it can help, yes.  
(43 year old female, basic computer skills) 
 
PT10: …advice about going further with losing weight, I mean, I’m not vastly fat, 
but I’ve now, I have got a tummy. And, it would be a good idea to try and lose 
some of that…And maybe losing weight, a bit more 
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(67 year old male, intermediate computer skills) 
 
Certain features of the website were reported as being particularly useful for participants’ 
learning, including the videos and animation content which were viewed as easy to follow and 
understand. For some this content managed to explain diabetes information in such a clear way 
that they reported understanding concepts for the first time. 
PT13: the two videos I watched about diabetes, anyway, they were very 
informative and very simple to understand. They weren’t very complicated at 
all…I mean, it presents, I think for me it's a complicated thing, in a very simple 
way. You know, everybody can understand, anyway, in any case. 
(52 year old male, Italian, intermediate computer skills) 
 
Other benefits from using HeLP-Diabetes included raising awareness. Participants reported 
having found information on HeLP-Diabetes that was useful for them that they had not known 
before. This was true for serious issues such as the complications of high blood glucose and 
more practical issues like the need to inform insurance companies about diabetes.  
PT4: … learned about if you have diabetes when your blood sugar levels are 
very high or those kinds of things I didn’t really know anything about it and how 
important to eat, like, in reasonable quantities because I used to think that if it’s 
fruit you can eat as much as you want, you know, but now I know that you can 
eat fruit, I have to eat a certain amount  
(43 year old female, basic computer skills) 
 
PT5: I didn't know, and really ought to have known, was that if one was 
diagnosed with Type 2 Diabetes, you tell your motor insurance. And that I've 
done….that was a very important bit of useful information, you know, I thought. 
(76 year old male, intermediate computer skills) 
 
As well as improving diabetes related knowledge and awareness in the participants themselves, 
one participant reported that she had used HeLP-Diabetes as a tool to explain her condition to 
her family. She reported that HeLP-Diabetes had worked where other resources had failed in 
increasing understanding of diabetes in her family members, which in turn increased the 
support they offered her. Use of HeLP-Diabetes for this participant was beneficial in aiding her 
social support and her family’s understanding.  
PT4: they never actually understand why, but now they are more aware of 
everything…It helps them to understand and it helps me... they are very helpful, 
now, because if I say really, I’m so tired, you know, before... they were helpful 
before but now they are more, if there is something which needs to be done you 
can see they’re more caring; we can do it Mum. 
(43 year old female, basic computer skills) 
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Use of HeLP-Diabetes influenced how well participants perceived themselves to be self- 
managing their condition. For some participants joining HeLP-Diabetes and using it felt like they 
had taken positive action with regards to looking after their diabetes. And others reported that 
using HeLP-Diabetes had encouraged them with their self-management.  
PT7: I feel as if I’m doing something that is good for me.  
R: By going on to the website?  
PT7: Yes. 
(68 year old female, intermediate computer skills) 
 
PT4: …I think, when you go there and you read the stories about other people 
saying what they think about it, you know, it encourages you. 
(43 year old female, basic computer skills) 
For others, using HeLP-Diabetes had altered their perception of diabetes. For some, using the 
website had made them feel as though diabetes was more manageable and decreased their 
feelings of disease burden. This participant, after hearing about the impact that making positive 
lifestyle changes had had on others using the website, had changed the way he perceived his 
diabetes. Rather than perceiving it as a burden he now viewed it as an opportunity to make 
some positive health improvements.  
PT14: I find it useful hearing other people’s stories to realise that I’m no longer 
going to look at the diabetes as a… what’s the word… it’s not even a 
hindrance… so what’s the difference between them and me at the moment, it’s 
exercise, exercise and I’ve to put more veg on my plate 
(56 year old male, advanced computer skills) 
 
For others however, reading information about diabetes and the possible future complications 
had increased the perceived seriousness of diabetes.  
PT4: I never knew it was that serious until when they said... I think I read it, 
actually, in one of the emails about that, you know, you can lose... if you don’t 
take care of yourself you can end up losing, you know, like your legs, your 
arms. 
(43 year old female, basic computer skills) 
 
Using HeLP-Diabetes influenced participants’ interactions with their healthcare professionals. In 
some cases using HeLP-Diabetes meant that participants did not have to make appointments 
with healthcare professionals because they had found the answers to their questions on the 
website. In this way HeLP-Diabetes was time saving for both participant and healthcare 
professionals as well as being accessible and convenient.  
PT2: …it’s all there for you if you want it, and you don't have to wait to go and 
see a doctor. You don't have to wait for your annual appointment 
(63 year old male, White British, advanced computer skills) 
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Use of HeLP-Diabetes also resulted in participants feeling more informed which improved their 
consultations with healthcare professionals. Some participants had reported not fully 
understanding information that they were given by healthcare professionals during consultation, 
and using HeLP-Diabetes had helped participants to make sense of information and increased 
their feelings of being empowered during consultations.  
PT4: the GP was discussing with me about... asking me if I knew, you know, 
how to... how to diet how to blood sugar, and I told her that I got a lot of 
information from Help Diabetes, so I was aware of what she was asking me.  
(43 year old female, Black African, basic computer skills) 
 
Participants made several suggestions to improve HeLP-Diabetes and its implementation.  
 
In terms of implementation, more widespread advertising of HeLP-Diabetes was suggested by 
the majority of the participants as a way to raise awareness and increase access to other 
people with diabetes. Suggestions for advertising ranged from TV adverts to paraphernalia that 
could be displayed in pharmacies and libraries.  
PT3: I don’t know. Media is one of the big things involved but it is expensive. 
You can’t make the programme on the TV 
(59 year old male, advanced computer skills) 
 
PT7: …through chemists, maybe, you know, if the leaflet is there. Hospital 
waiting rooms. Somewhere where people, you know, are medically minded 
when they go somewhere, so that it actually grabs the attention. I guess you 
could put it in libraries 
(68 year old female, intermediate computer skills) 
 
Participants overwhelmingly perceived the role of staff in making HeLP-Diabetes available of 
critical importance and had firmly made the association between HeLP-Diabetes and the health 
service because of this recommendation. Many participants thought that HeLP-Diabetes should 
become even more integrated into the health service and suggested that it could be made 
available to use in waiting rooms, that the registering of patients on HeLP-Diabetes should 
become a key feature of diabetes related appointments and that medical records should detail 
whether patients had been offered access to HeLP-Diabetes by their healthcare professionals.  
PT4: I think they should put it to any surgery so that people can use it 
(43 year old female, basic computer skills) 
 
PT2: … think that it should be part of the initial diagnosis interview. That web 
address should be given out and the people should be invited to look at it and 
to ask the relevant questions. And try and encourage them to use it, and then 
subsequent visits to the diabetic nurse or whatever, perhaps the nurses could 
be trained to say what have you looked at recently on the website? Are you 
using it? 
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(63 year old male, advanced computer skills) 
 
PT14: …anyone who is a diabetic should automatically be … asked if they want 
to join it and then you should have a record somewhere in your doctor’s records 
that you are on it, so that way they know who’s on it, who’s not on it, so they 
can remind people to use it 
(56 year old male, advanced computer skills) 
 
Participants also saw the potential for HeLP-Diabetes to be used in alternative ways. Some, 
particularly those who had expressed a desire for social support in their management of their 
diabetes, suggested that HeLP-Diabetes could be introduced and used in group settings. This 
idea seemed to particularly appeal to participants who had previously mentioned preferences for 
face-to-face diabetes information and support.  
PT4: create a group of maybe ten or 15 people for the first time and they bring 
them that website and they teach them, you know. 
(43 year old female, basic computer skills) 
 
In terms of HeLP-Diabetes, the majority of the suggestions for improvement centred on 
strategies to keep people engaged with HeLP-Diabetes as opposed to suggestions to improve 
the content. This reflected some participants’ usage patterns which displayed attrition to HeLP-
Diabetes over time. One participant thought that an information video with a healthcare 
professional describing what HeLP-Diabetes was and the benefits of using it would facilitate 
interest and routine use. Alternative forms of prompts to increase engagement were also 
suggested such as text message reminders and notifications when posts had been made in the 
forum.  
PT3: …you have to make habits for them then use it regularly….maybe giving a 
small video, a couple of minutes for example, a short video for information, and 
maybe a conversation with two people explaining it…a professional person.  
(59 year old male, advanced computer skills) 
 
PT2: I don't mind texts….If it's to flag up something to say this month there's 
going to be information about how to look after your feet, or this month is going 
to be about how diabetes can affect vision, that would be quite interesting and 
that would draw my attention to it. 
(63 year old male, advanced computer skills) 
 
PT1: Maybe notify customers…You know, every time, not just from say if I put a 
question just notify me when there’s an answer. You know, notify everybody 
what’s going on on the forum. So in other words, reach your hand out and grab 
hold of the diabetics and drag them in. 
(58 year old male, advanced computer skills) 
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10.5 Discussion 
Interviews with patients with type 2 diabetes who had registered to use HeLP-Diabetes aimed to 
explore perceptions of the implementation of an e-health intervention to support self-
management. Generally the interviews confirmed that patients saw potential benefits of an 
online tool to support self-management of type 2 diabetes, particularly as a resource for gaining 
and corroborating information.  
 
HeLP-Diabetes was reported to be used most frequently for information provision purposes 
despite the availability of other features such as behaviour change tools and forums.  The use 
of HeLP-Diabetes for information reflected the fact that patients perceived there to be a lack of 
clear information about diabetes and self-management from other sources and participants 
reported valuing HeLP-Diabetes as resource that allowed them to check and corroborate 
information from health care professionals. This reflected a perception of inadequacy of care 
from NHS in terms of quality and quantity of information. Previous studies suggest that people 
with diabetes prefer to gain most of their diabetes information from health professionals (267, 
273), however patients in this study reported variability in perceptions of the adequacy and 
trustworthiness of information from their health professionals, difficulty in accessing information 
from them when needed, and that there was often not enough time with health professionals in 
order to meet their information needs. Patients reported regularly making use of the internet in 
order to search for information about their diabetes. This suggests that the implementation of an 
e-health intervention was acceptable and valued as a resource to address unmet needs of 
current information provision.  Interviews with staff (presented in Chapter 9) also revealed that 
there is often not time in consultations to provide patients with all the information that they 
should have about their diabetes, and therefore HeLP-Diabetes was perceived as useful by 
both groups as an information provision source. There were patients however, who perceived 
that all their diabetes related information needs were currently being met by their health 
professionals and therefore did not need to use HeLP-Diabetes. This is in keeping with findings 
that people who have a regular primary care physician are more likely to have higher attrition to 
diabetes education programmes than those who do not (39) and suggests that e-health 
interventions may not be used by patients who are happy with the support they receive from 
other sources.  
 
An important finding that highlights the value of an e-health intervention to support self-
management was that the ability of HeLP-Diabetes to present information in various formats 
including, text, animation and video which was perceived as beneficial in helping to explain 
difficult concepts clearly with patients reporting that HeLP-Diabetes had helped them 
understand concepts that they previously had not been able to from other mediums of 
information provision. It may be that for some patients, even if they receive an adequate amount 
of information from health professionals it is important to have this information presented in 
different formats in order for it to be clear and understandable, which an online intervention such 
as HeLP-Diabetes is particularly suited to do.  
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There were fewer patients who reported in engaging with other aspects of HeLP-Diabetes. A lot 
of time and money was invested into creating functions such as behaviour change tools and 
self-monitoring functionality which patients in this study rarely mentioned using (although the 
usage data presented in Chapter 8 suggests a wide range of content was accessed). A few 
talked about using the self-monitoring tools for tracking their glucose but this was rare. Given 
the cost of these features compared to providing information provision only websites, it raises 
important questions for the design of future interventions. One reason that these tools may have 
been so scarcely used (or reportedly used) could be due to the lack of facilitation to use HeLP-
Diabetes that was provided. Many of these tools, especially the behaviour change ones were 
designed to be used during consultations with health professionals to set collaborative goals 
and the self-monitoring tools were designed to help patients stick to these goals and provide 
patients with a way of sharing their progress with their health professionals. However, this 
interaction around HeLP-Diabetes during consultations was rarely reported by patients who took 
part in these interviews.   
 
Certain features of HeLP-Diabetes that were designed to encourage patients to interact with it 
and stay engaged were perceived as annoying and intrusive by some participants. Although 
some patients discussed how useful the email and text reminders were in prompting use, others 
suggested that these reminders were a source of annoyance and actually served to disengage 
patients from HeLP-Diabetes. This has important implications for the design of future 
engagement strategies for websites like HeLP-Diabetes which attempt to encourage user 
engagement with strategies such as text and emails. A possible reason for these negative 
reactions in the cases reported here is that patients were already experiencing a great burden of 
managing their diabetes, and these reminders served to increase this sense of burden that 
having diabetes placed on them. Including an opt in (or out) option at registration rather than 
relying on patients to unsubscribe might be a way of addressing this problem for future e-health 
interventions.  
 
However, there were reported benefits of using HeLP-Diabetes including patients feeling more 
knowledgeable and having increased self-efficacy to manage their condition. Use of HeLP-
Diabetes changed the way that patients perceived themselves to be managing their diabetes, 
making some feel like they had taken a positive step, providing encouragement to others and 
altering perceptions of the manageability of diabetes for others. Interestingly, patients who 
reported improved ability to managing diabetes or now having enough information following use 
of HeLP-Diabetes also described a low continued need to use HeLP-Diabetes. Other studies 
have found that confidence in knowledge and ability to manage diabetes act as barriers to 
patients engaging in diabetes education (39) as do perceptions of wellness (37). This 
represents a tension between the goals of internet interventions for diabetes self-management 
(to be used) and the goals of self-management education to increase patient knowledge and 
confidence which may then result in patients not feeling the need to use them. This has 
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important implications for understanding what might be effective use of an intervention like 
HeLP-Diabetes and what the expected use should be.  
 
Features of HeLP-Diabetes which were particularly well received by patients were the privacy 
and accessibility that using a website afforded patients. In terms of lessening the burden of 
managing a long term condition like HeLP-Diabetes, being able to access information whenever 
needed and at a frequency and pace that was completely user led was perceived as beneficial 
and unique to an e-health intervention like HeLP-Diabetes. These perceptions were often 
presented in contrast to group based education which was consistently reported as difficult for 
people to attend and unfulfilling in terms of knowledge acquisition because of limitations of 
group based education. The contrast that patients drew between the value and limitations of 
group based education and HeLP-Diabetes have important implications for the commissioning 
and implementation of diabetes education resources, with the two different formats likely to 
provide a complimentary menu of options for patients to select from. Several patients perceived 
that the information from group based education was too basic, others reported that the groups 
were not able to address a patient’s specific needs because of time limitations and the group 
based nature, others reported that the group based nature was not conducive to learning as 
there were other participants who had been disruptive and one participant reported not being 
able to participate fully as he had hearing difficulties. These barriers were all seen to be 
overcome by HeLP-Diabetes which was perceived as useful because of the tailored information, 
accessibility and the ability for patients to spend as much time using it as they liked. However, 
there were positive features of group based education which were not perceived as replicable 
with an internet based intervention. These largely centred on the peer support that patients 
received from attending groups with others. Some patients felt alone and isolated with their 
diabetes and the groups helped to alleviate these feelings. Peer interaction was also reported to 
be encouraging and motivating. The high use of the forum feature on HeLP-Diabetes (as 
reported in Chapter 8) also suggests the importance of peer support in the management of 
diabetes, which can be a facilitator for people with type 2 diabetes achieving their self-
management goals (274). Previous research with people with long term conditions around use 
of internet interventions found that interventions that allow the sharing of experiences are 
perceived most favourably (275). Diabetes interventions with added peer support have also 
been reported to foster more user engagement than those without added peer support (262). 
This suggests that e-health interventions should aim to include functions that enable users to 
gain social support for managing their condition.  
 
HeLP-Diabetes was reported by some to increase social support from family members through 
access to information and support. Previous studies have found that self-management of long 
terms conditions can be facilitated by the support of family members (274). As described in the 
staff interview chapter (Chapter 9), although it hadn’t been part of the initial implementation 
strategy, several health professionals adapted the way they offered HeLP-Diabetes to patients 
by involving a family member in the registration process and encouraging families to use it 
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together to support the patient. Going forward, this could be an additional implementation 
strategy for e-health interventions. This is unique as other sources of diabetes education such 
as group based education which excludes family and friends. Allowing access to family and 
carers might be an important consideration of the design and implementation of e-health 
interventions in the future and may help address the digital divide in accessing online 
information resources for people with low IT literacy or English language skills.  
 
Also, important for the design of future health interventions like HeLP-Diabetes is the credibility 
and assurance that patients reported that the affiliation with the NHS and UCL gave to HeLP-
Diabetes. Often patients do not trust the internet for health information (276-279) and the source 
of online information has been reported as particularly important for people’s judgments of 
health information credibility (280). Seals of credibility are important for promoting trust and 
include the information being provided from a well-known organisation and endorsements or 
credibility seal such as a logo (279). Similarly, the recommendations patients received from 
health professionals to use HeLP-Diabetes were perceived as particularly crucial for their 
registering.  In a context where patients are bombarded with information this recommendation 
helped HeLP-Diabetes to stand out and increased its credibility. Patients reported that being 
offered HeLP-Diabetes through their GP practice or diabetes clinic made it feel like a legitimate 
part of care rather than an optional add on. For some patients HeLP-Diabetes being 
recommended by a health professional was the only reason they decided to register. The 
importance of health care providers in engaging patients in their diabetes self-management and 
diabetes education has been stressed and the benefits of communication around self-
management in improving patients’ self-management behaviours reported (242, 274, 281).  
Although websites may be traditionally viewed as a medium of information which is generally 
self-directed, the participants in this study valued the assistance that staff provided in registering 
to use HeLP-Diabetes.  Other studies have found that diabetes internet interventions that 
include an element of interaction with healthcare providers are seen as attractive to patients 
(65). There were other patients however, generally who reported having intermediate or 
advanced computer skills, who reported joining HeLP-Diabetes via the self-sign up method with 
no problems. These findings have important implications for the way that internet interventions 
are made available to patients in order to facilitate uptake and use. For example it might be 
important for health professionals and for the allocation of resources to recognise patients that 
might benefit from the extra assistance, but also realise there will be many patients who are 
capable of joining e-health interventions by themselves.  
 
Ongoing use of HeLP-Diabetes was not frequently reported by many patients which suggests 
that although health care professional recommendations may be beneficial for encouraging 
patients to register, more might be needed to keep patients engaged. This may be the same for 
group based education where patients are given a referral to attend by their health professional 
but then do not attend (as reflected in the high rates of referral and low rates of patient 
attendance). Patients perceived being able to use HeLP-Diabetes collaboratively with their 
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health professionals as potentially useful and motivating, although this was only reported to 
have happened in one case. Patients were particularly keen on making HeLP-Diabetes even 
more integrated into integrated into routine health care.  They felt that services should put more 
effort into registering patients and introducing them to the programme, and that patients should 
be encouraged to use the programme in routine diabetes appointments.  They felt nurses 
should be trained to routinely ask about use of the programme, and provide encouragement 
where needed. Although it was hoped that there would be ongoing encouragement of use of 
HeLP-Diabetes by health professionals in routine consultations, this was not reported to have 
happened with any consistency, and may be particularly important for encouraging ongoing use 
of HeLP-Diabetes and other e-health interventions.   
 
Reported use of HeLP-Diabetes varied considerably between participants.  The degree to which 
patients had already engaged in self-management of their diabetes impacted on their use of 
HeLP-Diabetes, and those at each end of the spectrum of engaged/ not engaged were less 
likely to report needing HeLP-Diabetes. Those who had not yet engaged often reported not 
being ready or being afraid of engaging and perceived that using HeLP-Diabetes may force 
them to address their diabetes, which they were not ready to do. Others who reported being 
engaged with managing their diabetes and felt that they were managing very well didn’t 
perceive any need to use HeLP-Diabetes as they had no use for it. In both instances patients 
described having registered to use HeLP-Diabetes as a resource that they could access in the 
future if needed. This has important implications for the way that interventions to support self-
management are offered with a benefit of an e-health intervention such as HeLP-Diabetes being 
that they are available to patients whenever they are ready to engage with their diabetes and 
self-management. This also strengthens the argument for ongoing reminders and 
encouragement by health professionals about the availability of resources like HeLP-Diabetes 
to ensure that patients have access to them when they are ready. It also raises questions as to 
whether the incentivisation of referrals to diabetes education through schemes such as the QOF 
are adequate. Alternatively, incentives could be provided upon evidence that patients have 
actually attended or engaged with self-management education. Providing feedback on 
intervention use as the well as number of patients who register might be important for 
commissioning decisions for future e-health interventions and should be considered by those 
developing e-health interventions.  
 
The implications that these findings have for practice, policy and research are further discussed 
in the overall discussion chapter (Chapter 11), as are the methodological strengths and 
weaknesses of the studies in this thesis.  
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11 CHAPTER 11: OVERALL DISCUSSION 
 
11.1 Chapter summary 
This thesis explored the adoption, uptake and use of an internet based self-management 
intervention for people with type 2 diabetes and determined the barriers and facilitators to 
implementation within routine NHS care and to patient use. It addressed these objectives 
through a series of empirical studies, using a range of research methods suited to each 
research question. Each study mirrored the aims and objectives of the thesis and addressed 
questions of importance to the development of this emerging field. An in-depth discussion of 
each empirical study contributing to this thesis was provided in the previous chapters (8, 9 and 
10), which included consideration of the existing literature. This chapter begins by drawing 
together the findings from each study by presenting the main findings of the thesis as a whole. 
The methodological strengths and weaknesses are then discussed and finally the implications 
of this work for practice, policy and research are considered. 
 
11.2 Main findings 
Overall, the findings from the studies within this thesis suggest that HeLP-Diabetes was 
attractive to commissioners of diabetes services and to health professionals within practices 
and clinics. There was a high level of adoption, with three quarters of services making the 
decision to adopt HeLP-Diabetes. The qualitative data from interviews with staff suggested that 
HeLP-Diabetes was perceived to fill an unmet need in current diabetes education provision, and 
the potential for it to alleviate some of the pressures felt within general practice to deliver 
diabetes care was reported. In particular, HeLP-Diabetes was perceived to offer patients a 
credible, accessible, and easy to use information source.  
 
The context in which HeLP-Diabetes was being implemented was one of the biggest factors to 
influence the degree of implementation achieved. The favourable fit that it had with CCG priority 
areas (diabetes, self-management, and health technologies) meant that there was great support 
of HeLP-Diabetes at the CCG level. This provided a sense that it was a worthwhile and 
important intervention for staff to consider and positively influenced adoption decisions. 
However, the implementation context proved very challenging for health professionals to use 
HeLP-Diabetes and offer it to patients. Data on patient uptake revealed that less than half of 
services in the CCG registered a patient to use HeLP-Diabetes, and collectively, the services 
who adopted HeLP-Diabetes only registered 205 patients, which represented approximately 
3.4% of their eligible patients. Staff interview findings suggested that the biggest barriers to the 
implementation related to the availability of resources. The current NHS context, which sees GP 
practices stretched to capacity with workloads increasing in both volume and complexity (248) 
meant that time to implement HeLP-Diabetes was generally not available and that HeLP-
Diabetes was not prioritised over other tasks that were incentivised as part of the QOF. 
Furthermore, despite the support of the CCG towards the idea of HeLP-Diabetes, this was not 
supported by the allocation of any resources to enable services to implement it, and instead 
services had to rely on fitting HeLP-Diabetes into existing roles and workloads. 
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Despite this, the findings on the uptake of HeLP-Diabetes by patients suggest that it appealed 
to a wide range of patients as patients representing a range of backgrounds in terms of age, 
ethnicity, educational level, duration of diabetes, and computer skills registered to use HeLP-
Diabetes. Fears were reported in the staff interviews that HeLP-Diabetes would not be suitable 
for certain groups of patients including older patients and those from non-white British 
backgrounds. These fears appeared unsubstantiated as there was no difference in the use 
made of HeLP-Diabetes by either of these characteristics. Similarly, there are concerns reported 
in the literature about the digital divide (the gap that is reported to exist between those who 
have access to health technologies and those who do not) (66). Data on patient registration 
methods showed that those with lower education were more likely to be registered to use HeLP-
Diabetes by a member of staff, suggesting that staff may be able to increase access for patients 
traditionally deemed less likely to have access. This study therefore provides some evidence 
that the digital divide can be overcome, particularly with the involvement of health professionals 
in supporting patients to access internet interventions. 
 
The role of staff in supporting patients to register to HeLP-Diabetes was regarded very 
differently by staff and patients. Findings from the staff interviews suggest that there was a 
degree of resistance by some staff to undertake this work due to a perception that it was not a 
legitimate part of their role. However, there was a strong perception from patients that staff 
recommendations to use HeLP-Diabetes, and staff support to access it was extremely valuable 
in promoting uptake and use.  
 
The majority of patients reported finding HeLP-Diabetes an acceptable form of diabetes 
education, and particularly valued the accessibility that an internet based intervention can 
provide. Quantitative data showed that patients made use of HeLP-Diabetes at all hours of the 
day suggesting that it may be more convenient to access than group-based education which is 
held during working hours.  
 
11.3 Methodological strengths and weaknesses 
The work described in this thesis had many strengths. These included: the use of theory to 
guide development of the implementation plan, data collection and analysis; the case study 
design; the mixed methods approach combining both quantitative and qualitative data; and the 
flexible, iterative approach towards implementation which allowed for rapid responses to 
identified problems. These are now discussed.  
 
The use of theory within this thesis was viewed positively. A call for a greater explicit use of 
theory within implementation projects has been made by many authors in order to shorten the 
time needed to develop improvement interventions, optimise their design, identify conditions of 
context necessary for their success, and enhance learning from those efforts (2, 175, 181, 182, 
282, 283). The application of theory in this thesis helped to strengthen the development of the 
implementation plan and facilitate the evaluation of the implementation.  
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Grol, Wensing and Eccles’ model of effective implementation (2) helped to sensitise me to the 
stages of implementation planning that should be considered in order to implement an 
intervention within healthcare, and provided valuable guidance on this process. Normalization 
Process Theory (NPT) was used throughout this thesis in order to inform the HeLP-Diabetes 
implementation plan, develop the topic guide for staff interviews and as a framework with which 
to analyse the implementation research diary and staff interviews.  
 
It became clear that NPT was a very appropriate theory for use in this thesis. Firstly, given its 
origins (much of the early work was related to implementation of e-health applications), NPT 
fitted very well to the nature of the HeLP-Diabetes intervention as an internet based 
intervention, as well as to the implementation setting. This meant that generating the study-
specific meanings of the constructs (a task recommended to operationalise NPT) was not too 
complicated. Secondly, there are lots of previous examples in the literature of NPT being 
applied to the implementation of innovations within healthcare settings which provided a point of 
reference for this work and confidence that I was applying NPT to this work in a way that had 
previously been undertaken successfully. Thirdly, there were no data from analysis of the 
research diary or the staff interviews which did not map adequately to one of the constructs of 
NPT.  
 
The use of NPT in this thesis was deemed to be very beneficial. Firstly, in the development of 
the implementation plan NPT was used as a sensitising tool in the planning phases of the 
implementation. By considering the constructs of NPT it helped me to think about how the 
implementation of HeLP-Diabetes would likely impact upon the work of staff and helped me to 
develop strategies to increase the likelihood that HeLP-Diabetes would become normalised 
within practice. For example, when selecting a strategy to implement HeLP-Diabetes in routine 
practice, by considering the constructs of NPT I was able to question whether the target group 
understood what was being asked of them, whether it fitted with their skills and whether they 
reflected positively on it. Secondly, NPT was used as an evaluative tool which was applied to 
the analysis of the research diary and staff interviews. NPT provided an explanatory theoretical 
framework which helped me to identify factors that promoted and inhibited the implementation 
of HeLP-Diabetes. In this context NPT was useful for allowing me to focus on the everyday work 
of staff in order to find explanations as to why HeLP-Diabetes did not implement well within 
many practices and clinics. It was particularly useful in explaining observed variations in 
implementation processes rather than simply focusing on notions of barriers and facilitators. 
 
However, there were limitations to the applicability of NPT to certain areas of this thesis. Firstly, 
I chose to code data within the systematic review to the constructs of the Consolidated 
Framework for Implementation Research (CFIR) (122) due to perceived limitations of NPT for 
this task. The nature of the data within the included reviews often focussed on factors that were 
not directly related to the processes involved in embedding or integrating interventions. For 
example, antecedents to adoption decisions, national and international policies, and financial 
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factors arose in many of the reviews, but were not described within any context of ‘work’. 
Secondly, NPT did not appear to lend itself well to the analysis of the patient interviews. As 
there was limited data on the ‘work’ involved in implementing HeLP-Diabetes in the patient 
interviews it made it difficult to attempt to apply the constructs of NPT to this data which mainly 
centred on perceptions of diabetes and self-management in general (given that many patients 
had not made use of HeLP-Diabetes). 
 
The case study design employed here was also considered a strength. Case studies are 
particularly well suited for studying implementation processes which tend to be fluid, non-linear 
and context sensitive (202). By employing a case study design I was able to conduct an in-
depth analysis of the implementation of HeLP-Diabetes and could compare implementation 
across different practices and clinics, this in-depth method allowed me to collect rich data from a 
range of participants and offer rich descriptions of the implementation of HeLP-Diabetes. This 
method allowed me to gain insight into the complexities of implementation in the everyday 
context of routine NHS care. However, limitations of case study designs must also be noted, 
primarily their potential for not generalising to other populations.  
 
The CCG selected as the case for this research study was chosen pragmatically: firstly, the 
CCG was familiar to the study team, it was local and therefore physical access to sites was 
possible; it was also known as being receptive to research and new innovations; in addition the 
CCG was in the process of introducing initiatives surrounding self-management and diabetes 
and was therefore considered to be receptive to an intervention which aimed to support patient 
self-management. For more widespread implementation of HeLP-Diabetes, there might be 
limitations as to how well the findings from this case study would generalise to less familiar, 
accessible and innovative CCGs. 
A mixed methods approach has also been described as particularly beneficial for understanding 
the implementation of innovations within healthcare settings (284) as quantitative and qualitative 
approaches in combination can provide a better understanding of research issues than either 
approach alone. In this thesis, quantitative methods were used to measure the rates of adoption 
and uptake of HeLP-Diabetes by NHS services and patients and the use of HeLP-Diabetes by 
patients. Qualitative methods were used to explore and obtain depth of understanding as to the 
reasons for the adoption, uptake, implementation and use of HeLP-Diabetes allowing a deeper 
understanding of the implementation of HeLP-Diabetes than if just one approach had been 
taken. Specifically, combining the two approaches was invaluable to explain why there had 
been relatively high levels of adoption of HeLP-Diabetes but low use made of it by health 
services, with the qualitative data shedding light on the important role of the context of the NHS 
and the resource work needed to implement HeLP-Diabetes. 
 
The iterative nature of the HeLP-Diabetes implementation also proved extremely beneficial in 
order to allow me to rapidly respond to problems arising with the implementation at various sites 
and to avoid continuing with strategies that were not working. Having the freedom of an iterative 
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approach meant that I could develop methodological innovations to overcome challenges of 
doing research in routine care such as developing online and automated patient recruitment 
procedures and developing alternative HeLP-Diabetes registration methods.  
 
There were several limitations of this study which proved beyond my control, but that had 
important implications for the research. Firstly, despite the plan to implement HeLP-Diabetes in 
a staged way, in batches of practices at a time; as soon as the CCG endorsed HeLP-Diabetes 
they requested that it be rolled out to all services at once. There were insufficient resources 
available from the research programme grant to support the widespread roll out, with only me 
available to support practices. This meant that I was unable to provide the level of support I had 
planned to practices. This is important, as in the practices where I did manage to give staff the 
level of support originally planned, they went on to implement HeLP-Diabetes relatively 
successfully (compared to other practices/clinics). This suggests that if I had been able to 
continue with the batch roll out, much higher levels of implementation would have been 
observed. Secondly, although I was interested in the digital divide, and which patients would 
take up and use HeLP-Diabetes, the nature of the study did not allow for any formal hypothesis 
about these issues to be tested. The study design was exploratory, with the primary focus on 
determining the uptake and use by unselected populations. The introduction of alternative 
patient registration methods arose in response to challenges identified during the study as 
opposed to being developed at the outset as different methods to be evaluated and compared. 
The results from the study have generated a hypothesis; that health professional input can help 
overcome the digital divide; but this needs further investigation.  
  
There are also several limitations of specific aspects of the research that need highlighting. 
Firstly, the representativeness of the patient interview sample must be discussed in light of the 
findings. Recruitment of patients to take part in interviews proved difficult, and it is possible that 
those patients who put themselves forward to take part in the interviews differed to other users 
of HeLP-Diabetes. Many of the participants expressed extremes of views in relation to HeLP-
Diabetes, either extremely positive or extremely negative. It may have been that they 
volunteered to be interviewed because of these extremes of views, and that other patients who 
held more moderate views were not as inclined to share these in an interview.  
 
A limitation of the recruitment, that on reflection I would want to address if I was to undertake 
this research again, is that patients who declined to register on HeLP-Diabetes could not be 
contacted to take part in the research. I had first hoped that staff within practices would be able 
to ask any patients who declined use of HeLP-Diabetes to participate; however, it quickly 
became apparent that asking staff to conduct any of the research components of the study was 
unworkable in practice. Therefore, the research procedures were moved online, and whilst this 
was beneficial for the overall research as a whole, it meant that it was not possible to capture 
the views of patients who declined use of HeLP-Diabetes. This would have been extremely 
valuable in order to better understand the reasons for patient non-uptake. Due to the low 
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enrolment in the research study by patients the interview sample was relatively small and it is 
likely that data saturation was not reached. 
 
For example, I did not manage to sample any patients who were managing their diabetes with 
insulin. Given that themes arose from the interviews about non-engagement with HeLP-
Diabetes being related to perceptions that diabetes was not too serious and the absence of 
medications and complications, it would have been desirable to gain the views of people for 
who diabetes was likely to be more present in their everyday lives.  
 
Similarly, for the staff interviews I would have also liked to be able to recruit staff to take part in 
interviews from practices that did not respond at all to offers of HeLP-Diabetes in order to gain 
the views of staff from these services on reasons for non-responses and non-adoption. 
 
Two technical issues with the HeLP-Diabetes intervention are worth noting here. Firstly, as 
described in Chapter 2, HeLP-Diabetes was intended to have a link to patients’ electronic health 
records. However, due to technical problems with establishing this link, which were outside of 
the control of the programme grant team, this feature of HeLP-Diabetes was never functional. 
Anecdotal data gained throughout the study period from both healthcare professionals and 
patients indicated that the inclusion of this feature may have been successful in promoting 
engagement with HeLP-Diabetes as access to electronic records would have potentially 
reduced workload for both health care professionals and engaged patients.  
The second issue related to the collection of data concerning patients’ use of HeLP-Diabetes. A 
technical problem with HeLP-Diabetes software meant that patient use of HeLP-Diabetes was 
only recorded from 01.01.2014, meaning that the first six months of data were not captured. 
This means that the usage data reported here is actually an under representation of the use of 
HeLP-Diabetes by patients during the implementation study.  
 
There was also missing data on the patient education variable, which was introduced to the 
online registration form at a later date than other patient characteristic variables. As described in 
Chapter 6, originally this variable was not included on the online form when patient registration 
to HeLP-Diabetes was completed in practices and clinics by health care professionals and this 
information could not be easily obtained. This variable was introduced as soon as the patient 
registration model had been introduced in order to explore whether registration method was 
influenced by any patient characteristics given the potential of staff facilitation to help bridge the 
digital divide for some patients. Therefore, the quantitative findings related to patient education 
should be considered with caution. 
 
Finally, as this thesis represents one of very few studies that have explored the implementation 
of an internet intervention into routine practice and the adoption and use by health services and 
patients; it is difficult to draw solid conclusions as to whether the implementation succeeded or 
failed. There were very few yard sticks to guide this exploratory study and therefore definitions 
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of success or failure could not be generated or judged against. Similarly, for the use of HeLP-
Diabetes by patients there were no predefined markers of the amount or type of use that was 
expected by patients. As described in Chapter 10, a tension between the goals of internet 
interventions for diabetes self-management (to be used) and the goals of self-management 
education to increase patient knowledge and confidence which may then result in patients not 
feeling the need to use them, has important implications for understanding what might be 
effective use of an intervention like HeLP-Diabetes and what the expected use should be.  
Further studies of this nature are needed in order to increase understanding of these issues. 
 
11.4 Implications of the findings 
The findings of this research have implications for practice, policy, research and the 
development of internet based interventions for diabetes.  
 
11.4.1 Implications for practice 
The findings from this thesis suggest that HeLP-Diabetes can be implemented into healthcare 
services and does provide an alternative form of diabetes education to patients that is 
acceptable to both staff and patients. However, in order for an internet intervention like HeLP-
Diabetes to become part of routine practice, it needs to be much better resourced within the 
services in which it is to be used. Resources are needed in terms of staff availability to 
undertake the tasks of implementing it including promoting it to other staff, recommending it to 
patients and facilitating patient access. Time pressures within consultations prevented HeLP-
Diabetes from being more widely implemented, and given the current NHS climate, this is 
unlikely to change for GPs and nurses. Mobilising other staff such as health care assistants, 
receptionists or having a dedicated change manager to undertake the role that I had in the 
implementation process is likely to increase the chances of implementation.   
 
The findings from staff interviews, and the implementation data from practices where I provided 
assistance to register patients suggests that it may be crucial to have a dedicated person to 
take responsibility for the implementation of interventions like HeLP-Diabetes within practices. 
However, these individuals require the support of other staff within the practice to keep the work 
as a legitimate part of their role. This research provided useful data to help inform decisions as 
to which staff may be best suited to deliver interventions like this in practice. Although all health 
professionals are important in supporting patients to self-manage diabetes, nurses, because of 
their increased role in long-term condition management within the NHS were originally 
perceived to be most suitable to undertake the work of implementing HeLP-diabetes. However, 
as discussed, health care assistants and receptionists were both identified by staff as a more 
suitable group to undertake the role. Furthermore, interviews with these groups of staff revealed 
that the work of implementing HeLP-Diabetes was valued and enjoyed by them. In a context 
where GPs and practice nurses are under a considerable amount of strain to deliver services, 
the utilisation of the skill sets of other staff members to deliver interventions like HeLP-Diabetes 
to patients might be beneficial.  
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The findings from both the quantitative and qualitative data strongly point to the beneficial role 
of staff introducing patients to HeLP-Diabetes in order to engage them with the intervention. 
This finding is important as questions were raised by some staff as to why HeLP-Diabetes 
should be recommended through the NHS rather than just freely searchable on the internet. 
Patient interviews strongly suggest that the recommendation from staff was the main driving 
factor in them registering to use it and that this recommendation provided HeLP-Diabetes with a 
sense of credibility which set it apart from other online resources. Furthermore, the finding that 
staff facilitation in helping patients to register to use HeLP-Diabetes may help to make 
interventions like this more accessible to patients with lower education provides further support 
for the role of health professionals in the delivery of such interventions. 
 
11.4.2 Implications for policy 
Currently it is policy for patients with type 2 diabetes to be provided access to structured 
diabetes education within nine months of diagnosis. The findings from this work suggest that the 
assumption that diagnosis is the best time to engage people in their diabetes may not be 
accurate. Many patients may not feel ready to engage at diagnosis as they struggle to accept, 
come to terms with and cope with the diagnosis. The provision of information at this time was 
described by some as overwhelming to take in at diagnosis. Uptake of HeLP-Diabetes was not 
associated with the duration patients had had diabetes, suggesting the view expressed in 
findings from staff interviews that those who are newly diagnosed are more likely to be engaged 
with self-management is not necessarily the case. Other theories of living with a chronic 
condition suggest that people may cycle through periods of wellness and illness which impacts 
on their willingness to engage with information (269). This raises questions as to whether 
interventions providing information and support should primarily be focused at the point of 
diagnosis. People may be more ready to engage later on when the opportunity to take up 
education may not be so available. 
 
Currently group based education is the only education that is incentivised by the QOF for people 
with diabetes, however, the use of interventions like HeLP-Diabetes could be considered as a 
viable alternative. The findings from this work suggest that both patients and health 
professionals find HeLP-Diabetes to be acceptable as a form of diabetes self-management 
education, it has similar uptake to group based education, addresses several identified 
shortcomings of group based education and with facilitation, can reach a wide range of patients. 
Given the limited financial resources of the NHS, an internet intervention that can be accessed 
by a nearly unlimited number of patients could also provide a cost-effective alternative to group 
based education. Given the current drive of the NHS towards utilising health technologies, it 
seems likely that more health care will be delivered via mediums such as the internet. In order 
to make these successful, incentivisation through frameworks like the QOF should be 
considered in order for them to be given equal prioritisation by the health care professionals 
delivering them.  
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11.4.3 Implications for research  
This study has provided new insights to add to the current implementation of e-health research. 
Firstly, this study has highlighted the importance of the role of facilitation. Although one of the 
benefits of e-health interventions like HeLP-Diabetes is that they can be used autonomously by 
patients whenever and wherever they choose, it may be necessary for patients to be initially 
supported to join e-heath interventions by members of NHS staff in order to encourage uptake 
and to assist those who have lower levels of education. Similarly, ongoing encouragement of 
use may be needed to engage patients in using these interventions beyond the initial sign up 
and to sustain use. In order for this to happen behaviour change needs to occur at the level of 
the health professionals as well as the patient which may prove challenging. For future 
researchers developing and implementing e-health interventions like HeLP-Diabetes it would be 
extremely important to consider the role of facilitation and to plan strategies that will increase 
the likelihood of facilitation being delivered in order to maximise uptake and use of e-health 
interventions designed to be used by patients. 
  
Secondly, this study has shown that the digital divide may not be problematic for interventions 
like HeLP-Diabetes if they are offered to patients in a way that supports patients’ access. The 
population within the study CCG who signed up to use HeLP-Diabetes represented a diverse 
sample of patients with type 2 diabetes in terms of education and computer skills. The role of 
facilitating access is again stressed as important for helping those with lower education to 
access these types of resources, as is the careful design of interventions that are easy to use 
and accessible to a wide range of people.  
 
Finally, the importance of studying implementation has been argued throughout this thesis and 
the perceived benefits described. This study was conducted alongside the randomised control 
trial of HeLP-Diabetes. As described in Chapter 2, it was believed by the programme grant 
research team that it would be beneficial to have a study based completely in a real world 
setting to mirror what would happen if HeLP-Diabetes was commissioned by CCGs in the NHS. 
Conducting these two studies in parallel broke from the traditional linear trajectory of 
developing, evaluating and implementing complex interventions. Reflecting upon the findings of 
both the trial (Murray et al, submitted) and this implementation study has led to the conclusion 
that conducting these two studies in parallel has indeed been of great benefit. For example, the 
fact that the facilitation model developed in the trial could not be replicated in the 
implementation study proved the decision to study HeLP-Diabetes in a real world setting was 
worthwhile and has demonstrated the differences between the study settings. In addition, this 
implementation study has been able to produce modified strategies to implement HeLP-
Diabetes into routine practice that will be valuable to those commissioning it going forward, 
which would not have been available if the trial had been conducted alone. It is also true that 
the population in this implementation study varied greatly from the population that took part in 
the trial in terms of ethnicity, age, education and computer skills, thus supporting the value of 
conducting implementation studies such as this alongside trials of interventions, as even in trials 
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designed to be pragmatic and conducted in real world settings face constraints that may limit 
their generalizability to routine practice and populations. 
 
By conducting the two studies in parallel, there is now (at the end of both studies) data on both 
the efficacy of HeLP-Diabetes and the adoption and use of it within routine practice. This has 
substantially closed the gap between the development of HeLP-Diabetes and its implementation 
into routine practice, which would have been wider had one study followed the other. There is 
now data to provide to commissioners of services about the expected benefits of HeLP-
Diabetes and the expected adoption and reach. This thesis has also provided valuable 
suggestions and recommendation on ways that HeLP-Diabetes can be delivered within routine 
care optimally.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
267 
 
REFERENCES 
 
1. Rabin BA, Brownson RC, Haire-Joshu D, Kreuter MW, Weaver NL. A glossary for dissemination 
and implementation research in health. Journal of Public Health Management and Practice. 
2008;14(2):117-23. 
2. Grol R, Wensing M, Eccles M. Improving patient care: the implementation of change in clinical 
practice: Elsevier Butterworth Heinemann Edinburgh; 2005. 
3. Rogers EM. Diffusion of innovations. 5th ed: Simon and Schuster; 2003. 
4. Greenhalgh T, Robert G, Bate P, Macfarlane F, Kyriakidou O. Diffusion of Innovations in Health 
Service Organisation: A systematic literature review: Blackwell Publishing; 2005. 
5. Linton J. Technovation: Elsevier; 2002. 
6. Mowatt G, Thomson MA, Grimshaw J, Grant A. Implementing early warning messages on 
emerging health technologies. International journal of technology assessment in health care. 
1998;14(04):663-70. 
7. May C, Finch T. Implementing, embedding, and integrating practices: an outline of 
Normalization Process Theory. Sociology. 2009;43(3). 
8. Murray E, Treweek S, Pope C, MacFarlane A, Ballini L, Dowrick C, et al. Normalisation process 
theory: a framework for developing, evaluating and implementing complex interventions. BMC 
medicine. 2010;8:63. 
9. Danaei G, Finucane M, Lu Y, Singh G, Cowan M, Paciorek C, et al. Global Burden of Metabolic 
Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and 
global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic 
analysis of health examination surveys and epidemiological studies with 370 country-years and 
2.7 million participants. Lancet. 2011;378(9785):31-40. 
10. Alwan A. Global status report on noncommunicable diseases 2010: World Health Organization; 
2011. 
11. Diabetes UK. Diabetes in the UK 2012 Key statistics on diabetes 2012. 
12. Holman N, Forouhi NG, Goyder E, Wild SH. The Association of Public Health Observatories 
(APHO) Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010-
2030. Diabetic medicine : a journal of the British Diabetic Association. 2011;28(5):575-82. 
13. Mathers C, Stevens G, Mascarenhas M. Global health risks: mortality and burden of disease 
attributable to selected major risks: World Health Organization; 2009. 
14. Alberti KGMM, Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its 
complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a 
WHO consultation. Diabetic Medicine. 1998;15(7):539-53. 
15. International Classification of Diseases (ICD). International Statistical Classification of Diseases 
and Related Health Problems 10th Revision 2010 [28 October 2013]. Available from: 
http://apps.who.int/classifications/icd10/browse/2010/en. 
16. World Health Organization. ICD-10: International statistical classification of diseases and related 
health problems: World Health Organization; 2004. 
17. Department of Health. National service framework for diabetes. 2001. 
268 
 
18. Roberts S, Britain G. Working Together for Better Diabetes Care: Clinical Case for Change: 
Report: Department of Health; 2007. 
19. Kanavos P, van den Aardweg S, Schurer W. Diabetes expenditure, burden of disease and 
management in 5 EU countries. London School of Economics Health. 2012. 
20. Department of Health. Turning the Corner: Improving Diabetes Care. Report from Dr Sue 
Roberts, National Clinical Director for Diabetes, to the Secretary of State for Health. 2006. 
21. Funnell MM, Anderson RM. Empowerment and self-management of diabetes. Clinical diabetes. 
2004;22(3):123-7. 
22. Pruitt SD, Epping-Jordan JE. Preparing the 21st century global healthcare workforce. BMJ 
(Clinical research ed). 2005;330(7492):637-9. 
23. Lorig KR, Holman HR. Self-management education: history, definition, outcomes, and 
mechanisms. Annals of Behavioral Medicine. 2003;26(1):1-7. 
24. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? 
Effective clinical practice: ECP. 1998;1(1):2-4. 
25. Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for 
people with chronic conditions: a review. Patient education and counseling. 2002;48(2):177-87. 
26. Corbin JM, Strauss A. Unending work and care: Managing chronic illness at home: Jossey-
Bass; 1988. 
27. Brown SA. Studies of educational interventions and outcomes in diabetic adults: a meta-
analysis revisited. Patient education and counseling. 1990;16(3):189-215. 
28. Norris SL, Engelgau MM, Narayan KV. Effectiveness of Self-Management Training in Type 2 
Diabetes A systematic review of randomized controlled trials. Diabetes care. 2001;24(3):561-87. 
29. Nicolucci A, Cavaliere D, Scorpiglione N, Carinci F, Capani F, Tognoni G, et al. A 
comprehensive assessment of the avoidability of long-term complications of diabetes. A case-
control study. . Diabetes care. 1996;19(9):927-33. 
30. Norris SL, Lau J, Jay Smith S, Schmed CH, Engelgau MM. Self-management education for 
adults with type 2 diabetes. Diabetes care. 2002;25:1159-71. 
31. Glasgow RE, Osteen VL. Evaluating diabetes education: Are we measuring the most important 
outcomes? Diabetes care. 1992;15(10):1423-32. 
32. Davies MJ, Heller S, Skinner T, Campbell M, Carey M, Cradock S, et al. Effectiveness of the 
diabetes education and self management for ongoing and newly diagnosed (DESMOND) 
programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. 
BMJ (Clinical research ed). 2008;336(7642):-. 
33. Deakin T, Cade J, Williams R, Greenwood D. Structured patient education: the Diabetes 
X‐PERT Programme makes a difference. Diabetic Medicine. 2006;23(9):944-54. 
34. DAFNE 2002. DAFNE Study Group. Training in flexible, intensive insulin management to enable 
dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) 
randomised controlled trial. BMJ: British medical journal. 2002;325(7367):746. 
35. Health and Social Care Information Centre. National Diabetes Audit 2013-2014 and 2014-2015 
Report 1: Care Processes and Treatment Targets. 
http://digital.nhs.uk/catalogue/PUB19900/nati-diab-rep1-audi-2013-15.pdf: 2016. 
269 
 
36. Gucciardi E. A Systematic Review of Attrition from Diabetes Education Services: Strategies to 
Improve Attrition and Retention Research. Canadian Journal of Diabetes. 2008;32(1):53-65. 
37. Winkley K, Evwierhoma C, Amiel SA, Lempp HK, Ismail K, Forbes A. Patient explanations for 
non-attendance at structured diabetes education sessions for newly diagnosed Type 2 diabetes: 
a qualitative study. Diabetic medicine : a journal of the British Diabetic Association. 
2015;32(1):120-8. 
38. Glasgow RE, Christiansen SM, Kurz D, King DK, Woolley T, Faber AJ, et al. Engagement in a 
Diabetes Self-management Website: Usage Patterns and Generalizability of Program Use. 
Journal of medical Internet research. 2011;13(1):e9. 
39. Gucciardi E, DeMelo M, Offenheim A, Stewart DE. Factors contributing to attrition behavior in 
diabetes self-management programs: A mixed method approach. BMC health services 
research. 2008;8:33-. 
40. Schäfer I, Pawels M, Küver C, Pohontsch NJ, Scherer M, van den Bussche H, et al. Strategies 
for Improving Participation in Diabetes Education. A Qualitative Study. PloS one. 
2014;9(4):e95035. 
41. Graziani C, Rosenthal MP, Diamond JJ. Diabetes education program use and patient-perceived 
barriers to attendance. Family medicine. 1999;31(5):358-63. 
42. Winkley K, Stahl D, Chamley M, Stopford R, Boughdady M, Thomas S, et al. Low attendance at 
structured education for people with newly diagnosed type 2 diabetes: general practice 
characteristics and individual patient factors predict uptake. Patient education and counseling. 
2016. 
43. Eng T. The e-Health Landscape: A Terrain Map of Emerging Information and Communication 
Technologies in Health and Health Care. Princeton, NJ: The Robert Wood Johnson Foundation; 
2001. 
44. Fox S. Health topics: 80% of internet users look for health information online: Pew Internet & 
American Life Project; 2011. 
45. Office for National Statistics. Statistical bulletin: Internet users: 2015 Adults who have and have 
not used the internet in the last 3 months, including adults who have never used the internet. 
http://www.ons.gov.uk/peoplepopulationandcommunity/householdcharacteristics/homeinterneta
ndsocialmediausage/bulletins/internetaccesshouseholdsandindividuals/2015-08-06#internet-
activities: 2015. 
46. Fisher J, Burstein F, Lynch K, Lazarenko K. “Usability+ usefulness= trust”: an exploratory study 
of Australian health web sites. Internet Research. 2008;18(5):477-98. 
47. Kerr C, Murray E, Stevenson F, Gore C, Nazareth I. Internet interventions for long-term 
conditions: patient and caregiver quality criteria. Journal of medical Internet research. 
2006;8(3):e13. 
48. Bliemel M, Hassanein K. Consumer satisfaction with online health information retrieval: a model 
and empirical study. E-service Journal. 2007;5(2):53-84. 
49. Cline R, Haynes K. Consumer health information seeking on the Internet: the state of the art. 
Health education research. 2001;16(6):671-92. 
50. Lindberg DAB, Humphreys BL. Computers in medicine. JAMA: the journal of the American 
Medical Association. 1995;273(21):1667-8. 
270 
 
51. Bernhardt JM, Lariscy RAW, Parrott RL, Silk KJ, Felter EM. Perceived barriers to Internet-based 
health communication on human genetics. Journal of health communication. 2002;7(4):325-40. 
52. Taylor H, Leitman R. The increasing impact of eHealth on consumer behavior. Health Care 
News. 2001;1(21):1-9. 
53. Fox S. Peer-to-peer healthcare: Washington, DC: Pew Internet & American Life Project;; 2011. 
54. NHS England. Five Year Forward View. https://www.england.nhs.uk/wp-
content/uploads/2014/10/5yfv-web.pdf: 2014. 
55. Bennett GG, Glasgow RE. The delivery of public health interventions via the Internet: actualizing 
their potential. Annual review of public health. 2009;30:273-92. 
56. Murray E, Burns J, See TS, Lai R, Nazareth I. Interactive Health Communication Applications 
for people with chronic disease. Cochrane database of systematic reviews (Online). 2005;4. 
57. Jackson CL, Bolen S, Brancati FL, Batts‐Turner ML, Gary TL. A Systematic Review of 
Interactive Computer‐assisted Technology in Diabetes Care. Journal of general internal 
medicine. 2006;21(2):105-10. 
58. Pal K, Eastwood SV, Michie S, Farmer AJ, Barnard ML, Peacock R, et al. Computer-based 
diabetes self-management interventions for adults with type 2 diabetes mellitus. Cochrane 
Database of Systematic Reviews. 2013(3). 
59. Minet L, Møller S, Vach W, Wagner L, Henriksen JE. Mediating the effect of self-care 
management intervention in type 2 diabetes: a meta-analysis of 47 randomised controlled trials. 
Patient education and counseling. 2010;80(1):29-41. 
60. Deakin TA, McShane CE, Cade JE, Williams R. Group based training for self-management 
strategies in people with type 2 diabetes mellitus. The Cochrane Library. 2004:-. 
61. Haas L, Maryniuk M, Beck J, Cox CE, Duker P, Edwards L, et al. National standards for 
diabetes self-management education and support. Diabetes care. 2013;36(Supplement 
1):S100-S8. 
62. Cotter AP, Durant N, Agne AA, Cherrington AL. Internet interventions to support lifestyle 
modification for diabetes management: A systematic review of the evidence. Journal of 
Diabetes and its Complications. 2014;28(2):243-51. 
63. Tao D, Or CK. Effects of self-management health information technology on glycaemic control 
for patients with diabetes: a meta-analysis of randomized controlled trials. Journal of 
telemedicine and telecare. 2013. 
64. van Vugt M, de Wit M, Cleijne WHJJ, Snoek FJ. Use of Behavioral Change Techniques in Web-
Based Self-Management Programs for Type 2 Diabetes Patients: Systematic Review. Journal of 
medical Internet research. 2013;15(12):e279. 
65. Pereira K, Phillips C, Johnson A, Vorderstrasse. Internet Delivered Diabetes Self-Management 
Education: A Review. Diabetes technology & therapeutics. 2015;17(1):55-63. 
66. Bernhardt JM. Health education and the digital divide: building bridges and filling chasms. 
Health education research. 2000;15(5):527-31. 
67. Eysenbach G. The law of attrition. Journal of medical Internet research. 2005;7(1). 
68. Glasgow RE, Boles SM, McKay HG, Feil EG, Barrera M. The D-Net diabetes self-management 
program: long-term implementation, outcomes, and generalization results. Preventive medicine. 
2003;36(4):410-9. 
271 
 
69. Alkhaldi G, Hamilton FL, Lau R, Webster R, Michie S, Murray E. The Effectiveness of Prompts 
to Promote Engagement With Digital Interventions: A Systematic Review. Journal of medical 
Internet research. 2016;18(1):e6. 
70. Hardiker NR, Grant MJ. Factors that influence public engagement with eHealth: a literature 
review. International journal of medical informatics. 2011;80(1):1-12. 
71. Ström L, Pettersson R, Andersson G. A controlled trial of self-help treatment of recurrent 
headache conducted via the Internet. Journal of consulting and clinical psychology. 
2000;68(4):722. 
72. Smith L, Weinert C. Telecommunication support for rural women with diabetes. The Diabetes 
educator. 2000;26(4):645-55. 
73. Schubart JR, Stuckey HL, Ganeshamoorthy A, Sciamanna CN. Chronic health conditions and 
internet behavioral interventions: a review of factors to enhance user engagement. Computers 
Informatics Nursing. 2011;29(2):81-92. 
74. Berger RG, Kichak J. Computerized physician order entry: helpful or harmful? Journal of the 
American Medical Informatics Association. 2004;11(2):100-3. 
75. Delpierre C, Cuzin L, Fillaux J, Alvarez M, Massip P, Lang T. A systematic review of computer-
based patient record systems and quality of care: more randomized clinical trials or a broader 
approach? International Journal for Quality in Health Care. 2004;16(5):407-16. 
76. Hillestad R, Bigelow J, Bower A, Girosi F, Meili R, Scoville R, et al. Can electronic medical 
record systems transform health care? Potential health benefits, savings, and costs. Health 
Affairs. 2005;24(5):1103-17. 
77. Kaushal R, Jha AK, Franz C, Glaser J, Shetty KD, Jaggi T, et al. Return on investment for a 
computerized physician order entry system. Journal of the American Medical Informatics 
Association. 2006;13(3):261-6. 
78. Koppel R, Metlay JP, Cohen A, Abaluck B, Localio AR, Kimmel SE, et al. Role of computerized 
physician order entry systems in facilitating medication errors. Jama. 2005;293(10):1197-203. 
79. Øvretveit J, Scott T, Rundall TG, Shortell SM, Brommels M. Implementation of electronic 
medical records in hospitals: two case studies. Health policy (Amsterdam, Netherlands). 
2007;84(2):181-90. 
80. Sidorov J. It ain’t necessarily so: the electronic health record and the unlikely prospect of 
reducing health care costs. Health Affairs. 2006;25(4):1079-85. 
81. Walker J, Pan E, Johnston D, Adler-Milstein J, Bates DW, Middleton B. The value of health care 
information exchange and interoperability. Health affairs (Project Hope). 2005;Suppl Web 
Exclusives:W5-10-w5-8. 
82. Codagnone C, Lupiañez-Villanueva F. Benchmarking Deployment of eHealth among General 
Practitioners (2013). European Commssion, 2013. 
83. Patsopoulos NA. A pragmatic view on pragmatic trials. Dialogues in Clinical Neuroscience. 
2011;13(2):217-24. 
84. Zwarenstein M, Oxman A. Why are so few randomized trials useful, and what can we do about 
it? Journal of clinical epidemiology. 2006;59(11):1125-6. 
85. Treweek S, Zwarenstein M. Making trials matter: pragmatic and explanatory trials and the 
problem of applicability. Trials. 2009;10:37. 
272 
 
86. Weiss NS, Koepsell TD, Psaty BM. Generalizability of the results of randomized trials. Archives 
of internal medicine. 2008;168(2):133-5. 
87. Gaglio B, Phillips SM, Heurtin-Roberts S, Sanchez MA, Glasgow RE. How pragmatic is it? 
Lessons learned using PRECIS and RE-AIM for determining pragmatic characteristics of 
research. Implementation Science. 2014;9(1):1-11. 
88. Eccles MP, Mittman BS. Welcome to implementation science. Implementation science : IS. 
2006;1(1):1-3. 
89. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating 
complex interventions: the new Medical Research Council guidance. BMJ (Clinical research ed). 
2008;337:a1655. 
90. Peters DH, Tran N, Taghreed A. Implementation research in health: a practical guide. Alliance 
for Health Policy and Systems Research, World Health Organization.: 2013. 
91. Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: 
designing trials that are fit for purpose. BMJ (Clinical research ed). 2015;350. 
92. Panisset U, Koehlmoos TP, Alkhatib AH, Pantoja T, Singh P, Kengey-Kayondo J, et al. 
Implementation research evidence uptake and use for policy-making. Health Research Policy 
and Systems. 2012;10:20-. 
93. King M, Nazareth I, Lampe F, Bower P, Chandler M, Morou M, et al. Conceptual framework and 
systematic review of the effects of participants' and professionals' preferences in randomised 
controlled trials. Health technology assessment (Winchester, England). 2005;9(35):1-186, iii-iv. 
94. Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid 
designs: combining elements of clinical effectiveness and implementation research to enhance 
public health impact. Medical care. 2012;50(3):217-26. 
95. Stetler CB, Mittman BS, Francis J. Overview of the VA Quality Enhancement Research Initiative 
(QUERI) and QUERI theme articles: QUERI Series. Implementation science : IS. 2008;3:8-. 
96. Atkins D. QUERI and implementation research: Emerging from adolescence into adulthood: 
QUERI Series. Implementation science : IS. 2009;4:12-. 
97. May CR, Mair F, Finch T, MacFarlane A, Dowrick C, Treweek S, et al. Development of a theory 
of implementation and integration: Normalization Process Theory. Implementation science : IS. 
2009;4:29. 
98. Linke S, Brown A, Wallace P. Down Your Drink: A web-based intervention for people with 
excessive alcohol consumption. Alcohol and Alcoholism. 2004;39(1):29-32. 
99. Yardley L, Ware LJ, Smith ER, Williams S, Bradbury KJ, Arden-Close EJ, et al. Randomised 
controlled feasibility trial of a web-based weight management intervention with nurse support for 
obese patients in primary care. International Journal of Behavioral Nutrition and Physical 
Activity. 2014;11(1):1-11. 
100. Michie S, Brown J, Geraghty AW, Miller S, Yardley L, Gardner B, et al. Development of 
StopAdvisor: A theory-based interactive internet-based smoking cessation intervention. 
Translational behavioral medicine. 2012;2(3):263-75. 
101. Williams C. Living Life to the Full. http://www.llttf.com/: 2016. 
273 
 
102. Herxheimer A, McPherson A, Miller R, Shepperd S, Yaphe J, Ziebland S. Database of patients' 
experiences (DIPEx): a multi-media approach to sharing experiences and information. The 
Lancet. 2000;355(9214):1540-3. 
103. Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, et al. Assessment 
of diabetes-related distress. Diabetes Care. 1995;18(6):754-60. 
104. Welch G, Weinger K, Anderson B, Polonsky WH. Responsiveness of the Problem Areas In 
Diabetes (PAID) questionnaire. DiabetMed. 2003;20(1):69-72. 
105. Sturt J, Hearnshaw H, Wakelin M. Validity and reliability of the DMSES UK: a measure of self-
efficacy for type 2 diabetes self-management. Primary Health Care Research & Development. 
2010;11(04):374-81. 
106. EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group. 
Health Policy. 1990;16(3):199-208. 
107. Currie WL, Seddon JJ. A cross-national analysis of eHealth in the European Union: Some policy 
and research directions. Information & Management. 2014;51(6):783-97. 
108. Lewis T, Synowiec C, Lagomarsino G, Schweitzer J. E-health in low-and middle-income 
countries: findings from the Center for Health Market Innovations. Bulletin of the World Health 
Organization. 2012;90(5):332-40. 
109. van Gemert-Pijnen JE, Wynchank S, Covvey HD, Ossebaard HC. Improving the credibility of 
electronic health technologies. Bulletin of the World Health Organization. 2012;90(5):323. 
110. Public Accounts Committee. The national programme for IT in the NHS: an update on the 
delivery of detailed care records systems. United Kingdom: 2011 Forty-fifth Report of Session 
2010–12. 
111. Lau R, Stevenson F, Ong BN, Dziedzic K, Eldridge S, Everitt H, et al. Addressing the evidence 
to practice gap for complex interventions in primary care: a systematic review of reviews 
protocol. BMJ open. 2014;4(6):e005548. 
112. Sugarhood P, Wherton J, Procter R, Hinder S, Greenhalgh T. Technology as system innovation: 
a key informant interview study of the application of the diffusion of innovation model to telecare. 
Disability and Rehabilitation: Assistive Technology. 2013;9(1):79-87. 
113. Mair FS, May C, O'Donnell C, Finch T, Sullivan F, Murray E. Factors that promote or inhibit the 
implementation of e-health systems: an explanatory systematic review. Bulletin of the World 
Health Organization. 2012;90(5):357-64. 
114. van Gemert-Pijnen J, Wynchank S, Covvey H, Ossebaard H. Improving the credibility of 
electronic health technologies. Bulletin of the World Health Organization. 2012;90(5):323-A. 
115. Computing. Addenbrooke's Hospital £200m IT system proves an Epic fail. 2015. 
116. Srivastava S, Pant M, Abraham A, Agrawal N. The Technological Growth in eHealth Services. 
Computational and Mathematical Methods in Medicine. 2015;2015:18. 
117. Charles D, Gabriel M, Furukawa MF. Adoption of electronic health record systems among US 
non-federal acute care hospitals: 2008-2012. ONC data brief. 2013;9:1-9. 
118. Houses of Parliament Parliamentary Office of Science & Technology. Electronic Health 
Records. 2016. 
119. Lupton D. Critical perspectives on digital health technologies. Sociology compass. 
2014;8(12):1344-59. 
274 
 
120. Higgins J, Green S, Scholten R. Chapter 3: Maintaining reviews: updates, amendments and 
feedback.  Higgins JPT, Green S (editors) Cochrane Handbook for Systematic Reviews of 
Interventions Version 510 (updated March 2011): The Cochrane Collaboration, 2011. ; 2011. 
121. Smith V, Devane D, Begley C, Clarke M. Methodology in conducting a systematic review of 
systematic reviews of healthcare interventions. BMC medical research methodology. 
2011;11(1):15. 
122. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering 
implementation of health services research findings into practice: a consolidated framework for 
advancing implementation science. Implementation science : IS. 2009;4:50. 
123. Ross J, Stevenson F, Lau R, Murray E. Exploring the challenges of implementing e-health: a 
protocol for an update of a systematic review of reviews. BMJ open. 2015;5(4). 
124. Tong A, Flemming K, McInnes E, Oliver S, Craig J. Enhancing transparency in reporting the 
synthesis of qualitative research: ENTREQ. BMC medical research methodology. 2012;12:181. 
125. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA 
statement for reporting systematic reviews and meta-analyses of studies that evaluate 
healthcare interventions: explanation and elaboration. BMJ (Clinical research ed). 
2009;339:b2700. 
126. Noblit GW, Hare RD. Meta-ethnography: Synthesizing qualitative studies: Sage; 1988. 
127. Bearman M, Dawson P. Qualitative synthesis and systematic review in health professions 
education. Medical education. 2013;47(3):252-60. 
128. Adaji A, Schattner P, Jones K. The use of information technology to enhance diabetes 
management in primary care: a literature review. Informatics in primary care. 2008;16(3). 
129. Archer N, Fevrier-Thomas U, Lokker C, McKibbon KA, Straus SE. Personal health records: a 
scoping review. JAmMedInformAssoc. 2011;18(4):515-22. 
130. Benavides-Vaello S, Strode A, Sheeran BC. Using technology in the delivery of mental health 
and substance abuse treatment in rural communities: a review. JBehavHealth ServRes. 
2013;40(1):111-20. 
131. Boonstra A, Broekhuis M. Barriers to the acceptance of electronic medical records by 
physicians from systematic review to taxonomy and interventions. BMC Health ServRes. 
2010;10:231-. 
132. Botsis T, Hartvigsen G. Current status and future perspectives in telecare for elderly people 
suffering from chronic diseases. Journal of telemedicine and telecare. 2008;14(4):195-203. 
133. Broens THV-H, Miriam MR; Hermens, Hermie J; van Halteren, Aart T; Nieuwenhuis, Lambert 
JM. Determinants of successful telemedicine implementations: a literature study. Journal of 
telemedicine and telecare. 2007;13(6):303-9. 
134. Castillo VH, Martinez-Garcia AI, Pulido JR. A knowledge-based taxonomy of critical factors for 
adopting electronic health record systems by physicians: a systematic literature review. BMC 
MedInformDecisMak. 2010;10:60-. 
135. Demaerschalk BM, Miley ML, Kiernan T-EJ, Bobrow BJ, Corday DA, Wellik KE, et al., editors. 
Stroke telemedicine. Mayo Clinic Proceedings; 2009: Elsevier. 
275 
 
136. Fitzpatrick L, Melnikas A, Weathers M, Kachnowski S. Understanding communication capacity. 
Communication patterns and ICT usage in clinical settings. Journal of healthcare information 
management: JHIM. 2007;22(3):34-41. 
137. Fontaine P, Ross SE, Zink T, Schilling LM. Systematic review of health information exchange in 
primary care practices. JAmBoard FamMed. 2010;23(5):655-70. 
138. Gagnon MP, Desmartis M, Labrecque M, Car J, Pagliari C, Pluye P, et al. Systematic review of 
factors influencing the adoption of information and communication technologies by healthcare 
professionals. JMedSyst. 2012;36(1):241-77. 
139. Gagnon MP, Legare F, Labrecque M, Fremont P, Gagnon PP, Car J, et al. Interventions for 
promoting information and communication technologies adoption in healthcare professionals 
(Review). Cochrane Database of Systematic Reviews. 2009(1). 
140. Gagnon M-P, Nsangou E-R, Payne-Gagnon J, Grenier S, Sicotte C. Barriers and facilitators to 
implementing electronic prescription: a systematic review of user groups' perceptions. Journal of 
the American Medical Informatics Association. 2014;21(3):535-41. 
141. Goldstein DH, Phelan R, Wilson R, Ross-White A, VanDenKerkhof EG, Penning JP, et al. Brief 
review: Adoption of electronic medical records to enhance acute pain management. Canadian 
Journal of Anesthesia-Journal Canadien D Anesthesie. 2014;61(2):164-79. 
142. Gruber D, Cummings GG, Leblanc L, Smith DL. Factors influencing outcomes of clinical 
information systems implementation: a systematic review. Computers Informatics Nursing. 
2009;27(3):151-63. 
143. Hsieh CT, Lin B. Information technology for competitive advantage: the case of learning and 
innovation in behavioural healthcare service. IntJElectron Healthc. 2011;6(2-4):213-28. 
144. Jarvis-Selinger S, Chan E, Payne R, Plohman K, Ho K. Clinical telehealth across the disciplines: 
lessons learned. Telemedicine and e-Health. 2008;14(7):720-5. 
145. Jennett PG, MP; Brandstadt, HK. Preparing for success: readiness models for rural telehealth. 
Journal of postgraduate medicine. 2005;51(4):279. 
146. Jennett PS, RE; Affleck Hall, L; Hailey, D; Ohinmaa, A; Anderson, C; Thomas, R; Young, B; 
Lorenzetti, D. Policy implications associated with the socioeconomic and health system impact 
of telehealth: a case study from Canada. Telemedicine Journal and E-health. 2004;10(1):77-83. 
147. Kilsdonk E, Peute LW, Knijnenburg SL, Jaspers MW. Factors known to influence acceptance of 
clinical decision support systems. StudHealth TechnolInform. 2011;169:150-4. 
148. Kukafka RJ, Stephen B; Linfante, Allison; Allegrante, John P. Grounding a new information 
technology implementation framework in behavioral science: a systematic analysis of the 
literature on IT use. Journal of biomedical informatics. 2003;36(3):218-27. 
149. Lau F, Price M, Boyd J, Partridge C, Bell H, Raworth R. Impact of electronic medical record on 
physician practice in office settings: a systematic review. BMC MedInformDecisMak. 
2012;12:10-. 
150. Lluch M. Healthcare professionals' organisational barriers to health information technologies-a 
literature review. IntJMedInform. 2011;80(12):849-62. 
151. Lu Y-CX, Yan; Sears, Andrew; Jacko, Julie A. A review and a framework of handheld computer 
adoption in healthcare. International journal of medical informatics. 2005;74(5):409-22. 
276 
 
152. Ludwick DA, Doucette J. Adopting electronic medical records in primary care: lessons learned 
from health information systems implementation experience in seven countries. International 
journal of medical informatics. 2009;78(1):22-31. 
153. Mack EH, Wheeler DS, Embi PJ. Clinical decision support systems in the pediatric intensive 
care unit*. Pediatric Critical Care Medicine. 2009;10(1):23-8. 
154. McGinn CA, Grenier S, Duplantie J, Shaw N, Sicotte C, Mathieu L, et al. Comparison of user 
groups' perspectives of barriers and facilitators to implementing electronic health records: a 
systematic review. BMC Med. 2011;9:46-. 
155. Mollon B, Chong JJ, Holbrook AM, Sung M, Thabane L, Foster G. Features predicting the 
success of computerized decision support for prescribing: a systematic review of randomized 
controlled trials. BMC medical informatics and decision making. 2009;9(1):11. 
156. Moxey A, Robertson J, Newby D, Hains I, Williamson M, Pearson SA. Computerized clinical 
decision support for prescribing: provision does not guarantee uptake. JAmMedInformAssoc. 
2010;17(1):25-33. 
157. Ohinmaa A. What lessons can be learned from telemedicine programmes in other countries? 
Journal of telemedicine and telecare. 2006;12(suppl 2):40-4. 
158. Oluoch T, Santas X, Kwaro D, Were M, Biondich P, Bailey C, et al. The effect of electronic 
medical record-based clinical decision support on HIV care in resource-constrained settings: a 
systematic review. IntJMedInform. 2012;81(10):e83-e92. 
159. Oroviogoicoechea C, Elliott B, Watson R. Review: evaluating information systems in nursing. 
Journal of clinical nursing. 2008;17(5):567-75. 
160. Orwat C, Graefe A, Faulwasser T. Towards pervasive computing in health care–A literature 
review. BMC medical informatics and decision making. 2008;8(1):26. 
161. Peleg MT, S. Decision support, knowledge representation and management in medicine. 
Yearbook of medical informatics. 2006:72-80. 
162. Police RL, Foster T, Wong KS. Adoption and use of health information technology in physician 
practice organisations: systematic review. InformPrimCare. 2010;18(4):245-58. 
163. Rahimi B, Vimarlund V, Timpka T. Health information system implementation: a qualitative 
meta-analysis. JMedSyst. 2009;33(5):359-68. 
164. Saliba V, Legido-Quigley H, Hallik R, Aaviksoo A, Car J, McKee M. Telemedicine across 
borders: a systematic review of factors that hinder or support implementation. IntJMedInform. 
2012;81(12):793-809. 
165. Shekelle PM, Sally C; Keeler, Emmett B. Costs and benefits of health information technology. 
2006. 
166. Stolee P, Steeves B, Glenny C, Filsinger S. The use of electronic health information systems in 
home care: facilitators and barriers. HomeHealthcNurse. 2010;28(3):167-79. 
167. Studer M. The effect of organizational factors on the effectiveness of EMR system 
implementation--what have we learned? Healthc Q. 2005;8(4):92-8. 
168. Vreeman DJT, Samuel L; Rhine, Michael D; Worrell, Teddy W. Evidence for electronic health 
record systems in physical therapy. Physical therapy. 2006;86(3):434-46. 
169. Waneka R, Spetz J. Hospital information technology systems' impact on nurses and nursing 
care. JNursAdm. 2010;40(12):509-14. 
277 
 
170. Yarbrough AK, Smith TB. Technology acceptance among physicians: a new take on TAM. 
Medical Care Research and Review. 2007. 
171. Yusof MM, Stergioulas L, Zugic J. Health information systems adoption: findings from a 
systematic review. Studies in health technology and informatics. 2007;129(1):262. 
172. Charnock D, Shepperd S. Learning to DISCERN online: applying an appraisal tool to health 
websites in a workshop setting. Health education research. 2004;19(4):440-6. 
173. Lau R, Stevenson F, Ong BN, Dziedzic K, Treweek S, Eldridge S, et al. Achieving change in 
primary care—causes of the evidence to practice gap: systematic reviews of reviews. 
Implementation Science. 2016;11(1):1-39. 
174. May C. Towards a general theory of implementation. Implementation Science. 2013;8(18). 
175. French SD, Green SE, O’Connor DA, McKenzie JE, Francis JJ, Michie S, et al. Developing 
theory-informed behaviour change interventions to implement evidence into practice: a 
systematic approach using the Theoretical Domains Framework. Implementation Science. 
2012;7(1):38. 
176. Tabak RG, Khoong EC, Chambers DA, Brownson RC. Bridging research and practice: models 
for dissemination and implementation research. American journal of preventive medicine. 
2012;43(3):337-50. 
177. Rycroft-Malone J, Bucknall T. Models and frameworks for implementing evidence-based 
practice: linking evidence to action: Wiley-Blackwell; 2010. 
178. Kitson AL, Rycroft-Malone J, Harvey G, McCormack B, Seers K, Titchen A. Evaluating the 
successful implementation of evidence into practice using the PARiHS framework: theoretical 
and practical challenges. Implementation science : IS. 2008;3:1. 
179. Davies P, Walker AE, Grimshaw JM. A systematic review of the use of theory in the design of 
guideline dissemination and implementation strategies and interpretation of the results of 
rigorous evaluations. Implementation science : IS. 2010;5(14):5908-5. 
180. Eccles M, Grimshaw J, Walker A, Johnston M, Pitts N. Changing the behavior of healthcare 
professionals: the use of theory in promoting the uptake of research findings. Journal of clinical 
epidemiology. 2005;58(2):107-12. 
181. Improved Clinical Effectiveness through Behavioural Research Group. Designing theoretically-
informed implementation interventions. Implementation science : IS. 2006;1(4):-. 
182. Grol RP, Bosch MC, Hulscher ME, Eccles MP, Wensing M. Planning and studying improvement 
in patient care: the use of theoretical perspectives. Milbank Quarterly. 2007;85(1):93-138. 
183. May C, Harrison R, Finch T, MacFarlane A, Mair F, Wallace P. Understanding the normalization 
of telemedicine services through qualitative evaluation. Journal of the American Medical 
Informatics Association. 2003;10(6):596-604. 
184. Gallacher K, May CR, Montori VM, Mair FS. Understanding patients' experiences of treatment 
burden in chronic heart failure using normalization process theory. Annals of family medicine. 
2011;9(3):235-43. 
185. Elwyn G, Légaré F, van der Weijden T, Edwards A, May C. Arduous implementation: does the 
Normalisation Process Model explain why it’s so difficult to embed decision support 
technologies for patients in routine clinical practice. Implementation science : IS. 2008;3(1):57. 
278 
 
186. May CR, Finch T, Ballini L, MacFarlane A, Mair F, Murray E, et al. Evaluating complex 
interventions and health technologies using normalization process theory: development of a 
simplified approach and web-enabled toolkit. BMC health services research. 2011;11:245. 
187. Kennedy A, Rogers A, Bowen R, Lee V, Blakeman T, Gardner C, et al. Implementing, 
embedding and integrating self-management support tools for people with long-term conditions 
in primary care nursing: a qualitative study. International journal of nursing studies. 
2014;51(8):1103-13. 
188. Pope C, Halford S, Turnbull J, Prichard J, Calestani M, May C. Using computer decision support 
systems in NHS emergency and urgent care: ethnographic study using normalisation process 
theory. BMC health services research. 2013;13:-. 
189. Murray E, Burns J, May C, Finch T, O'Donnell C, Wallace P, et al. Why is it difficult to implement 
e-health initiatives? A qualitative study. Implementation science : IS. 2011;6:6. 
190. May C. A rational model for assessing and evaluating complex interventions in health care. 
BMC health services research. 2006;6:86. 
191. May C, Rapley T, Mair F, Treweek S, Murrary E, Ballini L, et al. Normalization Process Theory 
On-line Users’ Manual, Toolkit and NoMAD instrument http://www.normalizationprocess.org/npt-
toolkit2015. 
192. Grol R, Wensing M, Hulscher M, Eccles M. Theories on implementation of change in healthcare.  
Improving Patient Care The Implementation of Change in Clinical Practice: Elsevier; 2005. p. 
15-57. 
193. National Institute for Health and Clinical Excellence. Clinical Guideline 66: Type 2 diabetes. 
National guideline for management in primary and secondary care (update). National 
Collaborating Centre for Chronic Conditions. London: Royal College of Physicians, 2008. 
194. National Diabetes Audit. National Diabetes Audit 2010-2011 Report into the Data Quality of 
Diabetes Structured Education. http://digital.nhs.uk/catalogue/PUB06325/nati-diab-audi-10-11-
stru-edu.pdf: 2012. 
195. Ivers NM, Sales A, Colquhoun H, Michie S, Foy R, Francis JJ, et al. No more ‘business as 
usual’ with audit and feedback interventions: towards an agenda for a reinvigorated intervention. 
Implementation Science. 2014;9(1):1-8. 
196. Medical Research Council. A framework for development and evaluation of RCTs for complex 
interventions to improve health: Medical Research Council Health Services Public Health 
Research Board.; 2000. 
197. Portela MC, Pronovost PJ, Woodcock T, Carter P, Dixon-Woods M. How to study improvement 
interventions: a brief overview of possible study types. BMJ Quality & Safety. 2015. 
198. Bauer MS, Damschroder L, Hagedorn H, Smith J, Kilbourne AM. An introduction to 
implementation science for the non-specialist. BMC Psychology. 2015;3(1):32. 
199. Murray E, Dack C, Barnard M, Farmer A, Li J, Michie S, et al. HeLP-Diabetes: randomised 
controlled trial protocol. BMC health services research. 2015;15(1):578. 
200. Molloy LE, Moore JE, Trail J, Van Epps JJ, Hopfer S. Understanding real-world implementation 
quality and "active ingredients" of PBIS. Prevention science : the official journal of the Society 
for Prevention Research. 2013;14(6):593-605. 
279 
 
201. Crowe S, Cresswell K, Robertson A, Huby G, Avery A, Sheikh A. The case study approach. 
BMC medical research methodology. 2011;11(1):100. 
202. Yin RK. Case study research: Design and methods: Sage publications; 2013. 
203. Stake RE. The Art of Case Study Research: Sage; 1995. 
204. Grandy G. Instrumental Case Study. Encyclopedia of Case Study Research. SAGE 
Publications, Inc. Thousand Oaks, CA: SAGE Publications, Inc.; 2010. 474-6 p. 
205. Guba EG. Naturalistic evaluation. New directions for program evaluation. 1987;1987(34):23-43. 
206. Tashakkori A, Teddlie C. Sage handbook of mixed methods in social & behavioral research: 
Sage; 2010. 
207. Johnson RB, Onwuegbuzie AJ. Mixed methods research: A research paradigm whose time has 
come. Educational researcher. 2004;33(7):14-26. 
208. Morgan DL. Paradigms lost and pragmatism regained methodological implications of combining 
qualitative and quantitative methods. Journal of mixed methods research. 2007;1(1):48-76. 
209. Creswell JW, Clark VLP. Designing and conducting mixed methods research. 2007. 
210. Health and Social Care Information Centre. Recorded disease prevalence, achievements and 
exceptions. Quality and Outcomes Framework (QOF) for April 2013 - March 2014, England. 
http://digital.nhs.uk/catalogue/PUB157512014. 
211. Siddiqui MA, Khan MF, Carline TE. Gender Differences in Living with Diabetes Mellitus. Materia 
Socio-Medica. 2013;25(2):140-2. 
212. Bidmon S, Terlutter R. Gender Differences in Searching for Health Information on the Internet 
and the Virtual Patient-Physician Relationship in Germany: Exploratory Results on How Men 
and Women Differ and Why. Journal of medical Internet research. 2015;17(6):e156. 
213. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its 
Complications Report of a WHO Consultation. World Health Organization, Department of 
Noncommunicable Disease Surveillance, Geneva, 1999. 
214. Newbury D. Diaries and fieldnotes in the research process. . Research issues in Art Design and 
Media. 2001;1:1-17. 
215. Mays N, Pope C. Qualitative Research: Observational methods in health care settings. BMJ 
(Clinical research ed). 1995;311(6998):182-4. 
216. Macfarlane A, O'Reilly-de Brun M. Using a theory-driven conceptual framework in qualitative 
health research. Qualitative health research. 2012;22(5):607-18. 
217. Mair FS, Hiscock J, Beaton SC. Understanding factors that inhibit or promote the utilization of 
telecare in chronic lung disease. Chronic illness. 2008;4(2):110-7. 
218. Glaser B, Vs E. Forcing: Basics of Grounded Theory Analysis. San Francisco, CA: The 
Sociology Press; 1992. 
219. McEvoy R, Ballini L, Maltoni S, O’Donnell CA, Mair FS, MacFarlane A. A qualitative systematic 
review of studies using the normalization process theory to research implementation processes. 
Implementation Science. 2014;9(1):1-13. 
220. Aarts JWM, Faber MJ, Cohlen BJ, Van Oers A, Nelen WLDM, Kremer JAM. Lessons learned 
from the implementation of an online infertility community into an IVF clinic's daily practice. 
Human Fertility. 2015;18(4):238-47. 
280 
 
221. Gill P, Stewart K, Treasure E, Chadwick B. Methods of data collection in qualitative research: 
interviews and focus groups. British dental journal. 2008;204(6):291-5. 
222. Smith EM. Telephone interviewing in healthcare research: a summary of the evidence. Nurse 
researcher. 2005;12(3):32-41. 
223. Holbrook AL, Green MC, Krosnick JA. Telephone versus Face-to-Face Interviewing of National 
Probability Samples with Long Questionnaires: Comparisons of Respondent Satisficing and 
Social Desirability Response Bias. Public Opinion Quarterly. 2003;67(1):79-125. 
224. Richards H, Emslie C. The ‘doctor’ or the ‘girl from the University’? Considering the influence of 
professional roles on qualitative interviewing. Family practice. 2000;17(1):71-5. 
225. Hoddinott P, Pill R. Qualitative research interviewing by general practitioners. A personal view of 
the opportunities and pitfalls. Family practice. 1997;14(4):307-12. 
226. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative research in psychology. 
2006;3(2):77-101. 
227. Umukoro GF, Kuye LO, Abdul-Hameed AS. Matching strategies to situations: Programmed and 
adaptive implementation approaches. Serbian Journal of Management. 2009;4(2):259-72. 
228. Kilbourne AM, Abraham KM, Goodrich DE, Bowersox NW, Almirall D, Lai Z, et al. Cluster 
randomized adaptive implementation trial comparing a standard versus enhanced 
implementation intervention to improve uptake of an effective re-engagement program for 
patients with serious mental illness. Implementation Science. 2013;8(1):136. 
229. Lingard L, Albert M, Levinson W. Grounded theory, mixed methods, and action research. BMJ 
(Clinical research ed). 2008;337(aug07_3):a567-a. 
230. The Evidence Hub. Islington: Census 2011 Second Release. 
http://evidencehub.islington.gov.uk/Demographics/census/Pages/default.aspx: 2016  Contract 
No.: 20.04.2016. 
231. Islington Clinical Commissioning Group. About us http://www.islingtonccg.nhs.uk/about-us2016. 
232. Brown M. Islington’s Approach to Integrated Care. http://www.selfcareforum.org/wp-
content/uploads/2014/08/Islingtons.Approach.to_.Integrated.Care_.pdf: 2014. 
233. Diabetes UK. Year of Care: Report of findings from the pilot programme. London: Diabetes UK. 
2011. 
234. The Guardian. NHS reforms: 100 voices - interactive 2012 [updated 15 March 2012]. Available 
from: http://www.theguardian.com/society/interactive/2012/mar/15/nhs-reforms-100-voices-
interactive. 
235. Islington Council & Clinical Commissioning Group. Adult Joint Commissioning Strategy 2012-
2017 2012. Available from: http://www.islington.gov.uk/publicrecords/library/Health-and-social-
care/Information/Advice-and-information/2012-2013/(2012-10-02)-Joint-Commssioning-
Strategy-final.pdf. 
236. Hobbs FDR, Bankhead C, Mukhtar T, Stevens S, Perera-Salazar R, Holt T, et al. Clinical 
workload in UK primary care: a retrospective analysis of 100 million consultations in England, 
2007-14. The Lancet. 2016. 
237. Alderwick H, Ham C. NHS in England embraces collaboration in tackling biggest crisis in its 
history. BMJ (Clinical research ed). 2016;352. 
281 
 
238. Royal College of General Practitioners. Patient safety implications of general practice workload. 
London: Royal College of General Practitioners. 2015. 
239. Doran N, Fox F, Rodham K, Taylor G, Harris M. Lost to the NHS: a mixed methods study of why 
GPs leave practice early in England. British Journal of General Practice. 2016;66(643):e128-
e35. 
240. Health and Social Care Information Centre. General and Personal Medical Services England 
2004-14. http://digital.nhs.uk/catalogue/PUB16934: 2015. 
241. The Independent. Thousands of patients forced to hunt for a new GP as staffing shortages 
accelerate practice closures. 2015 Sunday 31 May 2015. Report No. 
242. All-party parliamentary group for diabetes. Taking Control: Supporting people to self-manage 
their diabetes, March 2015. 2015  
243. NHS Employers. 2015/16 General Medical Services (GMS) contract Quality and Outcomes 
Framework (QOF) Guidance for GMS contract 2015/16. 2015. 
244. Wallace LM, Turner A, Kosmala-Anderson J, Sharma S, Jesuthasan J, Bourne C, et al. Co-
creating Health: Evaluation of first phase: An independent evaluation of the Health Foundation's 
Co-creating Health improvement programme. http://www.health.org.uk/publication/co-creating-
health-evaluation-first-phase#sthash.pq6fneOW.dpuf: The Health Foundation,, 2012. 
245. Weiner BJ, Helfrich CD, Savitz LA, Swiger KD. Adoption and implementation of strategies for 
diabetes management in primary care practices. American journal of preventive medicine. 
2007;33(1 Suppl):S35-44; quiz S5-9. 
246. Rushforth B, McCrorie C, Glidewell L, Midgley E, Foy R. Barriers to effective management of 
type 2 diabetes in primary care: qualitative systematic review. British Journal of General 
Practice. 2016;66(643):e114-e27. 
247. Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Barriers to diabetes management: patient 
and provider factors. Diabetes research and clinical practice. 2011;93(1):1-9. 
248. Baird B, Charles A, Honeyman M, Maguire D, Das P. Understanding pressures in general 
practice. The King's Fund: 2016. 
249. Kaplan HC, Brady PW, Dritz MC, Hooper DK, Linam WM, Froehle CM, et al. The Influence of 
Context on Quality Improvement Success in Health Care: A Systematic Review of the 
Literature. Milbank Quarterly. 2010;88(4):500-59. 
250. Lau R, Stevenson F, Ong BN, Dziedzic K, Treweek S, Eldridge S, et al. Achieving change in 
primary care—effectiveness of strategies for improving implementation of complex 
interventions: systematic review of reviews. BMJ open. 2015;5(12). 
251. Ehrlich C, Kendall E, St John W. How does care coordination provided by registered nurses "fit" 
within the organisational processes and professional relationships in the general practice 
context? Collegian. 2013;20(3):127-35. 
252. Murray E, Linke S, Harwood E, Conroy S, Stevenson F, Godfrey C. Widening access to 
treatment for alcohol misuse: description and formative evaluation of an innovative web-based 
service in one primary care trust. Alcohol and alcoholism (Oxford, Oxfordshire). 2012;47(6):697-
701. 
282 
 
253. Glasgow RE, Nelson CC, Strycker LA, King DK. Using RE-AIM Metrics to Evaluate Diabetes 
Self-Management Support Interventions. American journal of preventive medicine. 
2006;30(1):67-73. 
254. Owen JE, Bantum EOC, Criswell K, Bazzo J, Gorlick A, Stanton AL. Representativeness of two 
sampling procedures for an internet intervention targeting cancer-related distress: a comparison 
of convenience and registry samples. Journal of Behavioral Medicine. 2013;37(4):630-41. 
255. Andersson G, Carlbring P, Cuijpers P. Internet interventions: Moving from efficacy to 
effectiveness. Sensoria: A Journal of Mind, Brain & Culture. 2010;5(2):9-17. 
256. Andersson G, Bergstrom J, Hollandare F, Carlbring P, Kaldo V, Ekselius L. Internet-based self-
help for depression: randomised controlled trial. The British journal of psychiatry : the journal of 
mental science. 2005;187:456-61. 
257. Wallace P, Murray E, McCambridge J, Khadjesari Z, White IR, Thompson SG, et al. On-line 
Randomized Controlled Trial of an Internet Based Psychologically Enhanced Intervention for 
People with Hazardous Alcohol Consumption. PloS one. 2011;6(3):e14740. 
258. Kerr C, Murray E, Noble L, Morris R, Bottomley C, Stevenson F, et al. The potential of Web-
based interventions for heart disease self-management: a mixed methods investigation. Journal 
of medical Internet research. 2010;12(4):e56. 
259. Kim CJ, Kang DH. Utility of a Web-based intervention for individuals with type 2 diabetes: the 
impact on physical activity levels and glycemic control. Computers, informatics, nursing : CIN. 
2006;24(6):337-45. 
260. Carter EL, Nunlee-Bland G, Callender C. A patient-centric, provider-assisted diabetes telehealth 
self-management intervention for urban minorities. Perspectives in health information 
management / AHIMA, American Health Information Management Association. 2011;8:1b. 
261. Feil EG, Glasgow RE, Boles S, McKay HG. Who participates in Internet-based self-
management programs? A study among novice computer users in a primary care setting. The 
Diabetes educator. 2000;26(5):806-11. 
262. Glasgow RE, Kurz D, King D, Dickman JM, Faber AJ, Halterman E, et al. Outcomes of minimal 
and moderate support versions of an internet-based diabetes self-management support 
program. Journal of general internal medicine. 2010;25(12):1315-22. 
263. Noh JH, Cho YJ, Nam HW, Kim JH, Kim DJ, Yoo HS, et al. Web-based comprehensive 
information system for self-management of diabetes mellitus. Diabetes technology & 
therapeutics. 2010;12(5):333-7. 
264. Liebreich T, Plotnikoff RC, Courneya KS, Boulé N. Diabetes NetPLAY: A physical activity 
website and linked email counselling randomized intervention for individuals with type 2 
diabetes. International Journal of Behavioral Nutrition and Physical Activity. 2009;6(1):1-15. 
265. Lorig K, Ritter PL, Laurent DD, Plant K, Green M, Jernigan VBB, et al. Online diabetes self-
management program A randomized study. Diabetes care. 2010;33(6):1275-81. 
266. McKay HG, King D, Eakin EG, Seeley JR, Glasgow RE. The diabetes network internet-based 
physical activity intervention: A randomized pilot study. Diabetes care. 2001;24. 
267. Kalantzi S, Kostagiolas P, Kechagias G, Niakas D, Makrilakis K. Information seeking behavior of 
patients with diabetes mellitus: a cross-sectional study in an outpatient clinic of a university-
affiliated hospital in Athens, Greece. BMC research notes. 2015;8(1):1-7. 
283 
 
268. Pal K, Dack C, Ross J, May C, Michie S, Farmer A, et al. Patient wants and needs for online 
diabetes selfmanagement education and support: a qualitative study. Diabetic Medicine. 
Submitted. 
269. Paterson BL. The shifting perspectives model of chronic illness. Journal of nursing scholarship : 
an official publication of Sigma Theta Tau International Honor Society of Nursing / Sigma Theta 
Tau. 2001;33(1):21-6. 
270. Brouwer W, Kroeze W, Crutzen R, de Nooijer J, de Vries NK, Brug J, et al. Which intervention 
characteristics are related to more exposure to internet-delivered healthy lifestyle promotion 
interventions? A systematic review. Journal of medical Internet research. 2011;13(1):e2. 
271. Blanford A. Co-evolving Roles and Technologies in the NHS: Barriers and Forces for Change: 
ESRC Full Research Report, RES-335-25-0032. Swindon: ESRC: 2007. 
272. Crutzen R, de Nooijer J, Brouwer W, Oenema A, Brug J, de Vries NK. Strategies to Facilitate 
Exposure to Internet-Delivered Health Behavior Change Interventions Aimed at Adolescents or 
Young Adults: A Systematic Review. Health Education & Behavior. 2010. 
273. Longo DR, Schubert SL, Wright BA, LeMaster J, Williams CD, Clore JN. Health information 
seeking, receipt, and use in diabetes self-management. Annals of family medicine. 
2010;8(4):334-40. 
274. Morrow AS, Haidet P, Skinner J, Naik AD. Integrating diabetes self-management with the health 
goals of older adults: a qualitative exploration. Patient education and counseling. 
2008;72(3):418-23. 
275. Sillence E, Hardy C, Briggs P, Harris PR. How do people with asthma use Internet sites 
containing patient experiences? Patient education and counseling. 2013. 
276. Sillence E, Briggs P. Please advise: using the Internet for health and financial advice. 
Computers in Human Behavior. 2007;23(1):727-48. 
277. Sillence E, Briggs P, Fishwick L, Harris P, editors. Trust and mistrust of online health sites. 
Proceedings of the SIGCHI conference on Human factors in computing systems; 2004: ACM. 
278. Sillence E, Briggs P, Harris P, Fishwick L. Health Websites that people can trust - the case of 
hypertension. Interacting with Computers. 2007;19(1):32-42. 
279. Sillence E, Briggs P, Harris PR, Fishwick L. How do patients evaluate and make use of online 
health information? Social Science & Medicine. 2007;64(9):1853-62. 
280. Yang Q, Beatty M. A meta-analytic review of health information credibility: Belief in physicians or 
belief in peers? The HIM journal. 2016. 
281. Health Innovation Network. Structured Education for Type 2 diabetes A toolkit for optimal 
delivery. http://www.hin-
southlondon.org/system/resources/resources/000/000/047/original/Structured_Education_Toolki
t_(Final).pdf?1412668611: 2015. 
282. Foy R, Ovretveit J, Shekelle PG, Pronovost PJ, Taylor SL, Dy S, et al. The role of theory in 
research to develop and evaluate the implementation of patient safety practices. BMJ Quality & 
Safety. 2011;20(5):453-9. 
283. Davidoff F, Dixon-Woods M, Leviton L, Michie S. Demystifying theory and its use in 
improvement. BMJ Quality & Safety. 2015. 
284 
 
284. Palinkas LA, Aarons GA, Horwitz S, Chamberlain P, Hurlburt M, Landsverk J. Mixed Method 
Designs in Implementation Research. Administration and Policy in Mental Health and Mental 
Health Services Research. 2010;38(1):44-53. 
285. Winkler JD, Lohr KN, Brook RH. Persuasive communication and medical technology 
assessment. Archives of internal medicine. 1985;145(2):314-7. 
286. Scullion PA. Effective dissemination strategies. Nurse Res. 2002;10(1):65-77. 
287. Anderson M, Cosby J, Swan B, Moore H, Broekhoven M. The use of research in local health 
service agencies. Social science & medicine (1982). 1999;49(8):1007-19. 
288. Kingdon J. Agendas, alternatives, and public policies. 1984. 
289. Lester JP. The utilization of policy analysis by state agency officials. Science Communication. 
1993;14(3):267-90. 
290. Kramer DM, Cole DC. Sustained, Intensive Engagement to Promote Health and Safety 
Knowledge Transfer to and Utilization by Workplaces. Science Communication. 2003;25(1):56-
82. 
291. Riley BL, Stachenko S, Wilson E, Harvey D, Cameron R, Farquharson J, et al. Can the 
Canadian Heart Health Initiative inform the population Health Intervention Research Initiative for 
Canada? Canadian journal of public health Revue canadienne de sante publique. 
2009;100(1):Suppl I20-6. 
292. Owen N, Glanz K, Sallis JF, Kelder SH. Evidence-based approaches to dissemination and 
diffusion of physical activity interventions. American journal of preventive medicine. 2006;31(4 
Suppl):S35-44. 
293. Yuan CT, Nembhard IM, Stern AF, Brush JE, Jr., Krumholz HM, Bradley EH. Blueprint for the 
dissemination of evidence-based practices in health care. Issue brief (Commonwealth Fund). 
2010;86:1-16. 
294. Jacobson N, Butterill D, Goering P. Development of a framework for knowledge translation: 
understanding user context. Journal of health services research & policy. 2003;8(2):94-9. 
295. Atun R, de Jongh T, Secci F, Ohiri K, Adeyi O. Integration of targeted health interventions into 
health systems: a conceptual framework for analysis. Health policy and planning. 
2010;25(2):104-11. 
296. Langley GJ, Moen R, Nolan KM, Nolan TW, Norman CL, Provost LP. The improvement guide: a 
practical approach to enhancing organizational performance: John Wiley & Sons; 2009. 
297. Baumbusch JL, Kirkham SR, Khan KB, McDonald H, Semeniuk P, Tan E, et al. Pursuing 
common agendas: a collaborative model for knowledge translation between research and 
practice in clinical settings. Research in nursing & health. 2008;31(2):130-40. 
298. Lomas J. Retailing research: increasing the role of evidence in clinical services for childbirth. 
The Milbank quarterly. 1993;71(3):439-75. 
299. Funk SG, Tornquist EM, Champagne MT. A model for improving the dissemination of nursing 
research. Western journal of nursing research. 1989;11(3):361-72. 
300. Dobbins M, Ciliska D, Cockerill R, Barnsley J, DiCenso A. A Framework for the Dissemination 
and Utilization of Research for Health-Care Policy and Practice. Worldviews on Evidence-based 
Nursing presents the archives of Online Journal of Knowledge Synthesis for Nursing. 
2002;E9(1):149-60. 
285 
 
301. Mendel P, Meredith LS, Schoenbaum M, Sherbourne CD, Wells KB. Interventions in 
organizational and community context: a framework for building evidence on dissemination and 
implementation in health services research. Administration and policy in mental health. 
2008;35(1-2):21-37. 
302. Robinson K, Elliott SJ, Driedger SM, Eyles J, O'Loughlin J, Riley B, et al. Using linking systems 
to build capacity and enhance dissemination in heart health promotion: a Canadian multiple-
case study. Health education research. 2005;20(5):499-513. 
303. Kreuter MW. Enhancing Dissemination Through Marketing and Distribution SystemsThree 
propositions about the current environment and three recommendations for improving 
dissemination of evidence. CREd Library. 2014;4(1). 
304. Martin GW, Herie MA, Turner BJ, Cunningham JA. A social marketing model for disseminating 
research-based treatments to addictions treatment providers. Addiction (Abingdon, England). 
1998;93(11):1703-15. 
305. Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O. Diffusion of Innovations in 
Service Organizations: Systematic Review and Recommendations. The Milbank quarterly. 
2004;82(4):581-629. 
306. Harris JR. A framework for disseminating evidence-based health promotion practices. 
Preventing chronic disease. 2012;9. 
307. Ward VL, House AO, Hamer S. Knowledge brokering: exploring the process of transferring 
knowledge into action. BMC health services research. 2009;9(1):12. 
308. Ellen ME, Lavis JN, Ouimet M, Grimshaw J, Bédard P-O. Determining research knowledge 
infrastructure for healthcare systems: a qualitative study. Implementation Science. 2011;6(1):1-
5. 
309. Dearing JW, Maibach EW, Buller DB. A convergent diffusion and social marketing approach for 
disseminating proven approaches to physical activity promotion. American journal of preventive 
medicine. 2006;31(4 Suppl):S11-23. 
310. Dodson E, Brownson RC, Weiss S. Policy Dissemination Research.  Brownson, Ross C, 
Graham A Colditz, and Enola K Proctor Dissemination and implementation research in health: 
translating science to practice. Oxford University Press2012. 
311. Allen B, Currie G. Shaping strategic change: making change in large organizations. Journal of 
health services research & policy. 2011;16(3):184-6. 
312. Henriksen K, Battles JB, Marks ES, Lewin DI, Nieva VF, Murphy R, et al. From science to 
service: a framework for the transfer of patient safety research into practice. 2005. 
313. Meissner HI, Glasgow RE, Vinson CA, Chambers D, Brownson RC, Green LW, et al. The US 
training institute for dissemination and implementation research in health. Implementation 
Science. 2013;8(1):12. 
314. Wandersman A, Duffy J, Flaspohler P, Noonan R, Lubell K, Stillman L, et al. Bridging the gap 
between prevention research and practice: the interactive systems framework for dissemination 
and implementation. American journal of community psychology. 2008;41(3-4):171-81. 
315. Green LW, Orleans CT, Ottoson JM, Cameron R, Pierce JP, Bettinghaus EP. Inferring 
strategies for disseminating physical activity policies, programs, and practices from the 
286 
 
successes of tobacco control. American journal of preventive medicine. 2006;31(4 Suppl):S66-
81. 
316. Havelock RG, Guskin A, Frohman M, Havelock M, Hill M, Huber J. Planning for innovation: 
through dissemination and utilization of knowledge. Center for Research on Utilization of 
Scientific Knowledge, Michigan (EUA). 1971. 
317. Green LW, Ottoson JM, Garcia C, Hiatt RA. Diffusion theory and knowledge dissemination, 
utilization, and integration in public health. Annu Rev Public Health. 2009;30:151-74. 
318. Farkas M, Anthony WA. Bridging science to service: using Rehabilitation Research and Training 
Center program to ensure that research-based knowledge makes a difference. Journal of 
rehabilitation research and development. 2007;44(6):879-92. 
319. Kontos PC, Poland BD. Mapping new theoretical and methodological terrain for knowledge 
translation: contributions from critical realism and the arts. Implementation Science. 2009;4(1):1-
10. 
320. Green LW, Kreuter MW. Health program planning: An educational and ecological approach: 
McGraw-Hill New York; 2005. 
321. Dreisinger ML, Boland EM, Filler CD, Baker EA, Hessel AS, Brownson RC. Contextual factors 
influencing readiness for dissemination of obesity prevention programs and policies. Health 
education research. 2012;27(2):292-306. 
322. Majdzadeh R, Sadighi J, Nejat S, Mahani AS, Gholami J. Knowledge translation for research 
utilization: design of a knowledge translation model at Tehran University of Medical Sciences. 
The Journal of continuing education in the health professions. 2008;28(4):270-7. 
323. Frambach RT, Schillewaert N. Organizational innovation adoption: a multi-level framework of 
determinants and opportunities for future research. Journal of Business Research. 
2002;55(2):163-76. 
324. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion 
interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322-7. 
325. Damush T, Bravata D, Plue L, Woodward-Hagg H, Williams L. Facilitation of Best Practices 
(FAB) Framework. Stroke QUERI Center annual report. 2008. 
326. Bauman AE, Nelson DE, Pratt M, Matsudo V, Schoeppe S. Dissemination of physical activity 
evidence, programs, policies, and surveillance in the international public health arena. American 
journal of preventive medicine. 2006;31(4 Suppl):S57-65. 
327. Bowen S, Zwi AB. Pathways to “Evidence-Informed” Policy and Practice: A Framework for 
Action. PLoS medicine. 2005;2(7):e166. 
328. Collins C, Harshbarger C, Sawyer R, Hamdallah M. The diffusion of effective behavioral 
interventions project: development, implementation, and lessons learned. AIDS education and 
prevention : official publication of the International Society for AIDS Education. 2006;18(4 Suppl 
A):5-20. 
329. Feldstein AC, Glasgow RE. A practical, robust implementation and sustainability model (PRISM) 
for integrating research findings into practice. Joint Commission journal on quality and patient 
safety / Joint Commission Resources. 2008;34(4):228-43. 
287 
 
330. Fixsen DL, Naoom SF, Blase KA, Friedman RM, Wallace F. Implementation Research: A 
Synthesis of the Literature. Tampa, FL: University of South Florida, Louis de la Parte Florida 
Mental Health Institute, The National Implementation Research Network 2005. 
331. Weiner BJ, Lewis MA, Linnan LA. Using organization theory to understand the determinants of 
effective implementation of worksite health promotion programs. Health education research. 
2009;24(2):292-305. 
332. Klein KJ, Conn AB, Sorra JS. Implementing computerized technology: an organizational 
analysis. J Appl Psychol. 2001;86(5):811-24. 
333. Rycroft-Malone J. The PARIHS Framework—A Framework for Guiding the Implementation of 
Evidence-based Practice. Journal of nursing care quality. 2004;19(4):297-304. 
334. Pronovost PJ, Berenholtz SM, Needham DM. Translating evidence into practice: a model for 
large scale knowledge translation. BMJ (Clinical research ed). 2008;337. 
335. Elwyn G, Taubert M, Kowalczuk J. Sticky knowledge: A possible model for investigating 
implementation in healthcare contexts. Implementation Science. 2007;2(1):1-8. 
336. Kilbourne AM, Neumann MS, Pincus HA, Bauer MS, Stall R. Implementing evidence-based 
interventions in health care: application of the replicating effective programs framework. 
Implementation science : IS. 2007;2:42. 
337. Glisson C, Schoenwald SK. The ARC organizational and community intervention strategy for 
implementing evidence-based children's mental health treatments. Mental health services 
research. 2005;7(4):243-59. 
338. Aarons GA, Hurlburt M, Horwitz SM. Advancing a conceptual model of evidence-based practice 
implementation in public service sectors. Administration and policy in mental health. 
2011;38(1):4-23. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
288 
 
LIST OF ABBREVIATIONS 
 
CBT Cognitive Behavioural Therapy 
CCG Clinical Commissioning Group 
CDSS Clinical Decision Support Systems 
CFIR Consolidated Framework for Integrating Research 
CISs Clinical Information Systems 
DESMOND Diabetes Education and Self Management for Ongoing and Diagnosed 
DSME Diabetes Self Management Education 
EHIS Electronic Health Information Systems 
EHR Electronic Health Records 
EMR Electronic Medical Records 
GP General Practitioner 
HbA1c Glycated Hemoglobin 
HeLP-Diabetes Healthy Living for People with Type 2 Diabetes 
HIE Health Information Exchange 
HISs Healthcare Information Systems 
HITs Health Information Technologies 
ICT Information and Communication Technologies 
LCS Locally Commissioned Services 
LES Locally Enhanced Services 
MRC Medical Research Council 
NHS National Health Service 
NICE National Institute for Health and Care Excellence 
NIHR National Institute for Health Research 
NPM Normalization Process Model 
NPT Normalization Process Theory 
PDAs Personal Digital Assistants 
PHRs Electronic Personal Health Record Systems 
PPI Patient and Public Involvement 
QOF Quality and Outcomes Framework 
WHO World Health Organisation 
YOC Year Of Care 
 
 
 
 
 
 
 
 
 
289 
 
APPENDICES 
 
Appendix A Literature Review Search Strategy 
 
1) exp Medical Informatics Applications/ 
2) exp Management Information Systems/ 
3) exp Decision Making, Computer-Assisted/ 
4) exp Diagnosis, Computer-Assisted/ 
5) exp Therapy, Computer-Assisted/ 
6) exp Medical Records Systems, Computerized/ 
7) exp Medical Order Entry Systems/ 
8) exp Electronic Mail/ 
9) exp Videoconferencing/ 
10) exp Telemedicine/ 
11) exp Computer Communication Networks/ 
12) exp Internet/ 
13) 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 
14) "Routin*"[title, original title, abstract, name of substance word, subject heading 
word]  
15) “Normali?*”[title, original title, abstract, name of substance word, subject heading 
word]  
16) "Integrat*"[title, original title, abstract, name of substance word, subject heading 
word]  
17) "Facilitate*"[title, original title, abstract, name of substance word, subject heading 
word] 
18) "Barrier*"[title, original title, abstract, name of substance word, subject heading 
word] 
19) "Implement*"[title, original title, abstract, name of substance word, subject heading 
word]  
20) "Adopt*"[title, original title, abstract, name of substance word, subject heading 
word]  
21) 14 or 15 or 16 or 17 or 18 or 19 or 20 
22) 13 and 21 
23) limit 22 to (meta analysis or systematic reviews)  
24) limit 23 to yr="2009 -Current" 
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Appendix B Summary details of the forty-four included studies 
 
Author/ 
Date (date published online if 
different)/ 
Country of origin of 1st author 
Aim/purpose Setting Type of e-Health  Number of papers 
included 
Summary of main factors 
that influence e-health 
implementation 
Adaji et al. 
2008 
Australia 
 
To demonstrate the 
benefits of information 
technology in supporting 
a systematic approach to 
diabetes management in 
general practice and to 
increase understanding 
of perceived barriers to 
and facilitators to the use 
of information technology 
in this context.  
Primary care Information and 
Communication 
Technologies (ICT)  
29 Barriers: confidentiality 
concerns, inadequate 
funding, workforce 
shortages, lack of time and 
anxiety about change. 
Facilitators: Adequate 
training and integration into 
the usual process of care. 
Archer et al. 
2011 
Canada 
 
To review the literature 
on personal health record 
systems and to describe 
the design, functionality, 
implementations, 
applications, outcomes, 
and perceived and real 
benefits of personal 
Not defined Electronic Personal 
Health Record 
Systems 
130 PHR adoption is dependent 
on growth in electronic 
medical record adoption. 
Patient-oriented 
functionalities need to be 
provided to support self-
management and disease 
prevention. 
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health record systems, 
with an emphasis on 
experience in the USA 
and Canada. 
Benavides-Vaello et al. 
2013 
USA 
 
To explore the advances 
and uses of 
telecommunications 
technology, and related 
issues, in the delivery of 
mental health and 
substance abuse 
treatment services within 
rural areas. 
Mental health and 
substance abuse 
treatment services 
within rural areas 
Telehealth 38 Costs; financial sustainability 
was one of the primary 
barriers to expansion of 
telehealth services in rural 
areas. 
Boonstra and Broekhuis  
2010 
Netherlands 
 
To identify, categorise, 
and analyse barriers 
perceived by physicians 
to the adoption of 
electronic medical 
records in order to 
provide implementers 
with beneficial 
intervention options. 
Not defined Electronic Medical 
Records (EMR) 
22 Financial, technical, time, 
psychological, social, legal, 
organisational and change 
process. 
Botsis et al. 
2008 
Norway 
 
To review the literature 
on home telecare for 
elderly patients suffering 
from chronic diseases 
Homecare Home Telecare 
Systems 
54 Organisational, ethical, legal, 
design and usability issues 
need to be addressed before 
widespread implementation 
Broens et al. To identify determinants Not defined Telemedicine 45 Factors categorised as: 
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2007 
Netherlands 
 
that influence the 
implementation of 
telemedicine initiatives. 
technology, acceptance, 
financing, organisation and 
policy and legislation 
Castillo et al. 
2010 
Mexico 
 
To identify the critical 
adoption factors for 
electronic health records 
by physicians and to use 
them as a guide to 
support their adoption 
process automatically. 
Mixed Healthcare 
Information 
Systems (HIS) 
68 User attitude towards 
information systems, 
workflow impact, 
interoperability, technical 
support, communication 
among users, and expert 
support 
Demaerschalk et al. 
2009 
USA 
To describe the 
technology that makes 
stroke telemedicine 
possible, the members 
that should be included in 
a telestroke team, the 
hub-and-spoke 
characteristics of a 
telestroke network, and 
the format of a typical 
consultation. 
Hospitals Telemedicine not stated The long term sustainability 
and growth of telestroke 
practice remain threatened 
by unresolved legal, 
economic, and market 
factors 
Fitzpatrick et al. 
2008 
USA 
To gain a better 
understanding of 
communication problems 
in healthcare settings and 
identify gaps in the 
research.  
Mixed Information And 
Communication 
Technologies (ICT)  
98 Social and organisational 
culture 
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Fontaine et al. 
2010 
USA 
To gain a fuller 
understanding of the 
factors associated with 
health information 
exchange adoption by 
primary care practices. 
Primary Care Health Information 
Exchange (HIE) 
64 Cost, security and privacy 
issues, liability, leadership, 
strategic planning, 
competition, and technical 
barriers 
Gagnon et al. 
2012 (2010) 
Canada 
To systematically review 
factors that are positively 
or negatively associated 
with information and 
communication 
technology adoption by 
healthcare professionals 
in clinical settings. 
Mixed (mostly 
hospitals) 
Information and 
Communication 
Technologies (ICT)  
101 Facilitators: Perception of the 
benefits of the innovation 
and ease of use. Limiting 
factors: design, technical 
concerns, familiarity with 
ICT, and time. 
Gagnon et al. 
2009 
Canada 
To carry out a systematic 
review of the 
effectiveness of 
interventions to promote 
the adoption of 
information and 
communication 
technologies by 
healthcare professionals. 
Mixed Information and 
Communication 
Technologies (ICT)  
10 Training and audit and 
feedback. 
Gagnon et al. 
2014 (2013) 
Canada 
To review users’ 
perceptions of barriers 
and facilitators to e-
prescribing and 
Primary care E-Prescribing 34 papers 
accounting for 28 
studies 
Technical and organisational 
support. 
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implementation in 
primary care. 
Goldstein et al.  
2014 (2013) 
Canada 
To examine physician 
barriers to adopting 
electronic medical 
records as well as 
anaesthesiologists’ 
experiences. 
Not defined Electronic Medical 
Records (EMR) 
14 papers 
accounting for 12 
studies 
Identified barriers to adoption 
of were financial, 
technological, and time 
constraints. 
Gruber et al. 
2009 
Canada 
To determine the current 
evidence about the 
process and outcomes of 
the implementation of 
clinical information 
systems in healthcare 
facilities.  
Acute care facilities Clinical Information 
Systems (CIS) 
18 Clinical context and end user 
support 
Hsieh and Lin 
2011 
USA 
To identify benefits and 
challenges of the 
development and 
implementation of 
electronic medical 
records, tele-health, and 
electronic appointment 
reminders. 
Mixed (primary care 
and behavioural 
healthcare/mental 
health settings) 
Healthcare 
Information 
Systems (HIS) 
42 Personnel resistance and 
fear; availability of training, 
support and other resources 
for personnel; security and 
confidentiality; and 
infrastructure development to 
enhance clinical workflow, 
billing and collection 
activities, and quality 
assurance measures.  
Jarvis-Selinger et al. 
2008 
To provide policymakers, 
administrators, and 
Mixed Telemedicine 225 Necessary technical 
conditions need to be in 
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Canada healthcare professionals 
with an evidence-based 
foundation for informed 
decision-making 
regarding 
videoconferencing 
place and key strategies for 
organisational readiness and 
technology adoption 
Jennett and Brandstadt 
2005 
Canada 
To detail and critique the 
published international 
peer-reviewed studies 
that have focused on 
assessing telehealth 
readiness for rural and 
remote health. 
Rural Telehealth not stated An appreciation of practice 
context, strong leadership, 
and a perceived need to 
improve practice. 
Jennett et al. 
2004 
Canada 
To inform future 
telehealth policy 
directions regarding the 
socioeconomic impact of 
telehealth 
Mixed Telehealth 57 Barriers and facilitators 
included confidentiality, 
reimbursement, and legal 
and ethical considerations. 
To become fully integrated 
into the healthcare system, 
telehealth must be viewed as 
more than an add-on 
service. 
Kilsdonk et al. 
2011 
Netherlands 
To systematically review 
the status quo on what is 
known on factors 
contributing to clinical 
decision support systems 
Not defined Clinical Decision 
Support Systems 
(CDSS) 
29 Human (system use and 
user satisfaction), 
organisation (structure and 
environment and technology 
(system quality, information 
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acceptance. quality and service quality 
Kukafka et al. 
2003 
USA 
A systematic literature 
analysis was conducted 
to confirm the assertion 
that the literature on 
information technology 
use behaviour does not 
include a multi-level 
approach 
Mixed (academic non-
medical, government 
agency, academic 
medical 
centres/hospitals, 
businesses and other 
organisation) 
Information And 
Communication 
Technologies (ICT)  
24 Preparing the environment 
for change and providing 
economic resources, 
incentives, and social 
support to facilitate the 
change. A comfortable and 
flexible environment. User 
knowledge of, and belief in, 
the new system. Functional 
system which are compatible 
with the target population. 
Lau et al. 
2012 
Canada 
To examine the impact of 
electronic medical 
records in the physician 
office, factors that 
influenced their success 
and the lessons learned. 
Ambulatory Electronic Medical 
Records (EMR) 
43 Micro-level: technical design, 
performance and support 
affected usage and user 
satisfaction. Meso-level: the 
implementation process and 
resulting workflow. Macro-
level: incentives such as 
pay-for-performance were 
seen as an important driver 
for adoption. 
Lluch 
2011 
UK 
To identify the barriers to 
health information 
technology adoption from 
an organisational 
management perspective 
Mixed Health Information 
Technologies (HIT) 
79 Structure of healthcare 
organisations, Tasks, People 
policies, Incentives; and 
Information and decision 
processes 
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Lu et al. 
2005 
USA 
To examine the potential 
benefits of personal 
digital assistants as 
factors that will promote 
their adoption and 
identify barriers to their 
acceptance in healthcare.  
Any Handheld 
Computers And 
Personal Digital 
Assistants (PDA) 
95 Major barriers to adoption 
were identified as usability, 
security concerns, and lack 
of technical and 
organisational support 
Ludwick and Doucette 
2009 
Canada 
To identify the current 
state of knowledge about 
health information 
systems adoption in 
primary care and 
understand factors 
affecting implementation 
outcomes. 
Primary care Healthcare 
Information 
Systems (HIS) 
86 System design, project 
management, procurement 
and users’ previous 
experience effected 
implementation  
Mack et al. 
2009 
USA 
To review the use of 
clinical decision support 
systems available in the 
paediatric intensive care 
unit. 
Paediatric intensive 
care unit 
Clinical Decision 
Support Systems 
(CDSS) 
not stated Workflow, technological 
issues and change 
management 
McGinn et al. 
2011 
Canada 
To categorize, 
synthesize, and compare 
the perspectives of 
targeted groups of users 
(public, patients, 
healthcare professionals 
and managers) and to 
Mixed Electronic Health 
Records (EHR) 
60 Design and technical 
concerns, ease of use, 
interoperability, privacy and 
security, costs, productivity, 
familiarity and ability with 
EHR, motivation to use EHR, 
patient and healthcare 
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underline factors 
influencing electronic 
health record 
implementation specific 
to each user group. 
professional interaction, and 
lack of time and workload. 
Mollon et al. 
2009 
Canada 
To evaluate whether 
certain features of 
prescribing decision 
support systems predict 
successful 
implementation, change 
in provider behaviour, 
and change in patient 
outcomes. 
Mixed (hospital and 
ambulatory) 
Clinical Decision 
Support Systems 
(CDSS) 
41 A lack of attention to 
evidence-based optimization 
of CDSS interventions 
hampers 
the development and 
implementation  
Moxey et al. 
2010 
Australia 
To explore the barriers 
to, and facilitators of, 
clinical decision support 
systems uptake by 
physicians to guide 
prescribing decisions. 
Mixed (ambulatory and 
inpatient) 
Clinical Decision 
Support Systems 
(CDSS) 
60 papers 
accounting for 58 
studies 
Availability of hardware, 
technical support and 
training; integration of the 
system into workflows; and 
the relevance and timeliness 
of the clinical messages 
Ohinmaa 
2006 
Canada 
To assess telemedicine 
projects outside the USA 
and provide examples of 
promising results that 
could be disseminated to 
other countries.  
Mixed (non USA) Telemedicine not stated Success factors: key 
persons’ involvement in 
planning and 
implementation, extensive 
planning, the attitudes of 
participants, remote location, 
planning readiness, 
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leadership readiness, 
workplace readiness and 
technical readiness Factors 
contributing to failure: 
inadequate needs 
assessment, lack of ‘buy-in’, 
lack of healthcare 
professional preparation and 
resistance to change.  
Oluoch et al. 
2012 
Kenya 
To identify studies on 
electronic medical record 
based clinical decision 
support systems 
describing process and 
outcome measures and 
reported barriers to 
implementation. 
Mixed (inpatient and 
outpatient settings) 
Clinical Decision 
Support Systems 
(CDSS) 
12 Technical infrastructure 
problems 
Oroviogoicoechea et al. 
2008 
UK 
To review existing 
nursing research on 
inpatient hospitals’ 
information technology 
systems in order to 
explore new approaches 
for evaluation research 
on nursing informatics to 
guide further design and 
implementation of 
Inpatient hospital 
setting 
Information 
Technology 
Systems 
39 Social and organisational 
contexts 
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effective information 
technology systems.  
Orwat et al. 
2008 
Germany 
A systematic overview 
and analysis of system 
developments and 
implementations of 
pervasive computing in 
healthcare and 
highlighting experiences 
in deployment. 
Mixed (ambulatory, 
home and mobile, 
clinical, care and 
rehabilitation) 
Pervasive 
Healthcare 
69 (describing 67 
studies) 
Organisation, personnel, 
privacy concerns and 
financial issues. 
Peleg 
2006 
Israel 
To understand the 
challenges facing 
developers of clinical 
decision support 
systems. 
Not defined Clinical Decision 
Support Systems 
(CDSS) 
not stated The goals of CDSS are 
important in developing 
successful, usable clinical 
decision support systems as 
it is the vision that drives the 
way they are developed, 
implemented, integrated with 
the environment, and 
evaluated.  
Police et al. 
2010 
USA 
To better understand 
current utilisation rates 
along with benefits and 
barriers to health 
information technology 
adoption in physician 
practice organisations. 
Mixed (physician 
practice organisations) 
Health Information 
Technologies (HIT) 
119 The largest barrier to HIT 
adoption in physician groups 
is the high initial and ongoing 
costs of electronic systems. 
Lack of sufficient training, a 
disorganised or non-
receptive practice culture 
and technological problems 
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such as inadequate 
connectivity appear to 
impede effective HIT use. 
Rahimi et al. 
2009 
Sweden 
To organize the 
knowledge gained in 
qualitative studies 
performed in association 
with healthcare 
information systems 
implementations and to 
use this knowledge to 
outline an updated 
structure for 
implementation planning 
Mixed (primary care 
and hospitals) 
Healthcare 
Information 
Systems (HIS) 
17 Education and training 
support, information needs 
assessment, implementation 
process, management 
support, work routines and 
workflow, motivation and 
rationales, integration of the 
system, trust, technical 
system performance, 
participation and user 
involvement, system 
effectiveness. 
Saliba et al. 
2012 
UK 
To systematically identify 
factors that hinder or 
support implementation 
of cross-border 
telemedicine services. 
Cross-border 
telemedicine services  
Telemedicine 94 Legal factors; sustainability 
factors; cultural factors; and 
contextual factors. 
Shekelle et al. 
2006 
USA 
To assess the evidence 
base regarding benefits 
and costs of health 
information technology 
systems. 
Mixed (ambulatory, 
inpatient and 
outpatient) 
Information And 
Communication 
Technologies (ICT)  
256 of which 20 
focussed on 
barriers and 
facilitators to 
implementation  
Barriers were classified as; 
situational barriers (including 
time and financial concerns), 
cognitive and or physical 
barriers (include physical 
disabilities and insufficient 
computer skills), liability 
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barriers (including 
confidentiality concerns), and 
knowledge and attitudinal 
barriers. 
Stolee et al. 
2010 
Canada 
To identify barriers, 
facilitators, and 
recommendations for 
using electronic health 
information systems in 
home care settings. 
Homecare Electronic Health 
Information 
Systems (EHIS) 
45 Costs, especially during 
implementation, training, and 
lack of user 
acceptance/healthcare 
professional resistance. The 
most common facilitators 
included portable 
technology, strategies to 
decrease data entry errors, 
and managerial support and 
user incentives 
Studer 
2005 
USA 
To systematically review 
studies assessing the 
effect of organisational 
factors on the 
effectiveness of 
electronic medical 
records system 
implementation. 
Mixed (physician 
practices, group 
medical practices, 
hospitals and 
academic health 
centres) 
Electronic Medical 
Records (EMR) 
23 Factors influencing the 
effectiveness of EMR system 
implementation included 
management support, 
financial resource 
availability, implementation 
climate and implementation 
policies and practices. 
Vreeman et al. 
2006 
USA 
To identify, review, and 
summarize the benefits, 
barriers, and key factors 
for success in 
Mixed (physical 
therapy settings) 
Electronic Health 
Records (EHR) 
13 Essential conditions for 
successful implementation: 
workflow analysis, 
involvement of end users, 
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implementing electronic 
health records in physical 
therapist practice 
settings. 
significant resources for 
training, adequate software 
and hardware performance, 
commit to data standards.  
Waneka and Spetz  
2010 
USA 
To determine the impact 
of health information 
technologies on nurses 
and nursing care.  
Mixed (hospital and 
ambulatory) 
Health Information 
Technologies (HIT) 
74 Effective leadership and 
involvement from HIT users 
at all stages of the 
development and 
implementation processes 
can help improve the 
effective implementation 
Yarbrough and Smith 
2007 
USA 
To increase 
understanding of 
physician technology 
acceptance and barriers 
to such acceptance, 
Any Information 
Technology 
18 Time/practice-related issues, 
organisational issues, 
personal issues, and system-
specific characteristics 
influence a physician’s 
acceptance of a new 
technology. 
Yusof et al. 
2007 
Malaysia 
To present the main 
findings of a systematic 
review of selected case 
studies on healthcare 
information systems 
adoption in clinical 
practices. 
Not defined Healthcare 
Information 
Systems (HIS) 
55 Critical adoption factors: 
technology (ease of use, 
system usefulness, system 
flexibility, time efficiency, 
information accessibility and 
relevancy); human (user 
training, user perception, 
user roles, user skills, clarity 
of system purpose, user 
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involvement); organisation 
(leadership and support, 
clinical process, user 
involvement, internal 
communication) as well as 
the fit between them. 
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Appendix C CFIR codebook 
 
CFIR Codebook 
Note: This template provides inclusion and exclusion criteria for most constructs. Please post 
additional inclusion and exclusion criteria, guidance, or questions to the CFIR Wiki discussion 
tab in order to help improve the CFIR.  
 
This template only includes CFIR definitions and coding criteria; codebooks may include other 
information, such as examples of coded text, rating guidelines, and related interview questions.  
 
I. Innovation Characteristics  
A. Innovation Source Definition: Perception of key stakeholders about whether the 
innovation is externally or internally developed.  
 
Inclusion Criteria: Include statements about the source of the 
innovation and the extent to which interviewees view the 
change as internal to the organisation, e.g., an internally 
developed program, or external to the organisation, e.g., a 
program coming from the outside. Note: May code and rate as 
"I" for internal or "E" for external. 
 
Exclusion Criteria: Exclude or double code statements related 
to who participated in the decision process to implement the 
innovation to Engaging, as an indication of early (or late) 
engagement. Participation in decision-making is an effective 
engagement strategy to help people feel ownership of the 
innovation. 
B. Evidence Strength & 
Quality 
Definition: Stakeholders’ perceptions of the quality and validity 
of evidence supporting the belief that the innovation will have 
desired outcomes. 
 
Inclusion Criteria: Include statements regarding awareness of 
evidence and the strength and quality of evidence, as well as 
the absence of evidence or a desire for different types of 
evidence, such as pilot results instead of evidence from the 
literature. 
Exclusion Criteria: Exclude or double code statements 
regarding the receipt of evidence as an engagement strategy 
to Engaging: Key Stakeholders. 
Exclude or double code descriptions of use of results from 
local or regional pilots to Trialability. 
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C. Relative Advantage Definition: Stakeholders’ perception of the advantage of 
implementing the innovation versus an alternative solution.  
Inclusion Criteria: Include statements that demonstrate the 
innovation is better (or worse) than existing programs. 
Exclusion Criteria: Exclude statements that demonstrate a 
strong need for the innovation and/or that the current situation 
is untenable and code to Tension for Change.  
D. Adaptability Definition: The degree to which an innovation can be adapted, 
tailored, refined, or reinvented to meet local needs. 
 
Inclusion Criteria: Include statements regarding the (in)ability 
to adapt the innovation to their context, e.g., complaints about 
the rigidity of the protocol. Suggestions for improvement can 
be captured in this code but should not be included in the 
rating process, unless it is clear that the participant feels the 
change is needed but that the program cannot be adapted. 
However, it may be possible to infer that a large number of 
suggestions for improvement demonstrates lack of 
compatibility, see exclusion criteria below.  
 
Exclusion Criteria: Exclude or double code statements that the 
innovation did or did not need to be adapted to Compatibility.  
E. Trialability Definition: The ability to test the innovation on a small scale in 
the organization, and to be able to reverse course (undo 
implementation) if warranted. 
 
Inclusion Criteria: Include statements related to whether the 
site piloted the innovation in the past or has plans to in the 
future, and comments about whether they believe it is 
(im)possible to conduct a pilot.  
 
Exclusion Criteria: Exclude or double code descriptions of use 
of results from local or regional pilots to Evidence Strength & 
Quality. 
F. Complexity Definition: Perceived difficulty of the innovation, reflected by 
duration, scope, radicalness, disruptiveness, centrality, and 
intricacy and number of steps required to implement.  
 
Inclusion Criteria: Code statements regarding the complexity 
of the innovation itself. 
 
307 
 
Exclusion Criteria: Exclude statements regarding the 
complexity of implementation and code to the appropriate 
CFIR code, e.g., difficulties related to space are coded to 
Available Resources and difficulties related to engaging 
participants in a new program are coded to Engaging: 
Innovation Participants.  
G. Design Quality & 
Packaging 
Definition: Perceived excellence in how the innovation is 
bundled, presented, and assembled.  
 
Inclusion Criteria: Include statements regarding the quality of 
the materials and packaging. 
Exclusion Criteria: Exclude statements regarding the presence 
or absence of materials and code to Available Resources.  
Exclude statements regarding the receipt of materials as an 
engagement strategy and code to Engaging.  
H. Cost Definition: Costs of the innovation and costs associated with 
implementing the innovation including investment, supply, and 
opportunity costs.  
 
Inclusion Criteria: Include statements related to the cost of the 
innovation and its implementation. 
 
Exclusion Criteria: Exclude statements related to physical 
space and time, and code to Available Resources. In a 
research study, exclude statements related to costs of 
conducting the research components (e.g., funding for 
research healthcare professional, participant incentives).  
II. Outer Setting  
A. Needs & Resources of 
Those Served by the 
Organization  
Definition: The extent to which the needs of those served by 
the organization (e.g., patients), as well as barriers and 
facilitators to meet those needs, are accurately known and 
prioritized by the organization. 
 
Inclusion Criteria: Include statements demonstrating (lack of) 
awareness of the needs and resources of those served by the 
organization. Analysts may be able to infer the level of 
awareness based on statements about: 1. Perceived need for 
the innovation based on the needs of those served by the 
organization and if the innovation will meet those needs; 2. 
Barriers and facilitators of those served by the organization to 
participating in the innovation; 3. Participant feedback on the 
innovation, i.e., satisfaction and success in a program. In 
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addition, include statements that capture whether or not 
awareness of the needs and resources of those served by the 
organization influenced the implementation or adaptation of 
the innovation. 
 
Exclusion Criteria: Exclude statements that demonstrate a 
strong need for the innovation and/or that the current situation 
is untenable and code to Tension for Change.  
 
Exclude statements related to engagement strategies and 
outcomes, e.g., how innovation participants became engaged 
with the innovation, and code to Engaging: Innovation 
Participants.  
B. Cosmopolitanism Definition: The degree to which an organization is networked 
with other external organizations.  
 
Inclusion Criteria: Include descriptions of outside group 
memberships and networking done outside the organization. 
 
Exclusion Criteria: Exclude statements about general 
networking, communication, and relationships in the 
organization, such as descriptions of meetings, email groups, 
or other methods of keeping people connected and informed, 
and statements related to team formation, quality, and 
functioning, and code to Networks & Communications. 
C. Peer Pressure Definition: Mimetic or competitive pressure to implement an 
innovation, typically because most or other key peer or 
competing organizations have already implemented or are in a 
bid for a competitive edge.  
 
Inclusion Criteria: Include statements about perceived 
pressure or motivation from other entities or organizations in 
the local geographic area or system to implement the 
innovation. 
 
Exclusion Criteria:  
D. External Policy & 
Incentives 
Definition: A broad construct that includes external strategies 
to spread innovations including policy and regulations 
(governmental or other central entity), external mandates, 
recommendations and guidelines, pay-for-performance, 
collaboratives, and public or benchmark reporting. 
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Inclusion Criteria: Include descriptions of external performance 
measures from the system. 
 
Exclusion Criteria:  
III.  Inner Setting  
A. Structural Characteristics Definition: The social architecture, age, maturity, and size of 
an organization. 
 
Inclusion Criteria: 
 
Exclusion Criteria:  
B. Networks & 
Communications 
Definition: The nature and quality of webs of social networks, 
and the nature and quality of formal and informal 
communications within an organization. 
 
Inclusion Criteria: Include statements about general 
networking, communication, and relationships in the 
organization, such as descriptions of meetings, email groups, 
or other methods of keeping people connected and informed, 
and statements related to team formation, quality, and 
functioning. 
Exclusion Criteria: Exclude statements related to 
implementation leaders' and users' access to knowledge and 
information regarding using the program, i.e., training on the 
mechanics of the program and code to Access to Knowledge 
& Information.  
Exclude statements related to engagement strategies and 
outcomes, e.g., how key stakeholders became engaged with 
the innovation and what their role is in implementation, and 
code to Engaging: Key Stakeholders. 
Exclude descriptions of outside group memberships and 
networking done outside the organization and code to 
Cosmopolitanism. 
C. Culture Definition: Norms, values, and basic assumptions of a given 
organization. 
 
Inclusion Criteria: Inclusion criteria, and potential sub-codes, 
will depend on the framework or definition used for “culture.” 
For example, if using the Competing Values Framework 
(CVF), you may include four sub-codes related to the four 
dimensions of the CVF and code statements regarding one or 
more of the four dimension in an organization.  
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Exclusion Criteria:  
D. Implementation Climate Definition: The absorptive capacity for change, shared 
receptivity of involved individuals to an innovation, and the 
extent to which use of that innovation will be rewarded, 
supported, and expected within their organization.  
 
Inclusion Criteria: Include statements regarding the general 
level of receptivity to implementing the innovation. 
 
Exclusion Criteria: Exclude statements regarding the general 
level of receptivity that are captured in the sub-codes. 
1. Tension for 
Change 
Definition: The degree to which stakeholders perceive the 
current situation as intolerable or needing change.  
 
Inclusion Criteria: Include statements that (do not) 
demonstrate a strong need for the innovation and/or that the 
current situation is untenable, e.g., statements that the 
innovation is absolutely necessary or that the innovation is 
redundant with other programs. Note: If a participant states 
that the innovation is redundant with a preferred existing 
program, (double) code lack of Relative Advantage, see 
exclusion criteria below. 
Exclusion Criteria: Exclude statements regarding specific 
needs of individuals that demonstrate a need for the 
innovation, but do not necessarily represent a strong need or 
an untenable status quo, and code to Needs and Resources of 
Those Served by the Organization.   
Exclude statements that demonstrate the innovation is better 
(or worse) than existing programs and code to Relative 
Advantage. 
2. Compatibility Definition: The degree of tangible fit between meaning and 
values attached to the innovation by involved individuals, how 
those align with individuals’ own norms, values, and perceived 
risks and needs, and how the innovation fits with existing 
workflows and systems.  
Inclusion Criteria: Include statements that demonstrate the 
level of compatibility the innovation has with organizational 
values and work processes. Include statements that the 
innovation did or did not need to be adapted as evidence of 
compatibility or lack of compatibility.  
Exclusion Criteria: Exclude or double code statements 
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regarding the priority of the innovation based on compatibility 
with organizational values to Relative Priority, e.g., if an 
innovation is not prioritized because it is not compatible with 
organizational values. 
3. Relative 
Priority 
Definition: Individuals’ shared perception of the importance of 
the implementation within the organization.  
 
Inclusion Criteria: Include statements that reflect the relative 
priority of the innovation, e.g., statements related to change 
fatigue in the organization due to implementation of many 
other programs. 
 
Exclusion Criteria: Exclude or double code statements 
regarding the priority of the innovation based on compatibility 
with organizational values to Compatibility, e.g., if an 
innovation is not prioritized because it is not compatible with 
organizational values. 
4. Organizational 
Incentives & Rewards 
Definition: Extrinsic incentives such as goal-sharing, awards, 
performance reviews, promotions, and raises in salary, and 
less tangible incentives such as increased stature or respect. 
 
Inclusion Criteria: Include statements related to whether 
organizational incentive systems are in place to foster (or 
hinder) implementation, e.g., rewards or disincentives for 
healthcare professional engaging in the innovation. 
 
Exclusion Criteria:  
5. Goals & 
Feedback 
Definition: The degree to which goals are clearly 
communicated, acted upon, and fed back to healthcare 
professional, and alignment of that feedback with goals.  
 
Inclusion Criteria: Include statements related to the (lack of) 
alignment of implementation and innovation goals with larger 
organizational goals, as well as feedback to healthcare 
professional regarding those goals, e.g., regular audit and 
feedback showing any gaps between the current 
organizational status and the goal. Goals and Feedback 
include organizational processes and supporting structures 
independent of the implementation process. Evidence of the 
integration of evaluation components used as part of 
“Reflecting and Evaluating” into on-going or sustained 
organizational structures and processes may be (double) 
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coded to Goals and Feedback.  
 
Exclusion Criteria: Exclude statements that refer to the 
implementation team’s (lack of) assessment of the progress 
toward and impact of implementation, as well as the 
interpretation of outcomes related to implementation, and code 
to Reflecting & Evaluating. Reflecting and Evaluating is part of 
the implementation process; it likely ends when 
implementation activities end. It does not require goals be 
explicitly articulated; it can focus on descriptions of the current 
state with real-time judgment, though there may be an implied 
goal (e.g., we need to implement the innovation) when the 
implementation team discusses feedback in terms of 
adjustments needed to complete implementation. 
6. Learning 
Climate 
Definition: A climate in which: 1. Leaders express their own 
fallibility and need for team members’ assistance and input; 2. 
Team members feel that they are essential, valued, and 
knowledgeable partners in the change process; 3. Individuals 
feel psychologically safe to try new methods; and 4. There is 
sufficient time and space for reflective thinking and evaluation.  
 
Inclusion Criteria: Include statements that support (or refute) 
the degree to which key components of an organization exhibit 
a “learning climate.” 
 
Exclusion Criteria:  
E. Readiness for 
Implementation 
Definition: Tangible and immediate indicators of organizational 
commitment to its decision to implement an innovation. 
 
Inclusion Criteria: Include statements regarding the general 
level of readiness for implementation.  
 
Exclusion Criteria: Exclude statements regarding the general 
level of readiness for implementation that are captured in the 
sub-codes. 
1. Leadership 
Engagement 
Definition: Commitment, involvement, and accountability of 
leaders and managers with the implementation of the 
innovation.  
 
Inclusion Criteria: Include statements regarding the level of 
engagement of organizational leadership. 
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Exclusion Criteria: Exclude or double code statements 
regarding leadership engagement to Engaging: Formally 
Appointed Internal Implementation Leaders or Champions if 
an organizational leader is also an implementation leader, 
e.g., if a director of primary care takes the lead in 
implementing a new treatment guideline. Note that a key 
characteristic of this Implementation Leader/Champion is that 
s/he is also an Organizational Leader. 
2. Available 
Resources 
Definition: The level of resources organizational dedicated for 
implementation and on-going operations including physical 
space and time. 
 
Inclusion Criteria: Include statements related to the presence 
or absence of resources specific to the innovation that is being 
implemented. 
Exclusion Criteria: Exclude statements related to training and 
education and code to Access to Knowledge & Information.  
Exclude statements related to the quality of materials and 
code to Design Quality & Packaging. 
In a research study, exclude statements related to resources 
needed for conducting the research components (e.g., time to 
complete research tasks, such as IRB applications, consenting 
patients).  
3. Access to 
Knowledge & 
Information 
Definition: Ease of access to digestible information and 
knowledge about the innovation and how to incorporate it into 
work tasks.  
 
Inclusion Criteria: Include statements related to 
implementation leaders' and users' access to knowledge and 
information regarding use of the program, i.e., training on the 
mechanics of the program. 
Exclusion Criteria: Exclude statements related to engagement 
strategies and outcomes, e.g., how key stakeholders became 
engaged with the innovation and what their role is in 
implementation, and code to Engaging: Key Stakeholders.  
Exclude statements about general networking, communication, 
and relationships in the organization, such as descriptions of 
meetings, email groups, or other methods of keeping people 
connected and informed, and statements related to team 
formation, quality, and functioning, and code to Networks & 
Communications. 
IV.  Characteristics of  
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Individuals 
1. Knowledge & 
Beliefs about the 
Innovation  
Definition: Individuals’ attitudes toward and value placed on 
the innovation, as well as familiarity with facts, truths, and 
principles related to the innovation. 
 
Inclusion Criteria: 
 
Exclusion Criteria: Exclude statements related to familiarity 
with evidence about the innovation and code to Evidence 
Strength & Quality. 
2. Self-efficacy Definition: Individual belief in their own capabilities to execute 
courses of action to achieve implementation goals.  
 
Inclusion Criteria: 
 
Exclusion Criteria:  
3. Individual 
Stage of Change 
Definition: Characterization of the phase an individual is in, as 
s/he progresses toward skilled, enthusiastic, and sustained 
use of the innovation. 
 
Inclusion Criteria: 
 
Exclusion Criteria:  
4. Individual 
Identification with 
Organization  
Definition: A broad construct related to how individuals 
perceive the organization, and their relationship and degree of 
commitment with that organization.  
 
Inclusion Criteria: 
 
Exclusion Criteria: 
5. Other 
Personal Attributes 
Definition: A broad construct to include other personal traits 
such as tolerance of ambiguity, intellectual ability, motivation, 
values, competence, capacity, and learning style. 
 
Inclusion Criteria: 
 
Exclusion Criteria:  
V. Process  
A. Planning Definition: The degree to which a scheme or method of 
behavior and tasks for implementing an innovation are 
developed in advance, and the quality of those schemes or 
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methods. 
 
Inclusion Criteria: Include evidence of pre-implementation 
diagnostic assessments and planning, as well as refinements 
to the plan. 
 
Exclusion Criteria:  
B. Engaging Definition: Attracting and involving appropriate individuals in 
the implementation and use of the innovation through a 
combined strategy of social marketing, education, role 
modeling, training, and other similar activities. 
 
Inclusion Criteria: Include statements related to engagement 
strategies and outcomes, i.e., if and how healthcare 
professional and innovation participants became engaged with 
the innovation and what their role is in implementation. Note: 
Although both strategies and outcomes are coded here, the 
outcome of engagement efforts determines the rating, i.e., if 
there are repeated attempts to engage healthcare professional 
that are unsuccessful, or if a role is vacant, the construct 
receives a negative rating. In addition, you may also want to 
code the "quality" of healthcare professional - their capabilities, 
motivation, and skills, i.e., how good they are at their job, and 
this data affects the rating as well. 
 
Exclusion Criteria: Exclude statements related to specific sub 
constructs, e.g., Champions or Opinion Leaders. 
 
Exclude or double code statements related to who participated 
in the decision process to implement the innovation to 
Innovation Source, as an indicator of internal or external 
innovation source. 
1. Opinion 
Leaders 
Definition: Individuals in an organization that have formal or 
informal influence on the attitudes and beliefs of their 
colleagues with respect to implementing the innovation. 
 
Inclusion Criteria: Include statements related to engagement 
strategies and outcomes, e.g., how the opinion leader became 
engaged with the innovation and what their role is in 
implementation. Note: Although both strategies and outcomes 
are coded here, the outcome of efforts to engage healthcare 
professional determines the rating, i.e., if there are repeated 
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attempts to engage an opinion leader that are unsuccessful, or 
if the opinion leader leaves the organization and this role is 
vacant, the construct receives a negative rating. In addition, 
you may also want to code the "quality" of the opinion leader 
here - their capabilities, motivation, and skills, i.e., how good 
they are at their job, and this data affects the rating as well. 
 
Exclusion Criteria:  
2. Formally 
Appointed Internal 
Implementation 
Leaders 
Definition: Individuals from within the organization who have 
been formally appointed with responsibility for implementing 
an innovation as coordinator, project manager, team leader, or 
other similar role.  
 
Inclusion Criteria: Include statements related to engagement 
strategies and outcomes, e.g., how the formally appointed 
internal implementation leader became engaged with the 
innovation and what their role is in implementation. Note: 
Although both strategies and outcomes are coded here, the 
outcome of efforts to engage healthcare professional 
determines the rating, i.e., if there are repeated attempts to 
engage an implementation leader that are unsuccessful, or if 
the implementation leader leaves the organization and this 
role is vacant, the construct receives a negative rating. In 
addition, you may also want to code the "quality" of the 
implementation leader here - their capabilities, motivation, and 
skills, i.e., how good they are at their job, and this data affects 
the rating as well. 
 
Exclusion Criteria: Exclude or double code statements 
regarding leadership engagement to Leadership Engagement 
if an implementation leader is also an organizational leader, 
e.g., if a director of primary care takes the lead in 
implementing a new treatment guideline. 
3. Champions Definition: “Individuals who dedicate themselves to supporting, 
marketing, and ‘driving through’ an [implementation]”, 
overcoming indifference or resistance that the innovation may 
provoke in an organization. 
 
Inclusion Criteria: Include statements related to engagement 
strategies and outcomes, e.g., how the champion became 
engaged with the innovation and what their role is in 
implementation. Note: Although both strategies and outcomes 
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are coded here, the outcome of efforts to engage healthcare 
professional determines the rating, i.e., if there are repeated 
attempts to engage a champion that are unsuccessful, or if the 
champion leaves the organization and this role is vacant, the 
construct receives a negative rating. In addition, you may also 
want to code the "quality" of the champion here - their 
capabilities, motivation, and skills, i.e., how good they are at 
their job, and this data affects the rating as well. 
 
Exclusion Criteria: Exclude or double code statements 
regarding leadership engagement to Leadership Engagement 
if a champion is also an organizational leader, e.g., if a director 
of primary care takes the lead in implementing a new 
treatment guideline. 
4. External 
Change Agents  
Definition: Individuals who are affiliated with an outside entity 
who formally influence or facilitate innovation decisions in a 
desirable direction.  
Inclusion Criteria: Include statements related to engagement 
strategies and outcomes, e.g., how the external change agent 
(entities outside the organization that facilitate change) 
became engaged with the innovation and what their role is in 
implementation, e.g., how they supported implementation 
efforts. Note: Although both strategies and outcomes are 
coded here, the outcome of efforts to engage healthcare 
professional determines the rating, i.e., if there are repeated 
attempts to engage an external change agent that are 
unsuccessful, or if the external change agent leaves their 
organization and this role is vacant, the construct receives a 
negative rating. In addition, you may also want to code the 
"quality" of the external change agent here - their capabilities, 
motivation, and skills, i.e., how good they are at their job, and 
this data affects the rating as well.  
Exclusion Criteria: Note: It is important to clearly define what 
roles are external and internal to the organization. Exclude 
statements regarding facilitating activities, such as training in 
the mechanics of the program, and code to Access to 
Knowledge & Information if the change agent is considered 
internal to the study, e.g., a healthcare professional member at 
the national office. If the study considers this healthcare 
professional member internal to the organization, it should be 
coded to Access to Knowledge & Information, even though 
their support may overlap with what would be expected from 
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an External Change Agent. 
5. Key 
Stakeholders  
Definition: Individuals from within the organization that are 
directly impacted by the innovation, e.g., healthcare 
professional responsible for making referrals to a new program 
or using a new work process.  
 
Inclusion Criteria: Include statements related to engagement 
strategies and outcomes, e.g., how key stakeholders became 
engaged with the innovation and what their role is in 
implementation. Note: Although both strategies and outcomes 
are coded here, the outcome of efforts to engage healthcare 
professional determines the rating, i.e., if there are repeated 
attempts to engage key stakeholders that are unsuccessful, 
the construct receives a negative rating. 
 
Exclusion Criteria: Exclude statements related to 
implementation leaders' and users' access to knowledge and 
information regarding using the program, i.e., training on the 
mechanics of the program, and code to Access to Knowledge 
& Information.  
 
Exclude statements about general networking, 
communication, and relationships in the organization, such as 
descriptions of meetings, email groups, or other methods of 
keeping people connected and informed, and statements 
related to team formation, quality, and functioning, and code to 
Networks & Communications.  
6. Innovation 
Participants 
Definition: Individuals served by the organization that 
participate in the innovation, e.g., patients in a prevention 
program in a hospital.  
 
Inclusion Criteria: Include statements related to engagement 
strategies and outcomes, e.g., how innovation participants 
became engaged with the innovation. Note: Although both 
strategies and outcomes are coded here, the outcome of 
efforts to engage participants determines the rating, i.e., if 
there are repeated attempts to engage participants that are 
unsuccessful, the construct receives a negative rating. 
 
Exclusion Criteria: Exclude statements demonstrating (lack of) 
awareness of the needs and resources of those served by the 
organization and whether or not that awareness influenced the 
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implementation or adaptation of the innovation and code to 
Needs & Resources of Those Served by the Organization.  
C. Executing Definition: Carrying out or accomplishing the implementation 
according to plan.  
Inclusion Criteria: Include statements that demonstrate how 
implementation occurred with respect to the implementation 
plan. Note: Executing is coded very infrequently due to a lack 
of planning. However, some studies have used fidelity 
measures to assess executing, as an indication of the degree 
to which implementation was accomplished according to plan.  
Exclusion Criteria:  
D. Reflecting & Evaluating Definition: Quantitative and qualitative feedback about the 
progress and quality of implementation accompanied with 
regular personal and team debriefing about progress and 
experience. 
 
Inclusion Criteria: Include statements that refer to the 
implementation team’s (lack of) assessment of the progress 
toward and impact of implementation, as well as the 
interpretation of outcomes related to implementation. 
Reflecting and Evaluating is part of the implementation 
process; it likely ends when implementation activities end. It 
does not require goals be explicitly articulated; it can focus on 
descriptions of the current state with real-time judgment, 
though there may be an implied goal (e.g., we need to 
implement the innovation) when the implementation team 
discusses feedback in terms of adjustments needed to 
complete implementation. 
Exclusion Criteria: Exclude statements related to the (lack of) 
alignment of implementation and innovation goals with larger 
organizational goals, as well as feedback to healthcare 
professional regarding those goals, e.g., regular audit and 
feedback showing any gaps between the current 
organizational status and the goal, and code to Goals & 
Feedback. Goals and Feedback include organizational 
processes and supporting structures independent of the 
implementation process. Evidence of the integration of 
evaluation components used as part of “Reflecting and 
Evaluating” into on-going or sustained organizational 
structures and processes may be (double) coded to Goals and 
Feedback.  
Exclude statements that capture reflecting and evaluating that 
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participants may do during the interview, for example, related 
to the success of the implementation, and code to Knowledge 
& Beliefs about the Innovation. 
VI.  Additional Codes  
A. Code Name  Definition:  
 
Inclusion Criteria: 
 
Exclusion Criteria:  
B. Code Name  Definition:  
 
Inclusion Criteria: 
 
Exclusion Criteria:  
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Appendix D Excluded theories, Frameworks and Models of implementation 
Model Reference Primary exclusion reason 
Diffusion of Innovation (3) Not focussed on implementation only 
RAND Model of Persuasive 
Communication and Diffusion of 
Medical Innovation 
(285) Not focussed on implementation only 
Effective Dissemination 
Strategies 
(286) Not focussed on implementation only 
Model for Locally Based 
Research Transfer Development 
(287) Not focussed on implementation only 
Streams of Policy Process (288) Not focussed on implementation only 
A Conceptual Model of 
Knowledge Utilization 
(289) Not focussed on implementation only 
Conceptual Framework for 
Research Knowledge Transfer 
and Utilization 
(290) Not focussed on implementation only 
Conceptualizing Dissemination 
Research and Activity: Canadian 
Heart Health Initiative 
(291) Not focussed on implementation only 
Policy Framework for Increasing 
Diffusion of Evidence-Based 
Physical Activity Interventions 
(292) Not focussed on implementation only 
Blueprint for Dissemination (293) Not focussed on implementation only 
Framework for Knowledge 
Translation 
(294) Not focussed on implementation only 
A Framework for Analyzing 
Adoption of Complex Health 
Innovations 
(295) Not focussed on implementation only 
A Framework for Spread (296) Not focussed on implementation only 
Collaborative Model for 
Knowledge Translation Between 
Research and Practice Settings 
(297) Not focussed on implementation only 
Coordinated Implementation 
Model 
(298) Not focussed on implementation only 
Model for Improving the 
Dissemination of Nursing 
Research 
(299) Not focussed on implementation only 
Framework for the Dissemination 
& Utilization of Research for 
(300) Not focussed on implementation only 
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Health-Care Policy & Practice 
Framework of Dissemination in 
Health Services Intervention 
Research 
(301) Not focussed on implementation only 
Linking Systems Framework (302) Not focussed on implementation only 
Marketing and Distribution 
System for Public Health 
(303) Not focussed on implementation only 
OPTIONS Model (304) Not focussed on implementation only 
A Conceptual Model for the 
Diffusion of Innovations in 
Service Organizations 
(305) Not focussed on implementation only 
Health Promotion Research 
Center Framework 
(306) Not focussed on implementation only 
Knowledge Exchange Framework (307) Not focussed on implementation only 
Research Knowledge 
Infrastructure 
(308) Not focussed on implementation only 
A Convergent Diffusion and 
Social Marketing Approach for 
Dissemination 
(309) Not focussed on implementation only 
Framework for Dissemination of 
Evidence-Based Policy 
(310) Not focussed on implementation only 
Health Promotion Technology 
Transfer Process 
(306) Not focussed on implementation only 
Real-World Dissemination (311) Not focussed on implementation only 
A Framework for the Transfer of 
Patient Safety Research into 
Practice 
(312) Not focussed on implementation only 
Interacting Elements of 
Integrating Science, Policy, and 
Practice 
(313) Not focussed on implementation only 
Interactive Systems Framework (314) Not focussed on implementation only 
Push–Pull Capacity Model (315) Not focussed on implementation only 
Research Development 
Dissemination and Utilization 
Framework 
(316) Not focussed on implementation only 
Utilization-Focused Surveillance 
Framework 
(317) Not focussed on implementation only 
“4E” Framework for Knowledge 
Dissemination and Utilization 
(318) Not focussed on implementation only 
Critical Realism & the Arts (319) Not focussed on implementation only 
323 
 
Research Utilization Model 
(CRARUM) 
Davis' Pathman-PRECEED Model (320) Not focussed on implementation only 
Dissemination of Evidence-based 
Interventions to Prevent Obesity 
(321) Not focussed on implementation only 
Knowledge Translation Model of 
Tehran University of Medical 
Sciences 
(322) Not focussed on implementation only 
Multi-level Conceptual 
Framework of Organizational 
Innovation Adoption 
(323) Not focussed on implementation only 
Ottawa Model of Research Use (324) Not focussed on implementation only 
The RE-AIM Framework (320) Not focussed on implementation only 
The Precede–Proceed Model (320) Not focussed on implementation only 
Facilitating Adoption of Best 
Practices (FAB) Model 
(325) Not focussed on implementation only 
A Six-Step Framework For 
International Physical Activity 
Dissemination 
(326) Not focussed on implementation only 
Pathways to Evidence Informed 
Policy 
(327) Not focussed on implementation only 
CDC DHAP's Research-to-
Practice Framework 
(328) Not focussed on implementation only 
Practical, Robust Implementation 
and Sustainability Model (PRISM) 
(329) Not focussed on implementation only 
Active Implementation 
Framework 
(330) Doesn’t apply at system level 
An Organizational Theory of 
Innovation Implementation 
(331) Doesn’t apply at system, community, 
individual or policy level 
Implementation Effectiveness 
Model 
(332) Doesn’t apply at system, community or 
policy level 
Promoting Action on Research 
Implementation in Health 
Services (PARIHS) 
(333) Doesn’t apply at system or policy level and 
hadn’t been applied to implementation 
planning 
Pronovost's 4E's Process Theory (334) Doesn’t apply at system or policy level 
Sticky Knowledge (335) Doesn’t apply at system or policy level 
Consolidated Framework for 
Implementation Research 
(122) Meets criteria but doesn’t provide an 
explanatory framework 
Replicating Effective Programs 
Plus Framework 
(336) Doesn’t apply at system, individual or policy 
level 
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Availability, Responsiveness & 
Continuity (ARC): An 
Organizational & Community 
Intervention Model 
(337) Doesn’t apply at system, individual or policy 
level 
Conceptual Model of Evidence-
Based Practice Implementation in 
Public Service Sectors 
(338) Doesn’t apply at system, individual or policy 
level 
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Appendix E Patient Information Sheet 
 
[UCL departmental headed paper] 
  
PARTICIPANT INFORMATION SHEET 
A study to evaluate the HeLP-Diabetes website- can you help? 
 
What is the study about? 
 We want to find out how best to support patients to look after their diabetes and are 
interested to know what you think about HeLP-Diabetes and if it helps you with 
managing your diabetes. 
 We are inviting people with type 2 diabetes through their GP practice or diabetes clinic. 
 If you take part, you will be in the study until August 2015. 
 
Why are we doing this study? 
 Many people with type 2 diabetes need help and support to manage their condition well. 
We have developed HeLP-Diabetes, a website offering help and support for people with 
type 2 diabetes. 
 We want to know what people think about HeLP-Diabetes and the way that it is 
delivered through the NHS. We’re also interested to know if HeLP-Diabetes can help 
you with managing your diabetes. 
 
We invite you to take part in the study: 
 Before you decide whether to take part, it is important that you understand why the 
study is being done and what it will involve. Please read this information carefully. 
Discuss it with others if you wish. Take time to decide whether or not you want to take 
part. 
 It is up to you to decide whether or not to take part. Saying no will not affect the care 
you receive from the NHS. 
 Please contact us if you would like to ask any questions. 
 
Why am I being asked to take part? 
 We are looking for people aged 18 and above with type 2 diabetes who are registered 
at your general practice or diabetes clinic to take part.  
 
What will I need to do if I take part? 
 You can use HeLP-Diabetes whether or not you take part in this research study but if 
you do decide to take part: 
 You will be asked to complete some questionnaires online about you and your diabetes. 
We will ask you to complete some of the same questions again at 3 months into the 
study and again at 12 months. 
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 Your use of HeLP-Diabetes (number of logins, pages visited etc.) will be automatically 
recorded by the computer. 
 We may contact you during the study to ask you to participate in one or more interviews 
about your experiences of HeLP-Diabetes. This will be with the researcher and you can 
do this in person or over the telephone.  
 
Possible benefits and disadvantages of taking part: 
We think that people who take part in the study may benefit in two ways: 
 Firstly, you will be able to use a free website about type 2 diabetes until 1st March 
2016.  
 Secondly, using the website may have a positive impact on your health. Previous 
studies have found that the health of people who have been given information about 
their diabetes tends to improve more than in those not given information. 
 We think there is very little risk of harm in taking part. However, it is possible that some 
patients may worry as a result of reading information about the health of other people 
with diabetes. If this happens, please ask to talk with the researcher or your nurse or 
GP. 
 
More about taking part: 
 
Can I change my mind? 
 Yes. You can decide to take part and then later change your mind without giving a 
reason. Your usual NHS care would not be affected. However, any information you had 
given until that point would still be used in the study results. 
 
What happens when the study stops? 
 When the research stops in August 2015 you will not be required to do anything further 
and can use HeLP-Diabetes until 1st March 2016. The NHS may make HeLP-Diabetes 
available to all patients with diabetes across the country. But that will depend on what 
the study shows and whether funds are available. 
 
What will happen to my information in the study? 
 All information you give will be treated in confidence. It will be stored on a secure 
computer, using only a study number to identify you. Only authorised people will be able 
to read the information. 
 
Who is paying for and running the study? 
 The study is being funded by the National Institute for Health Research (NIHR), which is 
funded by the government and is the biggest funder of research in the NHS. 
 The study is run by University College London. The lead researcher is Professor 
Elizabeth Murray, who is a GP and a health researcher. The study is being managed by 
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Jamie Ross (Research Associate) and you should contact her if you have any 
questions. 
 
What if there is a problem? 
 If you took part in the study and felt unhappy about the way you were treated, you 
should contact the study manager, Jamie Ross (details below). If she cannot help, 
contact the lead researcher, Prof Elizabeth Murray (details below). If you remained 
unhappy, you could make a formal complaint through the NHS Patient Advice and 
Liaison Service (PALS) www.pals.nhs.uk  
 In the very unlikely event that someone took part and became unable to make decisions 
for themselves, that person would not continue in the study. 
 
Contact details: 
If you have any questions about the study, please contact the HeLP-Diabetes study manager, 
Jamie Ross: 
  
eHealth Unit 
UCL Research Department of 
Primary Care & Population Health 
Upper 3rd Floor 
Royal Free Hospital 
Rowland Street 
London NW3 2PF 
 
Tel: 020 7784 0500 (ext 37073) 
Email: Jamie.Ross@ucl.ac.uk 
 
Or the lead researcher, Prof Elizabeth Murray can be contacted at the same address or on: 
Tel: 020 7794 0500 ext 36747 
Email: elizabeth.murray@ucl.ac.uk
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Appendix F Patient Consent Form 
 
[UCL departmental headed paper] 
 
Centre Number:    Patient Identification Number for this study: 
 
 
CONSENT FORM 
 
Title of Project: A study to evaluate the implementation of the HeLP-Diabetes online self-
management programme for people with type 2 diabetes. 
 
Please initial all boxes in this section to say that you agree to and understand the 
following statements: 
Initial 
here 
I confirm that I have read and understood the information sheet dated 05.12.2013 
Version 3 for the above study. I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactorily. 
 
 
I am volunteering to participate in research to evaluate and improve HeLP-Diabetes and 
the way it’s offered to patients through the NHS. 
 
 
My HeLP-Diabetes registration and usage data will be used anonymously for research 
purposes.  
 
 
I will be asked to complete questionnaires after joining the research and again at 3 
months and12 months. 
 
 
I may be asked to participate in one or more interviews with a researcher to discuss my 
experiences of using HeLP-Diabetes.  
 
 
The information I provide in interviews will be tape recorded and saved on a computer. 
Once the information has been transcribed, names and all other personal data will be 
destroyed in accordance with the Data Protection Act 1998. 
 
My participation is voluntary and I am free to withdraw at any time without giving any 
reason, without my medical care or legal rights being affected. 
 
 
My GP may be informed of my participation in this research.   
 
All the information I provide will be confidential and that I will remain anonymous. 
However, if I discolse anything potentially dangerous to my health this may be reported 
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to my GP or doctor.  
I agree to take part in the research.  
 
 
 
   ______      _____    
  ____ 
Name of participant    Date      Signature 
   
   ______      _____    
  ____ 
Name of person taking consent  Date      Signature  
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Appendix G Healthcare professional Information Sheet 
 
 
[UCL departmental headed paper] 
 
 
Staff interview information sheet. Date of issue: 31.10.2012 
Staff interview information sheet. Version number: 1.0  
 
 
HEALTH CARE PROFESSIONAL INTERVIEW INFORMATION SHEET 
A study to evaluate the implementation of the HeLP-Diabetes online self-management 
programme for people with type 2 diabetes. 
 
 
Before you decide whether to take part, it is important that you understand why the research is 
being done and what it will involve for you. This information sheet will help you, so please take 
some time to read this information carefully and ask any questions you might have or if there is 
anything that is not clear. Talk to others about the study if you wish.  
 
Part 1 of this information sheet tells you the purpose of this study and what will happen to you if 
you take part. Part 2 gives you more detailed information about the conduct of the study. Please 
ask if there is anything that is not clear.  
 
PART 1. 
 
Why are we doing the study? 
 
Type 2 diabetes is one of the most common long term health conditions in the UK, affecting 
over 2 million adults. Many people with type 2 diabetes need help and support to live a healthy, 
happy life. The NHS recommends that every person with type 2 diabetes should have the 
opportunity to attend a course on diabetes when first told they have diabetes, and once a year 
thereafter. But not everybody who needs these courses gets them – either because there are 
not enough courses locally, or because the courses are hard to get to.  
 
We think one way of helping people with diabetes get the support and information they need to 
live a healthy, happy life is through the web. We have developed a web-based programme 
offering help and support for people with type 2 diabetes called HeLP-Diabetes. We are now 
trying to implement the programme so that people who could benefit from it have easy access to 
it. We know that it is difficult to get new ways of working into routine practice and we are looking 
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for the best way of doing this. We are asking for your help with this. You can use the 
programme whether or not you help us with our research.  
 
Why have I been chosen? 
 
We are looking for healthcare professionals working in GP practices and diabetes clinics where 
the HeLP-Diabetes programme has been introduced.  
 
Do I have to take part? 
 
No. It is up to you to decide whether or not to take part in the research. Take as long as you 
need to reach a decision and discuss the study with the researcher before making a decision. If 
you do decide to take part, you will be asked to sign a consent form. Even after signing this form 
you are free to withdraw at any time without giving a reason. However, if you do withdraw after 
providing the research team with some information about you, that information will be kept as 
part of the study.  
 
What will happen to me if I take part? 
 
We will ask you to participate in one or more interviews about your experience of using the 
HeLP-Diabetes programme. This will be with the researcher and you can do this in person or 
over the telephone.  
 
Will I benefit from taking part? 
 
Not directly. You can use the programme (HeLP-Diabetes) whether or not you take part. But if 
you do take part you will know you have helped us work out how best to implement and 
disseminate the programme for other people to use in the future.  
 
 
Are there any risks involved? 
 
It is very unlikely that you will come to harm as a result of taking part in this study. The 
programme has been developed by a team of NHS doctors, nurses, dieticians, psychologists 
and researchers. It reflects current best practice in the NHS. The research procedures are also 
very low risk. You will be asked to take part in one or more interviews about your experience of 
using HeLP-Diabetes.  
 
Do I have to take part? 
 
No. It is up to you to decide whether or not to take part in the research. You do not have to 
make a firm decision now. If you agree to take part, you will be asked to sign a consent form to 
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confirm you wish to take part before you start in the study. You are free to withdraw at ANY 
time, without giving a reason. You can still use the programme without participating in the 
research. Even after signing the consent form you are free to withdraw at any time without 
giving a reason. However, if you do withdraw after providing the research team with some 
information about you, that information will be kept as part of the study.  
 
 
What happens when the study stops? 
 
When the research stops you will not be required to do anything further.  
 
The HeLP-Diabetes programme may still be available for you to use, however, this is not 
guaranteed at this point and will partly depend on how many people use it. Following the 
research study amendments may need to be made to the programme, or the site may have to 
go offline for other reasons. More information on this will be made available on the HeLP-
Diabetes programme at the end of the study period. 
 
What if there is a problem? 
 
Any complaint about the way you have been dealt with during the study or any possible harm 
you might suffer will be addressed. The detailed information on this is given in Part 2. 
 
Will the information I give in the study be kept confidential?  
 
Yes. We will follow ethical and legal practice and all information about you will be handled in 
confidence. The details are included in Part 2. 
 
Can I withdraw from the study once I’m in it? 
 
Yes. You can withdraw from the study at any time without giving a reason. However, any 
information that you have already provided will be kept in the study. 
 
 
PART 2: Detailed information about the conduct of the study.  
 
What will happen to the information I provide? 
 
All information about you will be treated confidentially and in accordance with the Data 
Protection Act 1998. We will keep your personal identification data (your name, address) 
separate from the rest of the information about you in the study, which will only be identified by 
a unique participant identification number. The data will be stored online on a secure server 
which has been approved for clinical research. Only authorised persons (the research team and 
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the regulatory bodies that monitor researchers in the UK) will have access to your personal 
data.  
 
What if there is a problem? 
 
Any complaint about the way you have been dealt with during the study or any possible harm 
you might suffer will be addressed. If you have a concern about any aspect of this study, you 
should speak to the study researcher Jamie Ross who will do her best to answer your 
questions. If she cannot help, your concern will be passed to the Chief Investigator, Dr Elizabeth 
Murray, who has overall responsibility for the study. The contact details for both Jamie Ross and 
Dr Murray are below.  
 
In the unlikely event that you are harmed by taking part in this study, compensation may be 
available.  
 
If you suspect that the harm is the result of the Sponsor’s (University College London) or the 
hospital's negligence then you may be able to claim compensation. Please make the claim in 
writing to Dr Elizabeth Murray who is the Chief Investigator for the research and is based at the 
e-Health Unit (UCL Research Department of Primary Care – full address below). The Chief 
Investigator will then pass the claim to the Sponsor’s Insurers, via the Sponsor’s office. You may 
have to bear the costs of the legal action initially, and you should consult a lawyer about this. 
 
What will happen to the results of this study? 
 
The results of this study will be submitted for publication in academic journals and presented at 
conferences. We hope they will influence NHS policy and lead to improved information provision 
for patients. We would be happy to send you a summary of the results – if you would like us to 
do so please fill in the 2
nd
 page of the consent form. 
 
Loss of Capacity 
 
In the very unlikely and unfortunate event that someone who takes part in the study lost the 
ability to make informed decisions for him or herself, that person would not continue to take part 
in the study. Any information that we have received before such an event would be used in the 
study.  
 
Who is organising and funding the study? 
 
The study is being run by University College London. It is funded by the National Institute of 
Health Research. It is sponsored by the University College London.  
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The research team are: Dr Elizabeth Murray (General Practitioner and Researcher), Dr 
Kingshuk Pal (General Practitioner and Researcher), Dr Charlotte Dack (Psychologist and 
Researcher), Ms Jamie Ross (Psychologist and Researcher) and Ms Orla O’Donnell (Project 
Coordinator).  
 
The content of HeLP-Diabetes has been written and developed by a larger team including 
people with Type 2 Diabetes, Specialist Diabetes Consultants, General Practitioners, Diabetes 
Specialist Nurses, Practice Nurses, Dieticians, Sociologists, Psychologists, a Web Designer and 
a Software Company. For more information about the team, please see 
http://www.ucl.ac.uk/pcph/research-groups-themes/e-health  
 
Who has reviewed the study? 
 
All research in the NHS is looked at by an independent group of people, called a Research 
Ethics Committee, to protect your interests. This study has been reviewed by the [title] 
Research Ethics Proportionate Review Sub-Committee. 
 
Is there an independent contact point where I can get general advice about taking part in 
research? 
 
Yes. INVOLVE is a national advisory group that supports greater public involvement in NHS, 
public health and social care research. They provide advice and information on public 
involvement in research. You can find out more from their website: www.invo.org.uk 
You can contact them at: INVOLVE, Wessex House, Upper Market Street, Eastleigh, 
Hampshire, SO50 9FD or Telephone: 023 8065 1088 
 
Is there a contact point where I can find out further details about the research study? 
 
Yes. If you have any questions at all about the study or would like further information, please 
contact the study researcher, Ms Jamie Ross. 
 
Who do I contact if I wish to take part? 
 
If you are interested in taking part, have any questions at all about the study or would like further 
information please contact the Study Researcher, Ms Jamie Ross at the details below. 
  
CONTACT DETAILS 
Name Ms Jamie Ross  Dr Elizabeth Murray –  
Role Study Researcher Chief Investigator 
Tel 020 7794 0500 (Ext: 37370)  020 7794 0500 ext 36747 
Email jamie.ross@ucl.ac.uk elizabeth.murray@ucl.ac.uk 
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Address eHealth Unit,  
UCL Research Department of Primary Care & Population Health 
Upper 3rd Floor, Royal Free Hospital, Rowland Hill Street 
London NW3 2PF 
Fax 020 7794 1224. 
Web https://www.ucl.ac.uk/pcph/research-groups-themes/e-health 
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Appendix H Healthcare professional Consent Form 
 
 
[UCL departmental headed paper] 
 
Centre Number:       Study Number: 
Healthcare professional Identification Number for this study: 
 
HEALTH CARE PROFESSIONAL CONSENT FORM 
 
Title of Project: A study to evaluate the implementation of the HeLP-Diabetes online self-
management programme for people with type 2 diabetes. 
 
Name of Researcher: [Name of person taking consent]  
 
Please initial all boxes in this section Initial here 
I confirm that I have read and understand the information sheet dated 
31.10.2012 version 1.0 for the above study. I have had the opportunity to 
consider the information, ask questions and have had these answered 
satisfactorily. 
 
I understand that I am volunteering to participate in a research study evaluating 
the implementation of the HeLP-Diabetes online self-management programme 
for people with type 2 diabetes 
 
I understand that the purpose of the study is to inform and improve the 
implementation of HeLP-Diabetes in other practices / clinics 
 
I understand that I will be asked to attend one or more interviews with a 
researcher to discuss my experiences of using the HeLP-Diabetes programme. 
I agree to take part in these interviews.  
 
I understand that the information I provide will be tape recorded or 
saved on a computer and used for the purposes of this research 
study only. I also understand that once the information has been 
transcribed, names and all other personal data will be destroyed in 
accordance with the Data Protection Act 1998. 
 
I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason, without my medical care or legal rights 
being affected. 
 
I understand that all the information I provide will be confidential and that I will 
remain anonymous.  
 
I agree to take part in the above study.  
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Name of participant   Date     Signature 
   
           
   
Name of person taking  Date     Signature  
Consent 
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Appendix I Patient measures collected by online registration form 
 
Type Variable  Response options Optional/ 
Mandatory 
Date 
variable 
added to 
registration 
page 
Verification 
R
e
g
is
tr
a
ti
o
n
 d
e
ta
il
s
 
Username  Free text 
 Must be more than 3 
characters, with no spaces, 
and using only 0-9 and a-z, 
A-Z. 
M 01.03.2013 Software 
checks that no 
one else has 
registered 
using this 
username. 
Password  Free text 
 At least 6 characters and can 
include upper and lower case 
characters, numbers and 
special characters. 
M 01.03.2013 Participants 
asked to enter 
this twice and 
are given an 
indication of 
password 
strength using 
a 10 point 
colour scale 
and either the 
words Weak, 
OK, Good, 
Strong, Very 
Strong. 
C
o
n
ta
c
t 
D
e
ta
il
s
 
First name  Free text M 01.03.2013  
Last name  Free text M 01.03.2013  
Email 
address 
 Free text M 01.03.2013 Participants 
asked to enter 
this twice and 
the software 
checked that it 
was a valid 
email address. 
Telephone 
number 
 Free text O 01.03.2013 Software 
checks that the 
number 
entered is the 
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correct number 
of characters 
and are all 
numerical 
digits. 
Mobile 
number 
 Free text O 01.03.2013 Software 
checks that the 
number 
entered is the 
correct number 
of characters 
and are all 
numerical 
digits. 
D
e
m
o
g
ra
p
h
ic
 d
e
ta
il
s
 
Date of birth  DD/MM/YYYY M 01.03.2013  
Gender  Single item, select one out of 
two options: 
 
 Male 
 Female 
M 01.03.2013  
Ethnic Group  Single item, select one out of 
eighteen options: 
 
 Asian or Asian British- 
Bangladeshi     
 Asian or Asian British- 
Chinese    
 Asian or Asian British- Indian   
 Asian or Asian British- Other    
 Asian or Asian British- 
Pakistani    
 Black or Black British- 
African     
 Black or Black British- 
Caribbean  
 Black or Black British- Other  
 Mixed- Other  
 Mixed- White and Asian  
 Mixed- White and Black 
African  
M 01.03.2013  
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 Mixed- White and Black 
Caribbean  
 Other ethnic group- Arab  
 Other ethnic group- Other  
 Prefer not to say 
 White- 
English/Welsh/Scottish/North
ern Irish/British 
 White- Irish    
 White-Other   
Highest 
educational 
attainment 
 Single item, select one out of 
six options: 
 
 None 
 School leaver (e.g., CSE, 
GCSE, O-Level, NVQ1-2) 
 A-level or vocational 
equivalent (e.g. NVQ 3) 
 Degree or NVQ 4, HND or 
similar 
 Post-graduate degree or 
NVQ 5 
 Not stated 
M 05.03.2014  
D
ia
b
e
te
s
/c
li
n
ic
a
l 
in
fo
rm
a
ti
o
n
 
Date of 
diagnosis 
 DD/MM/YYYY O 01.03.2013  
How long 
have you had 
diabetes? 
 Single item, select one out of 
four options: 
 
 <1 year 
 1-5 years 
 5-10 years 
 10-20 years 
 >20 years 
M 01.03.2013  
What would 
you most like 
help with for 
your 
diabetes? 
 Select all options that apply: 
 
 Attending my appointments
  
 Connecting with others  
 Cutting down on alcohol  
 Eating healthily   
M 01.03.2013  
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 Increasing my activity levels
    
 Living and working with 
diabetes  
 Losing weight  
 Managing my feelings 
  
 Preventing complications
  
 Quitting smoking 
 Taking my medicines 
  
 Understanding my medicines
  
 Understanding what diabetes 
is 
How is your 
diabetes 
managed? 
 Single item, select one out of 
four options: 
 
 Lifestyle alone (i.e. diet and 
physical activity) 
 Lifestyle and tablets 
 Lifestyle tablets and insulin 
 Other injectables 
M 01.03.2013  
GP/clinic 
name 
 Free text M 01.03.2013  
Have you 
ever been 
offered or 
referred to 
any diabetes 
self-
management 
or education 
groups or 
classes (e.g. 
DESMOND)?: 
 Single item, select one out of 
two options: 
 
 Yes 
 No 
M 19.08.2014 
 
Specifically 
for patients 
who were 
from 
Camden 
 
Are you 
currently 
attending or 
have you 
 Single item, select one out of 
two options: 
 
 Yes 
M 19.08.2014 
 
Specifically 
for patients 
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attended any 
diabetes self-
management 
or education 
groups or 
classes (e.g. 
DESMOND)?: 
 No who were 
from 
Camden 
In
te
rn
e
t 
a
c
c
e
s
s
 a
n
d
 e
x
p
e
ri
e
n
c
e
 
Internet 
access 
 Single item, select one out of 
two options: 
 
 Home 
 Public 
M 01.03.2013  
Use of 
computer 
 Single item, select one out of 
three options: 
 
 Basic 
 Intermediate 
 Advanced 
M 01.03.2013  
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Appendix J Recoding of patient characteristic variables 
 
Variable Original classification Recoded to 
 
 
Ethnic 
Group 
White - English/Welsh/Scottish/Northern 
Irish/British 
White British  
White - Irish Non White British 
White - Other 
Black or Black British - African 
Black or Black British - Caribbean 
Black or Black British - Other 
Asian or Asian British - Bangladeshi 
Asian or Asian British - Chinese 
Asian or Asian British - Indian 
Asian or Asian British - Other 
Asian or Asian British - Pakistani 
Mixed - White and Asian 
Mixed - White and Black African 
Mixed - Other 
Other ethnic group - Arab 
Other ethnic group - Other 
Prefer not to say 
Duration of 
diabetes 
<1 year <1 year 
1-5 years 1-5 years 
5-10 years 5-10 years 
10-20 years >10 years 
>20 years 
How 
diabetes is 
managed 
Lifestyle alone (i.e. diet and physical 
activity) 
Lifestyle alone (i.e. diet and physical 
activity) 
Lifestyle and tablets Lifestyle and tablets 
Lifestyle tablets and insulin Lifestyle, tablets and injectables 
Other injectables 
Education None None/school leaver 
School leaver 
A-levels A-levels or higher 
Degree 
Post-graduate 
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Appendix K Histograms representing distribution of intervention use 
 
Histogram representing the distribution of the number of days patients used the intervention 
following registration (n=205) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Histogram representing the distribution of the number of days patients used the intervention 
following registration, excluding patients who didn’t use it again (n=104) 
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Appendix L Staff demographic data collection form 
[UCL departmental headed paper] 
 
Study Title: Evaluating the implementation of HeLP-Diabetes within the NHS 
 
Thank you very much for expressing an interest in participating in our study. To ensure we 
collect opinions from a range of people about this topic and to help us make sense of the results 
we need to know a little bit about your background and experience. When reporting our results 
we will ensure you are not identifiable. If you are happy to take part in our study please 
complete this questionnaire. 
 
For internal use only: 
Study ID: 13/EM/033 
 
Participant ID:  
 
 
Name: 
 
 
Guidance on preferences: how to contact you 
Address:        Telephone: 
 
 
          Email: 
 
 
How old are you? 
 
18-24 
 25-34 
 
 
35-44 
  
45-54 
 
 
55-64 
 
65-74 
 
75+ 
 
  
Are you male or female? Please tick relevant 
box: 
Male 
 
Female 
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What is your role in looking after patients with type 2 diabetes? Please tick the box that 
best describes your role 
GP Partner 
 Salaried GP 
 
 
Diabetes Specialist Nurse 
  
Practice Nurse 
 
 
Diabetes Specialist Dietician 
 
Management 
 
Hospital Doctor 
 
Commissioner 
 
HCA 
 
Receptionist/Admin 
 
Other (please give details) 
How long have you been in your current role?  
Years 
 Months 
 
 
 
What is your ethnic background?  
Please tick 1 box or complete 1 section which best describes your ethnic background 
White 
British 
 
 
Black or 
Black 
British 
Caribbean 
 
Irish 
 
 
African 
 
Other white background (please write in) 
 
 
Other Black background (please write in) 
 
Asian or 
Asian 
British 
Indian 
 
Mixed 
Race 
White and Black 
Caribbean 
 
Pakistani 
 
 White and Black 
African 
 
Bangladeshi 
 
 White and Asian 
 
 
Other Asian background (please write in) 
Other Mixed race background (please write 
in) 
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Other 
ethnic 
background 
Chinese 
 Other ethnic background (please write in) 
 
 
How much experience do you have of using the Internet?  
Please tick 1 box which best describes your level of experience.  
 
Novice (e.g. never used the Internet 
before) 
 
 
Basic (e.g. used the Internet a 
few times but not often)  
 
Experienced (e.g. used or currently use 
the Internet regularly) 
 Expert (e.g. work is to do with 
the Internet) 
 
Is there a computer linked to the Internet that you 
can use when you see patients?  
Yes 
 
No 
 
Have you ever attended a diabetes education 
programme?  
Yes 
 
No 
 
Have you ever used HeLP-Diabetes with a patient?  Yes 
 
No 
 
Have you ever used any computer programme to 
help manage patients with type 2 diabetes? 
Yes 
 
No 
 
 
What is the current list size at your practice/ clinic? (if applicable)  
 
How many of these patients have type 2 diabetes? 
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Appendix M Staff interview Topic Guide 
 
1. Can you explain you job role to me? 
 
2. Can you explain a little about the nature of this practice in particular? 
o number of doctors 
o healthcare professional 
o patients 
o How does it compare to other practices you’ve worked in? 
 
3. What is the usual care pathway for someone with diabetes from diagnosis? 
 
4. What are the biggest challenges for the practice in relation to diabetes?  
 
5. What are your views on the role of the patient in taking care of their diabetes? 
 
6. What is your role in supporting self-management? 
a. How do you support it? 
 
7. What services does the practice offer to patients with diabetes? 
o Does the practice refer patients to DESMOND etc. or any other structured education? 
 
8. How do you decide upon new services to take on or endorse? 
o Who decides? 
o How are those decisions reached?  
 
9. Initially you expressed an interest in HeLP-Diabetes, what was it that got you 
interested? 
 
10. What value, if any do you think HeLP-Diabetes has in diabetes care in general? 
a. How does it compare to other diabetes resources? 
 
11. What did you think to HeLP-Diabetes after I came to demonstrate it? 
a. How was that meeting received by the other healthcare professional? 
b. Was there resistance from anyone? If so why? 
 
12. How did you envisage HeLP-Diabetes being used in the practice/with patients? 
 
13. Can you describe how you’ve introduced and used HeLP-Diabetes in the practice? 
a. Who has done the work? How was this allocated? Are they supported? 
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14. How would you describe the success of HeLP-Diabetes in the practice? 
 
15. What do you think the main barriers or facilitators are? 
 
a. In what way, if any, has buy in from healthcare professional impacted on the 
implementation? 
b. In what way, if any, have resources impacted on the implementation? 
c. In what way, if any, have people’s understanding of the value/utility of HeLP-Diabetes 
impacted on the implementation? 
d. In what way, if any, has support from colleagues/ management impacted on the 
implementation? 
 
16. How do you think we could make HeLP-Diabetes more workable in a practice like this 
one? 
 
17. What do you think the role of technology like HeLP-Diabetes is within General Practice? 
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Appendix N Patient Interview Topic Guide 
 
Diabetes and impact 
 
1. How long have you had diabetes for? 
2. How did you find out that you have diabetes? 
3. How did you feel getting the diagnosis? 
4. Can you explain what diabetes is? 
5. What does having diabetes mean to you? 
6. How do you feel about having diabetes now? 
7. How serious would you say diabetes is for you? 
8. How do you think others perceive your diabetes? 
9. Do you talk to your friends and family about it? 
a. Is it easy or difficult for you to talk to others about it? 
 
10. Do you know anyone else with diabetes? 
11. Where do you get support from for diabetes? 
12. How do you manage your diabetes? 
a. How easy or difficult do you find it to manage your diabetes? 
b. Any specific areas you feel you need help with? 
c. How does diabetes affect your life?  
d. What aspect of diabetes care is most important for you?  
e. Are there any aspects of your diabetes that concern you? 
 
13. What is your role in looking after your diabetes? 
14. Have you made any lifestyle changes in order to manage your diabetes? 
a. What changes have you made?  
 
15. Do you feel you know enough about diabetes? 
 
Role of NHS 
 
16. What is the role of the NHS in looking after your diabetes? 
17. How often do you attend your GP? 
18. How well does your GP/nurse support you with your diabetes?  
19. Have you attended any diabetes education or support groups? If not why not? 
a. What did you think of these? 
b. Did they help you with managing your diabetes? 
c. Would you want a refresher course or ongoing support or education? 
d. Where do you get advice about managing your diabetes? e.g. internet, family, 
friends, peers, healthcare professionals 
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HeLP-Diabetes 
20. Can you explain what you think HeLP-Diabetes is? 
21. How did you first hear about the HeLP-Diabetes website? 
a. Who introduced it to you? 
b. How was it described to you? 
c. How were you set up with a username and password? 
d. Were you shown the website at the time of registration? 
e. How did you find this process? What would make it better? 
 
22. Why did you decide to sign up to HeLP-Diabetes? 
a. Anything in particular that sounded interesting to you? 
b. How important was the recommendation from your GP practice? 
 
23. Was there anything that made you unsure about using it? 
a. Did you feel confident that you could go home and use it on your own? 
 
24. Have you used HeLP-Diabetes since being registered? 
a. What for/ why not? 
b. How often? 
c. Where do you use it? 
d. Have you had any help in using it? 
e. Is there anything we can do that would help you use it more? 
f. Has the way you use it changed over time (content looked at/ frequency of use/ 
style of use-booklet vs browsing) 
 
25. What are your impressions of HeLP-Diabetes?  
a. Any features you particularly like or dislike? 
b. Which sections do you visit most? 
c. Anything missing that you would like to see on it? 
d. Have you experienced any difficulties in using the website? 
e. What could we do to improve it? 
 
26. Do you feel you have learned anything from using HeLP-Diabetes? 
 
27. Has using HeLP-Diabetes helped you with any specific aspect of looking after your 
diabetes? 
a. Which? 
b. How has it helped? 
c. Have you changed any behaviours? 
d. What aspects have not been supported? 
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28. We are interested in improving the way that HeLP-Diabetes is advertised and made 
available to people with diabetes through GP practices, do you have any suggestions for 
ways we can do this? 
a. Were you given enough information about HeLP-Diabetes by your practice? 
b. Do you read any diabetes related websites/magazines? Do you attend any 
other healthcare services for your diabetes care? Would any of those services be 
good opportunities to introduce HeLP-Diabetes? 
c. Have you used/mentioned the website in appointments since being registered 
and if yes for what/how did it go etc. 
 
29. Have you received the fortnightly emails and newsletters for HeLP-Diabetes? 
a. What do you think of them? 
b. Have they encouraged you to visit the website? Why/why not? 
c. Could they be improved? 
d. Other options – Telephone calls, personal emails? 
 
Information seeking and e-health 
 
30.  What do you think about the use of a website to help people manage their diabetes? 
a. Positives/ negatives 
b. How does this compare to other diabetes support/education you’ve 
experienced? 
c. Would you use an app or a smartphone? If so which parts of the website would 
you use on the go? 
 
31. Where do you seek information from about your diabetes? 
a. Role of the internet 
 
32. Do you have any final thoughts or comments on how we could improve HeLP-Diabetes 
and the way that it is offered to patients? 
 
33. Is there anything else you would like to add? 
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Appendix O Patient self-sign up information leaflet
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Appendix P Characteristics of practices/clinics who adopted HeLP-Diabetes 
 
ID List size No. of 
people on 
diabetes 
register 
QOF score 
(max=107) 
No. of 
healthcare 
professional 
% referred to 
diabetes 
structured 
education 
(QOF data)  
Estimated 
number of 
patients with 
type 2 
Months 
between 
adoption 
decision and 
study end 
No. 
registered to 
intervention 
% of eligible 
A 11955 568 81.7 32 81.5 511.2 21 40 7.8 
B 9814 386 101.8 24 75.0 347.4 20 40 11.5 
C 6928 263 105.7 18 90.0 236.7 25 28 11.8 
D 10027 427 107.0 27 87.0 384.3 20 15 3.9 
E 5727 271 95.0 14 94.1 243.9 21 11 4.5 
F 11945 521 94.5 26 85.2 468.9 21 11 2.4 
G 3985 295 81.2 10 66.7 265.5 22 8 3.0 
H 15273 356 107.0 36.5 81.3 320.4 13 7 2.2 
I 12963 397 106.5 39 93.8 357.3 20 3 0.8 
J 8472 243 103.4 19 75.0 218.7 23 3 1.4 
K 5387 272 95.3 15 83.3 244.8 9 2 0.8 
L 5448 284 94.5 21 93.8 255.6 24 1 0.4 
M 6846 263 93.7 21.5 81.3 236.7 20 1 0.4 
N 5565 257 103.9 9 57.1 231.3 20 1 0.4 
O 3075 154 107.0 13 100.0 138.6 18 1 0.7 
P 2472 135 92.6 10 100.0 121.5 14 1 0.8 
Q 9939 299 105.1 22 94.4 269.1 21 1 0.4 
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R 6184 293 106.1 14 100.0 263.7 16 1 0.4 
S* 1,849  83  102.42  7 75.00  74.7 7 0 0.0 
T* 7,729  311  105.42  16 93.33  279.9 14 0 0.0 
U* 6,846  263  93.72  18 81.25  236.7 24 0 0.0 
V* 2,871  146  105.41  11.5 100.00  131.4 25 0 0.0 
Hospital            882 18 29  3.3 
Community         983 3 1 0.1 
*Practices who adopted but did not use HeLP-Diabetes 
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Appendix Q Summary of implementation at each site 
 
ID No. patients 
registered to 
intervention  
 
(number 
registered by 
healthcare 
professional) 
Implementation 
of registration 
methods 
What 
introduction/training 
did the practice 
receive for HeLP-
Diabetes? 
Which healthcare 
professional 
were involved in 
the 
implementation 
How was HeLP-
Diabetes 
incorporated 
into practice? 
 
Any identified 
facilitators to 
implementation  
Any identified 
barriers to 
implementation 
A 40 (39) Adoption was 
agreed using the 
staff registration 
method. When the 
patient registration 
method was 
created leaflets 
were provided to 
the practice to 
use, but 
registrations 
remained mostly 
healthcare 
professional led. 
Initial practice meeting 
with whole clinical team 
and practice manager. 
 
Training of two 
healthcare assistants 
who had been 
nominated to deliver 
HeLP-Diabetes. 
 
Initially I registered 
some of the patients in 
this practice until 
healthcare professional 
felt confident to take 
Two healthcare 
assistants 
supported by 
practice manager 
It became part of 
the diabetic 
clinics held by 
the two HCA’s. 
Patients were 
asked if they 
were interested 
and then either 
registered on the 
spot or their 
details were 
noted and they 
were registered 
by one of the 
HCA’s over the 
Healthcare 
professional 
training.  
 
Strong sense of 
buy-in from the 
two HCA’s who 
saw value in 
HeLP-Diabetes.  
 
Positive feedback 
they received from 
patients using it.  
 
Support from me 
Time constraints 
within 
appointments 
 
Forgetting to offer 
HeLP-Diabetes to 
patients 
No real support or 
push for HeLP-
Diabetes among 
other healthcare 
professional 
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over. phone at a later 
time.  
 
The HCA used 
HeLP-Diabetes 
during 
consultations as 
a tool to explain 
things to 
patients. 
in delivering it 
early on.  
 
Dedicated 
diabetes clinics 
where a number 
of patients with 
diabetes would 
attend 
appointments in 
the same morning 
or afternoon and 
therefore HeLP-
Diabetes wasn’t 
as easily 
forgotten. 
 
Ongoing 
communication 
with me and 
practice 
healthcare 
professional  
 
HCAs thought 
HeLP-Diabetes 
was useful for 
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their work in giving 
them more 
information about 
diabetes 
B 40 (38) Adoption was 
agreed using the 
staff registration 
method. When the 
patient registration 
method was 
created leaflets 
were provided to 
the practice to 
use, but 
registrations 
remained mostly 
healthcare 
professional led. 
Meeting and training 
with lead GP for 
diabetes, two practice 
nurses and HCA. 
 
Additional training 
provided to new HCA at 
a later date. 
GPs, nurses and 
HCA. 
Clinical 
healthcare 
professional 
would 
recommender 
the use of HeLP-
Diabetes to 
patients and 
directly following 
their 
appointments 
would be sent to 
the HCA to be 
signed up. In 
cases where this 
wasn’t possible, 
their details were 
taken and the 
HCA would 
phone up and 
register them at 
a later time.  
Strong support 
and push for 
intervention by GP 
at practice 
 
Enthusiasm of 
HCA who enjoyed 
taking on this new 
role. 
 
Financial 
incentives (service 
support costs) 
 
GP asked for 
additional content 
to be added to 
HeLP-Diabetes for 
specific patients 
Competing 
pressures for 
healthcare 
professional 
 
No buy in to 
intervention from 
one nurse 
 
Relied on GPs and 
nurses to 
remember to refer 
patients during 
consultations 
 
Numbers of patient 
registration 
dropped when the 
first HCA left the 
practice. A 
replacement wasn’t 
appointed for a 
long time 
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afterwards. 
C 28 (28) Adoption was 
agreed using the 
staff registration 
method. When the 
patient registration 
method was 
created leaflets 
were provided to 
the practice to 
use, but 
registrations 
remained 
healthcare 
professional led. 
Initial practice meeting 
with whole clinical team 
and practice manager. 
 
Training of two practice 
nurses who had been 
nominated to deliver 
HeLP-Diabetes. 
 
Initially I registered 
some of the patients in 
this practice until 
healthcare professional 
felt confident to take 
over. 
Two practice 
nurses and HCA 
Initially I came to 
the practice on a 
weekly basis and 
registered 
patients who 
were sent to me 
by the practice 
nurses following 
their 
appointments 
during a regular 
diabetes clinic.  
 
When the nurses 
and HCA felt 
confident in 
registering 
patients 
themselves, they 
did the 
registrations as 
part of their 
routine 
appointments 
with patients.  
 
Healthcare 
professional 
training.  
 
Strong sense of 
buy-in from the 
two HCA’s who 
saw value in 
HeLP-Diabetes.  
 
Positive feedback 
they received from 
patients using it.  
 
Support from me 
in delivering it 
early on.  
 
Dedicated 
diabetes clinics 
where a number 
of patients with 
diabetes would 
attend 
appointments in 
the same morning 
Not implemented 
within the wider 
practice and 
remained a 
nurse/HCA role 
only. 
 
HCA used 
intervention as a 
tool during 
consultations but 
often forgot to 
register patients. 
Saw it more as a 
resource for 
healthcare 
professional.  
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The HCA used 
HeLP-Diabetes 
during 
consultations as 
a tool to explain 
things to 
patients. 
or afternoon and 
therefore HeLP-
Diabetes wasn’t 
as easily 
forgotten. 
 
Ongoing 
communication 
with me and 
practice 
healthcare 
professional  
 
Financial 
incentives (service 
support costs) 
 
HCA used 
intervention as a 
tool to help her 
with appointments 
D 15 (13) Adoption was 
agreed using the 
staff registration 
method.  
 
When the patient 
Initial meeting with one 
GP who then informed 
other healthcare 
professional of 
intervention. 
GP and reception 
healthcare 
professional 
Paper copies of 
the online 
registration form 
were created 
and posted out 
to all patients 
GP had a strong 
interest in 
diabetes and self-
management and 
saw value in 
HeLP-Diabetes  
Only the GP took 
ownership of 
HeLP-Diabetes 
and did not 
communicate 
about it with other 
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rgistration method 
was created 
leaflets were 
provided to the 
practice to use, 
these replaced the 
previous 
implementation 
method.  
with type 2 
diabetes on the 
register. Patients 
would return 
these and then, 
at a convenient 
time, reception 
healthcare 
professional 
would register 
patients on 
HeLP-Diabetes. 
 
Patient 
registration 
method leaflets 
handed out 
during 
appointments 
along with other 
diabetes related 
information. 
 healthcare 
professionals  
 
Time to register 
patients. 
 
Forgetting to 
mention HeLP-
Diabetes to 
patients.  
E 11 (8) Adoption was 
agreed using the 
staff registration 
method. When the 
patient registration 
Initial meeting with two 
GPs and then training 
with the receptionist on 
registering patients 
GPs and 
receptionist 
Patients would 
be informed 
about HeLP-
Diabetes by 
healthcare 
New and 
enthusiastic GPs 
with an interest in 
diabetes, self-
management and 
Concerns HeLP-
Diabetes was only 
available for 
duration of 
research study 
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method was 
created leaflets 
were provided to 
the practice to 
use, but 
registrations 
remained 
healthcare 
professional led. 
professionals 
and then 
registered at 
reception by the 
receptionist. 
 
The practice 
held a patient 
self-
management 
evening where 
several patients 
were informed 
about HeLP-
Diabetes and 
registered to use 
it.  
patient 
empowerment 
 
Strong buy-in to 
HeLP-Diabetes by 
healthcare 
professional 
 
Demonstration of 
HeLP-Diabetes 
 
 
Large healthcare 
professional 
turnover 
F 11 (4) Adoption was 
agreed using the 
staff registration 
method. When the 
patient registration 
method was 
created leaflets 
were provided to 
the practice to use 
which proved 
Initial clinical meeting 
attended by GPs and 
practice managers. 
 
Subsequent training 
with 3 practice nurses, 3 
HCAs and receptionists 
Practices nurses, 
HCA and 
receptionist 
Originally the 
receptionist took 
the lead on 
registering 
patients who 
were referred to 
him via the 
nurses and 
some GPs.  
 
Training session 
especially the 
demonstration of 
HeLP-Diabetes 
 
Receptionist who 
was keen to 
undertake the role 
of registering 
patients 
Following the initial 
meeting with staff 
the adoption of 
HeLP-Diabetes 
had not been well 
communicated by 
GPs to the 
nurses/HCAs, who 
were unaware at 
the training session 
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more successful 
than the staff 
registration 
method. 
A practice nurse 
incorporated a 
reminder to the 
diabetes 
template within 
the practice to 
recommend 
HeLP-Diabetes. 
 
The intervention 
discussed with 
patients during 
appointments 
with the practice 
nurses and HCA. 
 
Once the patient 
registration 
leaflet was 
created these 
became the 
main strategy for 
offering HeLP-
Diabetes to 
patients. Leaflets 
were handed out 
to patients by 
 
Strong 
understanding of 
value of 
intervention from 
practice nurses 
 
Big nurse/NCA 
team who worked 
closely together 
 
Intervention kept 
at forefront of 
mind during 
diabetes 
appointments 
because of the 
reminder on the 
practice template 
 
Feedback from 
patients about 
using it 
that this was 
something they 
were expected to 
take on 
 
GPs within the 
practice not 
involved in 
implementation, 
referrals for 
registration did not 
come from 
appointments with 
GPs 
 
Receptionist left 
during 
implementation 
period 
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the practice 
nurses and the 
HCA and any 
patients who 
require 
assistance in 
registering were 
helped by the 
receptionist. 
G 8 (0) Initially, adoption 
was declined 
because the 
practice perceived 
there to be 
inadequate 
resources to 
deliver the staff 
registration 
method. This 
practice became 
the catalyst for the 
patient registration 
method and was 
the first practice to 
use the patient 
registration 
leaflets.  
Initial practice meeting 
with one GP with 
training on registering at 
the same time 
One GP At the practice 
meeting the GP 
said that it would 
not be possible 
to implement 
HeLP-Diabetes 
within this 
practice as they 
had no 
healthcare 
professional or 
resources to do 
the registering. 
This was the 
catalyst for 
developing the 
patient 
registration 
Keen GP with 
interest in 
technology and 
self-management 
 
Demonstration of 
HeLP-Diabetes 
patient registration 
method leaflets 
Very small practice 
with limited 
resources 
 
No communication 
to other healthcare 
professional in the 
practice about 
HeLP-Diabetes 
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method which 
was tested at 
this practice. 
 
The GP would 
hand out leaflets 
to every patient 
following a 
diabetes related 
appointment 
H 7 (0) This practice was 
introduced to 
HeLP-Diabetes 
when both models 
were up and 
running. They 
selected to use 
the patient 
registration 
method only. 
Clinical meeting 
attended with 
demonstration of HeLP-
Diabetes. 
 
No training as they 
opted to use patient 
registration method 
only. 
Leaflets given to 
all healthcare 
professional to 
give to patients 
Leaflets given to 
patients during 
appointments 
All healthcare 
professional 
present at clinical 
meeting so all 
knew about HeLP-
Diabetes 
 
Difficult to establish 
contact with the 
practice about 
HeLP-Diabetes 
following the initial 
meeting.  
I 3 (2) Adoption was 
agreed using the 
staff registration 
method. When the 
patient registration 
method was 
created leaflets 
Initial meeting with GP 
and two practices 
nurses with 
demonstration of HeLP-
Diabetes.  
 
Subsequent training on 
One practice 
nurse 
Initially the 
practice nurses 
tried to register 
patients to use 
HeLP-Diabetes 
during routine 
appointments 
Strong interest 
and belief in the 
value of HeLP-
Diabetes by the 
practice nurse 
 
Two training 
Large healthcare 
professional 
turnover with the 
practice nurse 
having to absorb 
workload of other 
nurse who left 
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were provided to 
the practice to 
use. A 
combination of 
models were 
adopted. 
registering and using 
HeLP-Diabetes with 
patients 
but found it too 
difficult 
technically and 
too time 
consuming. 
 
They replaced 
the healthcare 
professional led 
model with the 
patient 
registration 
method when it 
was available 
sessions provided 
 
Ongoing 
communication 
and support for 
the nurse 
 
The practice 
nurse requested 
additional content 
be added to 
HeLP-Diabetes for 
a particular area 
of diabetes care 
she had no 
additional 
resources for, this 
was created. 
 
Competing 
pressures 
Competing 
services to offer to 
patients 
 
Tasks associated 
with the research 
study overwhelmed 
healthcare 
professional  
 
Only the practice 
nurse involved in 
delivering 
intervenient with no 
other healthcare 
professional 
involved 
J 3 (3) Adoption was 
agreed using the 
staff registration 
method. When the 
patient registration 
method was 
created leaflets 
Initial practice meeting 
with all partners 
 
Subsequent training 
with two practices 
nurses and HCA 
Practice nurse Intervention 
mentioned to 
patients during 
routine 
appointments 
and practice 
nurse signed 
One practice 
nurse saw real 
value and need 
for intervention 
Tasks associated 
with the research 
study overwhelmed 
healthcare 
professional  
 
Time needed to 
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were provided to 
the practice to 
use, but no 
patients registered 
in this way. 
patients up to 
intervention 
register patients 
 
Practice nurse not 
confident in 
registration 
procedure 
 
Practice nurse 
went on sabbatical 
for 12 months 
 
Intervention wasn’t 
well communicated 
to other healthcare 
professional 
 
Other practice 
nurse wasn’t 
engaged and did 
not see it as part of 
her role 
 
K 2 (0) This practice was 
introduced to 
HeLP-Diabetes 
when both models 
were up and 
Initial meeting with all 
partners 
 
Training with practice 
nurse and HCA 
Practice Nurse 
and HCA 
patient 
registration 
method leaflets 
were given to the 
practice nurse 
Partners and 
practice manager 
seemed very keen 
on intervention 
Practice nurse and 
HCA did not see 
value in HeLP-
Diabetes, did not 
think it would be 
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running. They 
selected to use 
the patient 
registration 
method only.  
and HCA to give 
out to patients 
suitable for any of 
their patients 
 
Even though senior 
healthcare 
professionals were 
engaged they did 
not encourage the 
practice nurse or 
HCA with 
implementing it 
L 1 (1) Adoption was 
agreed using the 
staff registration 
method. When the 
patient registration 
method was 
created leaflets 
were offered to 
the practice but 
they did not take 
up this offer. 
Initial meeting with the 
practice manager to 
discuss HeLP-Diabetes. 
 
Training session with 
practice nurse and 
receptionist. 
 
I attended a patient 
evening to demonstrate 
HeLP-Diabetes to 
healthcare professional 
and patients but the 
practice did not have the 
screens set up properly 
and so the 
Practice nurse 
and receptionist 
It wasn’t Practice nurse 
saw value in  
Practice manager 
wasn’t engaged 
and did not 
respond to any 
further 
communication 
about HeLP-
Diabetes 
 
GP said the 
practice was under 
too much pressure 
with additional 
changes they were 
implementing to 
take on anything 
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demonstration did not 
work. 
else 
 
M 1 (0) Adoption was 
agreed using the 
staff registration 
method. When the 
patient registration 
method was 
created leaflets 
were provided to 
the practice to 
use. In addition to 
this, the peer-led 
implementation 
model (described 
in Chapter 7) was 
offered to this 
practice but they 
declined.  
Initial meeting with GPs 
at practice 
 
Training session with 
HCAs and reception 
healthcare professional  
Reception 
healthcare 
professional 
Initially the staff 
registration 
method was 
demonstrated to 
healthcare 
professional but 
this proved 
unsuccessful.  
 
Practice offered 
peer led 
registration 
method but 
declined. 
 
Patient 
registration 
method leaflets 
sent to practice 
but not used.  
All healthcare 
professional 
appeared very 
interested in 
HeLP-Diabetes 
initially and could 
see value in it. 
GP lead for 
diabetes in the 
borough 
Competing 
priorities 
No clear person to 
take responsibility 
for the 
implementation 
 
Those who agreed 
to adoption were 
not the same 
people as were 
expected to 
implement it. 
 
Time to register 
patients to use 
intervention 
 
Practice manager 
point of contact 
and no contact with 
healthcare 
professional who 
would be 
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responsible for 
implementation 
 
Contact not 
maintained with 
practice healthcare 
professional 
 
N 1 (1) Adoption was 
agreed using the 
staff registration 
method. When the 
patient registration 
method was 
created leaflets 
were offered to 
the practice but 
they did not take 
up this offer. 
Meeting and training 
with two GPs, Practice 
nurse, HCA and 
receptionist 
Whole team Whole team 
agreed to offer 
to patients 
during routine 
appointments 
and the HCA 
and receptionist 
would take 
responsibility for 
patient 
registrations 
All healthcare 
professional very 
keen and saw 
value in HeLP-
Diabetes 
Practice had some 
very serious 
problems with their 
estate and closed 
down temporarily.  
O 1 (0) Adoption was 
agreed using the 
staff registration 
method. When the 
patient registration 
method was 
created leaflets 
Meeting and training 
with GP, practice nurse, 
practice manager, 
assistant practice 
manager and 
receptionist 
All healthcare 
professional 
Originally it was 
planned that 
healthcare 
professional 
would mention 
intervention to 
patients and 
 Healthcare 
professional were 
not engaged with 
intervention, did 
not see the value 
in it 
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were provided to 
the practice to 
use, but no 
patients registered 
in this way. 
assistant 
practice 
manager would 
register them. 
However this 
proved 
unsuccessful. 
 
patient 
registration 
method leaflets 
provided, but 
these were not 
given out by 
healthcare 
professional, 
instead they 
were left at 
reception for 
patients to take if 
interested.  
GP was vocal in 
practice meeting 
that HeLP-
Diabetes would not 
be suitable for their 
patients based on 
IT skills and age 
 
Healthcare 
professional did 
not recommend 
HeLP-Diabetes to 
patients 
 
Contact with 
practice was very 
difficult to establish 
and maintain 
P 1 (0) Adoption was 
agreed using the 
staff registration 
method but no 
patients registered 
in this way. When 
Meeting and 
demonstration of 
intervention to practice 
manager, GP and 
practice nurse. 
Practice nurse List of all the 
diabetes patients 
created by the 
practice nurse 
and given to the 
receptionist so 
Practice nurse 
and GP very 
interested in 
HeLP-Diabetes 
 
Practice nurse 
Practice nurse did 
not think many 
patients would 
have 
computer/English 
language skills to 
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the patient 
registration 
method was 
created leaflets 
were provided to 
the practice to 
use. 
that when they 
come in they can 
be asked 
whether they use 
the internet and 
would be 
interested in 
HeLP-Diabetes.  
 
Practice nurse 
mentioned 
intervention 
during routine 
diabetes 
appointments. 
 
Patient 
registration 
method leaflets 
given to 
interested 
patients. 
took ownership of 
intervention  
use it 
 
Practice nurse 
thought 
intervention was 
better aimed as an 
educational tool for 
healthcare 
professional 
 
Tensions between 
healthcare 
professional within 
the practice 
 
GP left during 
implementation 
period 
 
Practice nurse 
forgetting to 
mention 
intervention to 
patients 
Q 1 (1) Adoption was 
agreed using the 
staff registration 
Practice meeting with 5 
GPs and 1 trainee 
doctor. 
Receptionist Receptionist was 
taking on 
additional HCA 
Receptionist 
thought the 
registration 
Adoption decision 
was made 
healthcare 
374 
 
method. When the 
patient registration 
method was 
created leaflets 
were provided to 
the practice. 
Subsequent training 
with receptionist on 
delivering HeLP-
Diabetes. 
duties and it was 
planned that she 
would sign newly 
diagnosed 
patients up to 
intervention.  
process was 
simple and not 
time consuming 
 
professional who 
did not take 
responsibility for 
implementation 
Receptionist did 
not see value in 
HeLP-Diabetes, 
wasn’t sure why 
someone would 
use it 
 
Receptionist 
thought 
intervention wasn’t 
appropriate for the 
age of the patients 
she saw 
 
Only one member 
of healthcare 
professional 
responsible for 
offering it to 
patients 
 
No senior 
healthcare 
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professional 
support  
R 1 (0) Adoption was 
agreed using the 
patient registration 
method. 
Meeting attended with 
practice manager and 
all GPs 
Unsure Unsure Unsure Practice was going 
through a period of 
instability with 
healthcare 
professional 
turnover and 
difficulty in 
recruiting GPs. 
 
Unable to establish 
contact with the 
practice following 
the initial meeting. 
Hospital 29 (3) Adoption was 
agreed using the 
staff registration 
method. However, 
very few patients 
were signed up 
this way. When 
the patient 
registration 
method was 
created leaflets 
were provided to 
Lead diabetes specialist 
nurse invited me to give 
a talk to all hospital 
healthcare professional 
before the 
implementation phase 
and explain HeLP-
Diabetes. 
 
A meeting with all the 
diabetes specialist 
nurses followed which 
Consultant. 
 
Diabetes 
specialist nurses. 
 
I also came to the 
clinic on several 
occasions to 
register patients in 
the waiting rooms. 
Healthcare 
professional 
discussed HeLP-
Diabetes with 
patients in 
appointments 
and gave leaflets 
out. 
 
The intervention 
was also used 
by one of the 
Strong support 
and buy-in of 
HeLP-Diabetes by 
all healthcare 
professional 
 
Mail out of patient 
registration 
method leaflets 
 
My assisting 
patient registration 
Very old computers 
and very slow 
internet connection 
made the staff 
registration method 
nearly impossible 
 
Competing 
demands within 
appointments 
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the practice. included training on 
registering patients. 
nurse in their 
teaching course 
for HCAs in the 
borough on 
supporting 
patient self-
management. 
 
After the staff 
registration 
method proved 
problematic a 
mass mail out to 
all eligible 
patients was 
posted out with 
patient 
registration 
method leaflets 
which were 
accompanied by 
a letter from the 
consultant.  
by canvasing the 
waiting rooms on 
several occasions 
 
Ongoing 
communication 
with healthcare 
professional 
patient registration 
method leaflets 
Community 1 (0) Adoption was 
agreed using the 
patient registration 
method. 
Initial meeting and 
demonstration with 
Operational Lead for 
Intermediate Diabetes 
HCA and 
community 
dietician. 
Initially the HCA 
was to discuss 
HeLP-Diabetes 
with patients and 
Strong support for 
HeLP-Diabetes by 
the Operational 
Lead for 
The Operational 
Lead for 
Intermediate 
Diabetes Service 
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Service, 2 diabetes 
specialist nurse and 
HCA. 
 
After a change of 
healthcare professional 
a second meeting and 
demonstration was held 
with the community 
dieticians. 
assist them with 
registering if 
needed.  
 
The patient 
registration 
method leaflets 
were given out at 
the end of the 
DESMOND 
course ran by 
the dietician (this 
strategy began 
to work well but 
did not fall within 
the time frame of 
the 
implementation 
study and 
therefore these 
patient 
registrations are 
not counted 
here). 
Intermediate 
Diabetes Service 
and the dieticians 
 
left position shortly 
after 
implementation 
Large healthcare 
professional 
turnover and 
reliance on agency 
healthcare 
professional 
Competing 
pressures 
Implementation 
was the 
responsibility of a 
part time HCA with 
no support from 
other healthcare 
professional 
 
 
 
